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Abstract	
Context:	Prehospital	recognition	of	adult	patients	with	sepsis	may	inform	scene	management	 by	 ambulance	 clinicians,	 improve	 decisions	 concerning	 both	appropriate	 hospital	 destination	 and	 urgency	 of	 transport,	 as	well	 as	 facilitate	early	intervention	before	arriving	at	hospital.	
Objective:	 To	 develop	 a	 prehospital	 sepsis	 screening	 tool,	 derived	 from	prehospital	data,	for	use	by	ambulance	clinicians.	
Design:	The	thesis	comprises	a	systematic	review	of	sepsis	among	adult	patients	in	 the	 prehospital	 environment,	 followed	 by	 the	 derivation	 and	 validation	 of	 a	sepsis	screening	tool,	utilising	a	retrospective	data	cohort	comprising	data	from	West	Midlands	 Ambulance	 Service	 (WMAS)	 and	 the	 Emergency	Department	 at	University	Hospital	North	Staffordshire	(UHNS).	This	is	followed	by	a	comparison	with	alternate	screening	tools.		
Patients:	 Consecutive	 patients	 transported	 by	 WMAS	 (n=38483)	 to	 UHNS	between	01	 July	2013	and	30	 June	2014.	Records	were	 linked	using	LinkPlus®	software.	Successful	linkage	was	achieved	in	33289	cases	(86%).	Eligible	patients	included	adult,	non-trauma,	non-mental	health,	non-cardiac	arrest	cases.	Of	33289	linked	cases,	22945	cases	were	eligible.	The	eligible	cases	were	randomly	divided	into	derivation	(n=16063,	70%)	and	validation	(n=6882,	30%)	cohorts.	
Outcome	Measure:	High	risk	of	sepsis,	as	defined	by	the	2016	National	Institute	for	Health	and	Care	Excellence	(NICE)	Sepsis	guideline	(NG51).	
Results:	High	risk	of	sepsis	was	present	in	3.7%	of	both	derivation	(n=593)	and	validation	(n=254)	cohorts.	The	Screening	to	Enhance	PrehoSpital	Identification	of	 Sepsis	 (SEPSIS)	 tool	 is	 composed	of	 the	 following	variables:	age,	 respiratory	rate,	 peripheral	 oxygen	 saturations,	 heart	 rate,	 systolic	 blood	 pressure,	temperature	and	level	of	consciousness	(p<0.001	for	all	variables).	Area	under	the	receiver	 operating	 characteristic	 curve	 was	 0.87	 (95%CI	 0.85-0.88)	 for	 the	derivation	cohort,	and	0.86	(95%CI	0.84-0.88)	for	the	validation	cohort.	Applying	a	cut-off	of	3	or	higher,	sensitivity	for	the	SEPSIS	screening	tool	was	0.80	(95%CI	0.74-0.84),	specificity	was	0.78	(95%CI	0.77-0.79),	positive	predictive	value	was	0.12	 (95%CI	0.10-0.14),	 negative	predictive	 value	was	0.99	 (95%CI	0.99-0.99),	positive	likelihood	ratio	was	3.56	(95%CI	3.30-3.85),	negative	likelihood	ratio	was	0.26	(95%CI	0.21-0.34)	and	the	diagnostic	odds	ratio	was	13.5	(95%CI	9.9-18.4).		
Conclusion:	The	SEPSIS	screening	tool	was	significantly	associated	with	high	risk	of	sepsis	status	on	arrival	at	the	Emergency	Department.	It	performs	marginally	better	 than	 both	 the	 UK	 Sepsis	 Trust	 “Red	 Flag”	 algorithm	 and	 National	 Early	Warning	Score	(NEWS≥5)	in	an	undifferentiated,	adult,	medical	population.	The	SEPSIS	 screening	 tool	 requires	 external	 validation,	 in	 clinical	 practice	 by	ambulance	clinicians,	in	an	independent	population.
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Chapter	1	
Introduction 
 
1.1	Introduction	Sepsis	 is	 not	 a	 specific	 illness,	 it	 is	 a	 syndrome,	 characterised	 by	 a	 broadly	consistent	pathophysiology.	This	chapter	presents	a	broad	overview	of	sepsis.	It	describes	 the	 burden	 of	 sepsis	 and	 the	 causes	 of	 sepsis,	 it	 also	 provides	 an	overview	of	our	current	understanding	of	sepsis	pathophysiology	and	reports	international	diagnostic	recommendations.	Finally,	it	identifies	the	aims	of	this	thesis.	
1.2	What	is	sepsis?	
1.2.1	Overview	The	 immune	 response	 to	 a	pathogen	 is	 a	 complex	 inflammatory	process	 that	attempts	 to	 limit	 the	 spread	 of	 the	 pathogen	 and	 repair	 any	 tissue	 damage	resulting	from	infection	by	the	pathogen.1	This	response	involves	the	activation	of	the	immune	system	to	produce	both	pro-inflammatory	and	anti-inflammatory	mediators.	 The	 balance	 between	 these	 groups	 of	 mediators	 is	 regulated	 and	helps	to	protect	the	host	against	the	invading	pathogens	and	to	facilitate	tissue	healing.	Sepsis	occurs	when	the	host	response	 to	 infection	becomes	amplified	and	dysregulated.2	Balance	is	lost,	and	infection	extends	beyond	the	infected	site	causing	systemic	functional	alterations.3	
The	Society	of	Critical	Care	Medicine	and	the	European	Society	of	Intensive	Care	Medicine	 have	 coordinated	 an	 international	 effort	 to	 standardise	 the	management	of	sepsis	and	define	sepsis	as	a	life-threatening	organ	dysfunction	
caused	 by	 a	 dysregulated	 host	 response	 to	 infection.	 Organ	 dysfunction	 can	 be	
identified	as	an	acute	change	in	total	Sequential	Organ	Failure	Score	(SOFA	score)	
of	 2	 or	more	points	 consequent	 to	 the	 infection.4	 	 In	 lay	 terms,	 sepsis	 is	 a	 life-threatening	 condition	 that	 arises	 when	 the	 body’s	 response	 to	 an	 infection	injures	its	own	tissues	and	organs.5		
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1.2.2	Causes	of	sepsis	Sepsis	 may	 be	 the	 result	 of	 infection	 by	 endotoxic	 gram-negative	 bacteria,	exotoxin-producing	gram-positive	bacteria,	as	well	as	viral,	fungal,	and	parasitic	pathogens.6	 7	A	bacterial	 diagnosis	 is	made	 in	 about	half	 of	 sepsis	 cases	with	gram-negative	bacterial	infection	accounting	for	around	60%	of	bacterial	cases,	the	remainder	of	cases	result	from	gram-positive	bacterial	infection.2	The	most	common	sites	of	infection	are	the	lungs,	the	abdominal	cavity,	the	urinary	tract	and	primary	infections	of	the	blood	stream.8	
1.2.3	The	burden	of	sepsis	The	 incidence	of	sepsis	 is	difficult	to	quantify.	Until	 recently,	 the	 International	Classification	 of	 Diseases	 (ICD)	 coding,	 did	 not	 contain	 codes	 specifically	 for	sepsis,	therefore	the	underlying	cause	of	sepsis	was	commonly	recorded	without	noting	that	sepsis	was	present.9	For	example,	 if	a	patient	became	septic	whilst	hospitalised	for	pneumonia,	their	health	care	record	for	the	episode	will	likely	reflect	the	underlying	reasons	for	hospital	admission,	respiratory	infection,	but	may	not	include	any	of	the	ICD-10	(ICD	version	10)	codes	that	may	be	associated	with	sepsis.	Furthermore,	most	estimates	of	sepsis	prevalence	are	based	upon	hospital	statistics	and	do	not	include	patients	in	primary	care	settings,	as	these	data	are	seldom	collected	or	available.10	
Despite	the	aforementioned	limitations,	the	incidence	of	severe	sepsis	in	Europe	has	been	estimated	as	being	between	25-38	per	100	000	population,11	however	older	studies	from	the	United	States	have	reported	rates	as	high	as	240-300	per	100	000	population.3	There	are	no	conclusive	data	concerning	incidence	of	sepsis	in	the	United	Kingdom	(UK).		The	UK	Sepsis	Trust	has	identified	that	there	are	147000	cases	of	sepsis	per	year	resulting	in	44000	deaths.	However,	a	recently	published	report	indicates	that	there	could	be	as	many	as	260	000	cases	of	sepsis	each	year.12	Additionally,	27%	of	intensive	care	admissions	in	England	and	Wales	are	for	severe	sepsis,	and	half	of	these	patients	will	die.10	Mortality	data	from	the	UK	indicate	that	5.1%	of	all	deaths	are	definitely	associated	with	sepsis,	and	up	to	7.7%	of	all	deaths	may	be	related	to	sepsis.10	
1.2.4	Pathophysiology	of	sepsis	The	clinical	manifestation	of	sepsis	is	a	direct	consequence	of	host	immune	cell	response	 to	 pathogens.	 Immune	 cells	 have	 numerous	 receptors	 to	 detect	 the	presence	of	a	pathogen.	These	receptors,	collectively	termed	pattern	recognition	
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receptors	 (PRR’s),	 include	 several	 types	 of	 toll-like	 receptors	 (TLR’s)	 which	respond	to	different	pathogenic	molecules.	TLR’s	therefore	play	a	central	role	in	initiating	an	immune	response	within	the	host.	When	activated,	TLR’s	stimulate	the	 immune	 cell	 to	 produce	 chemical	 mediators	 which	 in	 turn	 will	 activate	different	components	of	the	immune	response.		
Chemical	mediators	subsequently	activate	different	immune	cells	or	regulate	the	expression	of	other	chemical	mediators.	For	example,	chemical	mediators	will	activate	 local	 macrophages	 and	 neutrophils	 to	 initiate	 a	 non-specific,	 innate	response	 to	 the	 infective	 organism,	 while	 activation	 of	 T-lymphocytes	 and	 B-lymphocytes	will	initiate	a	pathogen	specific,	adaptive	response	to	the	infective	organism.	 The	 host	 response	 to	 a	 pathogen	 therefore	 results	 in	 a	 complex	interplay	of	numerous	chemical	mediators	which	are	outlined	in	table	1.1.	
Table	1.1		Chemical	mediators	of	immune	response	
	 Mediator	 Typical	effect	
Cytokines	 Interleukin-1	(IL-1)	Interleukin-6	(IL-6)	Interleukin-12	(IL-12)	Interluekin-15	(IL-15)	Interleukin-18	(IL-18)	Tumour	necrosis	factor	alpha	(TNF-α)	Macrophage	migration	inhibitory	factor	(MAF)	High	mobility	group	B1	(HMBG1)	Plasminogen-activator	inhibitor	type-1	(PAI-1)	Interleukin-10	(IL-10)	
Activate	neutrophils,	lymphocytes	and	vascular	endothelium		Up-regulate	cellular	adhesion	molecules	Induce	prostaglandins,	nitric	oxide	(NO)	synthase	and	acute-phase	proteins		Induce	fever		
Note:	IL-10	predominantly	inhibits	
the	above	effects	
Chemokines	 Interleukin-8	(IL-8)	Macrophage	Inflammatory	Protein-1	alpha	(MIP-1α)	Macrophage	Inflammatory	Protein-1	beta	(MIP-1β)	Monocyte	chemoattractant	Protein-1	(MCP-1)	Monocyte	chemoattractant	Protein-3	(MCP-3)	
Mobilise	and	activate	inflammatory	cells,	especially	neutrophils	Activate	macrophages	
Lipid	
mediators	
Platelet	activating	factor	(PAF)	Prostaglandins	Leukotrines	Thromboxane	Tissue	factor	(TF)	
Activate	vascular	endothelium	Regulate	vascular	tone	Activate	extrinsic	coagulation	cascade	
Oxygen	
radicals	
Superoxide	radicals	Hydroxyl	radicals	Nitric	oxide	(NO)	 Antimicrobial	properties	Regulation	of	vascular	tone	Reproduced	from	Cohen	et	al	2	
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Activated	macrophages	express	Interleukin-1	(IL-1),	Interleukin-6	(IL-6),	Tissue	Necrosis	Facror	alpha	(TNF-α),	Platelet	Activating	Factor	(PAF)	as	well	as	reactive	oxygen	and	nitrogen	species.		Fibroblasts	and	T-lymphocytes	secrete	IL-6,	while	PAF	 is	 derived	 from	 neutrophils,	 macrophages,	 mast	 cells,	 basophils	 and	platelets.	 In	 addition,	 endothelial	 cells	 also	 produce	 Tissue	 Factor	 (TF),	Plasminogen	Activator	Inhibitor	type	1	(PAI-1),	nitric	oxide	(NO)	and	PAF.	
IL-1	and	TNF-α	promote	increased	neutrophil	adhesion	and	synthesis	of	acute	phase	proteins	(fibrinogen,	complement	components,	C-Reactive	Protein	(CRP))	in	 the	 liver.	 IL-6	 further	 stimulates	 the	 synthesis	 of	 acute	 phase	 proteins	(fibrinogen,	complement	components,	CRP)	by	the	liver	as	well	as	the	production	of	 immunoglobulins.	 Activation	 of	 the	 compliment	 pathway	 stimulates	 the	production	 of	 complement	 components	 C3a	 and	 C5a,	 both	 of	 which	 are	anaphylactoxins	 which	 leads	 to	 release	 of	 vasoactive	 amines	 (histamine,	bradykinin)	from	mast	cells	and	basophils.		
The	release	of	tissue	factor	(TF)	and	platelet	activating	factor	(PAF)	activates	the	clotting	cascade,	while	histamine,	nitric	oxide	and	oxygen	free	radicals	trigger	capillary	 leakage,	 vasodilation	 and	 reduced	 myocardial	 contractility.	 These	combined	physiologic	effects	when	exerted	systemically	lead	to	hypo-perfusion	characteristic	of	sepsis	(see	figure	1.1).	
Figure	1.1	Pathophysiology	of	sepsis	
	 	Reproduced	from	Cohen	et	al	2	
pathway inhibitor. These natural anticoagulants are of particular
interest because in addition to their effect on thrombin generation,
they also have anti-inflammatory properties, including effects on
release of monocyte-derived TNF-! by inhibiting activation of the
transcription factors NF-"B and activator protein (AP)-1 (ref. 60). 
Particular attention has focused on Protein C, which is converted
to the activated form (aPC) when thrombin complexes with throm-
bomodulin, an endothelial transmembrane glycoprotein. Once aPC
is formed it dissociates from an endothelial protein C receptor
(EPCR) before binding protein S, resulting in inactivation of factors
Va and VIIIa and thus blockade of the coagulation cascade. It has
been shown recently that aPC uses EPCR as a co-receptor for cleavage
of protease-activated receptor 1 (PAR1). Gene profiling showed that
PAR1 signalling could account for the activation of aPC-induced
protective genes, including the immunomodulatory monocyte
chemoattractant protein-1 (MCP-1), suggesting a role for PAR-1
activation in protection from sepsis61. In septic patients, aPC levels
are reduced and expression of endothelial thrombomodulin and
EPCR are impaired62, providing some support for the notion that
replacement of aPC might have therapeutic value.
The counter-inflammatory response — modifier or mediator?
The profound pro-inflammatory response that occurs in sepsis is bal-
anced by an array of counter-regulatory molecules that attempt to
restore immunological equilibrium. In this sense, the counter-
inflammatory response is seen as a ‘modifier’ — both appropriate and
beneficial. Counter-inflammatory cytokines include antagonists such
as the soluble TNF receptors and IL-1 receptor antagonist, decoy
receptors such as IL-1 receptor type II, inactivators of the complement
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(HMGB1) has recently been identified as a cytokine-like product of
macrophages that appears much later after LPS stimulation and may
represent a more tractable target for intervention51.
HMGB1 is a non-histone chromosomal protein that is abundant-
ly distributed and exists in nuclear, cytoplasmic and membrane-
bound forms. It participates in stabilizing nucleosomes, facilitates
gene transcription and modulates the activity of steroid hormone
receptors. When mice were injected with LPS, HMGB1 serum con-
centrations rose after a delay of about 24 hours, long after the initial
peak of IL-1 and TNF-! had declined. Importantly, mice could be
rescued from LPS-induced shock by administering an antibody to
HMGB1, even when this was provided up to 2 hours after the lethal
injection52. Subsequently it was shown that patients with sepsis have
elevated serum levels of HMGB1, and that higher levels are associated
with an increased mortality, suggesting that clinical intervention by
blocking or neutralizing HMGB1 might be a viable option.
Another macrophage-derived cytokine that has been identified as
a potential therapeutic target in sepsis is macrophage migration
inhibitory factor (MIF). Mice with a targeted disruption of the MIF
gene are resistant to LPS-induced shock53 and antibody to MIF is fully
protective, even in the more demanding caecal ligation and puncture
model that resembles clinical peritonitis54. MIF also seems to mediate
shock caused by Gram-positive bacteria, such as the toxic shock 
syndrome associated with S. aureus55, suggesting that anti-MIF
strategies might have broad application in septic patients. MIF has a
curious relationship with glucocorticoids, which are normally
thought of as being anti-inflammatory, as low doses of glucocorti-
coids paradoxically induce macrophage MIF. Once released, MIF
then acts as a pro-inflammatory agent, over-riding the ability of glu-
cocorticoids to prevent shock in animal models of sepsis56. How this
complex relationship manifests in a clinical setting is of particular
interest in the light of the recent studies demonstrating a protective
effect of low-dose steroids in patients with severe sepsis.
These pro-inflammatory cytokines are important because they in
turn are responsible for orchestrating a complex network of sec-
ondary responses (for a review, see ref. 49). A good example of this is
provided by IL-18, a cytokine that induces production of interferon-
# (IFN-#). In human mononuclear cells, IFN-# upregulates surface
expression of TLR4, MD-2 and MyD88, and counteracts the 
LPS-induced downregulation of TLR4 (ref. 57). It has long been
known that IFN-# sensitizes human mononuclear cells to the effects
of LPS, and these new findings suggest strongly that this effect is
probably mediated through upregulation (or at least, prevention of
downregulation) of TLR4.
The coagulation cascade
Cytokines are also important in inducing a procoagulant effect in
sepsis. Disorders of coagulation are common in sepsis, and 30–50%
of patients have the more severe clinical form, disseminated intravas-
cular coagulation58. Coagulation pathways are initiated by LPS and
other microbial components, inducing expression of tissue factor on
mononuclear and endothelial cells. Tissue factor in turn activates a
series of proteolytic cascades, which result in the conversion of 
prothrombin to thrombin, which in turn generates fibrin from 
fibrinogen. Simultaneously, normal regulatory fibrinolytic mecha-
nisms (fibrin breakdown by plasmin) are impaired because of high
plasma levels of plasminogen-activator inhibitor type-1 (PAI-1) that
prevent the generation of plasmin from the precursor plasminogen.
The net result is enhanced production and reduced removal of fibrin
leading to the deposition of fibrin clots in small blood vessels, inade-
quate tissue perfusion and organ failure (Fig. 2).
Pro-inflammatory cytokines, in particular IL-1 and IL-6, are
powerful inducers of coagulation, and conversely, IL-10 regulates
coagulation by inhibiting the expression of tissue factor on mono-
cytes (for a review, see ref. 59). An additional cause of the procoagu-
lant state in sepsis is the downregulation of three naturally occurring
anticoagulant proteins — antithrombin, protein C and tissue factor
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Complement
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Lipid mediatorsOxygen radicals
Coagulopathy Fever Vasodilation Capillary leak
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Figure 3Pathogenetic networks in shock. Lipopolysaccharide (LPS) and other
microbial components simultaneously activate multiple parallel cascades that
contribute to the pathophysiology of adult respiratory distress syndrome (ARDS) and
shock. The combination of poor myocardial contractility, impaired peripheral vascular
tone and microvascular occlusion leads to tissue hypoperfusion and inadequate
oxygenation, and thus to organ failure.
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1.3	Diagnosis	of	sepsis	At	present,	no	universally	accepted	diagnostic	standard	for	sepsis	exists.	Three	competing	sets	of	diagnostic	criteria	could	claim	to	represent	the	diagnostic	gold	standard	in	the	United	Kingdom.			
The	 American	 College	 of	 Chest	 Physicians	 and	 the	 Society	 of	 Critical	 Care	Medicine	developed	 the	original	 definitions	of	 sepsis,	 namely	 the	presence	of	infection	with	 two	or	more	systemic	 inflammatory	response	syndrome	(SIRS)	criteria.13-15	 This	 was	 the	 universally	 accepted	 definition	 of	 sepsis	 for	 over	 a	decade,	 however	 research	 increasingly	 suggested	 this	 definition	 was	 overly	sensitive	and	insufficiently	specific.	16-20	Subsequently,	the	Society	of	Critical	Care	Medicine	and	the	European	Society	of	intensive	Care	Medicine	have	revised	these	definitions,	publishing	updated	guidelines	in	April	2016,	the	so-called	Sepsis-3	guidelines.	 The	 updated	 guidelines	 define	 sepsis	 as	 a	 life-threatening	 organ	
dysfunction	caused	by	a	dysregulated	host	response	to	infection.	Organ	dysfunction	
can	be	identified	as	an	acute	change	in	total	Sequential	Organ	Failure	Score	(SOFA	
score)	of	2	or	more	points	consequent	to	the	infection.4		
Many	health	care	organisations	have	made	significant	efforts	to	improve	sepsis	recognition,	 implementing	 track	 and	 trigger	 systems	 that	 utilise	 routinely	measured	 physiologic	 variables,	 such	 as	 pulse	 rate	 and	 temperature.	 As	 a	consequence,	 there	 has	 been	 resistance	 to	 migrate	 to	 the	 revised	 Sepsis-3	definition,	 which	 requires	 measurement	 of	 blood	 biomarkers.	 The	 National	Institute	for	Health	and	Care	Excellence	(NICE)	published	their	guideline	[NG51]	“Sepsis:	recognition,	diagnosis	and	early	management”	in	July	2016,21	while	the	UK	Sepsis	Trust	have	been	advocating	their	“Red	Flag	Sepsis”	guidelines	since	2014.22	 Following	 release	 of	 the	 Sepsis-3	 guideline	 4	 the	 Royal	 College	 of	Emergency	Medicine	have	worked	with	the	UK	Sepsis	Trust	to	develop	bundles	of	 care	 for	 sepsis	 patients	 in	 the	 Emergency	 Department	 and	 suggest	 that	patients	meeting	revised	“Red	Flag	Sepsis”	criteria	will	also	meet	the	NICE	NG51	and	the	Sepsis-3	criteria.	22	
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1.3.1	Prehospital	recognition	of	sepsis	Emergency	Medical	 Services	 (EMS)	 transport	 a	 substantial	 number	 of	 sepsis	patients.23-25	 Over	 half	 of	 all	 sepsis	 patients	 hospitalised	 via	 the	 emergency	department	(ED)	will	arrive	via	the	Emergency	Medical	Services	(EMS)26-28	and	up	to	80%	of	severe	sepsis	patients	admitted	to	intensive	care	via	the	ED	will	arrive	by	EMS.29	30	Despite	 frequent	exposure	 to	patients	with	potentially	life-threatening	 pathophysiology,	 evidence	 suggests	 prehospital	 recognition	 of	sepsis	by	ambulance	clinicians	 is	poor.31-36	There	may	be	several	reasons	why	prehospital	 recognition	 is	 poor,	 including	 lack	 of	 education	 leading	 to	 poor	understanding	 of	 the	 condition,17	 28	 37	 38	 ambulance	 clinicians	may	 encounter	sepsis	cases	earlier	in	the	disease	process,	when	the	presenting	condition	may	be	less	obvious,39	lack	of	in-hospital	diagnostic	capability23		or	dependence	upon	SIRS	criteria	to	 formulate	a	diagnosis.16	19	Several	commentators	have	argued	that	a	prehospital	sepsis	screening	tool	would	help	improve	outcomes	for	sepsis	patients.28	40	NHS	England	have	issued	a	patient	safety	alert,	directing	ambulance	services	 to	address	prehospital	management	of	sepsis.41	There	 is	 therefore	an	urgent	 need	 to	 address	 prehospital	 identification	 of	 patients	 with	 sepsis	 by	ambulance	clinicians.	
1.4	Treatment	of	sepsis	Management	of	sepsis	can	be	challenging,	but	might	be	thought	of	in	terms	of	initial	basic	interventions	and	subsequent	complex	support,	both	of	which	aim	to	improve	end	organ	perfusion	and	to	combat	the	underlying	infection.15	
Basic	interventions	can	be	delivered	by	non-specialist	clinicians	in	non-specialist	areas	and	include	administration	of	high	concentration	oxygen,	administration	of	 intravascular	 fluids	(30ml/kg)	 to	achieve	a	Mean	Arterial	Pressure	(MAP)>	65mmHg,	drawing	of	blood	to	identify	the	causative	pathogen,	administration	of	intravenous	antimicrobial	therapy	(preferably	antimicrobials	appropriate	to	the	causative	 pathogen,	 rather	 than	 broad	 spectrum	 antibiotics),	 and	 urinary	catheterisation	 to	 measure	 urine	 output.	 These	 six	 interventions	 should	 be	achieved	within	the	first	hour	and	are	collectively	referred	to	as	the	‘sepsis	six’.42	
Once	the	basic	interventions	have	been	achieved,	more	complex	support	may	still	be	 required	 from	 specialist	 clinicians	 working	 in	 specialist	 units	 including	obtaining	 central	 vascular	 access	 to	 guide	 further	 fluid	 resuscitation,	 the	administration	of	vasopressor	and	inotropic	drugs	to	support	cardiac	output,	as	
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well	as	the	administration	of	corticosteroids	where	shock	persists	despite	fluid	and	vasopressor/inotropic	support.	In	addition	blood	glucose	levels	should	be	monitored	 and	 actively	 controlled	 with	 insulin	 if	 they	 exceed	 18mmol/L,	furthermore	adequate	nutrition	is	vital	to	support	recovery	while	prophylaxis	to	combat	deep	vein	thrombosis	and	stress	ulcers	may	be	required.43	
1.4.1	Prehospital	treatment	of	sepsis	Several	 elements	 of	 the	 “sepsis	 six”	 can	 be	 provided	 by	 ambulance	 clinicians	prior	to	arrival	at	hospital.	Delivery	of	oxygen,	intravenous	fluids	and	antibiotics	are	 already	 within	 the	 scope	 of	 practice	 for	 NHS	 paramedics.44	 However,		prehospital	antibiotics	for	sepsis	are	not	currently	indicated	within	the	National	Ambulance	Guidelines.44	Measurement	of	lactate	is	possible,34	45-49	while	studies	have	 indicated	 that	 obtaining	 prehospital	 blood	 cultures	 is	 feasible.50-52	 The	remaining	element	of	the	“sepsis	six”,	measurement	urine	output,	is	not	likely	to	be	feasible	in	the	context	of	an	acute	medical	emergency.	To	catheterise	such	a	patient	would	result	in	substantial,	potentially	life-threatening,	delay	to	hospital.		Despite	 the	 ability	 to	 deliver	 most	 the	 “sepsis	 six”,	 there	 is	 currently	 little	evidence	 addressing	 management	 of	 sepsis	 in	 the	 prehospital	 environment.	Several	studies	do	show	a	reduction	in	time	to	key	interventions	and	treatment	tragets,27	32	53	54	however	there	is	little	evidence	of	improved	outcomes.55	56	No	published	 studies	 address	 the	 potential	 impact	 of	 prehospital	 antibiotic	administration	on	 further	 care	 in	hospital.	 That	 is,	 studies	published	 thus	 far	have	 failed	 to	 include	 collection	 of	 prehospital	 blood	 samples	 prior	 to	administration	of	antibiotics.			There	are	major	implications	that	must	be	considered	with	respect	to	obtaining	prehospital	blood	samples.	First	is	the	potential	for	contamination,	due	to	poor	technique	and	the	unique	challenges	of	the	prehospital	environment,	resulting	in	misleading	 reporting	 of	 the	 causative	 pathogen.	 Second,	 administration	 of	prehospital	antibiotics,	before	obtaining	blood	samples,	will	limit	the	ability	of	hospital	based	laboratory	services	to	culture	the	causative	pathogen,	and	thus	limit	 the	 ability	 of	 critical	 care	 services	 to	 provide	 targeted	 treatment.	Responsible	antibiotic	stewardship	must	therefore	be	a	consideration	of	ethical	prehospital	sepsis	research.		
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Although	studies	conducted	thus	far	have	been	small,	non-randomised	studies	that	provide	weak	evidence,	higher	quality,	 robust	studies	are	underway.	The	PhANTASi	 (NCT01988428),	 PHRASE	 (ISRCTN36856873)	 and	 PITSTOP	(NCT03068741)	trials	will	hopefully	provide	a	clearer	picture	of	the	potential	impact	of	prehospital	care	on	outcomes	among	adult	patients	with	sepsis.	
	
1.5	Aims	and	objectives	The	aim	of	this	thesis	is	to	develop	a	screening	tool	that	will	improve	recognition	of	sepsis	by	ambulance	clinicians	in	the	prehospital	environment.	The	objective	of	 developing	 an	 accurate	 prehospital	 sepsis	 screening	 tool	 is	 to	 facilitate	delivery	of	appropriate	interventions	by	ambulance	clinicians,	to	adult	patients	with	potentially	life-threatening	sepsis,	before	arriving	at	hospital.	In	so	doing	it	is	hoped	that	outcomes	for	this	group	of	patients	will	be	improved.	
The	thesis	comprises	three	parts.		
Part	I	provides	the	background	to	contextualise	the	study:	
• Chapter	 one	 (this	 chapter)	provides	 an	 overview	 of	 sepsis	 and	defines	the	aims	of	the	thesis.			• Chapter	 two	 describes	 the	 methodologic	 approach	 adopted	 to	develop	the	SEPSIS	screening	tool.	• Chapter	three	contains	a	systematic	review,	addressing	sepsis	in	the	prehospital	environment,	which	informed	decision	making	in	subsequent	chapters.		
Part	II	addresses	development	of	the	prehospital	sepsis	screening	tool,	derived	from	NHS	Ambulance	Service	and	Emergency	Department	data.		
• Chapter	 four	explains	how	the	datasets	used	 in	this	study	were	prepared	prior	to	statistical	analysis.	• Chapter	 five	 describes	 how	 the	 different	 datasets	 used	 in	 this	study	were	linked	together.	• Chapter	 six	 includes	 an	 overview	 of	 missing	 data,	 and	 details	management	of	missing	data	in	this	study.	
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• Chapter	seven	provides	a	detailed	description	of	how	the	SEPSIS	screening	tool	was	derived.	• Chapter	 eight	 presents	 the	 statistical	 validation	 of	 the	 SEPSIS	screening	tool	in	a	clean	dataset.	
Part	III	places	the	SEPSIS	screening	tool	in	context			 • Chapter	nine	addresses	performance	of	existing	screening	tools	in	comparison	to	the	SEPSIS	screening	tool.	• Chapter	ten	identifies	the	strengths	and	limitations	of	this	study,	and	explores	the	research	and	clinical	implications	of	the	findings.	
1.6	Conclusion	This	 chapter	 presented	 an	 overview	 of	 the	 burden,	 causes,	 diagnosis,	 and	pathophysiology	 of	 sepsis.	 It	 has	 also	 provided	 an	 overview	 of	 the	 aims	 and	objectives	of	this	research	as	well	also	detailing	the	structure	of	the	thesis.	The	complexity	of	sepsis	makes	diagnosis	challenging;	the	purpose	of	this	thesis	is	to	simplify	this	challenge.	Chapter	two	will	describe	the	methodological	approach	taken	in	developing	this	thesis.	
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Chapter	2	
Methodology	
	
2.1	Introduction	This	 chapter	 identifies	 the	 methodology	 employed	 to	 develop	 the	 SEPSIS	screening	tool.	It	also	provides	a	brief	overview	of	how	the	thesis	is	structured	and	lists	the	permissions	obtained	prior	to	commencing	any	data	collection	or	analysis.		
2.2	Methodological	approach	The	thesis	‘begins’	with	a	systematic	review.	The	systematic	review	has	several	purposes.	To	establish	the	incidence	of	sepsis	within	ambulance	services,	to	draw	together	the	available	research	addressing	the	impact	of	prehospital	care	among	patients	with	sepsis,	and	importantly	 for	 future	chapters,	to	 identify	potential	predictors	of	sepsis,	as	well	as	identify	existing	screening	tools	and	compare	their	performance.	The	 bulk	 of	 this	 thesis	 is	 dedicated	 to	 the	 development	 of	 the	 “Screening	 to	
Enhance	 the	 PrehoSpital	 Identification	 of	 Sepsis”	 (SEPSIS)	 screening	 tool.	Screening	tools	are	a	form	of	clinical	prediction	rule;	they	may	also	be	referred	to	as	clinical	prediction	models,	decision	rules	or	risk	scores.57		They	estimate	the	probability	that	a	specific	illness	is	present	(diagnostic	model),	or	will	respond	to	a	form	of	treatment	(therapeutic	model),	or	will	have	a	well-defined	outcome	(prognostic	model)	for	an	individual	patient.58		Screening	tools	combine	multiple	predictors,	drawn	from	patient	characteristics,	clinical	observations,	test	results	and	disease	characteristics.	These	are	used	to	determine	the	probability	that	a	particular	outcome	is	present	or	will	occur.59	60	At	 heart	 screening	 tools	 are	 statistical	 models	 that	 inform	 clinical	 decision	making,	and	support	the	delivery	of	evidence	based	medicine.	Consequently,	the	bulk	of	this	thesis	is	based	entirely	in	the	realm	of	quantitative	statistics.	Standalone	 chapters	 are	 dedicated	 to	 describing	 the	 two	 datasets	 used,	documenting	how	the	datasets	were	prepared,	and	explaining	the	methods	used	to	link	the	records	in	the	two	datasets.		Management	of	missing	data	is	central	to	quantitative	 research,	 and	a	 chapter	 is	 devoted	 to	multiple	 imputation.	There	
PRoSAiC	Thesis	
11	
then	follow	three	chapters	addressing	derivation,	validation	and	comparison	of	the	SEPSIS	screening	tool.	Regression	 is	 the	 most	 common	 statistical	 technique	 used	 to	 derive	 clinical	prediction	 models.59	 Models	 developed	 by	 regression	 methods	 tend	 to	 have	higher	overall	accuracy,	that	is	better	overall	classification	of	all	patients,	but	may	suffer	poorer	sensitivity,	that	is,	imperfect	classification	of	atypical	patients.61		Methodological	standards	for	the	derivation	and	validation	of	clinical	decision	rules	have	been	described;	originally	by	Wasson,62	Feinstein,63	Laupacis,64	and	Steill.65	 More	 recently	 Steyerberg,59	 Toll,60	 Moons,57	 66-68	 Royston,69	Bouwmeester,70	Labarère58	and	Harrell71	have	proposed	several	modifications	of,	or	updates	to,	these	standards.		
At	present,	there	is	no	universally	agreed	methodology	for	the	development	of	clinical	prediction	rules.	However,	Labarere	et	al58	have	proposed	a	checklist	for	the	development	and	reporting	of	valid	clinical	prediction	models.	The	checklist	requires	that	several	key	elements	are	reported	to	ensure	robust	development	of	a	clinical	prediction	model.	This	is	the	methodology	that	will	be	adhered	to	in	this	thesis	(see	table	2.1).	
Table	2.1		Checklist	for	developing	and	reporting	valid	clinical	prediction	models	
Item	 Recommendation	
Rationale	 Explain	the	scientific	background	and	rationale	for	developing	a	clinical	prediction	model	
Objectives	 State	specific	study	objectives	
Study	design	 Describe	the	study	design	(cohort,	randomized	controlled	trial	or	cross-sectional),	including	whether	patient	selection	was	retrospective	or	prospective	
Participants	
and	setting	
Specify	the	study	inclusion	and	exclusion	criteria.	Report	the	flow	of	patients	throughout	model	development.	If	applicable,	consider	use	of	flow	diagrams	complying	with	the	STROBE	statement	for	the	derivation	and	validation	steps	and	with	the	CONSORT	extension	to	cluster	randomized	trials	for	impact	analysis	
Outcomes	 Precisely	define	the	outcome	of	interest	in	terms	of	timing	and	methods	of	ascertainment	(“hard”	outcomes	are	preferred)	
Missing	values	 Report	the	completeness	of	data	for	each	variable	separately	and	overall	for	observations.	Describe	how	missing	values	for	predictor	and	outcome	variables	were	handled	in	the	analyses	
Candidate	
predictors	
List	all	candidate	predictors	initially	considered	for	inclusion	in	the	clinical	prediction	model	(give	sources	of	data	and	methods	of	ascertainment	where	relevant)	
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Sample	size	 Report	rationale	for	sample	size:	The	minimum	number	of	events	per	candidate	predictor	is	at	least	10	for	derivation	studies	External	validation	data	set	should	contain	at	least	100	events	and	100	non-events	
Model	
specification	
Specify	statistical	model	building	strategy,	including	the	type	of	model	and	details	of	candidate	predictor	selection	procedures	
Continuous	
predictors	
Describe	how	continuous	predictors	were	handled	in	the	analyses.	If	relevant,	specify	how	thresholds	were	determined	
Internal	
validation	
Specify	internal	validation	approach	(split-sampling,	cross-validation	or	bootstrapping).	Bootstrapping	is	recommended	for	studies	with	limited	effective	sample	size	
External	
validation	
Report	all	dimensions	of	external	validation	level	(temporal,	geographical	or	fully	independent)	
Model	
estimation	
Derive	the	model	on	the	full	data	set	Where	relevant,	specify	shrinkage	method	used	in	order	to	attenuate	over-fitting	Indicate	whether	external	information	was	used	for	model	updating	Report	the	final	clinical	prediction	model,	including	the	regression	coefficient	for	each	predictor,	along	with	the	model	intercept	
Model	
performance	
Specify	how	calibration	and	discrimination	were	evaluated	Report	apparent,	internal	validation	and	external	validation	performance	
Model	
presentation	
Describe	model	presentation	for	use	in	routine	clinical	practice	
Model	
comparison	
Where	relevant,	directly	compare	models	developed	for	similar	outcomes	and	target	populations	in	the	external	validation	sample	
Model	impact	 Report	effectiveness	in	altering	intensivist	practices,	patient	outcomes	and/or	costs	of	care.	Cluster	randomized	trial	is	the	preferred	implementation	study	design	
Model	validity	 Discuss	internal	(potential	for	over-fitting)	and	external	(generalizability)	validity	and	clinical	usefulness	The	items	listed	in	table	2.1	are	all	addressed	within	this	thesis,	however	they	
are	spread	over	several	chapters	of	the	thesis,	and	may	not	be	addressed	
in	the	same	order	as	listed	in	table	2.1.		
2.3	Study	approvals	All	 required	 permissions	 to	 undertake	 this	 study	 were	 obtained	 via	 the	Integrated	Research	Application	 System	 (IRAS	project	 ID	152449)	before	 any	patient	or	clinical	data	was	sought	(see	Appendix	2).	
• A	favourable	ethical	opinion	was	obtained	 from	the	National	Research	Ethics	Service	(NRES)	Committee	South	Central	-	Oxford	C	on	02	April	2014	(REC	reference:	14/SC/0163).	
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• Permission	to	process	patient	identifiable	information	without	consent	was	obtained	from	the	Health	Research	Authority	(HRA)	Confidentiality	Advisory	Group	(CAG)	under	Regulation	5	of	the	Health	Service	(Control	of	 Patient	 Information)	 Regulations	 2002	 on	 19	 May	 2014	 (CAG	reference:	CAG4-03(PR2)2014).	• A	substantial	amendment,	submitted	to	reflect	the	HRA	CAG	approval	to	process	patient	identifiable	information	without	consent,	was	approved	by	 the	NRES	 Committee	 South	 Central	 -	 Oxford	 C	 on	 06	 August	 2014	(Amendment	number:	PRoSAiC	Amendment	1).	• Site	agreements	were	confirmed	with	West	Midlands	Ambulance	Service	NHS	Foundation	Trust	on	05	January	2015	and	with	University	Hospital	North	Midlands	NHS	Trust	on	19	January	2015	respectively.	• Formal	approval	to	commence	the	study	was	provided	by	the	National	Institute	 for	 Health	 Research	 (NIHR)	 Clinical	 Research	 Network	West	Midlands	on	09	April	2015.	• The	study	was	sponsored	by	the	University	of	Warwick.	• The	 study	 was	 funded	 by	 a	 Clinical	 Doctoral	 Research	 Fellowship	(CDRF2012-05-58)	 awarded	 by	 the	 National	 Institute	 for	 Health	Research	(NIHR).	
2.4	Conclusion	This	chapter	has	provided	an	overview	of	the	methodology	used	to	develop	the	SEPSIS	screening	tool.	It	also	provided	a	list	of	the	permissions	obtained	prior	to	commencing	 any	data	 collection	or	 analysis.	The	next	 chapter	documents	 the	systematic	review	supporting	the	study.	
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Chapter	3	
Systematic	review	of	sepsis	in	
adult	patients	in	the	prehospital	
environment 
 
3.1	Introduction	This	 chapter	 reports	 a	 systematic	 review	 of	 sepsis	 in	 the	 prehospital	environment.	It	addresses	themes	of	importance	to	this	thesis,	namely	to	report	the	incidence	of	sepsis	in	the	prehospital	environment,	to	identify	predictors	for	sepsis	 in	 the	 prehospital	 environment	 and	 to	 determine	 if	 screening	 tools	improve	recognition	of	patients	with	sepsis	in	the	prehospital	environment.		The	systematic	review	will	also	help	to	establish	if	early	identification	of	sepsis	in	 the	 prehospital	 environment	 has	 any	 impact	 on	 outcomes	 among	 adult	patients	with	 sepsis	 and	 finally,	 to	 determine	 if	 care	 delivered	 by	 ambulance	clinicians	in	the	prehospital	environment	leads	to	better	outcomes	among	adult	patients	with	sepsis.	Elements	of	this	systematic	review	have	been	published	and	are	included	in	Appendix	1.	
3.2	Background	Severe	 sepsis	 presents	 a	 major	 healthcare	 challenge.	 It	 results	 in	 significant	morbidity	 and	 mortality	 and	 carries	 a	 huge	 financial	 burden.	 Twenty	 seven	percent	of	admissions	to	intensive	care	in	England	and	Wales	are	due	to	sepsis	with	almost	half	of	these	cases	being	fatal,	and	patients	admitted	to	intensive	care	due	to	sepsis	having	longer	hospital	stays	than	those	admitted	for	other	causes.72	Accurate	mortality	statistics	are	difficult	to	ascertain	as	most	published	data	are	based	upon	in-hospital	data.10	In	the	United	Kingdom	(UK)	the	UK	Sepsis	Trust	have	 identified	 that	 there	 are	 147000	 cases	 of	 sepsis	 each	 year,	 resulting	 in	44000	deaths.5	However,	a	recently	published	report	indicates	that	there	could	be	as	many	as	260	000	cases	of	sepsis	each	year.12	Mortality	statistics	for	England	and	Wales	would	seem	to	support	these	estimates.	McPherson	et	al10	reported	that,	in	2010,	5.1%	of	all	deaths	were	definitely	associated	with	sepsis,	while	up	to	7.7%	may	have	been	associated	with	sepsis.		
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With	respect	to	the	financial	burden	of	sepsis,	Burchardi	et	al11	report	that	the	cost	of	sepsis	was	estimated	 to	 fall	between	€23000	and	€29000	per	case,	 in	European	countries.	Daniels	et	al42	estimate	that	the	cost	of	sepsis	to	the	National	Health	Service	(NHS)		exceeds	£2	billion	each	year.		Recent	 years	 have	 seen	 greater	 focus	 on	 improving	 outcomes	 from	 sepsis.	Hospital	data	suggests	that	early	recognition	and	initiation	of	treatment	leads	to	improved	 patient	 outcomes.	 Gaieski	 et	 al73	 reported	 that	 the	 time	 to	administration	of	 appropriate	 antimicrobials	was	 the	primary	determinant	of	mortality	 in	patients	with	 severe	 sepsis	and	 septic	 shock,	 noting	 a	significant	association	between	mortality	and	administration	of	antimicrobials	within	the	first	hour	of	ED	arrival	(mortality	19.5	vs.	33.2%;	odds	ratio	(OR)	0.30	95%	CI	0.11–0.83,	p=0.02).	Similarly,	Daniels	et	al42	demonstrated	 that	 the	delivery	of	early	 interventions	 was	 associated	 with	 reduced	 mortality	 -	 for	 patients	receiving	the	sepsis	six	bundle	(six	predefined	interventions	to	be	implemented	within	 the	 first	 hour)	 mortality	 was	 20.0%	 compared	 with	 44.1%	 for	 those	patients	 who	 did	 not	 receive	 the	 sepsis	 six	 bundle	 (p<0.001).	 Where	resuscitation	is	delayed,	evidence	suggests	outcomes	become	worse.	Kumar	et	
al74	 reported	 that	 for	 each	hour	delay	 to	 administration	of	 antibiotic	 therapy,	mortality	increased	by	7.6%	for	sepsis	patients	with	hypotension.	Despite	these	data	 indicating	 an	 association	 between	 time	 to	 antimicrobial	 therapy	 and	outcomes,	 some	 uncertainty	 regarding	 the	 optimal	 timeframe	 for	 delivering	particular	 treatments	 and	 interventions	 remains.75-78	 There	 is,	 however,	consensus	that	delays	to	recognition	of	sepsis	and	subsequent	resuscitation	will	likely	be	detrimental	to	patient	outcomes.79-81	The	burden	of	sepsis	upon	UK	ambulance	services	is	not	well	understood.	Guerra	
et	al32	identified	that	6.9%	of	emergency	medical	services	(EMS)	transports	in	the	United	States	are	for	patients	with	infection.	Furthermore,	it	is	estimated	that	8-10%	 of	 EMS	patients	who	 have	 infection	will	 be	 diagnosed	with	 sepsis24	 32	Following	a	10-year	observational	study,	Seymour	et	al25	reported	the	incidence	of	severe	sepsis	in	a	North	American	ambulance	service	to	be	3.3	per	hundred	ambulance	transports.	They	also	noted	that	the	incidence	of	severe	sepsis	among	EMS	patients	was	 increasing	at	11.8%	per	year,	 from	around	1.4%	in	2000	to	4.2%	in	2009.	 	Over	half	of	all	 sepsis	patients	hospitalised	via	 the	emergency	department	(ED)	will	arrive	by	EMS26-28	and	up	to	80%	of	severe	sepsis	patients	admitted	to	intensive	care	via	the	ED	will	arrive	by	EMS.29	30	
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Although	 few	 comparable	 UK	 ambulance	 service	 data	 exist,	 a	 recent	 Scottish	study	 involving	20	out	of	 25	mainland	district	general	 and	 teaching	hospitals	revealed	that	for	patients	who	had	severe	sepsis	or	septic	shock,	the	proportion	arriving	at	hospital	by	ambulance	was	as	high	as	88.1%30	These	data	suggest	that	ambulance	 services	 frequently	 provide	 treatment	 and	 transport	 of	 sepsis	patients,	 and	 furthermore	 that	patients	with	 life	 threatening	 sepsis	 are	more	likely	 to	 arrive	 via	 ambulance.	 Consequently,	 there	 is	 an	 opportunity	 for	ambulance	clinicians	to	aid	the	early	recognition	of	critically	ill	sepsis	patients	and	 potentially	 reduce	 time	 to	 intervention	 for	 this	 population	 in	 the	 same	manner	as	they	do	with	other	time	critical,	 life	threatening	conditions	such	as	acute	myocardial	infarction,	stroke	and	major	trauma.82-91	In	September	2014	NHS	England	issued	a	Stage	2	Patient	Safety	Alert41	outlining	how	 Ambulance	 Services	 could	 contribute	 to	 improved	 outcomes	 for	 sepsis	patients.	Key	to	this	strategy	is	recognition	of	the	septic	patient	by	the	ambulance	clinician.	However,	it	has	not	yet	been	established	if	ambulance	clinicians	are	able	to	 identify	 sepsis	 patients	 when	 access	 to	 advanced	 diagnostics	 such	 as	laboratory	 analysis	 services	 are	 limited.	 Little	 work	 has	 been	 undertaken	 to	improve	 sepsis	 recognition	 and	 management	 by	 ambulance	 clinicians.	 The	purpose	of	this	systematic	review	is	to	collate	the	existing	evidence	pertaining	to	prehospital	recognition	of	sepsis	and	to	determine	if	ambulance	services	might	be	able	to	improve	outcomes	for	sepsis	patients.		
3.3	Methods	
3.3.1	Review	questions	The	 purpose	 of	 the	 systematic	 review	 is	 to	 collate	 the	 available	 evidence	regarding	identification,	management	and	outcomes	among	adult	patients	with	sepsis,	when	cared	for	by	ambulance	clinicians	in	the	prehospital	environment.	The	specific	objectives	are:	• Establish	the	incidence	of	sepsis	in	the	prehospital	environment.	• Identify	known	predictors	for	sepsis	in	the	prehospital	environment.	• Determine	if	ambulance	clinicians	can	identify	patients	with	sepsis	in	the	prehospital	environment.	• Determine	 if	 prehospital	 sepsis	 recognition	 by	 ambulance	 clinicians	leads	to	improved	processes	of	care	among	adult	patients	with	sepsis.	• Determine	if	prehospital	care	delivered	by	ambulance	clinician	improves	outcomes	among	adult	patients	with	sepsis.	
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3.3.2	Review	methods	The	 protocol	 for	 this	 systematic	 review	 is	 registered	 with	 the	 International	Prospective	Register	of	Systematic	Reviews	(PROSPERO)	(CRD42014007654).	It	has	been	conducted	and	reported	 in	accordance	with	 the	Preferred	Reporting	Items	for	Systematic	Reviews	and	Meta-Analyses	(PRISMA)	guidelines.92	
3.3.3	Identification	of	studies	The	electronic	databases	MEDLINE,	EMBASE,	CINAHL	and	the	Cochrane	Library	(includes	 Database	 of	 Systematic	 Reviews	 and	 the	 Database	 of	 Abstracts	 of	Reviews	of	Evidence	 (DARE))	were	 systematically	 searched.	 Search	 strategies	were	developed	 in	 consultation	with	 a	medical	 information	 specialist	 using	 a	combination	of	Medical	Subject	Headings	(MeSH)	(or	equivalent)	and	text	terms	relating	to	both	sepsis	and	ambulance	clinicians	as	outlined	below:	
(Sepsis OR septic OR septic?emia OR systemic adj 
inflammatory adj response adj syndrome OR SIRS OR 
septic adj shock OR hypotension adj induced adj 
hypoperfusion OR cryptic adj shock OR bacterial adj 
infection)  
AND 
(emergency adj medical adj service OR EMS OR HEMS 
OR emergency adj medical adj technician OR EMT OR 
paramedic OR pre-hospital OR prehospital OR pre adj 
hospital OR out-of-hospital OR out adj of adj 
hospital OR OOH OR Ambulance). 		The	 above	 MEDLINE	 search	 strategy	 was	 adapted	 for	 each	 of	 the	 databases	searched,	for	example	by	modifying	subject	headings,	but	retaining	the	same	text	terms.	 Searches	 were	 not	 restricted	 by	 year	 of	 publication,	 study	 design	 or	language	 of	 publication.	 Primary	 searches,	 described	 in	 detail	 later,	 were	undertaken	 in	 July	 2014	 and	 were	 repeated	 in	 June	 2015.	 Citations	 were	exported	 into	 the	 bibliographic	 software	 EndNote®	 version	 X7	 (Thompson	Scientific,	 Carlsbad,	 CA),	 duplicate	 citations	 were	 removed	 manually	 within	EndNote®.	The	citations	were	exported	from	EndNote®	into	a	Microsoft	Excel	2013®	spreadsheet	(Microsoft	Corporation,	Redmond,	WA)	and	distributed	to	two	reviewers,	Michael	Smyth	(MAS)	and	Samantha	Brace-McDonnell	(SBM),	for	screening.	
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3.3.4	Selection	of	studies	for	inclusion	
A	 priori	 inclusion	 and	 exclusion	 criteria	 were	 used	 to	 screen	 the	 retrieved	citations:	
3.3.4.1	Inclusion	criteria	• Language:	 no	 restrictions	 were	 placed,	 however	 studies	 without	 an	English	full	text	document	were	not	included	in	the	systematic	review.		• Publication	type:	original	research	published	in	peer	reviewed	journals	• Study	 Design:	 systematic	 reviews,	 meta-analyses,	 randomised	controlled	 trials	 (RCT’s),	 case-control	 studies,	 cohort	 studies,	 cross-sectional	studies,	retrospective	analyses	and	conference	proceedings.	• Study	Population:	adult	participants.	Populations	could	comprise	a	mix	of	adult	and	child	participants	if	results	are	reported	separately.	• Case	Definition:	no	restrictions	as	to	severity	of	sepsis.	
3.3.4.2	Exclusion	criteria	• Publication	 type:	narrative	reviews,	 letters,	editorials,	 commentaries,	books	 and	 book	 chapters,	 lectures	 and	 addresses,	 and	 consensus	statements.	• Study	Design:	case	reports,	qualitative	studies,	non-systematic	reviews,	studies	that	fail	to	report	their	methods.	• Study	Population:	mixed	adult	 and	 child	population	without	distinct	reporting,	child	population,	animals	
3.3.5	Critical	appraisal	All	eligible	papers	were	 independently	appraised	by	 two	reviewers	(MAS	and	SBM).	 To	 control	 for	 subjective	 appraisal,	 a	 standardised	 approach	 to	 quality	assessment	 was	 adopted.	 Each	 study	 was	 assessed	 for	 risk	 of	 bias,	 any	inconsistency	of	results,	the	indirectness	of	the	evidence,	any	imprecision	in	the	results,	and	any	other	factors	such	as	publication	bias,	or	dose	effect	that	might	influence	 the	 quality	 assessment	 as	 recommended	 in	 the	 Grading	 of	Recommendations	 Assessment,	 Development,	 and	 Evaluation	 (GRADE)	approach	for	rating	the	quality	of	evidence.93		 • Risk	of	bias	 limitations	relate	 to	 issues	with	study	design	and	how	these	 limitations	 might	 affect	 confidence	 in	 the	 estimate	 of	 effect	reported	 in	 the	 study.94	 Within	 the	 hierarchy	 of	 evidence,	 well	conducted	randomised	controlled	trials	limit	the	potential	for	bias	and	
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may	therefore	be	at	low	risk	for	bias.	However,	factors	such	as	lack	of	allocation	concealment,	lack	of	blinding,	a	large	loss	to	follow-up,	trials	stopped	early	 for	benefit	 or	 selective	 reporting	of	 outcomes	will	all	introduce	the	potential	for	bias	and	thus	reduce	our	confidence	of	the	reported	 estimate	 of	 effect.	 Non-randomised	 studies	 are	 generally	limited	with	 respect	 to	what	 can	be	 inferred	 from	 results,	 and	how	generalisable	the	findings	are	to	the	wider	population	of	interest.	Non-randomised	studies	are	usually	therefore	at	significantly	higher	risk	for	bias.	• Indirectness	of	results	is	closely	related	to	the	populations	studied.95	The	populations	of	several	included	studies	contain	patients	who	do	not	 have	 sepsis.	 It	 is	 therefore	 appropriate	 to	 be	 very	 cautious	 in	generalising	the	findings	of	these	studies	to	the	population	of	interest	(adult	sepsis	patients).	• Inconsistency	of	results	refers	to	widely	differing	estimates	of	effect	between	studies	(heterogeneity	or	variability	in	results).96	Where	such	differences	exist,	it	is	important	to	determine	if	there	is	a	justification	for	the	observed	differences.	Differing	estimates	could	be	attributable	to	severity	of	disease,	timing	of	intervention,	dosage	of	drug	used	or	other	many	other	factors.	When	heterogeneity	exists,	and	influences	the	 interpretation	 of	 results,	 study	 authors	 have	 a	 responsibility	 to	identify	a	plausible	explanation,	or	the	risk	of	bias	increases	and	the	quality	of	evidence	decreases.	If	estimates	of	effect	vary	considerably,	without	 underlying	 reasons	 for	 the	 observed	 difference,	 extreme	caution	must	be	exercised,	when	generalising	to	the	wider	population.	• Results	can	be	considered	to	be	imprecise	when	studies	include	few	participants	and	few	events	and	thus	have	wide	confidence	intervals.97	Low	 numbers	 of	 participants	 or	 events	 limit	 the	 accuracy	 of	 the	calculated	estimate	of	effect.		• Publication	 bias	 refers	 to	 the	 selective	 reporting	 of	 outcomes	 or	failure	 to	 fully	 report	 estimates	 of	 effect	 e.g.	 by	 reporting	 a	 point	estimate	without	the	confidence	interval.98		The	heavy	involvement	of	commercial	 sponsors	 in	 trials	 also	 raises	 questions	 of	 whether	unpublished	data,	suggesting	no	benefit,	exists.99			
The	 GRADE	 approach	 stratifies	 quality	 of	 evidence	 into	 four	 categories;	 ‘high	quality’,	 ‘moderate	 quality’,	 ‘low	 quality’	 and	 ‘very	 low	 quality’.93	 Randomised	
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controlled	trials	are	initially	rated	as	‘high	quality’,	while	non-randomised	trials	studies	 are	 initially	 rated	 as	 ‘low	 quality’.	 Following	 critical	 appraisal	 each	reviewer	independently	adjusted	the	quality	assessment	upward	or	downward	depending	 upon	 the	 risk	 of	 bias,	 inconsistency	 of	 results,	 indirectness	 of	 the	evidence,	imprecision	in	the	results,	or	other	pertinent	factors.94	100		
3.4	Results	
3.4.1	Systematic	literature	search	The	systematic	search	of	the	literature	identified	4366	citations.	After	duplicates	were	 removed,	 2958	 unique	 citations	 remained.	 Applying	 a	 priori	 selection	criteria,	two	reviewers	(MAS	and	SBM)	independently	rated	each	citation	title	as	‘include’,	or	 ‘exclude’.	Citations	rated	as	 ‘include’	by	at	least	one	reviewer	were	considered	 potentially	 relevant,	 while	 citations	 rated	 as	 ‘exclude’	 by	 both	reviewers	were	considered	irrelevant.	Seventy-eight	citations	were	identified	as	potentially	 relevant,	while	 2880	 citations	were	 discarded	as	 irrelevant.	 	 	 One	additional	 study,33	 a	 manuscript	 pending	 publication,	 was	 identified	 by	contacting	Ambulance	Service	Medical	Directors	and	subject	experts.	Inter-rater	agreement	 for	 primary	 citation	 screening,	 to	 include	 or	 exclude	 studies,	calculated	using	Cohen’s	kappa	statistic	was	0.87	(95%	CI	0.81	to	0.92;	p<0.001).	During	the	second	stage	of	screening,	the	same	two	reviewers	(MAS	and	SBM)	independently	 reviewed	 the	 full	 manuscript	 for	 each	 of	 the	 79	 potentially	relevant	studies.	Each	study	was	rated	as	 ‘include’,	 ‘maybe’	or	 ‘exclude’.	If	both	reviewers	rated	a	manuscript	as	‘include’	it	was	automatically	considered	for	full	text	review.	Similarly,	if	both	reviewers	rated	the	manuscript	as	‘exclude’	it	was	automatically	 discarded.	 If	 there	 was	 disagreement	 between	 reviewers,	 for	example,	one	rated	 the	manuscript	as	 ‘maybe’	while	 the	other	 rated	the	same	manuscript	as	‘exclude’,	the	reviewers	met	to	discuss	their	reasons	for	rating	the	manuscript	as	they	did,	and	attempt	to	seek	a	consensus.	If	the	two	reviewers	were	not	able	to	achieve	consensus,	a	third	independent	reviewer	(Gavin	Perkins	(GDP))	was	available	to	adjudicate.		Seventy-nine	 manuscripts	 were	 independently	 reviewed.	 There	 were	 no	instances	where	 consensus	 could	not	be	 reached	by	 the	 two	 reviewers.	 Fifty-eight	manuscripts	were	discarded	following	the	second	stage	screening,	with	21	manuscripts	 included	 in	 the	 systematic	 review.	 	 Inter-rater	 agreement	 for	
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second-stage	screening,	calculated	using	Cohen’s	kappa	statistic,	was	0.82	(95%	CI	0.68	to	0.97).		Reference	lists	of	included	manuscripts	were	examined	to	identify	any	missed	studies.	No	additional	items	were	identified	by	this	approach	(see	figure	3.1).	
	
Figure	3.1	PRISMA	flow	chart	
	
3.4.2	Characteristics	of	included	studies	Most	studies	identified	involve	small	numbers	of	participants,	without	control	and	intervention	cohorts.	Only	one	randomised	controlled	trial	was	identified,	with	 the	 remainder	 being	 non-randomised	 studies.	 There	 was	 considerable	variation	 in	 the	 diagnostic	 standards	 utilised,	 reported	 outcomes	 and	methodological	 approach	 adopted	 across	 the	 studies.	 Because	 of	 these	differences,	meta-analysis	was	not	appropriate	and	a	narrative	approach	to	data	synthesis	was	adopted.		Key	characteristics	of	the	21	included	studies	are	presented	in	table	3.1.	A	clear	majority	(71%)	originate	from	the	United	States,	all	studies	were	published	in	English,	 six	 studies	 were	 published	 in	 abstract	 form	 only.	 There	 was	 one	randomised	controlled	trial	(published	in	abstract	only);	the	remaining	studies	were	all	non-randomised	studies.			
Unique	citations	
identified	by	
database	searches
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citations	identified	by	
other	means
n=1
potentially	relevant	
citations	n=2959
citations	excluded	
(irrelevant)	n=2880
manuscripts	
screened	n=79
(k=0.87)
Manuscripts	
included	in	
systematic	review
n=21
(k=0.82)
manuscripts	excluded	(n=58):
Not	intervention/diagnosis		n=13
Editorial	n=17
In-hospital	n=9
Mixed	population	n=6
Double	publication	n=5
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Dispatch	n=1
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Table	3.1	Characteristics	of	included	studies	
Characteristic	 Details	
Median	year	of	publication	[range]		 2012	[2010–2015]	
Country	of	publication	[n	(%)]	 	•	 United	States		 15	(71)	•	 	Germany	 2	(9)	•	 United	Kingdom	 1	(5)	•	 Sweden	 1	(5)	•	 Australia		 1	(5)	•	 Canada	 1	(5)	
Language	[n	(%)]	 	•	 English		 21	(100)	
Study	design	[n	(%)]	 	•	 Randomised	Controlled	Trial	 1	(5)	•	 Non-randomised	Study	 20	(95)	
Publication	type	[n	(%)]	 	•	 Full	publication	 15	(71)	•	 Abstract	publication	 6	(29)	
	
3.4.3	Assessment	for	risk	of	bias	For	 the	 randomised	 controlled	 trials,	 risk	 of	 bias	 was	 assessed	 across	 the	following	domains:	lack	of	allocation	concealment,	lack	of	blinding,	incomplete	accounting	of	patients	and	outcome	events,	selective	outcome	reporting	bias	and	other	 limitations	 such	 as	 stopping	 a	 trial	 early	 for	 benefit.	 Bias	 within	 non-randomised	studies	was	assessed	across	the	domains	of	failure	to	develop	and	apply	 appropriate	 eligibility	 criteria	 (inclusion	 of	 control	 population),	 flawed	measurement	 of	 exposure	 and	 outcome,	 failure	 to	 adequately	 control	confounding	and	incomplete	follow-up.				Two	reviewers	(MAS	and	SBM)	 independently	assessed	each	paper	across	 the	bias	domains	with	each	being	rated	as	either	high	risk,	low	risk	or	level	of	risk	unclear	as	per	GRADE	recommendations.94	Studies	with	high	risk	in	one	or	more	domains	were	considered	high	risk. Results	of	bias	assessments	are	reported	in	
table	3.2	and	table	3.3.			
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Table	3.2	Risk	of	bias	(randomised	controlled	trials)					 		 		 		 		 RCT	bias	assessment	
Author,	year	 Design	 Total	Patients	 Population	 Industry	Funding	 Alloc
ation:	 Genera
tion 	
Allocat
ion:	
Concea
lment 	 Blindin
g:	
Partici
pants	 Blindin
g:	
Assess
ors	 Outcom
e:	
Comple
te	
Outcom
e:	
Selectiv
e	
Other	B
ias	
Chamberlain	55	 RCT	 198	 Adult	OOH	sepsis	 no	 Unclear	 Unclear	 Unclear	 Unclear	 Low	 Unclear	 Unclear	RCT	–	randomised	controlled	trial,	OOH	–	out	of	hospital	
High	 Significant	risk	of	bias	 	 	 	 	 	 	 	 	
Unclear	 Risk	of	bias	unclear	 	 	 	 	 	 	 	 	
Low		 Minimal	risk	of	bias	 	 	 	 	 	 	 	 						
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Table	3.3	Risk	of	bias	(non-randomised	studies)	
	 	 	 	 	 	 Non-RCT	bias	assessment	
Author,	year	 Design	 Total	Patients	 Population	 Industry	Funding	 Eligibil
ity	
Criteria
	
Exposu
re/		
Outcom
e	
Confou
nding 	
Follow
	up	
Baez,	et	al.	101	 Non-RCT	 63	 ED	sepsis	patients	arriving	by	EMS	 no	 Low	 Low	 High	 Unclear	Band,	et	al.	53	 Non-RCT	 963	 OOH	sepsis	EMS	vs	POV	 no	 Low	 Low	 Low	 Low	Bayer,	et	al.	102	 Non-RCT	 56	 OOH	sepsis	patients	treated	by	Dr	 no	 Unclear	 High	 High	 Low	Bayer,	et	al.	102	 Non-RCT	 375	 ED	medical	patients	arriving	by	EMS	 no	 Low	 Low	 Low	 Low	Erwin,	et	al.	103	 Non-RCT	 151	 Patients	from	3	nursing	homes	 no	 High	 High	 High	 Unclear	Femling,	et	al.	104	 Non-RCT	 151	 OOH	sepsis	EMS	vs	POV	 no	 Low	 Unclear	 High	 Low	Guerra,	et	al.	23	 Non-RCT	 112	 ED	sepsis	patients	arriving	by	EMS	 no	 Low	 Low	 High	 High	Hokanson,	et	al.	46	 Non-RCT	 42	 ED	sepsis	patients	arriving	by	EMS	 no	 Low	 High	 High	 Unclear	McClelland,	et	al	33	 Non-RCT	 49	 ED	sepsis	patients	arriving	by	EMS	 no	 Unclear	 Unclear	 High	 Unclear	
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Milzman,	et	al.	105	 Non-RCT	 5,182	 OOH	suspected	infection	EMS	vs	POV	 no	 Unclear	 Unclear	 High	 Low	Polito,	et	al.	106	 Non-RCT	 66439	 ED	medical	patients	arriving	by	EMS	 no	 Low	 Low	 Low	 Low	Seymour,	et	al.	107	 Non-RCT	 144,913	 ED	medical	patients	arriving	by	EMS	 no	 Low	 Low	 Low	 Low	Seymour,	et	al.	107	 Non-RCT	 216	 ED	medical	patients	arriving	by	EMS	 no	 Low	 Low	 Unclear	 Low	Seymour,	et	al.	25	 Non-RCT	 407,176	 ED	medical	patients	arriving	by	EMS	 no	 Low	 Low	 Low	 Low	Seymour,	et	al.	56	 Non-RCT	 1350	 ED	severe	sepsis	arriving	by	EMS	 no	 Low	 Low	 Unclear	 Low	Shiuh,	et	al.	34	 Non-RCT	 183	 OOH	sepsis	identified	by	sepsis	protocol	 no	 Low	 High	 Unclear	 Low	Studnek,	et	al.	27	 Non-RCT	 311	 ED	severe	sepsis	arriving	by	EMS	 no	 Low	 Unclear	 Low	 Low	Suffoletto,	et	al.	24	 Non-RCT	 199	 EMS	infection	patients	 no	 High	 High	 High	 Low	Travers,	et	al.	35	 Non-RCT	 629	 OOH	Sepsis	patients	 no	 Low	 Unclear	 Low	 Unclear	Wallgren,	et	al.	36	 Non-RCT	 353	 OOH	sepsis	 no	 Low	 High	 High	 Low	Non-RCT	–	non	randomised	controlled	trial,	ED	–	Emergency	Department,	EMS	–	Emergency	Medical	Services,	OOH	–	out	of	hospital,	POV	–	privately	owned	vehicle	
High	 Significant	risk	of	bias	
Unclear	 Risk	of	bias	unclear	
Low	 Minimal	risk	of	bias	
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3.4.4	Incidence	of	sepsis	in	the	prehospital	environment	Seven	 studies	 addressing	 incidence	 of	 sepsis	 in	 the	 prehospital	 environment	were	 identified.24	25	32	33	56	107	108	All	 seven	studies	were	non-randomised	trials.	The	level	of	evidence	across	the	studies	was	downgraded	from	LOW	quality	to	VERY	LOW	quality	due	 to	risk	of	bias,	 inconsistency,	 indirectness,	 imprecision	and	publication	bias	 (see	table	3.4).	Two	of	 the	studies,	Seymour	 et	al107	and	Seymour	et	al25	reported	data	from	a	single	large	registry	spanning	the	period	2000-2009.		Seymour	et	al107	identified	patients	with	critical	illness,	defined	as	patients	with	sepsis	or	patients	in	need	of	mechanical	ventilation	or	patients	who	would	die	in	hospital.	They	reported	the	incidence	of	critical	illness	to	be	5.49%.	However,	for	the	subset	of	patients	with	severe	sepsis	incidence	was	3.4%.	In	their	later	paper,	Seymour	et	al	reported	the	incidence	of	severe	sepsis	or	septic	shock	to	be	3.3	per	 100	 ambulance	 transports25	 The	 authors	 however	 also	 identify	 that	 the	incidence	of	sepsis	in	the	prehospital	environment	was	steadily	rising	at	11.8%	per	year	over	the	period	of	data	collection	(95%	CI	10%	-	13.7%;	p<0.01).	At	the	start	of	data	collection	 in	2000	the	 incidence	was	2.2	per	hundred	transports	whereas	in	2009	the	incidence	had	risen	to	4.2	per	hundred	transports	(95%CI	4.1	-	4.3).25	It	was	not	established	if	the	increase	in	incidence	was	secondary	to	increasing	 awareness	 among	 EMS	 providers,	 improved	 diagnostic	 capability	within	EMS,	improved	documentation	at	hospital	or	a	genuine	increase	in	disease	prevalence.	 In	 their	 2014	 paper	 addressing	 the	 impact	 of	 prehospital	 fluid	therapy	on	outcomes	from	severe	sepsis	they	report	that	1,350	of	45,394	EMS	encounters	(2.97%)	met	criteria	for	severe	sepsis	on	admission	to	hospital.56		In	2013	Guerra	et	al32	published	their	analysis	of	15,338	EMS	patients	reporting	that	1069	patients	had	infection	(6.9%),	112	(10.5%)	of	whom	were	identified	as	 having	 sepsis	 by	 using	 a	 sepsis	 screening	 tool.	 These	 data	 establish	 the	incidence	of	sepsis	at	112/15338	(0.7%)	in	this	study.		A	similar	low	incidence	was	reported	by	Polito	 et	al108	who	 identified	that	555/66,439	(0.8%)	of	EMS	patients	met	their	‘at	risk	of	sepsis’	criteria	(heart	rate	>90bpm,	respiratory	rate	>20bpm,	systolic	blood	pressure	<110mmHg)	among	patients	with	infection.	In	this	study,	the	incidence	of	severe	sepsis	was	reported	to	be	75/66,439	(0.001%).	Both	of	these	studies32	108	suggest	the	incidence	of	sepsis	may,	in	fact,	be	far	lower	than	that	previously	reported	by	Seymour	et	al25	56	107	A	small	observational	study	by	Suffoletto	et	al24	reported	that	31/199	(15.6%)	of	EMS	patients	had	severe	infection,	while	16/199	(8%)	had	severe	sepsis.	However,	the	study	population	
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excluded	trauma	and	stroke	patients	and	as	such	these	data	will	overestimate	the	true	incidence	of	sepsis.		McClelland	et	al33	were	the	only	authors	to	publish	data	concerning	sepsis	in	a	UK	 ambulance	 service.	 They	 reported	 the	 number	 of	 sepsis	 cases	 within	 a	defined	period,	 but	 failed	 to	 report	 the	 total	number	of	 cases	 from	which	 the	sample	was	drawn.	Estimation	of	the	total	number	of	cases,	based	upon	annual	activity	figures,	suggests	a	crude	incidence	of	sepsis	in	a	UK	ambulance	service	in	the	region	of	1.8%.		There	is	considerable	variation	in	the	reported	incidence	of	sepsis	within	EMS.	Documented	incidence	of	severe	sepsis	range	from	0.001%	to	3.4%.	Most	data	identified	relate	 to	 the	United	States.	No	reliable	data	addressing	 incidence	of	sepsis	in	the	United	Kingdom,	or	elsewhere,	were	identified.
PRoSAiC	Thesis	
28	
Table	3.4		Summary	of	findings	(Incidence	of	sepsis)	
№	of	st
udies	
№	of	p
atients
	
Study	d
esign 	
Risk	of
	bias 	
Incons
istency
	
Indirec
tness	
Imprec
ision 	
Other		 Level	o
f	
eviden
ce	
Findings	
Incidence	of	sepsis	6	 1,927	 non-RCT	 very	serious1	 none		 not	serious2	 very	serious3	 very	serious4	 ⨁◯◯◯	VERY	
LOW	 Seymour	et	al	(2010a)	Incidence	of	severe	sepsis	3.4%	(4,896/144,913)																																																																																																				Suffoletto	et	al	(2011)	16.1%	(31/199)	of	patients	(adult,	non-trauma,	non-stroke)	had	serious	infection,	50%	(16/31)	of	infected	had	sepsis.	Incidence	among	non-trauma,	non-stroke	patients	8%	(16/199)																																																																																																																																																																							
Seymour	et	al	(2012)	3.3%	(13,249/407,176)	of	patients	(adult,	non-trauma,	non-cardiac	arrest)	had	ICD	codes	for	severe	sepsis.																																																																																																																																																																																																																																																
Seymour	et	al	(2014)	2.97%	(1350/45,394)	of	EMS	patients	diagnosed	with	severe	sepsis																																																																																																																																														
Guerra	et	al	(2013)	6.9%	(1,069/15,338)	of	patients	had	infection,	10.5%	(112/1,069)	of	infection	patients	met	screening	tool	criteria	for	severe	sepsis.	Overall	incidence	0.7%	(112/15,338).																																																																																																																																	
Polito	et	al	(2015)	0.8%	(555/66,439)	of	all	EMS	encounters	‘at	risk’,	13.5%	(75/555)	had	severe	sepsis.	Overall	incidence	of	severe	sepsis	0.001%	(75/66,439).				
McClelland	et	al	(2015)	crude	estimate	extrapolated	from	annual	call	volume	~1.8%																																																																																																																																																																		non-RCT:	non-randomised	controlled	trial	(observational	study),	EMS:	Emergency	Medical	Services,	ICD:	International	Classification	of	Disease.	1. See	risk	of	bias	tables	2. Single	centre	studies	may	limit	generalizability.	3. Small	study	numbers	limit	precision/accuracy,	failure	to	report	confidence	intervals	4. Publication	bias	(Guerra	et	al)		
PRoSAiC	Thesis	
29	
	
3.4.5	Predictors	of	sepsis	in	the	prehospital	environment	Twelve	studies	addressing	predictors	of	sepsis	in	the	prehospital	environment	were	identified.31-36	46	54	101	107-109	Four	studies	reported	strength	of	correlation	of	individual	 predictor	 variables	 with	 the	 outcome	 of	 sepsis.54	 101	 107	 108	 The	remaining	eight	studies	identified	variables	used	to	indicate	sepsis,	but	did	not	report	 correlation	 of	 variables	with	 the	 outcome	 of	 sepsis.	 All	 twelve	 studies	were	 non-randomised	 controlled	 trials.	 Five	 of	 the	 studies	were	 published	 in	abstract	only.31	34	35	46	109	The	level	of	evidence	across	the	studies	was	downgraded	from	 LOW	 quality	 to	 VERY	 LOW	 quality	 due	 to	 risk	 of	 bias,	 inconsistency,	indirectness	and	imprecision	(see	table	3.5).	The	majority	of	the	studies	base	their	diagnostic	criteria	on	Systemic	Inflammatory	Response	Syndrome	(SIRS)	criteria	as	defined	by	the	Survive	Sepsis	Campaign.15	
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Table	3.5	Summary	of	findings	(predictors	of	sepsis)	
№	of	st
udies	
№	of	p
atients
	
Study	d
esign 	
Risk	of
	bias 	
Incons
istency
	
Indirec
tness	
Imprec
ision 	
Other		 Level	o
f	
eviden
ce	
Findings	
Studies	reporting	correlation	of	variables	with	sepsis	4	 211790	 non-RCT	 very	serious1	 none		 not	serious2	 very	serious3	 none	 ⨁◯◯◯	VERY	
LOW	 Seymour	et	al	(2010a)		Age	(Age	45-64:	ßi=0.91	(95%	CI	0.80-1.02),	Age>64:	ßi=1.32	(95%	CI	1.22-1.43)),	Respiratory	rate	(RR	<12:	ßi=1.35	(95%	CI	1.22-1.43),	RR	24-35:	ßi=0.79	(95%	CI	0.72-0.86),	RR>35:	ßi=1.54	(95%	CI	1.43-1.64)),	Systolic	blood	pressure	(SBP<91:	ßi=0.92 (95%CI	0.82	-	1.0)) ,		Heart	rate	(pulse>119:	ßi=0.77 (95%CI	0.68-0.85)),	Pulse	oximetry	(SpO2	80-87:	ßi=0.83 (95%CI	 0.61-1.04),	 SpO2<80:	 ßi=0.1.08 (95%CI	 0.82-1.35)),	 Glasgow	 Coma	
Score	(GCS	12-14:	ßi=0.51	(95%	CI	0.38-0.63),	GCS	8-11:	ßi=1.24	(95%	CI	1.10-1.39),	GCS<8:	ßi=1.96	(95%	CI	1.81-2.10))	
Baez	et	al	(2013)	RR>20	(OR	4.81	(95%CI	1.16-21.01))	and	shock	index>0.7	(OR	5.96	(95%CI	1.49-25.78))	
Bayer	 et	 al	 (2015)	Temperature	 (Temp<36C:	 ßi=0.98 (95%CI	—0.19-2.1),	Temp>38C:	 ßi=3.92 (95%CI	 3.01-4.92)),	 Pulse	 oximetry	 (SpO2<92:	 ßi=1.85 (95%CI	1.1-2.64)),	Respiratory	rate	(RR	>22:	ßi=1.41	(95%	CI	0.62-2.26),	Heart	
rate	(pulse>90:	ßi=0.1.9 (95%CI	0.56-3.23)).	
Polito	 et	 al	 (2015)	 	 Age	 (age	 50-59:	 Odds	 Ratio	 (OR)	 3.83	 (95%CI	 1.05-14.07)),	age>59:	OR	1.63	(95%CI	0.39-6.75)),	Nursing	home	resident	(OR	4.47	(95%CI	1.77-11.25)),	EMS	dispatch	complaint	of	“sick	person”	(OR	2.46	(95%	CI	1.12-5.40)),	Hot	tactile	temperature	(Y/N)	(Odds	Ratio	(OR)	2.52 (95%CI	1.10-5.74)),	Systolic	blood	pressure	(SBP	per	1mmHg	increase	OR:	0.96	(95%	CI	0.94-0.99)),	Oxygen	saturation	(SpO2	per	1%	increase:	OR	0.94	(95%	CI	0.90-0.99)).			
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Studies	identifying	variables	used	to	diagnose	sepsis	without	reporting	correlations 8	 55398	 non-RCT	 very	serious1	 none		 not	serious2	 very	serious3	 very	serious4	 ⨁◯◯◯	VERY	
LOW 
Erwin	 et	 al	 (2011)	 Respiratory	 rate,	 Heart	 rate,	 Temperature,	 Level	 of	consciousness,	Lactate,	Skin,	Capillary	bed	refill	time.	
Shiuh	et	al	(2012)	Respiratory	rate,	Heart	rate,	Temperature,	Lactate.	
Hokansen	et	al	(2012)	Pulse	rate,	Respiratory	rate,	Temperature,	Lactate.		
Milzman	et	al	(2012)	Temperature,	Shock	index.																																																																																						
Guerra	et	al	(2013)	Respiratory	rate,	Heart	rate,	Temperature,	Systolic	blood	pressure,	Lactate.	
Wallgren	 et	 al	 (2014)	 (Robson	 tool)	 Respiratory	 rate,	 Heart	 rate,	Temperature,	 Level	 of	 consciousness,	 Blood	 glucose,	 Skin.	 (BAS	 90-30-90)	Systolic	blood	pressure,	respiratory	rate,	Oxygen	saturations.	
McClelland	 et	 al	 (2015)	 (modified	 Robson	 tool)	 Respiratory	 rate,	 Oxygen	saturations,	Heart	rate,	Temperature,	Level	of	consciousness,	Blood	glucose,	Skin.	
Bayer	et	al	(2015)	(MEWS	score)	Respiratory	rate,	Heart	rate,	Temperature,	Level	of	consciousness,	Systolic	blood	pressure,	Urine	output.	
 non-RCT:	non-randomised	controlled	trial,	ßi:	regression	coefficient,	CI:	confidence	interval,	RR:	respiratory	rate,	SBP:	systolic	blood	pressure,		SpO2:	peripheral	oxygen	saturations,	GCS:	Glasgow	Coma	Score,	OR:	Odds	ratio,	EMS:	Emergency	Medical	Services,	MEWS:	Modified	Early	Warning	Score	.	1. See	risk	of	bias	tables	2. Single	centre	studies	may	limit	generalizability.	3. Small	study	numbers	limit	precision/accuracy	4. Abstract	publication,	publication	bias	(Guerra	et	al)		
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Studies	reporting	correlation	of	variables	with	sepsis	VERY	 LOW	 quality	 evidence,	 from	 four	 non-randomised	 trials,54	 101	 107	 108	reporting	 correlation	 of	 variables	 with	 sepsis	 was	 identified	 (see	 table	 3.5).	Seymour	 et	 al107	 developed	 the	 Critical	 Illness	 Score	 (CIS)	 to	 identify	 EMS	patients	who	would	benefit	from	transport	to	a	specialist	centre.	They	defined	critical	illness	as	severe	sepsis,	delivery	of	mechanical	ventilation	or	death	at	any	point	 during	 hospitalisation.	 Their	 tool	 was	 not	 designed	 to	 identify	 sepsis	patients	specifically.	However,	the	authors	reported	operating	characteristics	of	the	 tool	 for	sepsis	patients	as	a	distinct	population.	The	study	utilised	clinical	records	 of	 144913	 EMS	 patients.	 Variables	 correlated	 with	 critical	 illness	included		age	(Age	45-64:	ßi=0.91	(95%	CI	0.80-1.02),	Age>64:	ßi=1.32	(95%	CI	1.22-1.43)),	respiratory	rate(RR)	(RR<12:	ßi=1.35	(95%	CI	1.22-1.43),	RR	24-35:	ßi=0.79	(95%	CI	0.72-0.86),	RR>35:	ßi=1.54	(95%	CI	1.43-1.64)),	systolic	blood	pressure	(SBP<91:	ßi=0.92 (95%CI	0.82	-	1.0)) ,	heart	rate	(pulse>119:	ßi=0.77 (95%CI	 0.68-0.85)),	 pulse	 oximetry	 (SpO2	 80-87:	 ßi=0.83 (95%CI	 0.61-1.04),	SpO2<80:	 ßi=0.1.08 (95%CI	 0.82-1.35)),	 Glasgow	 Coma	 Score	 (GCS	 12-14:	ßi=0.51	 (95%	 CI	 0.38-0.63),	 GCS	 8-11:	 ßi=1.24	 (95%	 CI	 1.10-1.39),	 GCS<8:	ßi=1.96	(95%	CI	1.81-2.10)).			Bayer	et	al54	derived	the	Prehospital	Early	Sepsis	Detection	(PreSep)	score	from	a	sample	of	375	EMS	patients,	of	whom	93	had	sepsis	(including	60	patients	with	severe	sepsis	and	12	patients	with	septic	shock).	Variables	correlated	with	sepsis	included	 temperature	 (Temp<36°C:	 ßi=0.98 (95%CI	 -0.19-2.1),	 Temp>38°C:	ßi=3.92 (95%CI	 3.01-4.92)),	 pulse	 oximetry	 (SpO2<92:	 ßi=1.85 (95%CI	 1.1-2.64)),	 respiratory	 rate	 (RR	 >22:	 ßi=1.41	 (95%	 CI	 0.62-2.26)	 and	 heart	 rate	(pulse>90:	ßi=0.1.9 (95%CI	0.56-3.23)).	Polito	et	al108	derived	the	Prehospital	Recognition	of	Severe	Sepsis	(PreSS)	score	from	 a	 population	66,439	 EMS	 encounters.	 The	 sample	 studied	 included	 555	patients	at	risk	of	sepsis,	of	whom	75	were	noted	to	have	severe	sepsis.	Variables	correlated	with	sepsis	 included	age	(age	50-59:	Odds	Ratio	(OR)	3.83	(95%CI	1.05-14.07)),	age>59:	OR	1.63	(95%CI	0.39-6.75)),	nursing	home	resident	(OR	4.47	 (95%CI	 1.77-11.25)),	 EMS	dispatch	 complaint	 of	 “sick	 person”	 (OR	2.46	(95%	 CI	 1.12-5.40)),	 hot	 tactile	 temperature	 (Y/N)	 (Odds	 Ratio	 (OR)	 2.52 (95%CI	1.10-5.74)),	systolic	blood	pressure	(SBP	per	1mmHg	increase	OR:	0.96	(95%	CI	0.94-0.99))	and	oxygen	saturation	(SpO2	per	1%	increase:	OR	0.94	(95%	CI	0.90-0.99)).	
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Baez	 et	 al101	 completed	 an	 observational	 study	 of	 adult	 EMS	 patients	with	 a	diagnosis	 of	 sepsis	 transported	 to	 hospital.	 Their	 population	 comprised	 63	patients	only,	so	statistical	estimates	should	be	interpreted	with	caution	because	of	 high	 uncertainty.	 Among	 patients	 with	 sepsis	 the	 only	 prehospital	physiological	 variables	 associated	 with	 admission	 to	 the	 Intensive	 Care	 Unit	were	 respiratory	 rate>20	 (OR	4.81	 (95%CI	1.16-21.01))	and	 shock	 index>0.7	(OR	5.96	(95%CI	1.49-25.78)).	The	preceding	four	studies	were	the	only	studies	to	report	statistical	estimates	addressing	correlation	of	variables	with	sepsis.	The	remaining	studies	identified	variables	 and	 any	 intervals	 or	 thresholds,	 but	 failed	 to	 report	 any	 statistical	estimates	for	the	individual	variables.		
Studies	 identifying	 variables	 used	 to	 diagnose	 sepsis	 without	
reporting	correlations	VERY	 LOW	 quality	 evidence,	 from	 eight	 non-randomised	 trials,31-34	 36	 46	 54	 109	identifying	variables	used	to	diagnose	sepsis	was	identified	(see	table	3.5).	In	their	prospective	observational	study	Erwin	et	al31	defined	sepsis	as	“identified	or	 suspected	 infection,	 plus	 two	 of	 abnormal	 temperature	 (Temp<96.8°	 or	>100.4°	 F),	 heart	 rate	 >	 90/min,	 respiratory	 rate>20/min	 or	 altered	 mental	status”	 (altered	 mental	 status	 was	 not	 explicitly	 defined).	 Severe	 sepsis	 was	defined	 as	 “Sepsis	 plus	mottled	 skin	 or	 capillary	 refill>3	 seconds	 or	 lactate>	2mmol/L	or	abrupt	changes	in	mental	status”.	Guerra	et	al32	defined	their	sepsis	criteria	as	18	years	or	older	and	not	pregnant,	plus	suspected	or	documented	infection,	 plus	 two	 systemic	 inflammatory	 response	 syndrome	 criteria	(temperature	 >38°	 or	 <36°C,	 pulse	 >	 90	 bpm,	 respiratory	 rate	 >	 20	 bpm	 or	mechanically	ventilated)	plus	hypoperfusion	(systolic	blood	pressure	<	90mmHg	or	mean	arterial	pressure	or	65mmHg,	lactate	>	4	mmol/L).			Wallgren	et	al36	compared	Robson	Tool	and	the	BAS	90-30-90	score	with	EMS	clinician	judgement	to	identify	sepsis	patients.	The	Robson	Tool	defines	sepsis	as	signs	and	symptoms	of	infection,	plus	any	two	of	temperature	>	38.3°	or	<	36°C,	heart	rate	>	90	bpm,	respiratory	rate	>	20	bpm	and	acutely	altered	mental	status,	plasma	 glucose	 >	 6.6mmol/L	 (unless	 diabetic).	 The	 BAS	 90-30-90	 employs	thresholds	for	sepsis	at	systolic	blood	pressure	below	90	mmHg,	respiratory	rate	>	30	bpm	and	oxygen	saturations	below	90%.	McClelland	et	al33	report	use	of	a	modified	 Robson	 tool,	 whereby	 an	 additional	 variable,	 pulse	 oximetry	(SpO2<90%),	was	included	over	and	above	those	previously	identified.		
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Three	studies	were	reported	in	abstract	form	only.34	46	109	Shiuh	et	al34	defined	sepsis	as	the	presence	of	“2	or	more	systemic	inflammatory	response	syndrome	(SIRS)	 criteria	 (continuous	 pulse	 rate>90,	 Respiratory	 Rate	 >20	 and	Temperature	>38	or	<36	C)	plus	clinical	suspicion	for	 infection”.	 In	 this	study,	EMS	 crews	 also	 stratified	 sepsis	 patients	 according	 to	 prehospital	 lactate	readings,	 if	 patients	 had	 a	 lactate	 >4mmol/L	 paramedic	 crews	 provided	 the	hospital	with	an	‘alert’	message	whereas	if	the	lactate	was	in	the	range	2.5-3.9	mmol/L	 they	 provided	 the	 hospital	 with	 an	 ‘inform’	 message	 prior	 to,	 or	 on	hospital	 arrival.	 Hokansen	 et	 al46	 defined	 sepsis	 as	 2	 or	 more	 SIRS	 criteria	without	defining	the	SIRS	criteria,	and	in	addition	utilised	lactate	to	stratify	risk.	Milzman	et	al109	described	the	utility	of	temperature	and	shock	index	as	a	pair	of	observations	to	predict	sepsis.			One	 study54	 included	 an	 assessment	 of	 the	 Modified	 Early	 Warning	 Score	(MEWS)	 to	 identify	 patients	 with	 sepsis.	 MEWS	 is	 a	 generic	 score	 that	 was	proposed	by	Stenhouse	et	al110	and	is	used	to	estimate	the	likelihood	of	patient	deterioration,	 needing	 subsequent	 surgical	 intervention	 or	 admission	 to	intensive	 care.	 It	 is	 a	 physiological	 scoring	 system	 that	 can	 be	 used	 by	 any	healthcare	provider	(see	figure	3.2).	It	is	intended	to	be	used	at	regular	intervals,	rather	 than	 at	 initial	 assessment	 only,	 to	 identify	 a	 deteriorating	 patient	 and	trigger	early	intervention	by	the	medical	team.		
Figure	3.2	Modified	Early	Warning	Score	(MEWS)	
 
(Image from https://twitter.com/blairbigham/status/823956305266311168)		
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Variables	 that	have	been	used	 to	 inform	sepsis	 recognition	across	 the	 studies	identified	are	summarised	in	table	3.6.	
Table	3.6	Variables	used	to	identify	sepsis	 	
Screening	tool		
(or	study	author)	
	
Variable	
	
Respir
atory	
rateα 	 Heart	r
ateα 	
Tempe
ratureα
	
LOCβ 	 SpO 2β 	 Blood	 pressu
reβ 	
Shock	i
ndex	
Lactate
β 	
Blood	 glucose
β 	
Skin	 CBRT	 Dispatc
h	
categor
y	
Locatio
n	
Age	 Urine	o
utput	
Seymour	et	al	(CIS)	 •	 •	 	 •	 •	 •	 	 	 	 	 	 	 	 •	 	Polito	et	al	(PRESS)	 	 	 •	 	 •	 •	 	 	 	 	 	 •	 •	 •	 	Bayer	et	al	(PRESEP)	 •	 •	 •	 	 •	 •	 	 	 	 	 	 	 	 	 	Baez	et	al	 •	 	 	 	 	 	 •	 	 	 	 	 	 	 	 	Wallgren	et	al	(Robson)	 •	 •	 •	 •	 	 	 	 •	 •	 •	 	 	 	 	 	McClelland	(modified	Robson)	 •	 •	 •	 •	 •	 	 	 •	 •	 •	 	 	 	 	 	Bayer	et	al	(BAS	90-30-90)	 •	 	 	 	 •	 •	 	 	 	 	 	 	 	 	 	Bayer	et	al	(Modified	Early	Warning	Score	(MEWS))	 •	 •	 •	 •	 	 •	 	 	 	 	 	 	 	 	 •	Erwin	et	al	 •	 •	 •	 •	 	 	 	 •	 	 •	 •	 	 	 	 	Guerra	et	al	 •	 •	 •	 	 	 •	 	 •	 	 	 	 	 	 	 	Hokansen	et	al	 •	 •	 •	 	 	 	 	 •	 	 	 	 	 	 	 	Milzman	et	al	 	 	 •	 	 	 	 •	 	 	 	 	 	 	 	 	Shiuh	et	al	 •	 •	 •	 	 	 	 	 •	 	 	 	 	 	 	 	
	 α	Systemic	Inflammatory	Response	Syndrome	(SIRS)	criteria,	β	organ	dysfunction,	LOC	reduced	level	of	consciousness,	SpO2	oxygen	saturations,	CBRT	capillary	bed	refill	time	
	
	
3.4.6	Accuracy	of	prehospital	sepsis	screening	Nine	 studies	describing	diagnosis	 of	 sepsis	among	patients	 in	 the	prehospital	environment	were	identified.31-36	54	107	108	All	nine	studies	were	non-randomised	controlled	 trials.	 Three	 were	 published	 in	 abstract	 only.31	 34	 35	 	 The	 level	 of	evidence	across	the	studies	was	downgraded	 from	LOW	quality	to	VERY	LOW	quality	 due	 to	 risk	 of	 bias,	 inconsistency,	 indirectness,	 imprecision	 and	publication	bias	(see	table	3.7).	Diagnostic	 accuracy	 is	 not	 simply	 concerned	with	 the	 proportion	 of	 patients	identified	 as	 having	 sepsis	 (true	 positives)	 versus	 the	 proportion	 of	 patients	incorrectly	identified	as	septic	(false	positives).	Measures	of	diagnostic	accuracy	
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should	 also	 consider	 those	patients	 correctly	 identified	 to	not	be	 septic	 (true	negatives)	as	well	as	those	incorrectly	identified	to	not	be	septic	(false	negatives).		For	the	bedside	clinician	to	assess	diagnostic	accuracy	of	a	screening	tool	it	 is	vital	that	they	can	interpret	a	test	result	and	apply	it	to	their	clinical	practice.	In	other	words,	if	the	screening	tool	suggests	the	patient	has	the	disease,	how	likely	is	 it	 that	 the	 patient	 actually	 has	disease?	 For	 this,	 positive	 predictive	 values	(PPV)	are	important.	Conversely,	if	screening	suggests	the	patient	does	not	have	the	 disease	 how	 likely	 is	 it	 that	 the	 patient	 is	 actually	disease	 free?	Negative	predictive	values	(NPV)	will	inform	the	clinician	in	this	instance.	Screening	tool	performance	can	be	assessed	by	reporting	the	following	measures:			 • Sensitivity	-	the	ability	of	a	test	to	identify	those	with	the	disease.	A	test	with	sensitivity	=	1	identifies	all	cases	with	the	disease.	• Specificity	-	the	ability	of	a	test	to	identify	those	who	do	not	have	the	disease.	A	test	with	specificity	=	1	identifies	all	cases	without	the	disease.	• Positive	predictive	value	(PPV)	-	probability	that	an	individual	with	a	positive	test	has	the	disease.	A	test	with	PPV	=	1	implies	all	cases	classified	as	having	disease	will	have	the	disease.	• Negative	predictive	 value	 (NPV)	 -	 	probability	 that	 an	 individual	with	a	negative	test	does	not	have	the	disease.	A	test	with	NPV	=	1	implies	all	cases	classified	as	being	disease	free	will	not	have	the	disease.	
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Table	3.7	-	Summary	of	findings	(Accuracy	of	sepsis	diagnosis)	
№	of	st
udies	
№	of	p
atients
	
Study	d
esign	
Risk	of
	bias	
Incons
istency
	
Indirec
tness	
Imprec
ision	
Other		 Level	o
f	
eviden
ce	
Findings	
Accuracy	of	prehospital	sepsis	screening	tools	(not	clinically	validated	by	EMS)	3	 211727	 non-RCT	 none	 none	 not	serious1	 very	serious2	 none	 ⨁◯◯◯	VERY	
LOW	 Seymour	(2010)	Critical	Illness	Score	(CIS):	Risk	of	Sepsis	0.76	(95%CI	0.75-0.77).																																																																																																																																																																																																																																																																																																																																																												Polito	(2015)	PreSS	score:		Sensitivity	0.85,	specificity	0.47,	PPV	0.19,	NPV	0.96	(95%	CI	not	reported)	PreSS	score	>=3	sensitivity	0.81	specificity	0.63																																																																																																																																							
Bayer	(2015)	PreSep	score:		Sensitivity	0.85	(95%	CI	0.77	to	0.92),	specificity	0.86	(95%	CI	0.82	to	0.90),	PPV	0.66,	NPV	0.95			
	
Accuracy	of	prehospital	sepsis	screening	tools	(in	clinical	use	by	EMS) 2	 161	 non-RCT	 very	serious3	 none		 not	serious4	 very	serious5	 very	serious6	 ⨁◯◯◯	VERY	
LOW 
Guerra	(2013)	Screening	based	on	SSC	criteria	identified	32/67	sepsis	patients	(47.8%).	(95%	CI	not	reported).	
McClelland	(2015)	Screening	using	modified	Robson	tool.	Sensitivity	&	Specificity	for	sepsis	43%	(95%CI	28-58%)	&	14%	(95%CI	0-40%)	respectively.	Sensitivity	and	specificity	for	severe	sepsis	30%	(95%CI	12%-47%)	&	77%	(95%CI	60-95%).				
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Retrospective	application	of	EMS	data	to	screening	tool	by	researcher	2	 728	 non-RCT	 very	serious3	 none	 not	serious4	 very	serious5	 none	 ⨁◯◯◯	VERY	
LOW 
Wallgren	(2014)	Retrospective	application	of	two	different	screening	tools	in	comparison	to	clinical	judgement.			For	sepsis	Robson	tool:	sensitivity	75%	(p<0.001),	BAS	90-30-90:		sensitivity	43%	(p<0.001),	Clinical	judgement:	12%	accuracy.	(95%	CI	not	reported).		For	severe	sepsis	Robson	tool:	sensitivity	93%	(p<0.001),	BAS	90-30-90:		sensitivity	70%	(p<0.001),	Clinical	judgement:	17%	accuracy.	(95%	CI	not	reported).	
Bayer	(2015)	Retrospective	application	of	three	different	screening	tools.		(modified)	Robson	tool:	sensitivity	0.95,	specificity	0.43,	PPV	0.32,	NPV	0.97.		BAS	90-30-90:		sensitivity	0.62,	specificity	0.83,	PPV	0.51,	NPV	0.89.	MEWS≥4	sensitivity	0.74,	specificity	0.75,	PPV	0.45,	NPV	0.91.	(95%	CI	not	reported).	
Sepsis	recognition	by	EMS	without	using	a	screening	tool.	4	 1316	 non-RCT	 very	serious3	 none	 not	serious4	 very	serious5	 very	serious7	 ⨁◯◯◯	VERY	
LOW 
Erwin	(2011)	Screening	based	on	SSC	criteria.		For	sepsis:	sensitivity	33%	(95%CI	18-53%),	specificity	89%	(95%CI	08-94%),	PPV	50%	(95%CI	28-72%),	NPV	80%	(95%CI	70-87%).	For	severe	sepsis:	sensitivity	20%	(95%CI	5-51%),	specificity	94%	(95%CI	87-97%),	PPV	29%	(95%CI	08-64%),	NPV	91	(95%CI	83-95%).						
Shiuh	(2012)	Screening	based	on	SSC	criteria,	also	stratified	by	lactate,	lactate<4	=	“sepsis	advisory”	while	lactate>4	=	“sepsis	alert”.	74.2%	of	“Sepsis	Advisory”	patients	and	76.7%	of	“Sepsis	Alert”	patients	received	a	hospital	diagnosis	of	severe	infection	or	sepsis.	(95%	CI	not	reported).																
Travers	(2013)	Screening	criteria	not	defined.	Specificity	78.85%	(95%	CI	75.23-82.17),	sensitivity	73.4%	(95%	CI	61.40-83.05),	PPV	30.59%	(95%	CI	23.76-38.11),	NPV	95.86%	(95%	CI	93.61-97.49),	accuracy	78%	(52	true	positives,	440	true	negatives).				
Wallgren	(2014)	For	sepsis	clinical	judgement:	12%	accuracy	(95%	CI	not	reported).		For	severe	sepsis	clinical	judgement:	17%	accuracy	(95%	CI	not	reported).	
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	non-RCT:	non-randomised		study;	SSC:	Surviving	Sepsis	Campaign;	PPV:	positive	predictive	value;	NPV:	negative	predictive	value;	BAS	90-30-90	=	SBP	<	90	mm	Hg;	respiratory	rate>	30	breaths/min;	SpO2	<	90%;	MEWS:	modified	early	warning	score;	Modified	Robson	=	Robson	tool	with	addition	of	SpO2		1. Seymour	et	al	CIS	not	specific	to	sepsis	(CIS	intended	to	identify	all	cases	of	critical	illness).	Polito	et	al	and	Bayer	et	al	studies	limited	to	single	EMS	systems,	Bayer	et	al	physician	based	EMS	2. Polito	et	al	failed	to	report	confidence	intervals,	small	sample	size	in	Bayer	et	al	study	3. See	bias	assessments	4. Single	EMS	agency/hospital	so	limited	generalisablity.		5. Included	studies	have	small	sample	sizes	thus	imprecise	point	estimates.	In	several	studies	confidence	intervals	are	not	reported.			6. Guerra	et	al	publication	bias	likely.		7. Studies	published	in	abstract	only,	unable	to	reliably	critically	appraise.		
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Accuracy	 of	 prehospital	 sepsis	 screening	 tools	 (not	 clinically	
validated	by	EMS)	VERY	LOW	quality	evidence	was	identified,	from	three	non-randomised	trials,54	107	108	addressing	accuracy	of	prehospital	sepsis	screening	tools	(see	table	3.7).	Each	of	the	studies	adopted	a	similar	approach	to	screening	tool	development.	Identification	 candidate	 predictors	 varied	 slightly	 between	 studies.	 However,	once	 candidate	 predictors	 were	 identified	 all	 studies	 utilised	 multivariable	logistic	 regression,	 in	 a	 stepwise	 fashion,	 to	 build	 their	 respective	 models.	Goodness	of	fit	was	assessed	by	Hosmer-Lemeshow	test	and	model	performance	determined	by	calculating	the	area	under	the	receiver	operating	characteristic	curve.	None	of	the	studies	included	a	clinical	validation	study	of	their	respective	screening	tools.	Seymour	et	al107	developed	the	Critical	Illness	Score	(CIS)	to	predict	the	risk	of	critical	 illness	 among	 EMS	 patients.	 It	 was	 not	 developed	 to	 identify	 sepsis	specifically,	although	the	statistical	estimates	reported	 in	 this	review	relate	 to	sepsis	 cases	 only.	 Their	 study	 utilised	 the	 clinical	 records	 of	 144,913	 EMS	patients	4,895	of	whom	had	severe	sepsis.	Polito	et	al108	derived	the	PreSS	score	from	a	population	66,439	EMS	encounters.	The	study	included	555	patients	at	risk	of	sepsis,	of	whom	75	had	severe	sepsis.	Bayer	et	al54	derived	the	Prehospital	Early	 Sepsis	 Detection	 (PreSep)	 score	 from	 a	 sample	 of	 375	 EMS	 patients,	 of	whom	93	had	sepsis	(including	60	patients	with	severe	sepsis	and	12	patients	with	septic	shock).		CIS,	 PRESS	 and	 PreSEp	were	 derived	 and	 validated	with	 EMS	 data.	 Reported	operating	characteristics	do	not	relate	to	use	in	clinical	practice	by	ambulance	clinicians.	
Accuracy	of	screening	tools	(in	clinical	use	by	EMS)	VERY	LOW	quality	evidence	was	identifed,	from	two	non-randomised	trials,32	33	addressing	recognition	of	sepsis	by	EMS	personnel	utilising	a	screening	tool	(see	
table	 3.7).	 Guerra	 et	 al32	 report	 that	 Emergency	Medical	 Technicians	 (EMTs)	trained	to	recognise	sepsis	correctly	 identified	32/67	(sensitivity	48%)	septic	patients,	with	 failure	 to	recognise	sepsis	 in	35/67	(False	Negative	Rate	(FNR)	52%)	of	cases.	However,	the	FNR	may	be	misleading.	In	5/35	(14%)	of	cases	the	patient’s	vital	signs	did	not	meet	the	criteria	of	the	sepsis	screening	tool	while	in	EMS	care,	in	8/35	(23%)	of	cases	the	patients	had	cryptic	shock	but	EMTs	did	not	 have	 lactate	 meters	 to	 enable	 detection	 and	 in	 13/35	 (37%)	 of	 cases	
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diagnosis	was	made	by	abnormal	white	cell	count	(only	available	in	hospital).	In	9/35	(26%)	of	cases	EMTs	 failed	to	 identify	sepsis	when	sufficient	diagnostic	criteria	were	available	to	them.	The	high	proportion	of	patients	missed	due	to	lack	of	white	cell	 count	highlights	a	 limitation	of	prehospital	sepsis	screening	tools.	Guerra	et	al32	further	reported	that	among	sepsis	patients	transported	by	EMS	crews	not	trained	to	recognise	sepsis	5/45	(11%)	were	identified	as	septic.			McClelland	and	Jones33	scrutinised	the	records	of	all	septic	patients	conveyed	by	a	regional	ambulance	service	to	a	university	hospital	to	determine	if	ambulance	clinicians	 (previously	 trained	 in	 the	 use	 of	 a	 screening	 tool)	 recognised	 and	documented	 suspected	 sepsis.	 The	 screening	 tool	 used	 was	 based	 upon	 the	Robson	 tool	 amended	 to	 include	 oxygen	 saturations	 as	 an	 indicator	 of	 organ	dysfunction.33	McClelland	and	Jones33	report	a	sensitivity	of	0.43	(95%	CI	0.28-0.58)	for	sepsis	and	0.30	(95%	CI	0.12-0.47)	for	severe	sepsis	and	a	specificity	of	0.14	(95%	CI	0.0-0.40)	for	sepsis	and	0.77	(95%	CI	0.60-0.95)	for	severe	sepsis.	The	authors	concluded	that	use	of	the	screening	tool	by	ambulance	clinicians	was	inconsistent	but	that	it	improved	sepsis	recognition.33		
Retrospective	application	of	EMS	data	to	screening	tool	by	
researcher		VERY	LOW	quality	evidence	was	identified,	from	two	non-randomised	trials,36	54	addressing	retrospective	application	of	prehospital	data	to	screening	tools	(see	
table	3.7).	Wallgren	et	al36	compared	two	screening	tools	(Robson	Tool	and	BAS	90-30-90	 score)	 with	 EMS	 clinician	 judgement.	 The	 Robson	 Tool	 performed	better	than	the	BAS	90-30-90	score	(see	table	3.7).		Sensitivity	with	the	Robson	tool	was	0.75	(95%	CI	not	reported)	and	0.93	(95%	CI	not	reported)	for	sepsis	and	severe	sepsis	respectively.	Sensitivity	with	the	BAS	90-30-90	tool	was	0.43	(95%	CI	not	 reported)	and	0.93	 (95%	CI	not	 reported)	 for	 sepsis	 and	 severe	sepsis	respectively.		Bayer	et	al54	compared	the	performance	of	their	PRESEP	score	with	the	Modified	Early	Warning	Score	(MEWS),	BAS	90-30-90	and	Robson	tool	reporting	that	the	PRESEP	score	surpassed	both	MEWS	and	BAS	90-30-90	for	sensitivity,	specificity,	positive	predictive	value	(PPV),	and	negative	predictive	value	(NPV).	The	Robson	tool	showed	better	sensitivity	however	the	PRESEP	tool	had	better	specificity.	Furthermore,	the	PRESEP	score	showed	better	PPV	and	comparable	NPV	than	the	Robson	tool	(see	table	3.7).	
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Sepsis	recognition	by	EMS	without	using	a	screening	tool.	VERY	LOW	quality	evidence	was	identified,	from	three	non-randomised	trials,31	34	35	addressing	accuracy	of	paramedic	diagnosis	of	sepsis	in	clinical	practice.		All	three	studies		were	published	in	abstract	form	only	(see	table	3.7).	Erwin	et	al31	compared	 paramedic	 diagnosis	 of	 sepsis	 and	 severe	 sepsis	 with	 physician	diagnosis.	The	level	of	agreement	between	paramedics	and	physicians	was	low	(kappa=0.25	and	0.16	respectively).	These	results	lead	the	authors	to	conclude	that	sepsis	criteria	were	more	useful	for	ruling-out	sepsis	than	diagnosing	sepsis.	In	 a	 study	 by	 Shiuh	 et	 al34	 EMS	 crews	 stratified	 sepsis	 patients	 according	 to	prehospital	lactate	readings.	If	patients	had	a	lactate>4mmol/L	paramedic	crews	provided	the	hospital	with	an	‘alert’	message	whereas	if	the	lactate	was	in	the	range	2.5-3.9	mmol/L	they	provided	the	hospital	with	an	‘inform’	message	prior	to,	or	on	hospital	arrival.	They	reported	data	for	219	sepsis	patients	for	whom	a	lactate	reading	was	available.	They	did	not	report	data	for	those	patients	where	a	 lactate	reading	was	not	known/unavailable.	Travers	et	al35	compared	sepsis	diagnosis	by	paramedics	and	ED	doctors	in	629	cases.	Diagnosis	by	the	ED	doctor	was	deemed	the	diagnostic	gold	standard.	However,	it	was	a	subjective	diagnosis	and	was	not	verified	against	any	established	diagnostic	criteria.	Thermometry	was	 not	 available	 to	 paramedics	 to	 accurately	 determine	 body	 temperature.	Paramedic	diagnosis	was	reported	to	be	consistent	with	physician	diagnosis	in	78%	 of	 cases.	 This	 is	 the	 largest	 paramedic	 diagnostic	 accuracy	 study	 but	unfortunately	detail	is	lacking.	Finally,	Wallgren	et	al36	reported	that	paramedics	documented	clinical	suspicion	of	sepsis,	defined	as	“documentation	of	suspected	sepsis,	septicaemia,	urosepsis	or	blood	poisoning	in	the	patient’s	clinical	record”,	in	11.9%	and	16.9%	of	cases	for	sepsis	and	severe	sepsis	respectively.	Confidence	intervals	were	not	reported.	
 	Accuracy	 of	 prehospital	 sepsis	 diagnosis	 across	 the	 studies	 identified	 is	summarised	in	table	3.8.
PRoSAiC	Thesis	
43	
Table	3.8	Performance	of	screening	tools	
Author	 Sensitivity	 Specificity	 PPV	 NPV	Seymour	(CIS)	 0.76	(95%CI	0.75-0.77)	 Not	reported	 Not	reported	 Not	reported	Polito	(PreSS)	 0.85	(95%	CI	not	reported)	 0.47	(95%	CI	not	reported)	 0.19	(95%	CI	not	reported)	 0.96	(95%	CI	not	reported)	Bayer	(PreSep)	 0.85	(95%	CI	0.77-0.92)	 0.86	(95%	CI	0.82-0.90)	 0.63	(95%	CI	not	reported)	 0.95	(95%	CI	not	reported)	McClelland	(sepsis)									(modified	Robson	Tool)	 0.43	(95%CI	0.28-0.58)	 0.14	(95%CI	0-0.40)	 Not	reported	 Not	reported	McClelland	(severe	sepsis)	(modified	Robson	Tool	 0.30	(95%CI	0.12-0.47)	 0.77	(95%	CI	0.60-0.95)	 Not	reported	 Not	reported	Bayer	(modified	Robson	Tool)	 0.95	(95%	CI	not	reported)	 0.43	(95%	CI	not	reported)	 0.32	(95%	CI	not	reported)	 0.97	(95%	CI	not	reported)	Wallgren	(sepsis)	(Robson	Tool)	 0.75	(95%	CI	not	reported)	 Not	reported	 Not	reported	 Not	reported	Wallgren	(severe	sepsis)	(Robson	Tool)	 0.93	(95%	CI	not	reported)	 Not	reported	 Not	reported	 Not	reported	Bayer	(BAS	90-30-90)	 0.62	(95%	CI	not	reported)	 0.83	(95%	CI	not	reported)	 0.51	(95%	CI	not	reported)	 0.89	(95%	CI	not	reported)	Wallgren	(sepsis)	(BAS	90-30-90)	 0.43	(95%	CI	not	reported)	 Not	reported	 Not	reported	 Not	reported	Wallgren	(severe	sepsis)						(BAS	90-30-90)	 0.70	(95%	CI	not	reported)	 Not	reported	 Not	reported	 Not	reported	Bayer	(MEWS)	 0.74	(95%	CI	not	reported)	 0.75	(95%	CI	not	reported)	 0.45	(95%	CI	not	reported)	 0.91	(95%	CI	not	reported)	Guerra	 0.48	(95%	CI	not	reported)	 Not	reported	 Not	reported	 Not	reported	Erwin	(sepsis)	 0.33	(95%CI	0.18-0.53)	 0.89	(95%CI	0.08-0.94)	 0.50	(95%CI	0.28-0.72)	 0.80	(95%CI	0.70-0.87)	Erwin	(severe	sepsis)	 0.20	(95%CI	0.05-0.51)	 0.94	(95%CI	0.87-0.97)	 0.29	(95%CI	0.08-0.64)	 0.91	(95%CI	0.83-0.95)	Shiuh	 0.75	(95%	CI	not	reported)	 Not	reported	 Not	reported	 Not	reported	Travers	 0.73	(95%	CI	0.61-0.83)	 0.79	(95%	CI	0.75-0.82)	 0.31	(95%	CI	0.24-0.38)	 0.96	(95%	CI	0.94-0.98)	CI	–	confidence	interval	 	 	 	
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3.4.7	Impact	of	prehospital	recognition	on	processes	of	care	Eight	 studies	 describing	 the	 impact	 of	 prehospital	 sepsis	 diagnosis,	 by	ambulance	clinicians,	on	processes	of	care	were	identified.27	29	32	33	53	55	102	111	One	study	 was	 a	 randomised	 controlled	 trial55	 while	 seven	 studies	 were	 non-randomised	controlled	trials.27	29	32	33	53	102	111	Three	studies29	55	102	were	published	in	abstract	form	only.		The	level	of	evidence	across	the	studies	was	downgraded	from	 LOW	 quality	 to	 VERY	 LOW	 quality	 due	 to	 risk	 of	 bias,	 inconsistency,	indirectness,	imprecision	and	publication	bias	(see	table	3.9).	
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Table	3.9	Summary	of	findings	(impact	on	processes	of	care)	
№	of	st
udies	
№	of	p
atients
	
Study	d
esign 	
Risk	of
	bias	
Incons
istency
	
Indirec
tness	
Imprec
ision	
Other		 Level	o
f	
eviden
ce	
Findings	
Impact	of	prehospital	care	upon	time	to	antimicrobial	therapy	1	 199	 RCT	 not	serious1	 none	 not	serious2	 very	serious3	 very	serious4	 ⨁◯◯◯	VERY	
	LOW	 Chamberlain	2009	prehospital	antibiotics	provided	3.4	±	2.6	hours	sooner	(p=0.02).	5	 1,927	 non-RCT	 very	serious5	 none		 not	serious2	 very	serious6	 very	serious7	 ⨁◯◯◯	VERY	
	LOW	 Band	2011	Median	time	to	antibiotics	reduced:		116	min	(IQR	66-199min)	EMS	vs	152	min	(IQR	92-252min)	‘other	means’	(p≤0.001).	Studnek	2012	if	arriving	by	EMS	vs	other	means	time	to	antibiotics	reduced	111min	(EMS)	vs	146min	(non-EMS);	(p=0.001).	If	EMS	recognised	and	documented	sepsis,	time	to	antibiotics	reduced	70min	(documented)	vs	122min	(not	documented)	(p=0.003).		
Bayer	2013	Median	time	of	administration	19min	(IQR	18-24min)	after	initial	emergency	call	(time	of	administration	estimated	as	10min	after	arriving	at	scene).		
Guerra	2013	No	significant	reduction	in	time	to	antibiotics	mean	72.6min	(SD	59.3min)	(pre-alert)	vs	98.5min	(SD	89.9min)	(no	pre-alert)	(p=0.07).	
Femling	2014	Time	to	antibiotics:	87min	(EMS)	(IQR	44-157min)	vs	120min	(non-EMS)	(IQR	141-271min),	diff	33min	(p=0.02).							
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Impact	of	prehospital	care	upon	fluid	resuscitation	4	 1347	 non-RCT	 very	serious5	 none		 not	serious2	 very	serious6	 very	serious8	 ⨁◯◯◯	VERY	LOW	 Seymour	2010]	patients	who	received	prehospital	fluids	had	shorter	time	to	MAP>65mmHg	17/24	(70%)	(EMS	IV	fluids)	vs	12/26	(44%)	(no	IV	fluids),	Unadj	RR	1.53	(95%	CI	0.9-2.65),	and	shorter	time	to	CVP>8mmH20	15/25	(60%)(EMS	IV	fluids)	vs17/24	(70%)		(no	IV	fluids),	Unadj	RR	1.2	(95%	CI	0.8-1.8)	
Band	2011]	Median	time	to	initiation	of	IV	fluid	reduced:	34	min	(IQR	10	-	88)	EMS	vs	68	min	(IQR	25-121min)	‘other	means’	of	arrival	(p≤0.001).	
Bayer	2013]	Median	time	of	administration	19min	(IQR	18-24min)	after	initial	emergency	call	(time	of	administration	estimated	as	10min	after	arriving	at	scene).	Patients	received	2.5l	intravascular	fluid	(IQR	1.5–3.0l)	until	admitted	to	the	ER.	
Guerra	2013]	No	significant	difference	in	fluid	administration	by	6	hours	42.97	cc/kg	(SD	33.23cc/kg)	(pre-alert)	vs	35.17cc/kg	(SD	26.81	cc/kg)	(no	pre-alert)	(p=0.30).																		
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Impact	of	prehospital	care	upon	Early	Goal	Directed	Therapy	5	 1173	 non-RCT	 very	serious5	 none		 not	serious2	 very	serious6	 very	serious8	 ⨁◯◯◯	VERY	LOW	 Seymour	2010	patients	who	received	prehospital	fluids	had	shorter	time	to	MAP>65mmHg	17/24	(70%)	(EMS	IV	Fluids)	vs	12/26	(44%)	(no	IV	fluids),	Unadj	RR	1.53	(95%	CI	0.9-2.65);	shorter	time	to	CVP>8mmH20	15/25	(60%)	(EMS	IV	Fluids)	vs17/24	(70%)		(no	IV	fluids),	Unadj	RR	1.2	(95%	CI	0.8-1.8);	and	shorter	time	to	svcO2>70%	13/24	(54%)	(EMS	IV	Fluids)	vs	9/25	(36%)	(no	IV	Fluids),	Unadj	RR	1.5	(95%	CI	0.8-2.9).	
Studnek	2012	if	arriving	by	EMS	vs	other	means	time	to	EGDT	reduced	119min	(EMS)	vs	160	min	(non-EMS)	(p=0.005).	If	EMS	recognised	and	documented	Sepsis	time	to	EGDT	69min	(documented)	vs	131	min	(not	documented)	(p=0.001).	
Guerra	2013	No	significant	reduction	in	proportion	of	patients	with	central	venous	line	placement	62%	(pre-alert)	vs	68%	(no	pre-alert)	(p=0.54).	
Femling	2014	Time	to	central	line:	200min	(EMS)	(IQR	89-368min)	vs	275min	(non-EMS)	(IQR	122-470min),	diff	75min	(p<0.01).	(95%	CI	0.34-0.98).		
McClelland	2015	Time	to	’Sepsis	6’:	mean	205min	(SD	271min,	range	10-720min)*	(EMS	identified)	vs	120	min	(SD	110,	17-450min)	(not	identified)	*	includes	outlier	where	the	fluid	balance	chart	was	not	started	for	12	hours,	excluding	this	case	mean	76min		(SD	95min,	range	10-240min)].	non-RCT:	non-randomised	controlled	trial	(observational	study),	IQR:	inter	quartile	range,	EMS:	Emergency	Medical	Services,	SD:	standard	deviation,	MAP:	mean	arterial	pressure,	IV:	intravascular,		RR:	risk	ratio,	95%	CI:	95%	confidence	interval’	CVP:	central	venous	pressure,	EGDT:	early	goal	directed	therapy.	1. Risk	of	bias	unclear.	2. Single	centre	study	may	limit	generalizability.	3. Small	study	numbers	limits	precision/accuracy.			4. Published	in	abstract	only,	insufficient	detail	to	rule	out	other	bias.	5. Concerns	relating	to	eligibility,	exposure,	confounding,	follow-up	6. Small	study	numbers	limits	precision/accuracy,	failure	to	report	confidence	intervals	(Guerra)	7. Abstract	only	publication	(Femling),	insufficient	detail	to	rule	out	other	bias,	Publication	bias	likely	(Guerra)	
8. Publication	bias	likely	(Guerra) 
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Time	to	antibiotic	therapy VERY	 LOW	 quality	 evidence	 was	 identified,	 from	 one	 randomised	 controlled	trial55	and	 five	non-randomised	trials,27	29	32	53	102	addressing	time	to	antibiotic	therapy	(see	table	3.9).		Three	of	these	studies	were	published	in	abstract	form	only.29	55	102		Three	studies27	29	53	indicate	that	Emergency	Department	(ED)	antibiotic	therapy	is	 administered	 30-50	minutes	 sooner	 if	 EMS	 identify	 sepsis	 and	 inform	 the	receiving	 clinician	 of	 their	 diagnosis.	 However,	 this	 finding	 is	 not	 universal	 -	Guerra	 et	 al32	 identified	 a	 reduction	 in	 time	 to	 antibiotic	 therapy	 (pre-alert:	72.6min	 Standard	 Deviation	 (SD)	 59.3min)	 vs	 no	 pre-alert:	 98.5min	 (SD	89.9min),	p=0.07),	however	this	difference	was	not	statistically	different.			Two	 studies55	 102	 address	 prehospital	 administration	 of	 antibiotic	 therapy.	Chamberlain55	 reported	 that	 antibiotics	 were	 delivered	 3.4±2.6	 hours	 sooner	while	 Bayer	 et	 al102	 noted	 that	 among	 EMS	 sepsis	 patients	 median	 time	 to	antibiotics	was	19min	(IQR	18-24min)	from	initial	emergency	call.	However,	this	should	be	interpreted	with	caution	as	time	of	administration	was	estimated	to	commence	 10	 minutes	 after	 arriving	 at	 scene.	 	 Furthermore,	 there	 was	 no	indication	of	time	to	antibiotic	therapy	in	hospital,	thus	it	is	not	possible	to	draw	conclusions	as	to	the	amount	of	time	saved	by	administering	antibiotics	before	arriving	at	hospital.	
Time	to	intravascular	fluid	therapy	VERY	LOW	quality	evidence	was	identified,	from	four	non-randomised	trials,32	53	102	111	 addressing	 time	 to	 intravascular	 therapy	 (see	 table	3.9).	 	One	of	 these	studies	was	published	in	abstract	only.102		Seymour	et	al111	noted	that	patients	who	received	prehospital	fluids	had	shorter	time	to	Mean	Arterial	Pressure	(MAP)>65	mm	Hg	17/24	(70%,	EMS	IV	fluids)	vs	12/26	(44%,	no	IV	fluids),	unadjusted	RR	1.53	(95%	CI	[0.9-2.65]).	Band	et	al53	reported	 that	 arrival	 by	 EMS	 reduces	 time	 to	 initiation	 of	 intravascular	 fluid	therapy	when	compared	with	those	who	arrive	by	privately	owned	vehicle	(POV)	(EMS:	 34	 min	 (IQR	 10-88min)	 vs	 POV:	 68	 min,	 IQR	 25-121min,	 p≤0.001).	Similarly,	Bayer	et	al102	noted	 that	among	EMS	sepsis	patients	median	 time	to	initiation	 of	 Intravascular	 fluids	 was	 19min	 (IQR	 18-24min)	 from	 initial	emergency	call	(time	of	administration	was	estimated	to	commence	10	min	after	
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arriving	at	scene),	with	patients	receiving	an	average	of	2.5l	intravascular	fluid	(IQR	1.5–3.0l)	until	admission	to	the	ED.	A	third	study	by	Guerra	et	al32	indicated	that	early	identification	of	sepsis	by	EMS	was	not	associated	with	improved	6-hour	 fluid	 resuscitation	 targets	 in	 the	 ED	 (EMS	 pre-alert:	 42.97	 cc/kg	 (SD	33.23cc/kg)	vs	no	EMS	pre-alert:	35.17cc/kg	(SD	26.81	cc/kg),	p=0.30).	
Time	to	Early	Goal	Directed	Therapy	(EGDT)	Targets	VERY	LOW	quality	evidence	was	identified,	from	five	non-randomised	trials,27	29	32	33	111	addressing	time	to	Early	Goal	Directed	Therapy	targets	(see	table	3.9).		One	of	these	studies	was	published	in	abstract	form	only.29			Femling	et	al29	reported	that	patients	who	arrived	at	the	ED	via	EMS	had	shorter	time	to	central	line	placement	(required	for	central	venous	pressure	monitoring)	than	those	who	arrived	by	other	means	(EMS:	200	min	(IQR	89-368min)	vs	non-EMS:275	min	(IQR	122-470	min),	difference	75	min,	p<0.01),	while	Guerra	et	al32	noted	 that	when	EMS	provided	a	 sepsis	pre-alert	 to	 the	hospital	 the	 advance	notification	it	did	not	impact	the	decision	to	place	a	central	venous	catheter	(EMS	pre-alert:	 61%	vs	no	EMS	pre-alert:	68%,	p=0.54).	Although	Seymour	et	 al111	reported	 that	 higher	 proportion	 of	 patients	 achieved	 a	 SvcO2>70%	 within	 6	hours	when	EMS	initiated	fluid	therapy	prior	to	arriving	at	the	ED,	the	unadjusted	Risk	Ratio	(RR)	found	no	evidence	of	a	difference	(EMS	IV	fluids:	13/24	(54%)	vs	no	IV	fluids:	9/25	(36%),	unadjusted	RR	1.5,	95%CI	0.8-2.9).	This	same	study	also	identified	no	improvement	in	time	to	MAP>65mmHg	(EMS	IV	fluids:	17/24	(70%)	vs	no	IV	fluids:	12/26	(44%),	unadjusted	RR	1.53	(95%	CI	0.9-2.65)),	and	time	to	CVP>8	mmH20	(EMS	IV	fluids:	15/25	(60%)	vs	no	IV	fluids:	17/24	(70%),	unadjusted	RR	1.2	(95%	CI	0.8-1.8)).111	Studnek	et	al27	reported	that	if	patients	arrived	by	EMS	they	had	shorter	times	to	EGDT	than	if	they	arrived	by	other	means	(EMS:	119min	vs	non-EMS:160	min,	SD/range	 not	 reported,	 p=0.005).	 Furthermore,	 among	 EMS	 transported	patients,	if	EMS	documented	suspicion	of	sepsis	then	time	to	EGDT	was	shorter	than	if	they	did	not	document	suspicion	of	sepsis	(documented	suspicion:	69min	vs	not	documented:	131	min,	SD/range	not	reported,	p=0.001).	McClelland	et	al33	similarly	 reported	 that	 time	 to	 delivery	 of	 the	 ’Sepsis	 6’	 (administration	 of	supplemental	 oxygen,	 intravenous	 fluids,	 antibiotics,	 measurement	 of	 venous	lactate,	 urine	 output,	 and	drawing	 blood	 to	 identify	 causative	 pathogen)	was	shorter	if	EMS	identified	sepsis	prior	to	arrival	at	hospital	(EMS	identified:	mean	
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205min	(SD	271min,	range	10-720min)	versus	not	identified:	mean	120	min	(SD	110,	17-450min).	
3.4.8	Impact	of	prehospital	care	on	clinical	outcomes	Six	 studies	 describing	 the	 impact	 of	 prehospital	 sepsis	 care,	 by	 ambulance	clinicians,	 on	 patient	 outcomes	were	 identified.29	 32	 33	 53	 55	 56	 One	 study	was	 a	randomised	controlled	trial55	while	five	studies	were	non-randomised	controlled	trials.29	32	33	53	56	Two	studies	were	published	in	abstract	form	only.29	55		The	level	of	evidence	across	the	studies	was	downgraded	from	LOW	quality	to	VERY	LOW	quality	 due	 to	 risk	 of	 bias,	 inconsistency,	 indirectness,	 imprecision	 and	publication	bias	(see	table	3.10).	
Impact	of	prehospital	care	on	Intensive	Care	Unit	care	VERY	LOW	quality	evidence	was	identifed,	from	four	non-randomised	trials,29	32	33	56	addressing	admission	to	intensive	care	(see	table	3.10).		One	of	the	studies	was	published	in	abstract	only.29		Guerra	et	al32	found	that	prehospital	care	did	not	lead	to	a	statistically	significant	reduction	in	length	of	intensive	care	unit	(ICU)	stay:	mean	7.3	days	(SD	6.8	days,	EMS	pre-alert)	 vs	8.4	days	 (SD	8.8	days,	 no	EMS	pre-alert,	 p=0.65).	 Similarly,	Femling	et	al29	failed	to	identify	any	reduction	in	length	of	stay	when	patients	arrived	by	EMS	versus	other	means:	15	days	(IQR	13-17	days,	EMS)	vs	14	days	(IQR	10-17	days,	non-EMS),	confidence	interval	and	p	value	not	given	but	stated	not	 significant.	 Conversely,	 McClelland	 et	 al33	 reported	 a	 large	 difference	 in	admission	 rates	 when	 EMS	 staff	 recognised	 and	 treated	 patients	 as	 septic	compared	to	when	sepsis	was	not	recognised:	4%	(EMS	identified)	versus	13%	(not	identified).	However,	it	should	be	noted	that	the	sample	size	was	very	small	indeed	 (n=23)	 and	 no	 confidence	 intervals	 or	 estimate	 of	 significance	 was	reported.	 Seymour	 et	 al56	 reported	 that	 prehospital	 vascular	 access	 reduced	intensive	care	unit	admission	adjusted	OR	0.41	(95%	CI	[0.24	-	0.70]).	However,	prehospital	 intravascular	 fluid	 therapy	 was	 not	 associated	 with	 reduced	 ICU	admission	(adjusted	OR	0.64;	95%CI	0.37-1.10).		
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Table	3.10	Summary	of	findings	(impact	on	outcomes)	
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Findings	
Impact	of	prehospital	care	upon	ICU	admission	4	 1996	 non-RCT	 very	serious1	 none		 not	serious2	 very	serious3	 very	serious4	 ⨁◯◯◯	VERY	LOW	 [Guerra	2013]	No	significant	reduction	in	length	of	stay:	mean	7.3	days	(SD	6.8days)	(Pre-alert)	vs	8.4	days	(SD	8.8	days)	(no	pre-alert)	(p=0.65).	[Femling	2014]		Length	of	stay:	15	days	(IQR13-17days)	(EMS)	vs	14days	(IQR	10-17days)	(non-EMS),	diff	1	day,	not	significant.		
[Seymour	2014]	Prehospital	vascular	access	reduced	ICU	admission	adjusted	OR	0.41	(95%	CI	0.24	-	0.70).	
[McClelland	2015]	ICU	admission:	4%	(1/23)	(EMS	identified)	vs	13%	(3/23)	(not	identified).	
Impact	of	prehospital	care	upon	mortality	5	 2959	 non-RCT	 very	serious1	 none	 not	serious2	 very	serious3	 very	serious4	 ⨁◯◯◯	VERY	LOW	 [Band	2011]	No	significant	difference	in	mortality	was	noted:	adjusted	RR	1.24	(95%	CI	0.92	-	1.66)	(p=0.16).		[Guerra	2013]	If	hospital	was	‘pre-alerted’,	unadjusted	mortality	was	improved	OR	3.19	(95%	CI	1.14–	8.88)	(p=0.04)	
[Femling	2014]		No	significant	difference	in	mortality	was	noted	113/378	(30%)	(EMS)	vs	34/107	(31%)	(non-EMS),	diff	1%,	not	significant.		
[Seymour	2014]	Prehospital	vascular	access	reduced	mortality	adjusted	OR	0.31	(95%	CI	0.17	-	0.57)	(p<0.01).	
[McClelland	2015]	3	month	mortality	21%	(5/24)	(EMS	identified)	vs	16%	(4/25)	(not	identified).		
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Impact	of	prehospital	antimicrobial	therapy	on	ICU	admission	1	 199	 RCT	 not	serious1	 none	 not	serious2	 very	serious3	 very	serious5	 ⨁◯◯◯	VERY	LOW	 [Chamberlain	2009]	Mean	ICU	length	of	stay:	reduced	6.8	±	2.1	days	(intervention)	vs	11.2	±	5.2	days	(control)	(p=0.001).		
Impact	of	prehospital	antimicrobial	therapy	on	mortality	1	 199	 RCT	 not	serious1	 none	 not	serious2	 very	serious3	 very	serious5	 ⨁◯◯◯	VERY	LOW	 [Chamberlain	2009]	28-day	mortality	reduced:	42.4%	(intervention)		vs	56.7%	(control),	OR	0.56	(95%	CI	0.32	to	1.00)	(p=0.049)		
Impact	of	prehospital	intravenous	fluid	therapy	on	ICU	admission	1	 1350	 non-RCT	 not	serious1	 none	 not	serious2	 none	 none	 ⨁◯◯◯	VERY	
LOW	 [Seymour	2014]	Prehospital	fluids	did	not	reduce	likelihood	of	ICU	admission	adjusted	OR	0.64	(95%	CI	0.37-1.10).		
Impact	of	prehospital	intravenous	fluid	therapy	on	mortality	2	 2313	 non-RCT	 not	serious1	 none	 not	serious2	 very	serious3	 none	 ⨁◯◯◯	VERY	
LOW	 [Band	2011]	No	significant	difference	in	mortality	was	noted:	adjusted	RR	1.24	(95%	CI	0.92	-	1.66)	(p=0.16).	[Seymour	2014]	Prehospital	fluids	reduced	hospital	mortality	adjusted	OR	0.46	(95%	CI	0.23-0.88)	(p=0.02).		non-RCT:	non-randomised	controlled	trial	(observational	study),	IQR:	inter	quartile	range,	EMS:	Emergency	Medical	Services,	SD:	standard	deviation,	MAP:	mean	arterial	pressure,	IV:	intravascular,		RR:	risk	ratio,	95%	CI:	95%	confidence	interval’	CVP:	central	venous	pressure,	EGDT:	early	goal	directed	therapy,	OR:	odds	ratio,	ICU:	intensive	care	unit.	1. See	risk	of	bias	table	2. Single	centre	studies	may	limit	generalizability.	3. Small	study	numbers	limits	precision/accuracy.		Failure	to	report	confidence	intervals	4. Includes	abstract	only	oublications.	Publication	bias	likely	(Guerra)	5. Abstract	only	publication,	insufficient	detail	to	rule	out	other	bias	
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Impact	of	prehospital	care	on	mortality	VERY	LOW	quality	evidence	was	identified,	from	five	non-randomised	trials,29	32	33	53	56	addressing	mortality	(see	table	3.10).		One	of	the	studies	was	published	in	abstract	form	only.29		Band	et	al53	did	not	find	any	significant	difference	in	mortality	adjusted	RR	1.24	(95%	CI	0.92	-	1.66,	p=0.16).	Femling	et	al29	also	failed	to	report	any	significant	difference	 in	 their	 study	 comparing	 patients	 arriving	 via	 EMS	 with	 patients	arriving	by	other	means.	They	identified	that	113/378	(30%,	arrived	by	EMS)	vs	34/107	 (31%,	 arrived	 by	 other	 means)	 patients	 died,	 neither	 confidence	intervals	nor	 the	p-value	was	given,	but	 there	was	a	statement	 that	statistical	analysis	failed	to	achieve	significance.		Guerra	et	al32	noted	that	if	EMS	providers	pre-alerted	the	hospital	that	a	patient	with	sepsis	was	 enroute	 to	 them	 that	unadjusted	mortality	was	 improved	OR	3.19	 (95%	 CI	 1.14–	 8.88,	 p=0.04),	 however	 no	 adjusted	 point	 estimate	 was	reported.		McClelland	et	al33	found	a	difference	in	mortality	rates	when	EMS	staff	recognised	 and	 treated	 patients	 as	 septic	 compared	 to	 when	 sepsis	 was	 not	recognised:	21%	(EMS	identified)	versus	16%	(not	identified).	Finally,	Seymour	
et	al56	reported	that	prehospital	vascular	access	reduced	mortality	adjusted	OR	0.31	(95%	CI	0.17	-	0.57,	p<0.01).	
Impact	of	prehospital	antibiotic	therapy	VERY	 LOW	 quality	 evidence	 was	 identified	 from	 one	 randomised	 controlled	trial,55	 reporting	 the	 impact	 on	 outcomes	 for	 patients	 receiving	 prehospital	antibiotics	 (see	 table	3.10).	 	 This	 study	was	published	 in	 abstract	 form	only.	Chamberlain55	reported	that	prehospital	antibiotic	therapy	leads	to	reduced	ICU	stay	 (mean	 ICU	 stay:	 6.8±2.1	 days	 (intervention)	 vs	 11.2±5.2	 days	 (control),	p=0.001)	 and	 reduced	 mortality	 (28-day	 mortality:	 42.4%	 (intervention)	 vs	56.7%	(control);	Odds	Ratio	(OR)	0.56;	95%CI	0.32-1.00).		
Impact	of	prehospital	intravascular	fluid	therapy	VERY	LOW	quality	evidence	was	identified,	from	two	non-randomised	controlled	trials,53	56	reporting	impact	on	outcomes	for	patients	receiving	prehospital	fluid	therapy	(see	table	3.10).		Band	et	al53	reported	that	initiation	of	intravascular	fluid	therapy	by	EMS	does	not	improve	mortality	(adjusted	Risk	Ratio	(RR)	1.24;	95%	CI	0.92	-	1.66).	The	
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only	 study	 to	 demonstrate	 a	 positive	 impact	 following	 prehospital	 fluid	administration	 among	 sepsis	 patients	 indicated	 that	 prehospital	 fluids	 were	associated	with	reduced	likelihood	of	organ	failures	(adjusted	OR	0.58;	95%CI	0.34-0.98)	and	reduced	hospital	mortality	(adjusted	OR	0.46;	95%CI	0.23-0.88),	but	not	reduced	ICU	admission	(adjusted	OR	0.64;	95%CI	0.37-1.10).56		
3.5	Discussion	Limited	evidence	supports	the	argument	that	ambulance	services	may	provide	care	 for	 a	 “not	 insignificant”	 number	 of	 patients	 with	 sepsis.	 However,	 the	evidence	identified	relates	predominantly	to	the	USA,	with	little	robust	evidence	pertinent	 to	 the	 UK.	 International	 evidence	 indicates	 sepsis	 may	 account	 for	more	than	3%	of	ambulance	workload.	Furthermore,	a	small	number	of	studies	each	 report	 that	 patients	 admitted	 to	 Intensive	 Care	 from	 the	 Emergency	Department	 are	 likely	 to	 have	 arrived	 at	 hospital	 via	 the	 ambulance	 service,	suggesting	ambulance	services	may	care	for	a	significant	proportion	of	critically	ill	sepsis	patients.		Identification	 of	 sepsis	 can	 be	 challenging.	 There	 is	 no	 single	 reliable	 test	 or	marker	to	confirm	sepsis.	Potential	predictors	of	sepsis	have	been	summarised	in	table	3.6.		The	studies	identified	in	this	systematic	review	suggest	accuracy	of	prehospital	sepsis	recognition	by	ambulance	clinicians	varies	considerably.	This	variation	 could	 have	 numerous	 causes.	 In	 many	 areas	 paramedic	 education	programs	have	not	focussed	sufficient	attention	on	sepsis	as	a	clinical	syndrome	and	 paramedic	 knowledge	 of	 sepsis	 is	 often	 poor.17	 28	 38	 112	 It	 is	 possible	 that	ambulance	clinicians	encounter	sepsis	patients	earlier	 in	 their	clinical	course,	before	 they	 become	 seriously	 ill,	 and	 it	 is	 also	 not	 known	 if	 in-hospital	 and	prehospital	 clinical	 assessments,	 such	 as	 blood	 pressure,	 correlate	 in	 sepsis	patients.	An	additional	factor	may	be	that	routine	in-hospital	tests	such	as	white	cell	count	and	lactate	are	not	commonly	used	within	EMS,	which	may	limit	the	ability	to	extrapolate	from	in-hospital	studies.		Many	prehospital	sepsis	screening	tools	rely	upon	the	Surviving	Sepsis	Campaign	Systemic	Inflammatory	Response	Syndrome	(SIRS)	criteria	which	were	initially	described	 to	 improve	 sepsis	 recognition	 in	 the	 ED	 and	 intensive	 care	environments.	Although	SIRS	describe	physiologic	signs	marking	the	transition	from	 infection	 to	 sepsis	 they	 lack	 specificity	 for	 sepsis.	 SIRS	 are	 observable	following	a	wide	variety	of	insults	other	than	infection,	leading	some	to	question	
PRoSAiC	Thesis	
55	
the	value	of	SIRS	to	identify	sepsis.16	20	 	Churpek	et	al16	recently	demonstrated	that	SIRS	criteria	were	not	reliable	predictors	of	sepsis	or	mortality	in	the	ward	setting.	Use	of	SIRS	criteria	to	identify	sepsis	in	the	prehospital	environment	may	therefore	be	equally	ineffective.			The	three	studies	documenting	the	development	of	prehospital	screening	tools	for	 sepsis	 included	 more	 organ	 dysfunction	 criteria	 and	 included	 non-SIRS	variables	(see	table	3.6).	Among	these	tools	sensitivity	for	severe	sepsis	ranged	from	 0.76	 to	 0.85	while	 specificity	 ranged	 from	 0.47	 to	 0.86;	 they	 appear	 to	perform	better	than	tools	based	upon	the	SIRS	diagnostic	criteria.	However,	none	have	been	clinically	validated.		In-hospital	data	indicate	that	early	identification	and	initiation	of	treatment	can	improve	 outcomes	 from	 severe	 sepsis.	 Recognition	 of	 sepsis	 in	 the	 patient’s	home	or	in	the	ambulance	before	arriving	at	the	ED	has	the	potential	to	further	reduce	time	to	diagnosis	and	potentially	to	reduce	time	to	a	limited	number	of	treatments;	this	in	turn	could	lead	to	further	improved	patient	outcomes.	There	have	 been	 a	 limited	 number	 of	 studies	 that	 have	 attempted	 to	 demonstrate	improved	outcomes	following	prehospital	recognition	of	sepsis.		Studnek	et	al27	report	that	prehospital	identification	lead	to	a	reduction	in	time	to	EGDT	(69	vs	131	minutes,	95%	CI	not	reported,	p=0.001)	as	well	as	a	reduction	in	time	to	antibiotic	therapy	(70	vs	122	minute,	95%	CI	not	reported,	p=0.003).	Seymour	 et	 al	 (2010b)	 reported	 that	 if	 EMS	 administered	 intravenous	 fluids	before	arriving	at	hospital	a	larger	proportion	of	severe	sepsis	patients	achieved	Mean	Arterial	Pressures	>65mmHg	within	6	hours	(EMS	IVF	70%	vs	no	IVF	44%)	however	 this	 result	was	not	 statistically	 significant	 (p=0.09).	Neither	of	 these	studies	demonstrated	a	reduction	in	mortality.		Bayer	et	al102	estimated	that	median	time	to	both	intravenous	fluid	therapy	and	antibiotics	was	19	minutes	from	call	time	when	prehospital	doctors	took	part	in	a	 small	 German	 study.	 However,	 this	 estimate	 assumed	 that	 both	 fluids	 and	antibiotics	would	be	administered	within	10	minutes	of	arriving	on	scene	and	was	 not	 verified	 from	 records.	 Band	 et	 al53	 reported	 that	 if	 EMS	 personnel	identified	sepsis	that	antibiotics	were	administered	36	minutes	sooner	and	fluids	administered	34	minutes	sooner	following	arrival	at	hospital.			
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The	 only	 study	 thus	 far	 that	 has	 demonstrated	 improved	 outcomes	 from	prehospital	 intervention	 was	 conducted	 by	 Chamberlain55	 who	 showed	 if	paramedics	 administered	 ceftriaxone	 in	 the	 ambulance	 that	patients	 received	this	treatment	3.4±2.6	hours	sooner	than	if	they	had	waited	until	hospital	arrival,	and	furthermore	that	28-day	mortality	was	reduced	from	56.7%	to	42.4%	(OR	0.56,	95%	CI	0.32	to	1.00,	p=0.049).		One	 plausible	 explanation	 for	 the	 apparent	 failure	 to	 demonstrate	 improved	outcomes	could	be	that	prehospital	clinicians	struggle	to	recognise	sepsis	and	therefore	 do	 not	 intervene	 soon	 enough,	 aggressively	 enough,	 or	 frequently	enough.	Many	prehospital	sepsis	studies	identified	in	this	systematic	review	rely	on	 an	 adaptation	 of	 traditional	 in-hospital	 diagnostic	 criteria.	 However,	 the	prehospital	environment	presents	unique	challenges	which	 limit	 the	ability	to	extrapolate	from	studies	conducted	in	hospitals.	For	example,	the	time	window	for	assessment	is	limited,	patients	present	earlier	in	their	course	of	illness	and	there	is	limited	access	to	supportive	investigations	such	as	white	blood	cell	count,	microscopy/culture	or	diagnostic	imaging.				
3.6	Limitations	This	 systematic	 review	employed	a	broad	 search	 strategy	 to	 capture	 as	much	published	 literature	 as	 possible.	 Inclusion	 criteria	 were	 intentionally	 not	restrictive	to	include	as	much	of	the	evidence	base	as	possible.	Despite	using	very	broad	search	criteria,	little	robust	evidence	regarding	sepsis	in	the	prehospital	environment	 was	 identified.	 The	 studies	 found	 employed	 disparate	methodologies,	 exhibit	 significant	 heterogeneity,	 generally	 involve	 small	numbers	 of	 patients	 (limiting	 the	 precision	 of	 reported	 results)	 and	 were	invariably	 of	 very	 low	 quality.	 The	 conclusions	 that	 can	 be	 drawn	 from	 this	systematic	review	are	therefore	limited	and	findings	should	be	interpreted	with	caution.	
3.7	Recently	published	evidence	This	 systematic	 review	 summarises	 the	 findings	 of	 searches	 for	 evidence	published	 before	 July	 2015.	 The	 chapter	 was	 not	 formally	 updated	 prior	 to	submission	of	the	thesis	in	November	2017	as	two	publications	(see	Appendix	
1.1		and	1.2)	had	already	been	secured	in	2016.	This	section	serves	to	update	the	
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chapter	with	more	recent	publications	relevant	 to	 the	 topic,	without	 formally	updating	the	chapter.		Two	 further	 papers	 reporting	 the	 incidence	 of	 sepsis	 among	 ambulance	transports	were	 identified.	Tusgul	et	 al	 identified	 that	among	11411	patients	transported	to	a	university	hospital,	3.8%	were	confirmed	to	have	sepsis	in	the	ED.113	 Intheir	 study,	Walchok	 et	 al114	 reported	 that	 1185	 of	56643	 (2.1%)	 of	patients	transported	by	EMS	received	a	Sepsis	alert.	Of	these,	848	received	an	admitting	diagnosis	 of	 sepsis	 (1.5%).	However,	 the	 authors	do	not	 report	 the	proportion	of	missed	 cases,	 that	 is	 the	proportion	of	patients	who	 received	a	sepsis	diagnosis	at	hospital	but	did	not	receive	a	sepsis	alert	from	EMS.		One	study	that	reported	the	correlation	of	individual	variables	with	the	outcome	of	sepsis.	Hunter	et	al115	reported	that	the	area	under	the	ROC	curve	predicting	sepsis	dependent	upon	end	tidal	carbon	dioxide	(EtCO2) was	0.99	(95%	CI	0.99-1.00)	and	for	temperature	was	0.64	(95%	CI	0.64-0.71).	The	area	under	the	ROC	curve	 predicting	 severe	 sepsis	 for	 EtCO2	 was	 0.80	 (95%	 CI	 0.73-0.86),	 for	temperature	was	0.41	(95%	CI	0.33-0.49),	for	SBP	was	0.65	(95%	CI	0.57-0.73),	for	DBP	was	0.64	(95%	CI	0.55-0.72),	and	for	Sp02	was	0.59	(95%	CI	0.52-0.68).	115		Two	 studies	 addressed	 the	 use	 of	 lactate	 and	 EtCO2	 to	 improve	 detection	 of	sepsis.	In	an	observational	study	of	112	patients	meeting	SIRS	criteria	for	sepsis	(heart	 rate	 >90bpm,	 Respiratory	 rate	 >20	 bpm,	 body	 temperature	 <36˚C	 or	>38˚C),	Boland	et	al116	assessed	the	potential	beneficial	effect	of	obtaining	lactate	readings	during	prehospital	assessments.	Elevated	prehospital	 lactate	was	not	associated	with	diagnosis	of	sepsis,	increased	hospital	admission,	ICU	admission,	length	 of	 hospital	 stay	 or	 mortality.	 They	 concluded	 that	 including	 lactate	measurements	 did	 not	 achieve	 a	 level	 of	 diagnostic	 accuracy	 in	 identifying	patients	with	severe	sepsis	or	septic	shock	that	would	warrant	measurement	of	lactate	in	the	field.	116		In	 a	 methodologically	 similar	 study,	 Hunter	 et	 al115	 assessed	 the	 potential	beneficial	effect	of	including	EtCO2	readings,	to	improve	sepsis	stratification	by	paramedics.	Their	study	included	330	patients	meeting	sepsis	alert	criteria	of	heart	rate	>90bpm,	Respiratory	rate	>20	bpm	and	body	temperature	<36˚C	or	>38˚C.	Patients	were	subsequently	stratified	according	 to	EtC02.	 	147	patients	
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had	 EtC02>25mmHg,	 while	 183	 patients	 had	 EtC02=<25mmHg.	 For	 patients	meeting	 the	 sepsis	 alert	 criteria	 with	 EtCO2=<25mmHg,	 sensitivity	 for	predicting	sepsis	was	0.69	(95%	CI	0.62-0.75),	the	specificity	was	0.67	(95%	CI	0.57-0.75),	the	PPV	was	0.78	(95%	CI	0.70-0.84),	and	the	NPV	was	0.99	(95%	CI	0.92-1.0).	The	 sensitivity	 for	predicting	 severe	 sepsis	was	0.90	 (95%	CI	081-0.95),	 the	specificity	was	0.58	(95%	CI	0.52-0.65),	 the	PPV	was	0.47	(95%	CI	0.39-0.97),	 and	 the	 NPV	 was	 0.93	 (95%	 CI	 0.87-0.97).	 The	 sensitivity	 for	predicting	mortality	was	0.76	(95%	CI	0.54-0.90),	the	specificity	was	0.46	(95%	CI	0.40-0.52),	 the	PPV	was	0.11	 (95%	CI	0.07-0.18),	 and	 the	NPV	was	0.95%	(95%	CI	0.90-0.98).	The	sensitivity	for	predicting	ICU	admission	was	0.67	(95%	CI	0.57-0.76),	the	specificity	was	0.50	(95%	CI	0.43-0.57),	the	PPV	was	0.41	(95%	CI	0.33-0.49),	and	the	NPV	was	0.75	(95%	CI	0.66-0.	82).	115		Three	recent	studies	report	the	effectiveness	of	screening	tools.	Dorsett	et	al117	reported	 a	 series	 of	 ED	 1255	 patients,	 of	 whom	560	 did	 not	 arrive	 by	 EMS.	Following	exclusions,	only	152	patients	were	included.	Of	these,	71	had	infection,	38	had	sepsis	and	43	had	severe	sepsis	or	septic	shock.	Among	these	patients,	performance	characteristics	for	the	qSOFA	score	were	as	follows,	sensitivity	0.16	(95%	CI	 0.07–0.31),	 specificity	 0.97	 (95%	CI	 0.92–0.99),	 positive	 likelihood	 ratio	(PLR)	5.91	(95%	CI	1.6–21.8)	and	negative	likelihood	ratio	(NLR)	0.86	(95%	CI	0.8	–	1.0). 117	The	authors	conclude	that	qSOFA	has	poor	sensitivity	to	detect	sepsis	in	the	prehospital	environment.117		Jouffrey	et	 al118	 reported	 a	 very	 small	 series	of	37	patients	with	 septic	 shock	attended	by	Paris	SAMU.	SAMU	is	a	prehospital	system	that	includes	a	doctor	as	part	 of	 the	 clinical	 team.	 Nine	 patients	 died	 by	 day	 28.	 Performance	characteristics	 of	 different	 screening	 tools	 were	 as	 follows	 (95%	 CI	 not	reported):	118		Modified	Robson	Tool:		sensitivity	100%,	specificity	16%,	PPV	39%,	NPV	100%	qSOFA>=2:	sensitivity	62%,	specificity	16%,	PPV	29%,	NPV	44%	MEWS>=5:	sensitivity	85%,	specificity	33%,	PPV	41%,	NPV	80%	PRESEP>=4:	sensitivity	92%,	specificity	29%,	PPV	41%,	NPV	88%		Tusgul	et	al	reported	that	a	pre-hospital	qSOFA>=2	had	a	sensitivity	of	36.3%	for	ICU	admission,	17.4%	for	ICU	stay	of	three	days	or	more	and	68.0%	for	48-hour	mortality.113	The	sensitivity	of	two	or	more	SIRS	criteria	reached	68.8%	for	ICU	
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admission,	 74.6%	 for	 ICU	 stay	of	 three	days	or	more	 and	64.0%	 for	48-hour	mortality.	Confidence	intervals	were	not	reported.113	
 
 Three	additional	papers	address	the	impact	of	prehospital	care	on	subsequent	management	in	hospital.	Axelsson	et	al119		reported	on	a	cohort	of	696	patients	who	attended	the	ED	who	were	subsequently	diagnosed	with	bacteraemia.	They	noted	308	patients	 arrived	 by	 EMS,	 infection	was	 suspected	 in	32%	 of	 these	cases	but	only	6%	of	cases	were	identified	as	possible	septicaemia	by	the	EMS	nurse.	Patients	arriving	by	ambulance	received	antibiotics	over	2	hours	sooner	(3	hours	15	min	vs	58	min).	Impact	on	outcomes	was	not	reported.119		Carberry	et	al120	noted	 that	 the	 introduction	of	a	sepsis	screening	 tool,	 in	 the	Scottish	Ambulance	Service	in	the	Lanarkshire	region,	reduced	the	time	to	triage	by	82%	(17	minutes	vs	3	minutes)	and	reduced	the	time	to	antibiotics	by	39%	(49	minutes	vs	30	minutes).	They	failed	to	report	impact	on	outcomes.120		Results	of	the	PHANTASi	study	were	published	online	in	late	Novemebr	2017. 121	This	study	enrolled	2698	patients,	with	1535	in	the	intervention	arm	and	1137	in	 the	 usual	 care	 arm.	 Patients	 in	 the	 intervention	 arm	 received	 prehospital	antibiotics	while	those	in	the	usual	care	arm	received	antibiotics	at	hospital.	The	primary	 outcome	was	 all	 cause	mortality	 at	 28	days.	 The	 intervention	 group	received	antibiotics	a	median	of	26	minutes	before	arriving	at	hospital	whereas	the	usual	care	group	received	antibiotics	70	minutes	after	arriving	at	hospital.	There	was	no	difference	in	outcomes	at	28	days.	In	the	intervention	group,	120	(8%)	of	patients	died.	In	the	usual	care	group	93	(8%)	died	(relative	risk	0·95,	95%	CI	0·74–1·24). 121 
 These	additional	publications	are	consistent	with	the	findings	of	the	systematic	review.	 An	 additional	 systematic	 review	 of	 prehospital	 recognition	 and	management	 of	 sepsis	 was	 published	 by	 Lane	 et	 al122	 that	 also	 confirms	 the	findings	reported	previously.	The	signal	from	the	various	papers	is	consistent	with	the	findings	reported	in	the	publications	arising	from	this	chapter.		
3.8	Conclusion	This	chapter	has	reported	a	 large	systematic	review.	 It	 identifies	 that	 there	 is	little	 robust	 evidence	 addressing	 sepsis	 in	 the	 prehospital	 environment.	 The	available	 evidence	 is	 generally	 of	 very	 low	 quality,	 and	more	 often	 than	 not,	
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comprises	very	small	study	populations.	The	review	has	collated	available	data	concerning	 the	 incidence	 of	 sepsis	 in	 the	 prehospital	 environment.	 Known	predictor	variables	have	been	identified	and	diagnostic	accuracy	with	respect	to	recognition	of	sepsis	by	ambulance	clinicians	has	been	reported,	while	accuracy	of	existing	prehospital	sepsis	screening	tools	has	also	been	established.			Sepsis	patients	represent	a	small,	but	important,	group	of	patients	managed	by	ambulance	 services,	 potentially	 up	 to	 3%	 of	 workload.	 Ambulance	 clinicians	could	play	an	important	role	in	reducing	time	to	identification	of	sepsis	for	this	group	of	patients.	However,	recognition	of	sepsis	in	the	prehospital	environment	is	challenging.	At	present	 the	available	data	suggest	 that	ambulance	clinicians	struggle	 to	 identify	patients	with	sepsis,	 and	 that	ambulance	 clinicians	would	benefit	from	further	education	to	improve	their	understanding	of	sepsis.			This	systematic	review	further	demonstrates	that	early	identification	of	sepsis	in	the	prehospital	environment	can	lead	to	improvements	in	processes	of	care,	and	expediting	 of	 patient	 passage	 through	 the	 emergency	 care	 pathway.	 Thus	 far,	however,	the	evidence	indicates	that	early	recognition	alone	does	not	translate	into	 improved	 clinical	 outcomes	 for	 patients.	 Research	 indicating	 that	prehospital	antibiotic	therapy	and	fluid	resuscitation	leads	to	improved	patient	outcomes	 is	 currently	 lacking.	Research	quantifying	 the	 impact	 of	prehospital	antibiotic	 administration	 on	 subsequent	 hospital	 care,	 and	 appropriate	antibiotic	 stewardship	 is	 also	 lacking.	 There	 may	 be	 scope	 for	 ambulance	clinicians	 to	 deliver	 a	 limited	 number	 of	 important	 interventions,	 such	 as	intravenous	 fluid	 therapy	 and	 antimicrobial	 therapy,	 provided	 it	 can	 be	demonstrated	 that	 ambulance	 clinicians	 are	 able	 to	 consistently	 recognise	patients	with	sepsis.			The	development	and	validation	of	a	reliable	prehospital	sepsis	screening	tool	has	been	called	for	and	should	be	considered	a	priority	for	improving	prehospital	care	of	sepsis	patients.	Thereafter,	well	conducted	studies	addressing	diagnostic	accuracy	 and	key	 clinical	 interventions,	 such	 as	 antibiotic	 administration	 and	fluid	resuscitation	will	be	required.	 	
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Chapter	4	
Study	data 
 
4.1	Introduction	This	chapter	describes	the	datasets	used	in	this	study.	It	will	also	address	how	the	 data	 were	 cleaned	 and	 processed	 to	 ensure	 subsequent	 analyses	 were	reliable.		
4.2	Datasets	This	study	utilises	two	distinct	datasets.	The	first	dataset	was	supplied	by	West	Midlands	Ambulance	Service	NHS	Foundation	Trust	(WMAS)	and	comprises	all	patients	 managed	 by	 WMAS	 and	 transported	 to	 University	 Hospital	 North	Staffordshire	NHS	Foundation	Trust	(UHNS)	between	01	July	2013	and	30	June	2014.	 The	 second	 dataset	 is	 supplied	 by	 UHNS	 and	 comprises	 all	 patients	attending	the	Emergency	Department	(ED)	who	arrived	by	ambulance	between	01	July	2013	and	01	July	2014.	An	additional	day	of	ED	data	was	requested	to	ensure	that	ambulance	cases	assigned	just	prior	to	midnight	on	30	June	2014,	but	 arriving	 at	 hospital	 following	 midnight	 on	 01	 July	 2014	 could	 be	appropriately	paired.	The	study	period	comprises	01	July	2013	to	30	June	2014.	Each	patient	visit	is	considered	a	unique	case.	
Most	cases	supplied	by	WMAS	were	transported	to	the	ED	at	UHNS.	However,	a	proportion	 were	 transported	 to	 other	 departments,	 for	 example	 the	 Surgical	Assessment	Unit.	Similarly,	most	cases	supplied	by	UHNS	ED	were	patients	who	arrived	 by	 WMAS	 ambulance,	 but	 a	 small	 proportion	 will	 have	 arrived	 by	 a	different	ambulance	provider,	for	example	St	John	Ambulance	(see	figure	4.1).	The	overwhelming	majority	of	 ambulance	 cases	arriving	at	 the	ED	on	01	 July	2014	will	have	no	corresponding	ambulance	record,	as	the	call	to	the	ambulance	service	is	likely	to	originate	on	01	July	2014	and	these	data	were	not	provided.	
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Figure	4.1	Relationship	between	datasets	
	PRF	–	patient	report	form		
4.2.1	Ambulance	Service	data	During	the	study	period,	two	distinct	methods	for	documenting	patient	care	were	in	operation	within	WMAS.	The	primary	method	of	documenting	patient	care,	accounting	for	approximately	75%	of	patient	encounters	in	the	region,	was	the	electronic	patient	report	form	(ePRF).	Electronic	Care	Solution	(ECS)	was	based	upon	 Siren	 ePCR®,	 developed	 by	 Medusa	 Medical	 Technologies	 of	 Halifax,	Canada.	The	remaining	cases	were	documented	on	paper	patient	report	forms	(pPRF’s).	Per	WMAS	operational	instruction,123	pPRF’s	are	only	to	be	used	when	the	 responding	 ambulance	 resource	 is	 not	 fitted	 with	 the	 required	 tablet	computer,	or	there	is	a	failure	of	the	tablet	computer.		
Data	from	the	ePRF	are	stored	in	a	relational	database	housed	on	the	NHS	Spine.	The	NHS	Spine	supports	the	Information	Technology	(IT)	infrastructure	for	the	NHS	 for	 Health	 and	 Social	 Care	 and	 is	 maintained	 by	 NHS	 Digital.	 It	 allows	information	to	be	shared	securely	through	national	services	such	as	the	Electonic	Prescription	 Service,	 Summary	 Care	 Record	 and	 the	 e-Referral	 Service.	 Paper	PRF’s	are	collated	at	local	ambulance	station	level	and	transported,	securely,	to	WMAS	 headquarters	where	 they	 are	 scanned.	 Specialist	 scanning	 software	 is	used	 to	 extract	data	 from	 the	 pPRF	and	 import	 them	 into	 a	Microsoft	 Excel®	
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spreadsheet.	There	is	approximately	eight	weeks’	delay	between	completion	of	the	clinical	case	and	electronic	availability	of	data	from	pPRFs.	
4.2.1.1	Data	requested	from	the	Ambulance	Service	All	WMAS	records	for	patients	transported	to	UHNS	between	01	July	2013	and	30	 June	 2014	 were	 requested.	 Detail	 concerning	 which	 data	 fields	 were	requested,	and	which	were	provided,	are	reported	in	table	4.1.	
Table	4.1	Data	requested	from	WMAS	Category	 Variable	 Provided	Incident	details	 Date	of	call	 Yes	Time	of	call	 Yes		 Ambulance	incident	number	 Yes		 Location	address	(including	postcode)	 Yes		 Dispatch	Complaint	 Yes		 Dispatch	Priority	 Yes	Ambulance	details	 Call	sign	 Yes	Time	assigned	 Yes		 Time	mobile	 Yes		 Time	arrived	 Yes		 Time	leaving	scene	 Yes		 Time	at	hospital	 Yes		 Hospital	department	 No	Patient	details	 Name	 Yes	Surname	 Yes		 Age	 Yes		 Date	of	birth	 Yes		 Gender	 Yes		 Ethnicity	 Yes1		 Address	(including	post	code)	 Yes		 Past	medical	history	 No	Clinical	observations	 Respiratory	rate	 Yes	Peripheral	oxygen	saturations	(SpO2)	 Yes		 End	tidal	carbon	dioxide	(EtCO2)	 Yes1		 Heart	rate	 Yes		 Blood	pressure	 Yes		 Capillary	bed	refill	time	(CBRT)	 Yes		 Blood	glucose	 Yes		 Temperature	 Yes		 Glasgow	coma	score	(GCS)	 Yes		 Alert/Verbal/Pain/Unresponsive	score	(AVPU)	 Yes		 Pupil	response	 Yes		 Pupil	size	 Yes	Interventions	 Vascular	access	 Yes		 Endotracheal	intubation	 Yes		 Mechanical	ventilation	 No	Treatments	 Oxygen	therapy	 Yes		 Fluid	therapy	 Yes	Outcome	 Crew	diagnosis	 Yes2	1	–	very	little	data	provided,	very	high	proportion	of	missing	data	2	–	only	generic	physiological	category	e.g.	cardiac	provided	
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4.2.1.2	Missing	Ambulance	Service	data	All	the	missing	data	fields	were	visible	within	the	online	individual	ePRF	record	viewer,	however	WMAS	IT	were	unable	to	locate	which	fields	within	the	database	were	 being	 used	 to	 store	 the	 data,	 to	 facilitate	 extraction.	 I	was	 assured	 that	WMAS	 IT	 would	 identify	 and	 extract	 the	 missing	 data	 fields	 upon	implementation	 of	 a	 new	 patient	 record	 database	 in	 June	 2016	 (following	introduction	of	a	new	ePRF).	Consequently,	I	did	not	resort	to	manual	review	of	the	records	to	update	the	supplied	ambulance	data	with	the	missing	data	fields.	In	July	2016	I	was	informed	that	WMAS	would	not	be	able	to	extract	the	missing	data	fields	as	this	work	had	not	yet	been	scheduled	for	completion	by	the	new	ePRF	 vendor.	 Unfortunately,	 the	 ‘old’	 database,	 on	 the	 NHS	 spine,	 had	 been	decommissioned	 and	 was	 no	 longer	 available	 to	 allow	 manual	 review.	 As	 of	August	2017,	these	data	are	still	unavailable.	
4.2.1.3	Source	of	data	provided	by	the	Ambulance	Service	After	a	several	months	delay,	WMAS	confirmed	they	were	unable	to	provide	any	data	from	pPRF’s.	This	was	due	to	an	error	in	the	configuration	of	the	Optical	Character	Recognition	(OCR)	software	used	by	WMAS	that	had	not	previously	been	identified.	Ambulance	crews	document	transport	destination	by	entering	a	unique	hospital	code	in	a	specified	field	of	the	pPRF.	In	the	case	of	UHNS	the	code	is	“UNS”.	Unfortunately,	the	OCR	software	used	to	extract	the	data	from	the	pPRF	had	not	been	configured	correctly.	It	had	been	configured	to	read	the	three	letters	as	 three	 integers	 and	 consequently	 the	 OCR	 software	 failed	 to	 recognise	 any	hospital	 codes.	 The	 study	 approvals	 specify	 that	 data	 will	 be	 provided	 for	patients	transported	to	UHNS	only.	As	it	was	not	possible	for	WMAS	to	limit	the	extraction	of	data	to	the	subset	of	patients	transported	UHNS,	it	was	not	possible	to	obtain	data	from	patients	whose	care	was	documented	on	a	pPRF.	
Data	from	the	ePRF	were	extracted,	however	there	were	several	issues	with	the	data	provided.	As	previously	noted,	the	database	of	patient	records	is	housed	on	the	NHS	Spine,	and	is	not	maintained	by	WMAS.	Furthermore,	the	database	used	is	a	commercial	product	designed	primarily	for	hospital	use.	As	such,	there	are	several	 hundred	 fields	 that	 are	 not	 appropriate	 to	 the	 ambulance	 record	 (for	example	results	of	hospital	 laboratory	 tests	or	diagnostic	 imaging),	and	many	fields	required	by	ambulance	services	were	not	defined	within	the	commercial	product	 (for	 example	 ambulance	 arrival	at	 scene	 time).	 Several	 unused	 fields	within	 the	 commercial	 database	 were	 re-mapped	 to	 enable	 recording	 of	 key	
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ambulance	data.	However,	no	map	of	where	data	was	stored	was	available	to	the	WMAS	Information	Technology	(IT)	staff.	Consequently,	WMAS	IT	staff	struggled	to	locate	and	extract	all	the	data	fields	requested.	Clinical	 records	 for	45292	patients	were	provided	 in	several	Microsoft	Excel®	files.	WMAS	reported	that	extraction	of	the	requested	data	over	the	NHS	Spine	was	complex	and	time	consuming.	As	a	result,	data	were	extracted	one	month	at	a	time.	Over	a	12-week	period	12	Microsoft	Excel®	files	were	provided,	each	of	which	related	to	one	month	of	the	year	for	which	the	data	were	requested.	The	12	 files	 were	 subsequently	 merged	 by	 Michael	 Smyth	 (MAS)	 into	 a	 single	Microsoft	Excel®	file	that	was	used	for	data	cleaning	and	data	linkage.	
4.2.2	Emergency	Department	data	Documentation	of	care	 in	 the	Emergency	Department	(ED)	at	UHNS	 is	via	 the	Emergency	Department	Information	System	(EDIS)	PatientFirst®	software.		EDIS	PatientFirst®	is	an	electronic	health	record	that	facilitates	a	complete	electronic	record	of	care	provided	in	the	Emergency	Department.	However,	in	practice,	it	was	not	implemented	as	a	paperless	system	at	UHNS.	Patient	details	and	initial	triage	are	all	recorded	electronically.	Thereafter,	a	paper	copy	is	printed	and	the	ED	doctor/clinician	annotates	this	paper	copy	with	the	medical	history,	pertinent	findings	and	treatments	delivered.	These	hand-written	notes	are	then	scanned	and	appended	as	an	image	file	to	the	initial	electronic	record.		
4.2.2.1	Data	requested	from	the	Emergency	Department	All	ED	records	for	patients	who	arrived	by	ambulance	at	UHNS	between	01	July	2013	and	01	July	2014	were	requested.	Detail	concerning	which	data	fields	were	requested,	and	which	were	provided,	are	reported	in	table	4.2.	Clinical	records	for	48534	patients	were	supplied	as	a	Microsoft	Excel®	file.		
4.2.2.2	Missing	Emergency	Department	data	Informal	 discussion	 with	 UHNS	 revealed	 that	 much	 of	 the	 missing	 data	 was	stored	within	the	electronic	patient	record,	but	not	in	an	accessible	format.	As	previously	mentioned,	clinicians	frequently	enter	hand	written	notes	or	append	scanned	images	into	the	patient’s	electronic	record.	These	additions	cannot	be	searched	 electronically.	 Unfortunately,	 resources	 to	 manually	 extract	 this	information	and	append	it	to	the	electronic	record	were	not	available.		
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Table	4.2	Data	requested	from	UHNS	
Category	 Variable		 Provided	Hospital	arrival	 Date	 Yes	Time	 Yes	Hospital	record	number	 Yes		 Ambulance	call	sign	 No	Patient	details	 Name	 Yes	Surname	 Yes		 Age	 Yes		 Date	of	birth	 Yes		 Gender	 Yes		 Ethnicity	 Yes		 Address	(including	post	code)	 Yes	Clinical	observations	 Respiratory	rate	 Yes	Peripheral	oxygen	saturations	(SpO2)	 Yes		 End	tidal	carbon	dioxide	(EtCO2)	 No		 Heart	rate	 Yes		 Blood	pressure	 Yes		 Capillary	bed	refill	time	(CBRT)	 No		 Temperature	 Yes		 Blood	glucose	 Yes		 Glasgow	Coma	Score	(GCS)	 Yes1		 Alert/verbal/pain/unresponsive	score	(AVPU)	 No		 Pupil	reaction	 No		 Pupil	Size	 Yes		 Partial	pressure	of	oxygen	(PaO2)(in	ED)	 No		 Partial	pressure	of	carbon	dioxide	(PaCO2)(in	ED)	 No		 Lactate	(in	ED)	 No		 Creatinine	(in	ED)	 No	Laboratory	observations	(where	available)	
White	blood	cell	count	(WCC)	 Yes	Platelet	count	 Yes	International	Normalised	Ratio	(INR)	 Yes	Prothrombin	time	(PTT)	 Yes	Creatinine	 Yes		 Lactate	 Yes2		 Base	deficit	 No		 C-Reactive	Protein	(CRP)	 Yes		 Causative	pathogen	 No	Interventions	 Peripheral	vascular	access	 No		 Central	venous	access	 No		 Endotracheal	intubation	 No		 Mechanical	ventilation	 No	Treatments	 Oxygen	therapy	 No		 Fluid	therapy	 No		 Antibiotic	therapy	 No		 Vasoactive	drug	administration	 No	Outcome	 ED	diagnosis	 Yes		 Discharged	or	admitted?	 Yes		 Admission	details	 Yes		 Survived	or	died	 Yes		 Date	of	death	 Yes		 Time	of	death	 Yes		 Location	of	death	 Yes	1	–	high	proportion	missing,		2	-	very	low	proportion	reported		
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Consequently,	the	availability	of	data	was	dependent	upon	how	information	was	entered	into	the	record.	For	example,	when	the	hospital	laboratory	service	were	reporting	 results	 of	 laboratory	 analysis,	 appropriate	 data	 fields	 within	 the	electronic	 record	were	 remotely	updated.	However,	when	blood	analysis	was	undertaken	by	the	clinician	in	the	ED,	pertinent	results	were	hand	written	by	the	attending	clinician	in	the	narrative	section,	or	the	print	out	from	the	blood	gas	analysis	machine	is	scanned	as	an	image	file,	rather	than	individual	values	being	entered	in	the	appropriate	data	field	of	the	electronic	patient	record	(as	occurs	with	results	from	the	laboratory).		
4.3	Data	cleaning	Data	 cleaning	 is	 a	 term	 without	 a	 well-established	 definition.	 Although	 data	cleaning	targets	errors	in	data,	the	definition	of	what	is,	and	what	is	not	an	error,	can	be	highly	 subjective,	 depending	upon	 the	 application,	 and	purpose	of	 the	intended	 analysis.124	 	 Rahm	 et	 al125	 describe	 data	 cleaning	 as	 the	 process	 of	detecting	 and	 removing	 errors	 and	 inconsistencies	 from	 data,	 in	 order	 to	improve	data	quality.	 Chu	et	 al126	 assert	 that	 analysis	 of	 clean	data	 facilitates	improved	 decision	 making,	 whereas	 analysis	 of	 ‘dirty’	 data	 can	 generate	erroneous	understandings	and	incorrect	decisions.	Chu	et	al126	propose	that	data	cleaning	is	comprised	of	two	stages:	error	detection	and	error	repair.	Muller	and	Freytag124	suggest	that	data	errors	be	classified	as	errors	in	syntax,	semantics	or	coverage.			
4.3.1	Errors	in	the	data	
4.3.1.1	Errors	of	syntax	
Lexical	 anomalies	 refer	 to	 discrepancies	 between	 the	 data	 content	 and	 the	expected	format.	For	example,	one	would	expect	an	integer	value	in	a	variable	reporting	age,	however	a	case	may	have	an	entry	recorded	as	“male”	suggesting	the	data	has	been	erroneously	inputted	in	to	that	field.	Such	anomalies	may	be	amenable	to	correction,	depending	on	the	structure	of	the	remaining	variables.			
Domain	format	anomalies	refer	to	discrepancies	in	the	format	of	a	variable.	For	example,	 a	 name	 variable	might	 be	 formatted	 as	 “John	 Smith”,	 but	 the	 entry	appears	as	“Smith,	John”.	Such	data	entries	are	not	incorrect,	but	require	cleaning	to	ensure	formatting	is	consistent	across	all	cases.		
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Data	 irregularities	 refer	 to	 the	 non-uniform	 use	 of	 values,	 units	 and	abbreviations.	For	example,	reporting	a	pressure	in	kilopascals	(kPa)	rather	than	millimetres	of	mercury	(mmHg).	These	data	are	not	incorrect,	but	will	require	conversion	to	the	appropriate	units.		
4.3.1.2	Errors	of	semantics	
Integrity	constraint	anomalies	refer	to	entries	that	violate	a	‘rule’	in	relation	to	a	variable.	For	example,	a	negative	age	value	violates	the	expectation	that	age	will	have	a	minimum	of	0	(in	years).	Integrity	constraints	enhance	our	understanding	of	the	data	by	restricting	the	data	to	a	set	of	valid	instances.	Each	constraint	is	a	rule	 representing	 knowledge	 about	 the	 domain	 and	 the	 values	 allowed	 for	representing	certain	facts.		
Contradictions	 are	 violations	 of	 a	 relationship	 between	 the	 variables	 for	 a	particular	case.	For	example,	a	discrepancy	between	the	variables	Age	and	Year	of	Birth.	Contradictions	are	either	violations	of	functional	dependencies	that	can	be	represented	as	integrity	constraints	or	duplicates	with	inexact	values.			
Duplicates	are	two	or	more	observations	representing	the	same	entity	within	the	dataset.	The	values	of	these	observations	need	not	be	identical.	Inexact	duplicates	are	 instances	 of	 contradiction	 between	 two	 or	 more	 observations.	 They	represent	 the	 same	 entity	 but	 with	 differing	 values	 for	 all,	 or	 some,	 of	 its	variables.	This	hardens	the	detection	of	duplicates	and	their	mergence.			
Invalid	 entries	 are	 by	 far	 the	 most	 challenging	 anomalies	 found	 within	 any	dataset.	 These	 errors	 cannot	 be	 categorised	 as	 one	 of	 the	 above	 anomalies.	However,	 such	 entries	 still	 do	 not	 represent	 valid	 entities	 from	 the	 dataset.	Invalid	entries	result	from	our	inability	to	describe	reality	within	a	formal	model	using	 integrity	 constraints.	 They	 are	 extremely	 hard	 to	 find,	 and	 even	 more	complicated	to	correct.	There	are	no	rules	(or	constraints)	which	are	violated	by	these	entries	and	we	only	have	incomplete	knowledge	about	every	entity	in	the	dataset.	
4.3.1.3	Errors	of	coverage	
Missing	 values	 occur	 when	 individual	 cases	 have	 missing	 data,	 commonly	attributable	from	omissions	during	the	initial	data	collection	or	because	of	errors	occurring	during	data	extraction	phase.			
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Missing	 cases	 occur	when	 all	 data	pertaining	 to	 a	patient	 is	missing	 from	 the	dataset.	
4.3.2	Errors	in	WMAS	data	The	primary	WMAS	dataset	includes	45292	observations	comprising	50	variables	(see	table	4.3).		
Table	4.3	Original	structure	of	WMAS	data	
Variable	name	 Type	 Variable	name	 Type	
PatientID character	 Heart Rate (BPM) integer	
Forename character	 Systolic BP (mmHg) integer	
Surname character	 Diastolic BP (mmHg) integer	
Address 1 character	 Temperature (Celcius) number	
Address 2 character	 Pain Score integer	
City character	 BloodGlucose number	
County character	 Glasgow Coma Scale integer	
Post Code character	 GCS Eye character	
DOB date	 GCS Verbal character	
Sex character	 GCS Motor character	
Incident Address character	 Skin Colour character	
Incident City character	 Cap Refill Time integer	
Incident Postcode character	 AVPU character	
Incident Time time	 Pupil Right Reactivity character	
Response Priority character	 Pupil Right Size integer	
Mobile time	 Pupil Left Reactivity character	
Arrive Scene time	 Pupil Left Size integer	
Leaving Scene time	 Airway Adjunct character	
Destination Arrival time	 Airway Signs character	
Chief Complaint character	 Airway Status character	
Secondary Complaint character	 Arrest Occurance character	
Respiratory Rate (BPM) integer	 Impression character	
Oxygen Saturation (%) integer	 Crew Level 1 character	
Peak Flow (l/min) integer	 Crew Level 2 character	
End Tidal CO2 (kPa) number	 Institution Name character		
	A	 second,	 supplementary	 table	 addressing	 treatments	 administered	 was	provided,	comprising	44302	observations	of	35	variables	(see	table	4.4).		
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Table	4.4	Drugs	administered	
Variable		 Variable	
Patient ID Hydrocortisone 
Adrenaline 1:1000  Ibuprofen 
Adrenaline 1:10000  Ipratropium 
Amiodarone Lidocaine 
Aspirin Low Molecular Weight Heparin 
Atropine Metoclopramide 
Benzyl Penicillin Morphine Sulphate 
Buccal suscard Naloxone 
Chlorphenamine Oramorph 
Dextrose 40% oral gel Oxygen 
Diazemuls Paracetamol 
Diazepam Paracetamol suspension 
Entonox Salbutamol 
Furosemide Sodium Chloride 0.9% 
Glucagon Sodium Chloride 5ml amps 
GlucoGel Tenecteplase 
Glucose 10% Water for Injection 
GTN spray  	
4.3.2.1	Errors	of	syntax	A	small	proportion	of	Lexical	anomalies	were	identified.	Inspection	of	the	WMAS	data	 revealed	 a	 sample	 of	 observations	 where	 the	 temperature	 and	 blood 
glucose readings	 appeared	 to	 be	 transposed.	 That	 is,	 blood glucose	appeared	to	be	documented	 in	the	temperature	 field	and	vice	versa.	Manual	review	 of	 the	 individual	 ePRF	 cases	 via	 the	 online	 viewer	 enabled	 review	 of	narrative	and	diagnostic	fields	to	confirm	entries	were	transposed.	For	example,	where	blood glucose	was	reported	to	be	37.9	mmol/L	and	temperature	5.8°C	and	 there	was	no	mention	 in	 the	narrative	of	hyperglycaemia	or	past	medical	history	 of	 diabetes,	 nor	 any	 mention	 of	 hypothermia	 with	 documentation	 of	normal	 skin	 colour	 that	 was	 warm	 to	 touch.	 Such	 cases	 were	 considered	transposition	 errors.	 In	 addition,	 a	 substantial	 proportion	 of	 these	 cases	 had	repeat	observations	with	readings	in	the	normal	range	in	the	appropriate	fields.	These	errors	are	assumed	to	be	due	to	user	input	as	the	two	fields	are	next	to	one	another	on	the	ePRF.	No	domain	format	anomalies	were	identified.	
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	A	small	number	of	data	irregularities	were	identified.	Inspection	of	the	WMAS	data	revealed	 a	 sample	 of	 temperature	 readings	 that	 were	 much	 higher	 than	expected.	 It	 would	 be	 very	 unusual	 indeed	 to	 identify	 a	 patient	 with	 a	temperature	more	than	42°C.	However,	a	group	of	readings	incompatible	with	life	were	found,	ranging	between	96°	and	102°	degrees.	Manual	review	of	these	records	via	the	online	ePRF	viewer	revealed	these	readings	had	been	incorrectly	documented	in	Fahrenheit	rather	than	Celsius.	Affected	entries	were	converted	to	 celsius	 by	 applying	 the	 formula	 	 !(℃) = &!(℉) − 32+ ∗ 59	 	 and	 rounded	 to	 one	decimal	place.	It	is	unclear	why	the	ePRF	entry	was	in	Fahrenheit.	
	
4.3.2.2	Errors	of	semantics	Numerous	integrity	constraint	anomalies	were	identified.	All	numeric	variables,	apart	from	peak flow	and	end tidal CO2	(due	to	very	high	missingness),	were	assessed	 to	 determine	 if	 they	 had	 observations	 that	 were	 outside	 “normal”	ranges	(see	table	4.5).	Where	a	potential	anomaly	was	identified,	the	case	was	manually	reviewed	via	the	online	ePRF	viewer.	In	many	cases,	the	out	of	expected	range	reading	was	confirmed	to	be	correct.	 	Reviewing	subsequent	values	and	the	 narrative	 often	 confirmed	 that	 the	 “suspect”	 reading	 was	 correct.	 For	example,	if	systolic	blood	pressure	was	above	180mmHg	(outside	the	“normal”	range),	but	the	past	medical	history	and	narrative	mentioned	hypertension,	and	there	were	subsequent	blood	pressure	readings	outside	the	“normal”	range	to	corroborate	the	queried	reading,	then	the	“suspect”	reading	was,	in	fact,	deemed	correct.	 In	 others,	 it	 was	 obvious	 that	 there	 was	 an	 error.	 For	 example,	 a	respiratory	rate	of	122,	and	within	the	narrative	section	of	the	ePRF	a	normal	respiratory	pattern	was	documented,	with	subsequent	respiratory	rate	readings	in	the	range	of	12	-	16.	In	many	cases	these	errors	are	likely	to	be	due	to	typing	error,	such	as	pressing	the	“2”	key	twice	rather	than	once.			Ambulance	crews	are	expected	to	document	at	least	two	sets	of	observations,44	123	 consequently	 where	 such	 errors	 were	 identified,	 if	 a	 second	 set	 of	observations	was	available,	the	suspect	reading	was	replaced	with	the	value	from	the	 next	 available	 set	 of	 observations.	 If	 no	 second	 set	 of	 observations	 was	available	the	suspect	reading	was	deleted.			
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Table	4.5	Integrity	constraint	thresholds	WMAS	
Variable name Manual review threshold 
Date of birth <01-01-1914	(equates	to	age>100)	
Respiratory Rate (BPM) >60	
Oxygen Saturation (%) <80	or	>100%	
Heart Rate (BPM) >180	
Systolic BP (mmHg) >160	or	<60	
Diastolic BP (mmHg) >120	or	<	40	
Temperature (Celsius) <35	or	>41	
Pain Score >10	
Blood Glucose <1	or	>12	
Glasgow Coma Scale <3	or	>15	
Cap Refill Time >5	
Pupil Right Size >10	
Pupil Left Size >10	
	
	A	 small	 number	 of	 contradictions	 were	 identified.	 All	 AVPU	 readings	 were	compared	with	components	of	the	Glasgow	Coma	Score.		All	cases	with	a	score	of	 “alert”	 or	 “no	 response”	on	AVPU	were	 compared	with	 the	Glasgow Coma 
Scale	 variable.	 All	 cases	 with	 a	 score	 of	 “verbal	 response”	 on	 AVPU	 were	compared	 with	 the	 GCS verbal	 variable.	 All	 cases	 with	 a	 score	 of	 “pain	response”	 on	 AVPU	 were	 compared	 with	 the	 GCS motor variable.	 Where	discrepancies	were	 identified,	 the	 case	was	manually	 reviewed	via	 the	online	ePRF	 viewer.	 It	 should	 be	 noted	 that	 it	 is	 possible	 for	 discrepancies	 to	 occur	between	these	two	variables	as	they	are	often	recorded	at	different	time	points.	Consequently,	 only	 obvious	 errors	 were	 corrected	 such	 as	 AVPU	 equal	 to	“conscious”	with	Glasgow Coma Scale	below	eight	and	a	narrative	indicating	the	patient	was	unresponsive	on	initial	assessment.		
	Within	the	WMAS	dataset	it	was	possible	to	identify	several	thousand	duplicate	
cases.	Duplicate	 cases	 commonly	 arise	 when	 ambulance	 crews	 fail	 to	 finalise	cases	on	the	ePRF	in	a	timely	manner.		Usual	practice	is	for	the	first	clinician	on	scene,	 for	 example	 the	 Rapid	 Response	 Vehicle	 (RRV)	 paramedic,	 to	 initiate	treatment	 and	 to	 begin	 documenting	 care	 provided	 on	 the	 ePRF.	 Following	arrival	of	the	ambulance	crew,	the	RRV	paramedic	would	hand	over	continuing	
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care	 to	 the	 ambulance	 crew,	 then	 finalise	 and	 close	 their	 ePRF	 record.	 The	transporting	ambulance	crew	would	continue	treatment	whilst	transporting	the	patient	to	hospital.	To	document	care	provided	the	transporting	ambulance	crew	re-open	the	case	generated	by	the	RRV	paramedic	and	continue	in	the	same	ePRF	record.	However,	if	the	RRV	paramedic	fails	to	finalise	and	close	his	or	her	ePRF	before	the	ambulance	crew	commence	documenting	their	care	in	the	ePRF,	a	new	ePRF	case,	with	a	different	identification	number,	is	generated.	In	addition,	the	RRV	paramedics	entry	will	not	be	imported	into	the	ambulance	crew	record.	As	such,	the	patient	will	now	have	two	ePRF	records	in	the	database,	one	initiated	by	the	RRV	paramedic	and	another	by	the	ambulance	crew,	relating	to	the	same	incident.	Such	cases	are	usually	easy	to	 identify	as	 the	 incident	 time,	 incident	location	details	and	patient	details	 are	 the	 same.	However,	 inspection	of	 both	ePRF	 records	 is	 required	 to	 confirm	 that	 the	 ePRF	entries	 relate	 to	 the	 same	patient,	and	ensure	 that	the	apparent	duplicate	ePRF	records	do	not	relate	 to	multiple	patients	at	the	same	 incident,	as	might	occur	 following	a	road	traffic	collision.		
Sorting	 the	 WMAS	 dataset	 by	 date	 and	 time	 of	 incident	 facilitates	 rapid	identification	 of	 potential	 duplicate	 cases.	 Sorting	 was	 performed	 within	Microsoft	Excel®	utilising	“sort	and	filter’	function	with	the	“expand	selection”	option	to	ensure	row	integrity	was	maintained.	All	potential	duplicate	cases	were	manually	reviewed	and	where	appropriate,	the	records	were	merged	to	ensure	the	maximum	amount	of	data	were	captured.	The	clinical	record	of	the	first	on	scene,	 that	 is	 the	 record	 with	 the	 earliest	 time	 for	 arrived scene,	 was	considered	the	primary	record	and	any	additional	information	from	the	second	or	 subsequent	 records	 was	 appended	 to	 the	 first.	 For	 example,	 it	 is	 not	uncommon	for	the	first	on	scene	to	obtain	the	patient’s	name	and	age,	but	not	the	date	of	birth	details,	as	they	are	not	essential	to	initiate	treatment.	These	are	commonly	completed	in	the	ambulance	record	when	more	time	is	available.	So,	the	first	record	was	updated	with	information	from	subsequent	records	where	appropriate.	 The	 first	 recorded	 clinical	 observations,	 such	 as	 pulse,	 blood	pressure	and	blood	glucose	reading,	were	used	in	all	cases.	After	duplicate	cases	had	 been	 harmonised	 the	 superfluous	 records	 were	 deleted.	 Following	 the	manual	 review	 of	 cases,	 6809	 duplicate	 cases	 had	 been	 removed	 and	 38483	unique	patient	cases	remained.	
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No	invalid	entries	were	identified.	All	numeric	variables,	apart	from	peak flow	and	end tidal CO2	(due	to	very	high	missingness),	were	assessed	to	determine	if	they	had	observations	that	were	negative	numbers	(see	table	4.5),	in	addition	all	 categorical	 clinical	 variables	 were	 assessed	 to	 determine	 if	 they	 had	observations	that	were	outside	of	“permitted”	ranges	(see	table	4.6).		
Table	4.6	Valid	categorical	entries	
Variable	 Valid	entries	
GCS_eye Spontaneous,	responds	to	voice,	responds	to	pain,	no	response	
GCS_verbal Oriented,	confused,	inappropriate	words,	incomprehensible	sounds,	no	response	
GCS_motor Obeys,	localizes,	withdraws,	flexion,	extension,	no	response	
Skin Normal,	cyanosed,	flushed,	pallor,	mottled,	rash,	jaundiced	
CBRT Normal,	delayed	
AVPU Alert,	responds	to	voice,	responds	to	pain,	no	response	
RPupilReact Brisk,	fixed,	sluggish	
LPupilReact Brisk,	fixed,	sluggish	
Airway Adjunct OPA,	NPA,	LMA,	ETI	
Airway Signs Patent,	partial	obstruction,	obstructed	
	
4.3.2.3	Errors	of	coverage	Thousands	of	cases	were	identified	with	missing	values.	Handling	of	missing	data	within	the	WMAS	dataset	is	addressed	in	Chapter	6	Missing	Data.	
	It	was	not	possible	to	confirm	how	many	patient	records	(missing	cases)	 there	were.	The	WMAS	dataset	was	ordered	chronologically	and	reviewed	to	ensure	cases	existed	for	each	consecutive	day.	No	days	were	identified	where	there	were	no	cases.				
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4.3.3	Errors	in	UHNS	data	The	UHNS	dataset	 includes	48	534	observations	comprising	43	variables	(see	
table	4.7).	
Table	4.7	Original	structure	of	UHNS	data	
Variable	 Variable	
ID_Number DischargeDate 
AttendanceDate DischargeTime 
AttendanceTime Disposal 
Category Pulse 
FirstName Resps 
Surname SpO2 
Address1 SBP 
Address2 DBP 
PostCode GCS-eye 
Sex GCS-verbal 
DoB GCS-motor 
Age Temp 
Outcome BM 
Date_Discharged CBRT 
Time_Discharged_ED WCC 
Diagnosis1 CRP wide 
Diagnosis2 platelet count 
Diagnosis3 lactate 
Diagnosis4 INR 
Diagnosis5 Bilirubin 
Did_Patient_Die_In_ED Creatinine 
Did_Patient_Die_In_Hospital  	
4.3.3.1	Errors	of	syntax	No	 lexical	 anomalies	 were	 identified.	 No	 domain	 format	 anomalies	 were	identified.	No	data	irregularities	were	identified.		
	
4.3.3.2	Errors	of	semantics	Numerous	integrity	constraint	anomalies	were	identified.	All	numeric	variables	were	 assessed	 to	 determine	 if	 they	 had	 observations	 that	 were	 outside	 of	 a	
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“normal”	range	(see	table	4.8).	Where	a	potential	anomaly	was	identified,	the	full	observation	was	reviewed	to	determine	if	the	suspect	entry	was	consistent	with	the	other	variables.	Where	it	was,	obvious	there	was	an	error,	for	example,	a	respiratory	rate	of	120,	with	other	observations	like	pulse	oximetry,	heart	rate	and	blood	pressure	all	 in	the	normal	range,	the	entry	was	deleted.	 	It	was	not	possible	to	review	the	records	electronically	or	to	request	a	third	party	to	do	so.	
Table	4.8	Integrity	constraint	thresholds	UHNS	
Variable	name	 Potential	error	threshold	
Date of birth <01-01-1914	(equates	to	age>100)	
Pulse >220	
Resps >80	
SpO2 <70	or	>100	
SBP >200	
DBP >140	
Temp <35	or	>41	
BM >10	
CBRT >5	seconds	
WCC >20000	
CRP wide >200	
platelet count <10	
lactate >10	
INR >5	
Bilirubin >300	
Creatinine >600	
		No	 contradictions	 were	 identified.	 Each	 patient	 is	 assigned	 a	 unique	identification	number	on	arrival	at	the	ED.	No	duplicate	cases	were	identified.	No	
data	irregularities	were	identified.			No	 invalid	 entries	 were	 identified.	 All	 numeric	 variables	 were	 assessed	 to	determine	if	they	had	observations	that	were	negative	numbers.	In	addition,	all	categorical	clinical	variables	were	assessed	to	determine	if	they	had	observations	that	were	outside	of	a	“permitted”	range	(see	table	4.9).		
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Table	4.9	Valid	entries	
Variable	 Valid	entries	
GCS Eye Spontaneous,	voice,	pain,	no	response	
GCS Verbal Oriented,	confused,	inappropriate	words,	incomprehensible	sounds,	no	response	
GCS Motor Obeys,	localises,	withdraws,	decorticate,	decerebrate,	no	response	
	
4.3.3.3	Errors	of	coverage	Only	a	very	small	proportion	of	cases	had	data	for	all	variables.	Most	cases	had	one	or	more	missing	data	points.	This	occurred	because	many	variables	were	optional.	For	example,	although	there	were	five	diagnostic	variables,	it	was	only	required	to	have	one	diagnosis	with	the	remaining	four	being	empty.	Similarly,	laboratory	 tests	 are	 only	 required	 for	 a	 subset	 of	 patients.	 The	 very	 high	missingness	of	data	meant	imputation	was	not	practical,	as	imputation	in	such	circumstances	may	not	yield	reliable	results.127		
The	UHNS	dataset	is	required	to	establish	the	hospital	diagnosis.	Missing	data	were	presumed	to	be	clinically	normal	when	modelling	the	UHNS	data	for	clinical	diagnosis.	 In	 other	 words,	 if	 any	 data	 point	 required	 for	 classification	 was	missing,	the	missing	value	was	assumed	to	be	in	the	normal,	healthy	range.	For	example,	when	 calculating	a	National	Early	Warning	(NEWS)	 score,	 a	 score	 is	assigned	depending	on	 the	oxygen	 saturations.	 Peripheral	 oxygen	 saturations	are	attributed	a	score	of	3,	2,	1	or	0	dependinare	categorised	as	being	below	92%	or	in	the	ranges	92%	to	93%,	94%	to	95%	or	above	95%,	and	respectively.	Where	a	NEWS	score	was	being	calculated	for	a	patient	with	a	missing	oxygen	saturation	value,	 the	missing	 value	would	be	assumed	to	be	 in	 the	normal	 range	 (above	95%)	and	score	 a	 ‘0’	was	applied.	This	approach	 is	 equivalent	 to	 single	 value	imputation	with	normal	value	substitution,	an	approach	that	has	previously	been	employed	among	critically	ill	patients.107	128	Normal	value	substitution	may	lead	to	an	underestimation	of	the	true	prevalence	of	sepsis	in	the	population	being	studied.	
It	was	not	possible	to	confirm	how	many,	if	any,	patient	cases	were	missing	from	the	 dataset	 provided	 (missing	 cases).	 The	 UHNS	 dataset	 was	 ordered	chronologically	and	reviewed	to	ensure	cases	existed	for	each	consecutive	day.	No	days	were	identified	where	there	were	no	cases.			
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4.4	Calculated	fields	
4.4.1	WMAS	calculated	fields	Several	additional	 fields	were	 ‘calculated’	and	appended	to	the	WMAS	dataset	(see	table	4.10):		
Table	4.10	Calculated	fields	(WMAS)	
Variable	 How	calculated	
Oxygen Calculation	of	the	NEWS	score	includes	use	of	supplemental	oxygen.	These	data	were	drawn	from	the	supplemental	treatments	table		
Fluids Calculation	of	the	SOFA	score	includes	the	need	for	fluid	resuscitation.	These	data	were	drawn	from	the	supplemental	treatments	table		
Age 
Required	to	determine	if	age	is	correlated	with	sepsis.	Determined	as	difference	(in	years)	between	Incident Time	and	Date of Birth.	Stored	as	integer	(rounded	down)	
Location Required	to	determine	if	place	of	residence	is	correlated	with	sepsis.	Determined	from	the	Incident PostCode,	address	PostCode		
	
4.4.2	UHNS	calculated	fields	Several	 additional	 fields	were	 ‘calculated’	 and	appended	 to	 the	UHNS	dataset	(see	table	4.11):		 	
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Table	4.11	Calculated	Fields	(UHNS)	
Variable	 Purpose	
ED_Infection Presence	of	infection	is	required	to	diagnose	sepsis.	Determined	from ED_Diagnosis1,	
ED_Diagnosis2,	ED_Diagnosis3,	
ED_Diagnosis4,	and	ED_Diagnosis5.	 
DrSepsis Variable	used	to	store	sepsis	diagnoses	by	the	ED	doctor.	Determined	from ED_Diagnosis1,	
ED_Diagnosis2,	ED_Diagnosis3,	
ED_Diagnosis4,	and	ED_Diagnosis5.	Required	as	potential	reference	standard.		
GCS_sum GCS	is	required	to	calculate	several	sepsis	related	scores	score.		
MAP MAP	is	required	to	calculate	SOFA	score.		
NEWS The	NEWS	score	is	required	to	determine	UK	Sepsis	Trust	2016	sepsis	status.		
UHNS_SIRS The	number	of	SIRS	criteria	are	required	to	determine	UK	Sepsis	Trust	2014	sepsis	status.		
UHNS_SIRS_Sepsis Required	as	potential	reference	standard.		
UHNS_NICE_Sepsis_Risk Required	as	reference	standard.		
UHNS_Organ_Failure_Score The	number	of	organ	failures	are	required	to	determine	organ	failure	sepsis	status.		
UHNS_Organ_Failure_Sepsis Required	as	potential	reference	standard.		
UHNS_qSOFA_Score The	number	of	qSOFA	score	required	to	determine	qSOFA	sepsis	status.	
UHNS_qSOFA_Sepsis Required	as	potential	reference	standard.		
UHNS_SOFA_Score The	number	of	SOFA	score	required	to	determine	SOFA	sepsis	status.		
UHNS_SOFA_Sepsis Required	as	potential	reference	standard.			
 
4.4	Conclusion	This	chapter	has	described	the	nature	of	the	datasets	as	received	from	WMAS	and	 UHNS.	 It	 has	 also	 detailed	 how	 the	 data	 were	 processed	 and	 cleaned	 to	prepare	them	for	record	linkage,	which	is	described	in	the	next	chapter.	
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Chapter	5	
Record	linkage 
 
5.1	Introduction	This	 study	 utilises	 patient	 records	 relating	 to	 a	 single	 health	 care	 episode	 to	develop	 a	prehospital	 sepsis	screening	 tool.	Data	pertinent	 to	 the	health	 care	episode	are	spread	between	two	datasets,	one	from	the	Ambulance	Service	and	the	other	 from	the	Emergency	Department.	The	process	of	pairing	a	patients’	ambulance	 record	 with	 their	 corresponding	 hospital	 record	 is	 referred	 to	 as	record	 linkage.	 Record	 linkage	 is	 defined	 as	 the	 process	 of	 bringing	 together	records,	relating	to	the	same	entity,	recorded	in	different	locations,	usually	from	different	databases.129	The	purpose	of	record	 linkage	 is	 to	create	richer,	more	detailed	records	 that	can	be	used	 in	subsequent	analysis.130	 	This	chapter	will	provide	an	overview	of	the	record	linkage	process,	describe	how	study	datasets	were	were	linked	in	this	study	and	evaluate	the	success	of	the	linkage	exercise.		
Christen129	described	the	record	linking	process	as	comprising	five	key	steps	as	per	figure	5.1.	
• During	data	pre-processing	the	format	of	data	fields	within	each	of	the	databases	are	standardised	to	ensure	compatibility.		• Indexing	 minimises	 the	 number	 of	 records	 being	 compared,	 to	facilitate	the	efficient	and	effective	generation	of	potential	record	pairs.		• During	record	pair	comparison,	key	variables	are	evaluated	using	a	variety	of	comparison	functions.		• During	 classification	 candidate	 record	 pairs	 are	 classified	 as	
matches,	 non-matches	 or	 potential	 matches	 the	 latter	 of	 which	mandates	clerical	review.		• During	evaluation	the	complexity	of	the	record	linking	exercise	is	determined,	and	the	quality	and	completeness	of	the	matched	data	are	assessed.129	
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Several	 statistical	 software	 packages,	 such	 as	 Stata®	 and	 R®,	 have	 specialist	functions	or	packages	 to	perform	 record	 linkage.	 In	 addition,	 bespoke	 record	linkage	software	packages,	 such	as	Link	Plus®	(as	used	 in	 this	study),	may	be	employed.	
Figure	5.1	Data	linkage	process		
	reproduced	from	Christen	(2012)		In	the	context	of	this	study,	record	linkage	brings	together	patient	records	from	a	 single	 Ambulance	 Service	 and	 a	 single	 Hospital	 Emergency	 Department.	Records	relate	to	a	specific	health	care	episode,	initiated	when	a	patient	called	‘999’.	The	Ambulance	Service	responded,	initiated	treatment	and	conveyed	the	patient	 to	 the	 Hospital	 Emergency	 Department,	 where	 further	 investigations	were	undertaken	and	treatments	continued.	Record	linkage	brings	together	data	concerning	 the	 ambulance	 and	 hospital	 episode	 for	 use	 in	 development	 of	 a	prehospital	sepsis	screening	tool,	detailed	in	chapters	7	and	8.	
5.2	Background	
5.2.1	Data	pre-processing	Data	 within	 different	 databases	 can	 be	 stored	 in	 differing	 formats,	 and	 may	require	standardisation	before	being	used	 for	record	 linkage.	The	objective	of	
data	pre-processing	 is	 to	 ensure	 that	 the	data	being	 compared	across	 the	 two	databases	have	a	consistent	structure	and	format,	to	optimise	the	comparison	
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process.	Common	examples	of	data	variations	that	may	adversely	impact	record	linkage	are	shown	in	table	5.1.	
Table	5.1	Common	record	field	standardisations	
Field	 Concern	 Examples	Names	 Case	 John	Smith	vs	JOHN	SMITH		 Nicknames	 Charles	vs	Chuck		 Synonyms	 William	vs	Bill		 Prefixes	 Dr	John	Smith		 Suffixes	 John	Smith,	Esq.		 Punctuation	 O’Malley,	Smith-Taylor		 Initials	 JR	Smith	vs	J.R.	Smith	vs	John	Robert		 Transposition	 John	Smith	vs	Smith,	John	Address	 Abbreviations	 Rd	vs	Road	Dates	 Format	 01-01-2017	vs	01JAN2017		 Invalid	values	 day=32,	month=13,	year=2025	Identification	numbers	 Format	 99999999	vs	99-999-999	vs	99	999	999	Geographic	detail	 Abbreviation	 UK	vs	United	Kingdom	Gender	 Format	 male/Female	vs	M/F	vs	1/2	
	
Fields	used	for	record	linkage	invariably	utilise	personal	information	including	names	 and	 addresses	 that	 can	 originate	 from	 several	 potential	 sources.	 The	information	may	be	dictated	by	 a	patient,	while	a	data	 entry	 clerk	 inputs	 the	information;	it	may	be	transcribed	from	an	audio	recording,	where	the	data	entry	clerk	is	not	able	to	clarify	spellings;	it	may	be	entered	from	scanned	notes,	where	the	handwriting	may	not	be	clear	(or	indeed	it	may	be	incorrectly	spelt)	or	it	may	be	 output	 from	 optical	 character	 recognition	 (OCR)	 software.	 Such	 data	 are	prone	to	error,	and	these	fields	require	appropriate	cleaning	and	standardisation	before	record	linkage	is	attempted.	
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Christen129	identifies	that	there	can	be	up	to	four	stages	in	data	pre-processing:	
• Removal	 of	 unwanted	 characters	 and	 words	 entails	 removal	 of	superfluous	punctuation	characters	 including	commas,	quotation	marks	and	excess	white	space.	Extraction	of	data	from	a	database	into	a	different	format	may	also	introduce	additional	characters	or	‘stop	words’	that	require	removal.	For	example,	special	characters,	such	as	letters	with	an	umlaut	are	encoded	using	unicode	numbers	(that	is	ë,	Unicode	number	U+00EA),	that	may	not	be	understood	by	 all	 software	 packages	 resulting	 in	 incorrect	 insertions,	 or	superfluous	characters.	For	example,	Microsoft	Excel®	commonly	inserts	a	question	mark	before	uncertain	data	entries.	• Expand	abbreviations	and	correct	spellings	to	reduce	variation,	for	example	‘Rd’	becomes	‘Road’,	in	addition	obvious	spelling	mistakes	should	be	corrected.	• Segment	attributes	into	well-defined	and	consistent	output	attributes	It	can	be	beneficial	to	parse	fields	with	several	important	sub-fields	into	multiple	 fields.	Most	 commonly	 this	 occurs	with	 an	address	field	where	the	single	data	field	is	divided	into	house	number,	street,	
suburb,	city,	postcode,	and	county	fields.	Parsing	fields	into	distinct	units	allows	the	linker	to	maximise	the	available	information	and	achieve	 partial	 agreement	 when	 record	 pairs	 do	 not	 agree	character	 for	 character.	 This	 can	 be	 particularly	 important	 to	account	 for	 changes	 across	 time,	 such	 as	 name	 changes	 after	marriage	or	address	changes	after	moving.	In	such	cases,	matching	on	 the	 separate	pieces	 allows	 for	 the	possibility	 of	 partial	 credit	which,	 when	 combined	 with	 other	 information,	 may	 provide	sufficient	evidence	that	the	records	being	compared	relate	to	the	same	person.131	• Verification	 of	 correctness	 of	 attribute	 values	 where	 a	 reliable	external	data	source	is	available,	both	databases	being	linked	can	be	checked	against	 the	reliable	data.	For	example,	the	Royal	Mail	produces	a	database	of	postcode	addresses	that	relate	a	postcode,	to	a	street	address.	These	data	could	be	used	to	verify	and	check	the	addresses	as	recorded	in	both	databases,	and	it	may	be	possible	to	amend	incorrect	entries	before	matching	is	attempted.	
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5.2.2	Indexing	When	 linking	 records	 in	 two	 databases,	 the	 potential	 number	 of	 comparison	pairs	 grows	 quadratically	with	 the	 number	 of	 records	 in	 the	 databases	 to	 be	matched.	In	other	words,	two	databases	containing	m	and	n	records	respectively,	will	 generate	m*n	 comparison	pairs.	 In	 contrast,	 the	number	of	 possible	 true	matches	 increases	 linearly.	 In	 other	 words,	 the	 maximum	 number	 of	 true	matches	is	m	or	n,	whichever	is	the	smaller	of	the	two.129	This	is	because	every	record	 from	database	one	should	be	compared	with	every	record	 in	database	two,	yet	only	a	small	number	of	records	 from	database	 two	should	match	any	single	 record	 from	 database	 one	 -	 the	 overwhelming	majority	 of	 comparison	pairs	 will,	 in	 fact,	 be	 non-matches.	 This	 has	 significant	 implications	 for	 the	computational	power	required	to	link	records.	
If	 two	databases	with	one	million	 records	 each	were	 to	be	 linked,	 this	would	result	 in	 one	 trillion	 (1000000*1000000)	 comparison	 pairs.	 Even	 if	 100000	comparisons	could	be	performed	per	second	it	would	still	take	almost	116	days	to	compare	the	two	databases.129	In	order	to	reduce	this	inefficiency,		indexing		is	used	 to	significantly	reduce	 the	 likelihood	of	non-matches.	This	minimises	 the	computational	overheads	and	the	time	taken	to	compare	records.	Indexing	filters	out	record	pairs	that	are	unlikely	to	be	matches,	and	generates	candidate	record	pairs	that	will	be	examined	in	greater	detail	during	the	comparison	stage.		
The	most	common	approach	to	indexing	is	blocking.	Blocking	reduces	the	number	of	candidate	pairs	through	focusing	on	specified	agreement	patterns.132	Without	
blocking,	record	one,	from	database	one,	would	be	compared	to	every	record	in	database	 two.	However,	with	blocking,	 record	one,	 from	database	one,	 is	 only	compared	with	a	subset	of	records	from	database	two.		Blocking	is	achieved	by	defining	a	blocking	variable	that	is	used	to	filter	records	in	the	second	database.		
A	 common	 choice	 for	blocking	 variable	 is	 surname.	 Thus,	 if	 record	 one,	 from	database	 one,	 has	 a	 surname	 of	 ’Miller’,	 then	 the	 only	 records	 used	 for	comparison	will	be	those	records	from	database	two,	with	the	surname	’Miller’.	In	practice,	if	an	exact	match	were	to	be	used	for	blocking	then	the	potential	for	missed	matches	would	 be	 very	 high.	 Consequently,	 exact	matching	 is	 seldom	used.	Rather,	phonetic	encoding	algorithms,	such	as	Soundex	or	New	York	State	Identification	and	Intelligence	System	(NYSIIS)	are	commonly	employed	when	
blocking	with	a	surname	field.			
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Phonetic	 encoding	maps	words	 from	natural	 language	 to	 strings	 representing	their	pronunciation	(the	phonetic	code).	Words	which	sound	similar	generate	the	same	phonetic	code.132	As	a	result,	record	one,	of	database	one	(surname	=	“Miller”),	will	be	compared	with	all	records	of	database	two	where	the	surname	sounds	like	“Miller”.	That	is,	record	one	from	database	one	will	be	compared	with	records	from	database	two	with	surnames	such	as	“Millar”,	“Millor”,	“Millie”	etc.	An	additional	 benefit	 of	 phonetic	 encoding	 is	 that	 it	 reduces	 the	 likelihood	of	missed	matches	due	to	minor	misspellings.130	Because	obvious	non-matches	are	not	compared,	blocking	significantly	reducing	the	computational	overhead	and	time	taken	for	processing.129	
5.2.3	Record	pair	comparison	Even	 if	 considerable	 effort	has	been	expended	during	 the	data	pre-processing	stage,	 it	 is	 highly	 likely	 that	 records	 corresponding	 to	 true	 matches,	 that	 is	relating	to	the	same	entity,	can	contain	different	attribute	values	across	the	two	different	databases.		A	common	example	would	be	that	of	a	person	who	married,	and	changed	their	surname,	with	pre-and	post-martial	surnames	being	recorded	in	each	of	two	databases.	If	the	only	field	used	for	comparison	is	surname	then	all	such	true	matches	would	most	likely	be	missed.		It	is	vital	therefore	that	data	matching	algorithms	employ	comparison	functions	that	return	some	indication	of	how	similar	two	records	are	overall.		
Candidate	 pairs	 identified	 during	 indexing	 require	 further	 assessment	 over	several	 additional	 fields	 to	 determine	 potential	 match	 status.	 Additional	 pre-specified	matching	variables	enable	comparison	of	records	to	determine	wider	similarity	 between	 candidate	 pairs.	 Common	matching	 variables	 include	 first	
names,	date	of	birth,	postcodes	and	unique	personal	identification	numbers	such	as	NHS	 number.	 The	 greater	 the	 similarity	 across	 the	matching	 variables,	 the	more	likely	it	is	that	the	records	correspond	to	the	same	entity.		Techniques	have	been	 developed	 to	 account	 for	 minor	 misspellings	 and	 typographical	 errors	within	matching	variables.	The	most	important	of	these	are:	
• Strings	can	be	converted	to	phonetic	codes	(Soundex	or	New	York	State	Immunisation	Information	System)	before	comparison.	• Strings	 can	 be	 compared	 using	 editing	 distance	 techniques	 to	determine	how	many	steps	(insertions,	deletions,	transpositions,	etc.)	are	required	to	get	from	String	A	to	String	B.	For	example,	it	
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would	 require	 one	 step--one	 character	 deletion--to	 get	 from	“Billy”	to	“Bill”.	• Names	 can	 be	 linked	 to	 an	 array	 of	 synonyms	 (“William”	 and	“Bill”)	to	account	for	the	use	of	nicknames.	
The	 above	methods	 ensure	minor	 variations	within	 fields	do	not	 result	 in	an	automatic	 non-match	 status	 being	 assigned	 when	 the	 records	 are	 formally	compared.	 There	 are	 two	 distinct	 approaches	 to	 formal	 record	 comparison:	deterministic	and	probabilistic.	
Deterministic	algorithms	provide	a	binary	outcome	when	comparing	a	given	set	of	matching	 variables,	 the	 algorithm	may	 be	 implemented	as	 a	 single-step	 or	multi-step	strategy.	In	a	single-step	strategy,	the	matching	variables	of	candidate	pairs	are	compared	all	at	once.	If	the	matching	variables	of	the	candidate	pair	agree,	character	for	character,	on	all	matching	variables	and	the	candidate	pair	is	uniquely	identified	(no	other	record	pair	matched	on	the	same	set	of	values),	then	the	record	pair	is	classified	as	a	match.	A	candidate	pair	is	classified	as	a	
non-match	if	any	of	the	matching	variables	disagree,	or	if	the	candidate	pair	is	not	uniquely	identified.	Because	deterministic	linkage	requires	exact	agreement	on	the	specified	matching	variables,	it	can	have	a	very	high	rate	of	missed-matches	(false	negatives),	as	any	recording	errors	or	missing	values	within	the	matching	
variables	will	result	in	a	non-match	pair.	However,	the	rate	of	false-matches	(false	positives)	can	be	very	low	indeed	as	unrelated	records	are	unlikely	to	have	exact	matches	on	the	matching	variables	by	chance	alone.133	
To	 reduce	 the	number	of	missed	matches,	a	multi-step	deterministic	 strategy	may	be	employed.	In	a	multiple-step	strategy,	also	referred	to	as	an	iterative	or	stepwise	strategy,	candidate	pairs	are	matched	in	a	series	of	progressively	less	restrictive	 steps	 in	 which	 candidate	 pairs	 that	 do	 not	 meet	 a	 first	 round	 of	matching	criteria	are	passed	to	a	second	round	of	matching	criteria	for	further	comparison.	If	a	candidate	pair	meets	the	criteria	in	any	step,	it	is	classified	as	a	
match.	Otherwise,	it	is	classified	as	a	non-match.131		
In	addition	to	the	potentially	high	false	negative	rate,	the	deterministic	approach	fails	to	consider	that	certain	matching	variables	may	have	greater	discriminatory	power	than	others.	For	example,	matching	unique	personal	identifiers,	such	as	
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NHS	number,	will	provide	greater	confidence	of	a	true	match	than	would	a	match	based	on	date	of	birth.		
Probabilistic	 strategies,	 first	 proposed	 by	 Fellegi	 and	 Sunter,134	 assess	 the	discriminatory	 power	 of	 each	matching	 variable	 in	 addition	 to	matching	 the	content	of	the	matching	variables.	The	weighting	of	each	variable	depends	on	the	discriminatory	power	of	the	variable,	so	that	agreements	on	important	variables	(for	 example	 the	 NHS	 Number	 is	 intended	 to	 be	 unique)	 makes	 a	 larger	contribution	 than	agreement	 on	 lesser	 variables	 (for	 example	 the	 probability	that	date	of	birth	matches	by	chance	is	1	in	365).135	
The	matching	 variables	 of	 each	 candidate	 pair	 identified	 during	 the	 indexing	phase	are	compared,	producing	an	agreement	pattern.	The	weight	assigned	to	agreement	or	disagreement	on	each	matching	variable	is	assessed	as	a	likelihood	ratio,	 comparing	 the	 probability	 that	 true	 matches	 agree	 on	 the	 matching	
variable	(“m-probability”),	to	the	probability	that	false	matches	randomly	agree	on	the	matching	variable	(“u-probability”).	
Where	the	candidate	pair	agree	on	a	matching	variable,	an	agreement	weight	is	calculated	by	dividing	the	m-probability	by	the	u-probability	and	taking	the	log	to	base	2	(log2)	of	the	quotient.	For	example,	if	the	probability	that	true	matches	agree	on	month	of	birth	is	97%,	and	the	probability	that	false	matches	randomly	agree	on	month	of	birth	is	8.3%	(1/12),	then	the	agreement	weight	for	month	of	birth	would	be	calculated	as	(log2[0.97/0.083]),	which	equates	to	3.54.	When	the	candidate	 pair	 disagree	 on	 a	 matching	 variable,	 a	 disagreement	 weight	 is	calculated	by	dividing	1	minus	the	m-probability	by	1	minus	the	u-probability.	For	example,	the	disagreement	weight	for	month	of	birth	would	be	calculated	as	(log2	[(1-0.97)/(1-0.083)]),	or	-	4.93.131	
The	initial	work	of	Fellegi	and	Sunter134	has	been	extended.	Porter	and	Winkler	demonstrated	that	it	is	possible	to	modify	the	m-	and	u-probabilities	to	reflect	similarities	 of	 the	 matching	 variables,	 between	 0.0	 and	 1.0,	 calculated	 by	approximate	 string	 comparison	 algorithms.	 Their	 results	 showed	 significant	improvements	in	matching	quality	rather	than	reliance	on	a	binary	match	or	non-
match	 dependent	 upon	 the	 exact	 string	matches	 as	 advocated	 by	 Fellegi	 and	Sunter.136	137	
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A	 second	 extension	 to	 the	 probabalistic	 approach	 focusses	 upon	 frequently	occurring	values	within	matching	variables.	The	rationale	underpinning	this	idea	asserts	 that	 the	 more	 frequent	 an	 attribute	 value	 is	 in	 a	 database,	 the	 less	discriminative	 this	value	 is	 for	classifying	a	candidate	pair	as	a	match	or	non-
match.	 For	 example,	 the	 surname	 value	 ‘Smith’	 is	 likely	 to	 occur	much	more	frequently	 than	 ‘Dijkstra’	 in	 the	West	Midlands	region	of	 the	United	Kingdom.	Consequently,	a	candidate	pair	with	the	surname	‘Dijkstra’	is	more	likely	to	be	a	match	than	a	candidate	pair	with	the	surname	‘Smith’.		
By	generating	comparison	scores	(likelihood	ratios)	for	the	blocking	key	and	each	of	the	matching	variables,	we	can	generate	an	overall	record	comparison	score	for	 the	 two	records	being	compared.	The	example	tables	below	 illustrate	how	these	record	comparison	scores	might	be	calculated.		
It	can	be	clearly	seen	that	candidate	pairs	1	and	2	relate	to	the	same	and	different	persons	respectively.	Candidate	pairs	3	and	4	however	present	a	much	greater	challenge	despite	very	similar	overall	scores.	Candidate	pair	3	could	potentially	be	a	sibling	or	married	couple	pairing	whereas	candidate	pair	4	most	likely	does	relate	to	a	true	match.	The	calculated	record	comparison	scores	above	can	be	used	 to	 assign	 provisional	match,	 non-match	 and	 potential	 match	 status	 for	candidate	pairs	 for	 scores	within	 certain	specified	ranges.	 For	 example,	 if	 the	score	is	greater	than	four	provisionally	assign	match	status,	if	the	score	is	below	two	provisionally	assign	non-match	status	and	if	the	score	is	between	two	and	four	provisionally	assign	potential	match	status.	Assessment	of	these	provisional	allocations	is	detailed	in	the	next	section.	Note	-	scores	attributed	to	variables	being	compared	have	been	arbitrarily	assigned	for	illustrative	purposes	ranging	from	0	(no	match)	to	1.0	(perfect	match).	
Table	5.2	Candidate	pair	1	Record		 Name	 Surname	 DoB	 Gender	 Post	code	 	
A1 James Lee 17/02/70 Male B31 2RP 	
B777 James Lee 17/02/70 Male B31 2RP Total	
Score	 1.0	 1.0	 1.0	 1.0	 1.0	 5.0	
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Table	5.3	Candidate	pair	2	Record	 Name	 Surname	 DoB	 Gender	 Post	code	 	
A1 James Lee 17/02/70 Male B31 2RP 	
B666 David Leigh 30/10/83 Male B27 5QX Total	
Score	 0	 0.4	 0	 1.0	 0.1	 1.5	
	
Table	5.4	Candidate	pair	3	Record	 Name	 Surname	 DoB	 Gender	 Post	code	 	
A1 James Lee 17/02/70 Male B31 2RP 	
B555 J Lee 07/03/72 Female B31 2RP Total	
Score	 0.1	 1.0	 0.3	 0	 1.0	 3.3	
	
Table	5.5	Candidate	pair	4	Record	 Name	 Surname	 DoB	 Gender	 Post	code	 	
A1 James Lee 17/02/70 Male B31 2RP 	
A1 Jim Lee  Male B31 2RP Total	
Score	 0.6	 1.0	 0	 1.0	 1.0	 3.6	
	
5.2.4	Record	pair	classification	Provisional	 record	 pair	 classification	 generates	 three	 potential	 outcomes	 of	
match,	non-match	or	potential	match.	Matches	are	assumed	to	refer	to	the	same	entity,	non-matches	refer	to	two	different	entities	and	potential	matches	are	those	candidate	pairs	where	the	match	status	is	not	clear,	and	which	require	further	
clerical	review	to	determine	the	final	match	status.	All	records	not	paired	during	
indexing	are	implicitly	classified	as	non-matches.	Following	record	comparison,	all	 provisional	 record	pairs	are	 re-evaluated	and	 classified	as	 either	match	 or	
non-match.	This	can	be	by	manual	review,	or	automated	by	defining	thresholds,	above	and	below	which,	record	pairs	are	automatically	assigned	match	or	non-
match	status.	All	potential	matches	require	manual	review	to	re-classify	them	as	either	match	or	non-match.	
In	a	perfect	linkage,	all	paired	records	are	correctly	classified	as	matches,	and	all	non-paired	 records	 are	 classified	 as	 non-matches.	 If	 record	 pairs	 are	misclassified,	 error	 is	 introduced.	 False	 matches	 occur	 when	 records	 from	different	entities	are	 incorrectly	assigned	match	 status.	Missed	matches	occur	when	records	from	the	same	entity	fail	to	link	and	are	assigned	non-match	status.	
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In	statistical	parlance,	a	match	is	the	equivalent	of	a	‘True	Positive’,	a	non-match	the	 equivalent	 of	 a	 ‘True	 Negative’,	 a	 false-match	 the	 equivalent	 of	 a	 ‘False	Positive’	and	a	missed-match	the	equivalent	of	a	‘False	Negative’.	
5.2.5	Evaluation	of	matched	data	Following	clerical	review,	when	all	candidate	pairs	have	been	formally	classified	into	matches	and	non-matches	the	results	of	matching	should	ideally	be	assessed	for	both	matching	quality	and	matching	completeness.		Matching	quality	refers	to	the	 proportion	 of	 identified	 matches	 that	 are	 true	 matches,	 or	 in	 statistical	parlance,	minimising	the	proportion	of	false	positives.			Matching	completeness	is	concerned	with	the	proportion	of	true	matches	within	the	databases	that	were	correctly	paired,	or	minimising	the	proportion	false	negatives/missed	cases.	
All	 the	 preceding	 steps,	 data	 pre-processing,	 indexing,	 comparison	 and	
classification	all	have	an	impact	on	matching	quality	and	matching	completeness.	
Data	 pre-processing	 ensures	 consistent	 data	 format	 to	 enable	 comparison,	
indexing	 filters	 out	 records	 that	 are	 unlikely	 to	 be	 a	 match,	 while	 detailed	
comparison	ensures	similarity	between	records	can	be	quantifiably	assessed.	The	
comparison	and	classification	stages	clearly	have	a	major	impact	upon	quality;	in	particular,	clerical	review	can	be	very	challenging	when	the	linker	is	required	to	make	a	manual	match	or	non-match	decision	when	multiple	matching	variables	have	values	 that	differ	 from	each	other.	 	 Indexing	will	have	a	major	 impact	on	
completeness	 due	 to	 filtering	 out	 cases	 not	 to	 be	matched	 -	 filtering	 ensures	records	 will	 not	 be	 paired	 and	will	 result	 in	 non-match	 classifications	 being	assigned	without	records	being	compared.	
To	reliably	report	quality	and	completeness,	the	true	status	of	matching	should	be	determined.	However,	in	practice,	it	may	be	exceedingly	difficult	to	establish	the	true	status	unless	some	external	mechanism	exists	to	confirm	the	findings,	e.g.	contacting	 individuals	 to	 verify	 the	 data.	 As	 such	 these	 measures	 of	 linkage	effectiveness	are	commonly	missing.	
	Accuracy	is	not	recommended	when	reporting	how	successful	record	linkage	has	been.	 	 Accuracy	 is	 calculated	 from	 the	 number	 of	 true	 positives	 (TP),	 true	negatives	(TN),	false	positives	(FP)	and	false	negatives	(FN):	
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In	data	matching,	the	number	of	non-match	(TN)	cases	far	exceeds	the	number	of	match	(TP)	cases,	which	will	significantly	bias	reported	accuracy.	For	example,	suppose	two	databases	each	containing	500000	records	are	to	be	matched,	of	which	250000	are	true	matches.	 	We	run	our	record	linkage	program	indexing	generates	say,	12500000	candidate	pairs,	and	our	user	classifies	300000	of	these	as	matches	and	12200000	as	non-matches.	We	will	assume	we	are	lucky	and	have	a	gold	standard	data	to	confirm	the	true	status	of	our	matches	are	can	report	that	of	 the	 300000	 matches,	 200000	 are	 true	 positives	 (TP),	 100000	 are	 false	positives	(FP),	furthermore	50000	of	the	non-matches	were	incorrectly	classified	and	should	have	been	matches	-	these	are	our	false	negatives	(FN).	The	remaining	11850000	non-match	pairs	are	true	negatives	(TN).	Accuracy	calculated	for	this	example	 is	 96%,	 despite	 identifying	 only	 200000	 of	 a	 potential	 250000	 true	positive	cases.	
	 	
															 																 		
More	appropriate	measures	to	report	are	precision,	recall	and	F-measure.		
Precision,	the	proportion	of	true	positives,	calculated	for	this	example	is	67%.	
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Recall,	the	proportion	of	true	matches	identified	as	true	matches,	calculated	for	this	example	is	80%.	
																																					 																																																	 																																																	 		
F-measure	is	a	balance	of	recall	and	recall.	For	this	example,	the	F-measure	is	73%	and	is	calculated	as	follows:	
																								 	
																																															 																																																 		Finally,	 the	 complexity	 of	 a	 data	 matching	 exercise	 may	 also	 be	 reported.		
Complexity	is	defined	as	the	number	of	candidate	pairs	identified	(c)	divided	by	the	product	of	number	of	records	in	database	A	(m)	and	number	of	records	in	database	B	(n).	Complexity	provides	a	measure	of	how	effective	indexing	has	been	in	reducing	the	number	of	non-matches.	Lower	complexity	values	indicate	more	successful	record	linkage.		Complexity	calculated	in	our	hypothetical	example	is	0.005%,	suggesting	indexing	has	been	very	successful. 
																											 																																																 																																																 		
5.3	Methods	
5.3.1	Pre-processing	of	WMAS	data	Fields	 from	 ambulance	 service	 data,	 used	 during	 record	 linkage,	 and	 all	 pre-processing	performed	are	outlined	in	table	5.6	below.	Patient	identifiable	data	including	patients	name,	 surname,	date	of	 birth	 and	home	address	post	 code	were	required	to	link	personal	records.	Ambulance	incident	date	was	required	to	ensure	 correct	 instances	 were	 linked	 together	 i.e.	 to	 ensure	 ambulance	 and	hospital	 records	 for	 patient	 who	 attended	 hospital	 on	 multiple	 occasions	
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throughout	the	12-month	period	were	linked	appropriately.	Suffixes	and	Prefixes	were	not	removed	as	Link	Plus	removes	these	automatically.	
Table	5.6	Preprocessing	of	ambulance	data	
Variable	name	 Definition	 Variable	type	 Pre-processing	
Amb_Forename text	 Patients	forename	 Convert	to	lower	case	
 	 	 Remove	all	punctuation	
 	 	 Remove	excess	white	space	
Amb_Surname text	 Patients	surname	 Convert	to	lower	case	
 	 	 Remove	all	punctuation	
 	 	 Remove	excess	white	space	
Amb_DOB date	 Patients	date	of	birth	 Remove	excess	white	space	
 	 	 Convert	to	DD-MM-YYYY	format	
 	 	 Delete	invalid	values	
Amb_Gender text	 Patients	gender	 Remove	all	white	space	
 	 	 Convert	to	male	or	female	
Amb_Pt_Postcode text	 Patients	post	code	 Convert	to	lower	case	
 	 	 Remove	all	punctuation	
 	 	 Remove	all	white	space	
Amb_Incident_Date date	 Date	of	999	call	 Remove	all	white	space	
 	 	 Convert	to	DD-MM-YYYY	format	
 	 	 Delete	invalid	values			
5.3.2	Pre-processing	of	UHNS	data	Fields	from	emergency	department	data,	used	during	record	linkage,	and	all	pre-processing	performed	are	outlined	in	table	5.7	below:	
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Table	5.7	Pre-processing	of	Emergency	Department	data	
Variable	name	 Definition	 Variable	type	 Pre-processing	
UHNS_Forename text	 Patients	forename	 Convert	to	lower	case	
 	 	 Remove	all	punctuation	
 	 	 Remove	excess	white	space	
UHNS_Surname text	 Patients	surname	 Convert	to	lower	case	
 	 	 Remove	all	punctuation	
 	 	 Remove	excess	white	space	
UHNS_DOB date	 Patients	date	of	birth	 Remove	excess	white	space	
 	 	 Convert	to	DD-MM-YYYY	format	
 	 	 Delete	invalid	values	
UHNS_Gender text	 Patients	gender	 Remove	all	white	space	
 	 	 Convert	to	male	or	female	
UHNS_Pt_Postcode text	 Patients	post	code	 Convert	to	lower	case	
 	 	 Remove	all	punctuation	
 	 	 Remove	all	white	space	
UHNS_Incident_Date date	 Date	ED	attended	 Remove	all	white	space	
 	 	 Convert	to	DD-MM-YYYY	format	
 	 	 Delete	invalid	values			Patient	 identifiable	 data	 including	 patients	 name,	 surname,	 date	 of	 birth	 and	home	 address	 post	 code	 were	 required	 to	 link	 personal	 records.	 Date	 of	emergency	 department	 attendance	 was	 required	 to	 ensure	 correct	 instances	were	 linked	 together.	 Suffixes	 and	 Prefixes	 were	 not	 removed	 as	 Link	 Plus	removes	these	automatically.	
5.3.3	Link	Plus	Software	Link	 Plus	 is	 a	 Windows-based	 software	 program	 developed	 by	 the	 Cancer	Division	of	the	Centres	for	Disease	Control	and	Prevention	(CDC)	in	the	United	States.	 	It	 is	 a	 probabalistic	 linkage	 program	 designed	 to	 match	 records	 in	registries.		Although	originally	designed	for	use	with	cancer	registries,	there	is	no	barrier	to	using	Link	Plus	with	data	other	than	cancer	registry	data.	
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In	2004,	the	CDC	released	the	first	production	version	of	Link	Plus,	Version	1.0,	which	probabilistically	linked	files,	and	allowed	1-1	matching,	but	provided	no	support	for	manual	review	of	comparison	pairs.		The	second	production	version	of	Link	Plus,	Version	2.0,	was	released	 in	2007	and	allowed	1-1	matching	and	included	powerful	support	for	the	manual	review	process.		The	third	version	of	Link	Plus	is	only	available	in	beta-version	and	has	the	following	enhancements:	
• It	 removes	 the	 limitation	on	 the	number	of	records	 included	 in	File	2;	the	program	works	for	any	number	of	records	in	File	2	if	the	computer	has	sufficient	memory	to	read	in	data	from	File	1	(estimated	limitation	of	4.5-4.8	million	records	for	the	file	size	of	File	1).	• Users	can	choose	whether	to	write	all	potential	matches	(many-to-many	linkages)	or	only	the	matches	with	the	highest	score	to	the	linkage	report	(1-to-many	linkages).	• It	provides	confirmation-like	matching	method	for	variables	such	as	address	where	an	exact	match	contributes	a	positive	weight	to	the	total	linkage	score	while	no	match	contributes	nothing	(zero	weight)	to	the	total	score.	• It	 provides	 Social	 Security	Number-like	matching	method	 for	 a	generic	ID	which	allows	partial	matching	by	calculating	similarity.	• It	provides	refined	name	matching	methods	that	are	more	robust	against	 the	 frequency	 of	 names	 or	 outlier	 of	 names,	 and	 can	handle	 the	 names	 with	 embedded	 spaces	 and	 apply	 partial	matching	algorithms	to	swapped	names.	
Link	Plus	version	3	(beta)	was	used	to	link	records	in	this	study.		
5.3.4	Choice	of	blocking	variable	Surname	was	chosen	to	be	the	blocking	variable.	Link	Plus	has	two	options	for	phonetic	encoding	-	Soundex	and	New	York	State	Identification	and	Intelligence	System	(NYSIIS).	NYSIIS	was	chosen	for	phonetic	encoding	as	it	has	a	reported	2.7%	increase	in	accuracy	over	Soundex.138	
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5.3.5	Choice	of	matching	variables	Variables	chosen	to	be	matching	variables	are	reported	in	table	5.8.	
Table	5.8	Variables	used	as	matching	variables	during	record	linkage	
Ambulance	Service	 Hospital													 Method	
WMAS_Forename UHNS_Forename NYSIIS							
WMAS_DOB UHNS_DOB Date										
WMAS_Gender UHNS_Gender Exact									
WMAS_Postcode UHNS_Postcode String								
WMAS_Incident_Date UHNS_Incident_Date Date												
5.4	Results	
5.4.1	Generation	of	candidate	pairs	Link	Plus	software	generated	35382	candidate	pairs.	No	linkage	score	threshold	was	defined	 to	assign	a	preliminary	match	 or	non-match	 status.	All	 candidate	record	pairs	were	subject	to	manual	review.	
5.4.2	Clerical	review	of	candidate	pairs	The	ambulance	incident	date	and	hospital	arrival	date	are	not	generated	by	user	input,	 they	 are	 system	 generated.	 As	 such,	 they	 are	 less	 prone	 to	 error.	Consequently,	all	candidate	pairs	were	required	to	have	identical	incident	dates.	The	only	 exception	 to	 this	 rule	would	occur	when	 the	 ‘999’	 call	was	 received	before	midnight,	but	the	ambulance	arrived	at	hospital	shortly	after	midnight.	Where	a	difference	of	one	day	was	identified,	the	ambulance	and	hospital	records	were	manually	 reviewed	 to	 determine	 if	 the	 times	 were	 consistent	with	 this	mechanism.	Any	candidate	pair	not	meeting	this	requirement	was	categorised	as	a	non-match.		
It	 is	highly	unlikely	that	two	individuals	with	almost	identical	personal	details	would	have	used	the	same	ambulance	service	and	attended	the	same	Emergency	Department	 on	 the	 same	 day.	 Generally,	 any	 one	 of	 date	 of	 birth,	 gender	 or	postcode	could	contain	an	error,	or	be	missing,	provided	there	was	agreement	on	forename,	surname	and	incident	date.	Minor	misspellings	between	forename	and	
PRoSAiC	Thesis	
97	
surname	fields	were	tolerated	provided	there	was	agreement	on	the	remaining	fields.	Cases	where	forename	or	surname	were	missing,	or	clearly	different,	were	categorised	as	non-match.	
Following	clerical	 review	33289	candidate	pairs	were	categorised	as	matches,	while	 2093	 were	 classified	 as	 false	 matches.	 Several	 thousand	 records	 were	unmatched,	 5194	 ambulance	 records	 had	 no	 corresponding	 hospital	 record,	while	no	ambulance	record	could	be	identified	for	15428	emergency	department	records.	
5.4.3	Evaluation	of	record	linkage	No	gold	standard	data	is	available	to	determine	which,	if	any,	match	records	were	false	positives	(FP)	and	which	non-match	records	were	false	negatives	(FN).	It	is	therefore	 not	 possible	 to	 report	precision,	 recall	 or	F-measure	 for	 this	 record	linking	exercise.	
Complexity	for	indexing	is	as	follows:	
																																					 																																													= 35382&38483+∗(48534)																																																												= 0.00000189		Of	38483	ambulance	records,	33289	(86.5%)	were	successfully	linked	with	an	emergency	department	record.	Manual	review	of	250	randomly	selected	record	pairs	 failed	 to	 identify	 any	 incorrect	 linkages.	 Results	 of	 this	 linkage	 exercise	compare	favourably	with	similar	EMS	linkage	studies.	Newgard139	undertook	a	probabilistic	linkage	of	EMS	and	trauma	registry	data	with	a	95.9%	success	rate.	Downing	 et	 al140	 linked	ambulance	 and	 Emergency	Department	 (ED)	 records	relating	 to	 assault	 in	 the	 United	 Kingdom	 (UK),	 reporting	 84.2%	 successful	linkage.	Mears	et	al141	linked	Emergency	Medical	Services	data	with	a	state-wide	stroke	registry	and	reported	63%	of	cases	correctly	 linked.	Finally,	 to	develop	their	Critical	Illness	Score,	Seymour	et	al107	report	successfully	linking	85%	of	cases,	spanning	a	ten	year	period,	using	the	same	Link	Plus	software	as	used	in	this	study.		
Of	the	5194	(13.5%)	unlinked	ambulance	cases	within	this	study,	a	significant	proportion	 are	 likely	 to	 be	 patients	 who	 were	 transported	 to	 hospital	
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destinations	other	than	the	Emergency	Department	(ED).	Manual	inspection	of	120	 unlinked	 cases	 confirmed	 that	 97	 (80.8%)	were	 transported	 to	 hospital	destinations	other	than	the	Emergency	Department.	Further	work	to	extract	the	hospital	 destination	 was	 promised	 by	 WMAS	 IT,	 however	 these	 data	 never	materialised.	 As	 reported	 in	Chapter	 4,	 the	 ability	 to	 review	WMAS	 records	online	 is	no	 longer	available	to	enable	manual	review	the	remaining	unlinked	cases,	 thus	 it	 has	 not	 been	 possible	 to	 determine	 if	 the	 same	 proportion	 of	records,	in	the	remaining	5074	unreviewed	cases,	were	transported	to	non-ED	destinations.	 However,	 if	 the	 proportion	were	 found	 to	 be	 similar	 this	would	suggest	 that	 4328	 of	 the	 unlinked	 cases	 could	 have	 been	 transported	 to	destinations	other	than	the	ED,	while	around	866	would	be	unlinked	ED	cases.	Such	an	adjustment	would	improve	successful	data	linkage	to	33289	of	34155	cases	(97.5%),	similar	to	that	reported	by	Newgard.139	
A	small	proportion	of	unlinked	cases	are	likely	to	result	from	an	ambulance	crew	being	unable	to	identify	a	patient	in	the	early	stages	of	a	health	care	episode	e.g.	when	the	patient	has	a	significantly	altered	level	of	consciousness	and	is	unable	to	confirm	their	name	or	address.	In	such	cases	the	ambulance	crew	generally	enter	 the	 name	 as	 ‘unknown’	 or	 leave	 the	 relevant	 fields	 blank.	 At	 hospital	however,	the	record	can	be	updated	once	the	patient	has	recovered	sufficiently	enough	to	provide	these	details,	or	has	been	identified	through	other	means	e.g.	relatives	 or	 police.	 Consequently,	 a	 mismatch	 between	 the	 ambulance	 and	hospital	records	is	to	be	expected	in	a	small	proportion	of	cases.		There	were	58	such	instances	within	the	5194	records	(1.1%	of	unlinked	cases)	where	the	name	and	surname	fields	of	the	ambulance	record	were	“missing”	or	“unknown”.	
5.5	Removal	of	identifiable	data	Permission	 to	 process	 patient	 identifiable	 information	 without	 consent	 was	obtained	 from	 the	 Health	 Research	 Authority	 (HRA)	 Confidentiality	 Advisory	Group	 (CAG)	 under	 Regulation	 5	 of	 the	 Health	 Service	 (Control	 of	 Patient	Information)	 Regulations	 2002	 on	 19	 May	 2014	 (CAG	 reference:	 CAG4-03(PR2)2014).	The	conditions	of	approval	specified	 that	personal	 identifiable	information	 would	 only	 be	 held	 for	 6	months	 and	 that	 once	 ambulance	 and	hospital	 records	 were	 linked	 all	 identifiable	 data	would	 be	 removed.	 Record	Linkage	 generated	 a	 unique	 record	 linkage	 key	 that	 was	 inserted	 into	 both	datasets	to	enable	future	pairing	of	linked	records.	Following	completion	of	the	
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record	 linkage	exercise	 the	 following	 fields	were	removed	 from	the	respective	datasets:	
5.5.1	Ambulance	data	• Incident	details	comprising	all	 incident	address	 fields	 including	postcode.	• Patient	details	comprising	 forename,	surname,	date	of	birth,	all	address	fields	including	postcode.	
5.5.2	Emergency	Department	data	• Patient	details	comprising	 forename,	surname,	date	of	birth,	all	address	fields	including	postcode.	
5.6	Conclusion	This	 chapter	 has	 provided	 an	 overview	 of	 the	 record	 linkage	 process.	 It	 has	detailed	 the	 pre-processing	 of	 data	 prior	 to	 record	 linkage,	 identified	 which	variables	 were	 selected	 as	 blocking	 and	 matching	 variables	 as	 well	 as	 the	approach	 to	 variable	 comparison.	 Comparison	 pairs	 were	 evaluated	 and	 the	effectiveness	of	the	linkage	exercise	was	explored	as	far	as	practicable	given	the	available	data.	The	next	chapter	will	focus	upon	management	of	missing	data	to	prior	to	statistical	analysis	being	performed.	
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Chapter	6	
Missing	data	
	
“The	only	really	good	solution	to	the	missing	data	problem	is	not	to	have	
any”	(Paul	D.	Allison,	2001)		
6.1	Introduction	Missing	 data	 are	 ubiquitous	 in	 clinical	 research.142	 Historically,	 analyses	 of	datasets	with	missing	values	has	commonly	proceed	with	an	assumption,	either	explicit	 or	 implicit,	 that	 the	 mechanism	 causing	 the	 missing	 data	 could	 be	ignored.143	However,	such	assumptions	can	significantly	bias	any	 findings.	For	example,	 if	study	participants	with	poorer	clinical	outcomes	are	more	likely	to	drop	out	of	a	study	before	completion,	then	subsequent	statistical	analysis	will	be	 biased	 if	 it	 fails	 to	 adequately	 account	 for	 the	 poor	 outcomes	 of	 those	participants	who	dropped	out.	Furthermore,	missing	data	also	has	a	significant	impact	 on	 which	 statistical	 analyses	 can	 be	 undertaken	 as	 many	 statistical	techniques	presume	complete	data	for	all	variables.144	
Where	data	are	incomplete,	datasets	usually	require	processing,	to	ensure	that	statistical	analysis	is	undertaken	with	complete	cases.144	This	chapter	addresses	missingness	 of	 data	 within	 the	 datasets	 used,	 provides	 an	 overview	 of	 the	strengths	and	weaknesses	of	the	different	options	for	management	of	missing	data,	and	describes	how	missing	data	were	handled	within	this	study.	
6.2	Background	
6.2.1	Identification	of	missing	data	In	addition	to	identification	of	cells	with	missing	data,	appropriate	management	of	missing	data	entails	determining	if	there	is	a	justification	for,	or	pattern	to,	the	missingness	of	data.	For	example,	a	survey	question	asks	if	a	participant	has	ever	smoked	marijuana.	 	Where	 the	response	 is	 “No”,	 the	participant	 is	directed	to	skip	 subsequent	 questions	 addressing	 recent	 use,	 and	 proceed	 to	 the	 next	section.	 Many	 researchers	 would	 not	 consider	 the	 skipped	 questions	 to	 be	missing,	 as	 never	 having	 smoked	marijuana	 implies	 no	 recent	 use.	 However,	there	will	be	no	recorded	values	in	the	dataset	for	the	skipped	questions	-		how	
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are	 these	 “missing”	 values	 to	be	handled	when	performing	 analyses	 that	 rely	upon	complete	data.145	Consequently,	although	identification	of	missing	values	is	straight	forward,	categorising	the	cause	of	missing	data	can	be	a	challenge,	and	is	required	to	ensure	appropriate	statistical	methods	are	employed.		
6.2.2	Categorising	the	cause	of	missing	data	Rubin’s143	 seminal	 work	 addressing	 missing	 data	 defined	 three	 categories	thereof:	
• Missing	 completely	 at	 random	 (MCAR):	MCAR	 indicates	 data	are	 missing	 independent	 of	 both	 observed	 and	 unobserved	(missing)	data.	For	example,	blood	test	observations	missing	due	to	accidental	damage	to	test	tubes	-	the	cause	of	missingness	is	not	 related	 to	 any	 variable	 in	 the	 dataset,	 but	 the	 random	occurrence	of	accidental	damage.	The	missing	data	are	in	effect	a	random	subset	of	the	dataset.	• Missing	at	random	(MAR):	MAR	indicates	that	missing	data	are	related	 to	 the	 observed	 data	 but	 the	 pattern	 of	 missingness	cannot	 be	 predicted.	 For	 example,	 a	 study	 is	 undertaken	 that	requires	 two	measurements	of	a	variable	be	 taken	at	 the	same	time.	The	study	protocol	dictates	that	 if	 the	two	measurements	differ	 by	 more	 than	 a	 specified	 amount,	 a	 third	measurement	must	be	taken.	A	third	measurement	will	thus	be	required	in	all	cases	 where	 the	 difference	 between	 the	 two	measurements	 is	greater	 than	 the	 specified	 amount,	 but	 missing	 in	 those	 cases	where	 the	 difference	 is	 less	 than	 the	 specified	 amount.	Missingness	of	measurement	three	is	therefore	dependent	upon	the	 observed	 data	 (measurements	 one	 and	 two),	 however	 the	occurrence	of	missing	values	cannot	be	predicted.	• Missing	not	at	random	(MNAR):	MNAR	indicates	missing	data	are	 related	 to	 missing	 data	 values	 themselves.	 For	 example,	clinicians	omit	an	expensive	diagnostic	 test	as	 they	can	make	a	diagnosis	 without	 the	 additional	 information	 provided	 by	 the	test.	
PRoSAiC	Thesis	
102	
If	the	data	are	MCAR	or	MAR:	the	missing	data	mechanism	is	said	to	be	ignorable,	this	 implies	 there	 is	 no	 need	 to	 model	 the	 missing	 data	 mechanism	 when	generating	replacement	values.	
If	the	data	are	MNAR:	the	missing	data	mechanism	is	said	to	be	non-ignorable,	this	 implies	 the	missing	data	mechanism	must	 be	modelled	when	 generating	replacement	values,	and	requires	a	thorough	understanding	of	the	missing	data	mechanism.		
6.2.3	Processing	of	missing	data	Many	statistical	analyses	are	predicated	on	the	assumption	of	complete	data	for	all	variables	included	in	analysis.	As	such,	it	is	essential	to	minimise	the	impact	of	missing	data	within	datasets.	There	are	two	divergent	approaches	to	minimise	the	impact	of	missing	data.	The	first	approach	is	to	omit	cases	with	missing	data	from	 calculations;	 the	 second	 is	 to	 impute	 values	 for	 missing	 data.	 These	approaches	are	further	expanded	below.	
6.2.4	Omission	methods		There	are	two	approaches	to	omission	of	missing	data	-		list	wise	deletion	(also	called	complete	case	analysis),	and	pair	wise	deletion	(also	called	available	case	analysis).	
6.2.4.1	List	wise	deletion		In	list	wise	deletion,	all	cases	with	missing	data	are	removed	from	the	dataset.	The	 major	 advantage	 of	 list	 wise	 deletion	 is	 its	 simplicity.	 However,	 this	approach	can	significantly	reduce	the	size	of	the	sample,	typically		30-50%,	on	which	 statistical	 analyses	 are	 performed.146	 The	 smaller	 sample	 size	 in	 turn	reduces	the	power	of	any	analysis	undertaken,147	widens	confidence	intervals,148	and	can	bias	many	parameter	estimates.149	Some	argue	 that	list	wise	deletion	should	only	be	considered	when	the	proportion	of	missing	data	is	below	5%	and	only	if	the	missing	data	are	MCAR.146	147	150	151	
For	example,	table	6.1	 lists	seven	cases	 in	a	population,	 four	of	which	have	a	missing	data	point.	Under	list	wise	deletion	only	the	three	cases	with	complete	data	would	be	available	for	analysis.	
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6.2.4.2	Pair	wise	deletion	In	pair	wise	deletion,	analysis	is	performed	on	all	cases	for	which	the	variables	of	 interest	are	present.	Consequently,	any	given	case	may	contribute	 to	some	analyses	but	not	 to	others.152	The	major	 advantage	of	 this	 approach	 is	 that	 it	utilises	as	much	of	the	available	data	as	possible	for	analysis.	The	disadvantage	of	this	approach	is	that	each	analysis	is	performed	on	a	different	sample,		indeed	sample	sizes	may	vary	considerably	as	a	result.153	A	major	concern	with	pairwise	deletion	is	that	there	is	no	basis	for	estimating	standard	errors.147	153	Pairwise	deletion	is	not	recommended	as	a	general	solution	for	missing	data.147	
For	example,	table	6.1	 lists	seven	cases	 in	a	population,	 four	of	which	have	a	missing	data	point.	Under	pairwise	deletion,	three	cases	would	contribute	to	all	analyses	while	all	cases	would	contribute	to	some	analyse.	Rows	two	and	four	cannot	contribute	to	analyses	requiring	weight	as	an	input,	but	can	contribute	to	analyses	requiring	gender	or	age	as	the	inputs.		
Table	6.1	List	wise	and	pair	wise	deletion	
List	wise	deletion	 	 Pair	wise	deletion	
Gender	 Age	 Weight	 	 Gender	 Age	 Weight	
M	 27	 96	 	 M	 27	 96	
M	 27	 NA	 	 M	 27	 NA	
F	 NA	 67	 	 F	 NA	 67	
M	 45	 NA	 	 M	 45	 NA	
F	 33	 58	 	 F	 33	 58	
NA	 50	 76	 	 NA	 50	 76	
F	 22	 80	 	 F	 22	 80			
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6.2.5	Imputation	methods	
6.2.5.1	Last	observation	carried	forward		Last	observation	carried	forward	methods	are	applicable	to	longitudinal	studies	only.	This	method	imputes	the	missing	values	with	the	last	recorded	observation	for	 the	 individual.	 Implicit	with	 this	method	 is	 the	 assumption	 that	 there	has	been	little	change	in	the	individual	since	the	last	observation,	which	may	well	be	an	unrealistic	assumption.154	If	the	assumptions	are	unrealistic	then	the	resulting	estimations	will	be	biased.	
6.2.5.2	Single	imputation		Single	imputation	is	a	simple	method	to	replace	missing	values	with	estimated	ones.	Predictive	mean	matching	(PMM)	is	the	most	common	single	imputation	method.	PMM	entails	substitution	of	the	missing	observation	with	the	variable	mean.	It	is	both	simple	to	implement	and	preserves	the	available	data.	However,	it	also	skews	the	distribution	of	the	variable	toward	the	mean,	and	consequently	biases	estimates	of	both	variances	and	covariances	and	impacts	on	correlations	between	variables.148	The	effect	 is	worse	 the	 larger	 the	proportion	of	missing	data.146	 Single	 imputation	 methods	 lead	 to	 an	 underestimation	 of	 standard	errors	 and	 consequently	 an	 overestimation	 of	 test	 statistics.148	 The	 primary	reason	 for	 this	 is	 due	 to	 the	 imputed	 values	 being	 entirely	 determined	 by	observed	 data	 without	 including	 any	 consideration	 for	 error	 in	 their	estimation.144	Single	value	imputation	is	not	recommended	as	a	general	solution	for	missing	data.	
6.2.5.3	Deterministic	regression	imputation	Deterministic	 regression	 imputation	 employs	 a	 regression	model	 to	 estimate	values	missing	from	an	observation	based	upon	variables	that	are	present	in	the	observation.	Usually,	linear	regression	is	used	for	numeric	variables,	whereas	for	categorical	data	logistic	regression	may	be	used.155	For	example,	using	cases	with	complete	data,	a	regression	model	is	developed	describing	how	weight	can	be	estimated	from	age,	height	and	waist	measurement.	For	those	cases	with	missing	weight	data,	 the	 same	 regression	model	 is	 employed	 to	predict	weight	based	upon	 age,	 height	 and	 waist	 measurements	 within	 the	 observation.	 A	disadvantage	of	regression	model	imputation	is	the	failure	to	include	an	error	term	within	the	regression	model,	as	such	the	imputed	estimate	will	always	be	located	on	 the	 regression	 line.	This	 implies	a	perfect	 correlation	between	 the	predictors	used	and	the	variable	with	missing	data	-	there	is	no	residual	variance.	
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Deterministic	 regression	 imputation	 thus	overestimates	 correlations	between	predictors	and	outcomes,	and	underestimates	the	variances	and	covariances.	
6.2.5.4	Stochastic	regression	imputation	Stochastic	regression	imputation	extends	the	deterministic	regression	method	by	including	a	residual	error	term,	to	reduce	the	bias	inherent	in	deterministic	regression.	This	residual	error	term	is	normally	distributed	with	a	mean	of	zero	and	a	variance	equal	to	the	residual	variance	from	the	regression	of	the	predictor	on	 the	 outcome.152	 This	 way	 the	 variability	 in	 the	 data	 is	 preserved	 and	parameter	estimates	are	unbiased	provided	the	data	are	MAR.152	However,	the	standard	error	tends	to	be	underestimated,	because	the	uncertainty	about	the	imputed	values	is	not	included,	which	increases	the	risk	of	type	I	errors.150	
6.2.5.5	Hot-deck	and	cold-deck	imputation		Hot-deck	imputation	pairs	observations	containing	missing	values,	with	similar	observations	 containing	 the	 required	 data,	 and	 then	 substitutes	 the	 value	recorded	 from	 the	 observed	 case	 into	 observation	with	 the	missing	 value.156	There	are	two	general	approaches	to	identifying	’similar’	cases	that	will	be	used	to	 provide	 substitute	 data,	 the	 nearest	 neighbour	 approach	 and	 the	 pattern	matching	approach.		
The	 nearest	 neighbour	 approach	 (also	 called	 a	 distance	 function	 approach),	imputes	the	missing	value	with	the	score	of	the	case	with	the	smallest	squared	distance	 statistic	 to	 the	 case	 with	 the	 missing	 value.	 The	 pattern	 matching	approach	stratifies	the	dataset	into	separate	homogenous	groups.	The	missing	data	value	is	then	randomly	drawn	from	the	cases	of	the	equivalent	homogenous	group.157	 Hot-deck	 imputation	 thus	 replaces	 the	missing	 data	 with	 plausible	scores	 that	 preserve	 the	 variable	 distribution,	 however	 the	 approach	underestimates	both	standard	errors	and	variability.156		
Cold-deck	 imputation	 is	 far	 less	 common	 than	 hot	 deck	 imputation,	 but	 is	essentially	the	same	as	hot-deck	implementation	with	the	only	difference	being	the	source	of	comparison	data.158	In	hot-deck	imputation	the	missing	values	are	imputed	 from	the	same	dataset,	whereas	 in	cold-deck	 imputation	 the	missing	values	are	imputed	from	a	different	dataset.159	
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6.2.5.6	Maximum	Likelihood	Estimation	(MLE)		Maximum	Likelihood	Estimation	(MLE)	is	one	of	the	most	commonly	employed	imputation	 techniques.	 A	model	 is	 defined	 that	 maximises	 the	 probability	 of	observing	the	data	that	is	present.	In	other	words,	MLE	generates	the	model	that	is	most	consistent	with	the	distribution	of	data	that	is	observed	(the	data	that	is	not	 missing).	 Missing	 values	 are	 neither	 replaced	 nor	 imputed,	 rather	 the	missing	 data	 is	 handled	 within	 the	 analysis	 model.	 Maximum	 Likelihood	Estimation	is	commonly	observed	in	clinical	practice,	for	example,	a	patient	with	a	history	of	asthma	is	experiencing	breathing	difficulties,	is	struggling	to	talk	and	appears	 to	 be	 tiring.	 Although	 there	 are	 several	 possible	 causes	 of	 breathing	difficulty	 (asthma,	 pulmonary	 embolism,	 pneumonia	 to	 name	 but	 a	 few),	 the	observable	data	suggest	the	most	likely	cause	is	an	acute	asthma	attack.	
6.2.5.7	Multiple	Imputation	(MI)		A	major	flaw	of	deterministic	regression	imputation	is	that	the	imputed	values	always	lie	directly	on	the	regression	line,	however	real	data	seldom	lies	directly	on	 the	 regression	 line.	The	deviation	 from	 the	 regression	 line	 represents	 the	variance	 in	 the	data.144	 Stochastic	 regression	 attempts	 to	 address	 this	 failing.	Multiple	 imputation	(MI)	 takes	a	 further	step	and	generates	multiple	datasets	that	 include	a	term	to	account	 for	variance	of	estimates.	Consequently	bias	 is	reduced	and	estimates	are	more	reliable.160	
The	key	to	MI	lies	in	creating	multiple	versions	of	the	dataset.	MI	seeks	to	replace	missing	 values	 with	 plausible	 values,	 rather	 than	 estimates	 of	 the	 missing	value,127	and	so	generates	multiple	versions	of	the	dataset,	each	of	which	will	contain	 different	 imputed	 values	 that	 have	 been	 substituted	 for	 the	 missing	values.144		
The	multiple	 imputation	process	 contains	 three	phases	 -	 imputation,	 analysis	and	pooling.127	143	161		
Imputation	phase	During	 imputation,	 multiple	 data	 sets	 are	 generated	 each	 of	 which	 contain	different	 imputed	 values.	 The	 imputed	 values	 are	 drawn	 from	 the	 posterior	probability	 distribution	 of	 the	 observed	 data144	 -	 thus	multiple	 imputation	 is	based	on	a	bayesian	approach.162	The	imputed	values	are	estimated	by	applying	a	 Gibbs	 sampling	 algorithm,	 a	 special	 Markov	 Chain	 Monte	 Carlo	 (MCMC)	
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technique,	to	the	means	and	covariances	of	observed	data;	thereafter	a	residual	term	 is	 added	 to	 the	 imputed	value.160	This	process	 is	 iterated	 several	 times,	updating	 the	 regression	 parameters	 following	 each	 iteration,	 resulting	 in	different	 imputed	values	 each	 time.	After	 a	defined	number	of	 iterations,	 the	generated	dataset	is	stored,	and	iterations	re-commence.	This	process	continues	until	the	required	number	of	imputed	datasets	is	reached.		
Analysis	phase	During	the	analysis	phase,	standard	statistical	methods	are	applied	to	each	of	the	imputed	datasets.163	
Pooling	phase	During	the	pooling	phase,	statistical	results	generated	during	the	analysis	phase	are	combined	into	a	single	set	of	results.	Statistical	estimates	are	pooled	using	Rubin’s	 rules,164	which	 account	 for	 variability	 between	 the	 imputed	datasets,	reflecting	 the	 uncertainty	 associated	 with	 the	 missing	 values.163	 Parameter	estimates	are	summarised	by	taking	the	average	over	the	parameter	estimates	from	 all	 imputed	 datasets.	 The	 standard	 errors	 are	 pooled	 by	 combining	 the	within	imputation	variance	and	the	between	imputation	variance.160		
Figure	6.1	Schematic	of	multiple	imputation	
	Reproduced	from	Van	Buuren	et	al165		Although	MI	fully	accounts	for	uncertainty	in	predicting	the	missing	values,	we	can	never	know	the	true	values	of	the	missing	data.163	
6.3	Method	Statistical	analyses	were	performed	using	R	Studio	(Version	0.99.903).	Missing	data	were	processed	by	multiple	 imputation	using	the	MICE	package	(Version	2.25).	 The	 MICE	 algorithm	 implements	 Multiple	 Imputation	 by	 Chained	
PRoSAiC	Thesis	
108	
Equations	(MICE)	with	a	Fully	Conditional	Specification	(FCS)	to	impute	missing	values.	A	unique	statistical	model	is	thus	derived	for	each	variable.	Standardised	processing	 methods	 are	 provided	 for	 continuous	 data	 (predictive	 mean	matching,	normal),	binary	data	(logistic	regression),	unordered	categorical	data	(polytomous	 logistic	 regression)	 and	 ordered	 categorical	 data	 (proportional	odds).165		
Multiple	 imputation	 with	 MICE	 requires	 consideration	 of	 several	 factors	 to	ensure	appropriate	specification	of	the	imputation	model. 
6.3.1	Multiple	imputation	
Assessment	 of	 missing	 data	 -	 establish	 which	 data	 are	 missing,	 the	 types	 of	variables	with	missing	data	and	determine	if	there	is	any	pattern	to	missingness.	
6.3.1.1	Classification	of	missing	data		Determine	if	the	data	are	MCAR,	MAR	or	MNAR.	The	likelihood	that	the	data	are	MCAR	is	very	low.	MICE	traditionally	imputes	data	that	are	MAR.	These	methods	are	also	valid	for	data	that	are	MCAR.	Although	MICE	can	impute	data	that	are	MNAR,	to	successfully	impute	MNAR	data	requires	additional	assumptions	that	will	influence	the	imputed	data	generated.	Most	often	data	are	MAR.	
6.3.1.2	Determine	the	imputation	method	for	each	imputed	variable	In	 a	 Fully	 Conditional	 Specification	 (FCS)	 a	 unique	 model	 will	 be	 created	 to	impute	missing	data	for	each	variable	i.e.	there	will	be	a	model	for	each	variable	requiring	imputation	of	missing	data.	The	imputation	method	will	be	informed	by	variable	type	(see	table	6.2).	
6.3.1.3	Selection	of	variables	to	be	included	in	the	imputation	model	Generally,	the	greater	the	number	of	variables	used	to	impute	missing	data	the	more	 reliable	 the	 imputation	 is	 likely	 to	 be.	 However,	 some	 variables	 will	contribute	very	little	toward	the	model.	Including	many	variables	that	contribute	little	to	the	model	creates	an	unwieldily	model,	increases	complexity	and	extends	computation	time	with	little	benefit.	Restricting	imputation	models	to	relevant	variables	optimises	the	imputation	process.	
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Table	6.2	Imputation	methods	
Method	 Description	 Scale	type	 Default	pmm	 Predictive	mean	matching	 numeric	 Yes	norm	 Bayesian	linear	regression	 numeric	 	norm.nob	 Non-Bayesian	linear	regression	 numeric	 	mean	 Unconditional	mean	imputation	 numeric	 	2l.norm	 Two	level	linear	model	 numeric	 	logreg	 Logistic	regression	 factor,	2	levels	 Yes	polyreg	 Polytomous	(unordered)	regression	 factor,	>2	levels	 Yes	lda	 Linear	discriminant	analysis	 factor	 	sample	 Random	sample	from	the	observed	data	 any	 	
	
6.3.1.4	 Decide	 whether	 to	 impute	 variables	 that	 are	 functions	 of	
other	(incomplete)	variables	Where	variables	 are	 functions	of	 included	variables,	 for	 example	 the	Glasgow	Coma	 Score	 (GCS)	 is	 calculated	 from	 its	 three	 constituent	 parts	 (eye,	 verbal,	motor	response),	it	is	possible	to	specify	this	relationship	within	the	imputation	model	 to	 ensure	 consistency,	 alternately	 one	 can	 omit	 the	 GCS	 variable	 and	calculate	it	following	imputation	of	the	constituent	parts.	
6.3.1.5	Determine	the	visit	sequence		The	order	in	which	variables	are	imputed	(visit	sequence)	can	have	an	impact	on	other	variables,	particularly	in	the	case	of	variables	that	are	functions	of	other	variables.	It	may	also	impact	convergence	of	the	imputation	algorithm.165	
6.3.1.6	Determine	the	number	of	imputations	Alison144	reports	that	early	advocates	of	MI	believed	that	three	to	five	imputed	data	sets	were	sufficient.	Schafer161	 later	suggested	 that	 there	was	 little	 to	be	gained	by	using	more	than	five	to	ten	imputed	data	sets,	as	the	loss	in	efficiency	was	small	even	with	50%	missing	data.	More	recent	debate	has	highlighted	that	a	minor	loss	in	efficiency	does	not	necessarily	equate	to	a	minor	loss	in	accuracy	of	standard	error	estimates,	confidence	intervals,	and	p-values.144		
Graham	et	al166	addressed	the	question	of	number	of	imputations	required	with	respect	 to	 loss	 of	 power	 for	 hypothesis	 testing.	 They	 suggested	 that	 if	 a	
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researcher	was	willing	to	accept	a	loss	of	1%	in	power,	then	20	imputations	were	required	for	for	10%	to	30%	missing	information,	and	40	imputations	would	be	required	for	50%	missing	information.	 	Bodner167	and	White	et	al168	approach	the	question	from	a	different	perspective,	they	estimated	the	Monte	Carlo	error	in	reported	p-values.	Although	they	adopted	different	statistical	approaches	to	the	question,	they	arrived	at	similar	conclusions,	resulting	in	the	current	“rule	of	thumb”	for	number	of	imputations	required,	namely,	the	number	of	imputations	
should	be	slightly	higher	than	the	percentage	of	cases	that	are	incomplete.	Thus,	if	37%	of	cases	have	missing	data	in	one	or	more	variables	then	40	imputed	data	sets	are	required.	
6.3.1.7	Choose	the	number	of	iterations		The	number	of	iterations	play	an	important	role	in	assessment	of	convergence.	As	 previously	 mentioned	 in	 Section	 6.2.5,	 imputed	 values	 are	 estimated	 by	applying	 a	 Gibbs	 sampling	 algorithm,	 a	 special	 Markov	 Chain	 Monte	 Carlo	
(MCMC)	technique,	to	the	means	and	covariance	of	observed	data.		This	process	is	iterated	several	times,	resulting	in	different	imputed	values	for	each	iteration.			The	mean	 and	 variance	 of	 the	 imputations	 can	 be	 plotted	 to	 help	 assess	 for	convergence	of	 the	Gibbs	sampling	algorithm.	On	a	practical	 level,	 the	greater	then	number	of	iterations	the	more	data	points	can	be	plotted	to	visually	assess	convergence.	
6.3.1.8	Assess	imputed	data	Successful	MI	with	MICE	is	dependent	upon	convergence	of	the	Gibbs	sampling	algorithm,	however	there	is	no	clear-cut	method	for	assessing	whether	the	Gibbs	sampling	algorithm	has	converged.	Technically,	convergence	is	diagnosed	when	the	 variance	between	different	 sequences	 is	no	 larger	 than	 the	 variance	with	each	individual	sequence.127	Practically	this	can	be	assessed	by	plotting	the	mean	and	variance	of	the	imputations	against	the	iteration	number.		On	convergence,	the	plots	should	be	 freely	 intermingled	with	each	other,	without	showing	any	definite	 trends.	Figure	 6.2	demonstrates	 unhealthy	mixing	 of	 the	 imputation	chains,	where	the	plotted	chains	fail	to	mingle.		Figure	6.3	demonstrates	healthy	convergence	with	adequate	mixing	of	the	plotted	chains.		
Alternatively,	 the	R-hat	 convergence	 statistics,	 calculated	 using	 the	MICEAdds	package	(Version	1.9-0),	can	be	calculated	for	each	imputed	variable.	The	R-hat	convergence	 statistics	 compare	 the	 variance	 between	 chains	 to	 the	 variance	
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across	chains.	Values	closer	to	1.0	indicate	little	is	to	be	gained	by	running	the	chains	longer	(more	iterations	not	required),	and	in	general,	values	greater	than	1.1	indicate	that	the	chains	should	be	run	longer	(more	iterations	required).169	Once	convergence	has	been	confirmed,	inspection	of	imputed	data	is	required.	For	large	datasets,	this	is	commonly	achieved	by	inspection	of	density	plots	for	each	 imputed	 variable	 to	 confirm	 the	 imputed	 data	 are	 consistent	 with	 the	observed	data.		
	
Figure	6.2	Unhealthy	convergence	demonstrated	by	lack	of	mixing		across	imputation	chains		
Reproduced	from	van	Buuren127		
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Figure	6.3	Healthy	convergence	demonstrated	by	mixing	across	imputation	chains		
	Reproduced	from	van	Buuren127		The	MAR	assumption	can	never	be	truly	confirmed	from	the	observed	data	-	this	is	because	we	do	not	know	what	the	true	missing	values	are.	However,	we	can	confirm	that	the	imputed	values	generated	are	plausible.	For	each	variable	we	have	 imputed,	we	 plot	 densities	 of	 both	 the	 observed	 and	 imputed	 values	 to	visually	 determine	 if	 the	 imputed	 values	 are	 reasonable.	 Differences	 in	 the	densities	 between	 the	 observed	 and	 imputed	 values	 suggest	 a	 problem	 that	requires	 further	 investigation.	 Figure	 6.4	 demonstrates	 a	 plot	 of	 healthy	imputation	where	the	densities	of	imputed	data	are	similar	to	the	observed	data.	
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Figure	6.4	Healthy	Density	Plots	
	Reproduced	from	van	Buuren127	
6.4	Results	
6.4.1	Removal	of	excluded	cases	The	previous	chapter	addressing	record	linkage	confirmed	that	33289	clinical	records	were	 successfully	 linked.	However,	 these	 linked	 records	 include	 cases	that	were	defined,	a	priori,	as	excluded	case	types.		Excluded	cases	included	age	under	18	years,	attendance	for	trauma,	attendance	for	mental	health	issue	and	cases	 of	 cardiac	 arrest.	 Prior	 to	 imputing	missing	 data,	 excluded	 cases	 were	removed	 from	the	dataset.	More	reliable	diagnostic	data	were	available	 in	the	UHNS	 dataset,	 the	 discharge	 diagnoses	 stored	 in	 the	 variables	 Diagnosis1,	
Diagnosis2, Diagnosis3,	 Diagnosis4	 and	 Diagnosis5	 were	 utilised	 to	removed	excluded	 cases	 from	 the	WMAS	 dataset.	Ultimately	10344	 cases	were	removed	while	22945	cases	were	included	for	development	of	the	prehospital	sepsis	screening	tool	(see	figure	6.1	for	further	details).		
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Figure	6.5	Included	cases	
	
	
	
6.4.2	Multiple	imputation	
6.4.2.1	Assessment	of	missing	data 
Examination	of	the	WMAS	data	indicates	they	comprise	22945	observations	each	having	39	variables	(see	table	6.3).	
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Table	6.3	Composition	of	WMAS	data	
Variable	 Type	 Unique	
WMASID character	 22945 
UHNSID character	 22945 
DispCat factor	 8 
DispComp1 factor	 30 
DispComp2 factor	 29 
Imp factor	 6 
Location factor	 3 
Age integer	 88 
Gender factor	 2 
Ethnicity factor	 7 
Resps integer	 53 
SpO2 integer	 58 
Pulse integer	 201 
SBP integer	 200 
DBP integer	 141 
Temp numeric	 84 
BM numeric	 302 
GCS_eye ordered-factor	 4 
GCS_verbal ordered-factor	 5 
GCS_motor ordered-factor	 6 
GCS_sum integer	 13 
Skin factor	 7 
CBRT ordered-factor	 2 
AVPU ordered-factor	 4 
RPupilReact ordered-factor	 3 
RPupilSize integer	 10 
LPupilReact ordered-factor	 3 
LPupilSize integer	 10 
Oxygen ordered-factor	 2 
Fluids ordered-factor	 2 
UHNS_Infection logical	 2 
UHNS_ED_Dr ordered-factor	 5 
UHNS_NICE_Sepsis ordered-factor	 4 
UHNS_OF_Sepsis logical	 2 
UHNS_SOFA_Sepsis ordered-factor	 3 
UHNS_SIRS_Sepsis ordered-factor	 3 
UHNS_ED_Outcome factor	 89 
UHNS_Died_In_ED logical	 2	
UHNS_Died_In_Hospital logical	 2		
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Proportions	of	missing	data	are	reported	in	table	6.4.		
Table	6.4	Missing	data	WMAS	
Variable	 Missing	(n)	 Missing	(%)	
WMASID 0	 0	
UHNSID 0	 0	
DispCat 0	 0	
DispComp1 46	 0.2	
DispComp2 18869	 82.24	
Imp 224	 0.98	
Location 0	 0	
Age 0	 0	
Gender 0	 0	
Ethnicity 11051	 48.16	
Resps 59	 0.26	
SpO2 163	 0.71	
Pulse 130	 0.57	
SBP 393	 1.71	
DBP 427	 1.86	
Temp 3540	 15.43	
BM 5238	 22.83	
GCS_eye 302	 1.32	
GCS_verbal 302	 1.32	
GCS_motor 302	 1.32	
GCS_sum 302	 1.32	
Skin 2638	 11.5	
CBRT 3052	 13.3	
AVPU 49	 0.21	
RPupilReact 2177	 9.49	
RPupilSize 1575	 6.86	
LPupilReact 2104	 9.17	
LPupilSize 1490	 6.49	
Oxygen 0	 0	
Fluids 0	 0	
UHNS_Infection 0	 0	
UHNS_ED_Dr 0	 0	
UHNS_NICE_Sepsis 0	 0	
UHNS_OF_Sepsis 0	 0	
UHNS_SOFA_Sepsis 0	 0	
UHNS_SIRS_Sepsis 0	 0	
UHNS_ED_Outcome 0	 0	
UHNS_Died_In_ED 0	 0	
UHNS_Died_In_Hospital 0	 0	
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Both	 DisComp2	 and	 Ethnicity	 have	 very	 high	 levels	 of	 missingness.	 The	variables	BM,	Temp,	CBRT	and	Skin	have	moderate	missingness.	The	remaining	variables	have	fewer	than	10%	missing	data	(see	table	6.4).	van	Buuren127	165	suggests	that	variables	with	high	missingness	should	be	removed	and	should	not	be	 imputed,	 consequently	DisComp2	 and	Ethnicity	were	 removed	 from	 the	
WMAS	dataset.	When	 assessing	 for	 any	 apparent	 patterns	 in	 the	missing	 data	 we	 note	 that	missingness	 for	 Glasgow	 Coma	 Score	 elements	 (GCS_eye,	 GCS_verbal,	
GCS_motor	and	GCS_sum)	is	identical,	in	addition	there	are	similar	proportions	of	 missingness	 between	 systolic	 and	 diastolic	 blood	 pressure	 (SBP	 and	 DBP),	pupil	 reactions	(RPupilReact	 and	LPupilReact)	and	pupil	 size	 (RPupilSize	and	LPupilSize).	 It	 can	be	useful	 to	 look	 for	patterns	 in	 the	missing	data	by	examining	a	graphical	output	of	missingness.	
Figure	6.6	 is	a	bar	chart	of	missing	data.	Variables	are	ordered	left	to	right	in	terms	 of	 proportion	 of	 missing	 data.	 Seven	 variables	 have	 greater	 than	 5%	missing	data,	while	four	have	greater	than	10%.	Most	variables	have	fewer	than	2%	 missing.	 Figure	 6.7	 shows	 missingness	 for	 each	 case	 with	 at	 least	 one	missing	 value	 (separation	 between	 observations	 are	 too	 small	 for	 this	 to	 be	clearly	visible),	blue	 is	observed	data	while	red	represents	missing	data.	Four	patterns	can	be	observed	to	suggest	 there	may	be	 a	relationship	between	the	missing	data.	Systolic	blood	pressure	(SBP)	and	diastolic	blood	pressure	(DBP)	appear	to	be	missing	together,	although	this	is	not	always	the	case.	Elements	of	the	 Glasgow	 Coma	 Score	 (GCS_eye,	 GCS_verbal,	 GCS_motor)	 appear	 to	 be	missing	 together.	 It	 also	 appears	 that	 the	 variables	 associated	 with	 pupil	reactions	(LPupilReact	and	RPupilReact)	and	pupil	size	(LPupilSize	and	
RPupilSize)	appear	to	be	missing	together.								
PRoSAiC	Thesis	
118	
	
Figure	6.6	Bar	chart	of	missing	data	
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Figure	6.7	Missingness	of	data	
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6.4.2.2	Classification	of	missing	data	Although	 there	 appear	 to	 be	 relationships	 between	 some	 of	 the	 missing	variables,	when	considered	from	the	perspective	of	the	clinician	performing	an	assessment	it	becomes	less	likely	that	the	data	are	MNAR.	For	example,	a	clinician	fails	to	take	a	blood	pressure,	resulting	in	both	SBP	and	DBP being	missing	-	the	two	 variables	 relate	 to	 a	 single	 assessment.	 Similarly,	 the	 variables	 GCS_eye,	
GCS_verbal	 and	 GCS_motor	 are	 elements	 of	 a	 single	 Glasgow	 Coma	 Score	assessment,	left	and	right	pupil	sizes	(LPupilSize	and	RPupilSize)	as	well	as	reactions	 (LPupilReact	 and	 RPupilReact)	 are	 also	 a	 single	 assessment.	Consequently,	 when	 considered	 as	 assessments	 performed,	 rather	 than	individual	variables,	the	missingness	pattern	disappears,	and	can	no	longer	be	considered	MNAR.	As	a	result,	 the	data	are	either	MAR	or	MCAR.	We	have	no	means	of	proving	data	are	MCAR.	As	such	the	data	can	be	assumed	to	be	MAR.	
6.4.2.3	Selection	of	variables	to	be	included	in	the	imputation	model	We	can	assess	which	variables	are	amenable	to	imputation	by	generating	a	flux	plot	(see	figure	6.8).	Variables	appearing	in	top	left	indicate	little	missing	and	very	amenable	to	 imputation,	bottom	right	suggest	high	missingness	and	may	generate	 unreliable	 imputations.	 Most	 variables	 are	 clustered	 in	 the	 top	 left	indicating	imputation	should	be	successful.	No	variables	appear	in	the	bottom	right	 suggesting	 no	 unreliable	 imputations	 will	 be	 generated.	 A	 number	 of	variables	are	clustered	slightly	above	mid-graph.	These	data	will	be	imputed	and	success	of	the	imputation	closely	examined.	
Figure	6.8	Fluxplot	of	variables		
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Only	variables	that	could	conceivably	be	included	in	a	screening	tool	are	imputed.	Several	variables	have	no	clinical	value	and	will	not	be	imputed	(see	table	6.5).		
Table	6.5	Imputation	of	variables	
Variable	 Imputed/not	imputed	
WMASID not	imputed	
UHNSID not	imputed	
DispCat not	imputed	
DispComp1 not	imputed	
Imp imputed	
Location not	imputed	–	no	missing	data	
Age not	imputed	-	no	missing	data	
Gender not	imputed	-	no	missing	data	
Resps Imputed	
SpO2 Imputed	
Pulse Imputed	
SBP Imputed	
DBP Imputed	
Temp Imputed	
BM Imputed	
GCS_eye Imputed	
GCS_verbal Imputed	
GCS_motor Imputed	
GCS_sum Imputed	
Skin Imputed	
CBRT Imputed	
AVPU Imputed	
RPupilReact Imputed	
RPupilSize Imputed	
LPupilReact Imputed	
LPupilSize Imputed	
Oxygen not	imputed	-	no	missing	data	
Fluids not	imputed	-	no	missing	data		
6.4.2.4	 Decide	 whether	 to	 impute	 variables	 that	 are	 functions	 of	
other	(incomplete)	variables	The	 only	 variable	 that	 is	 a	 function	 of	 other	 variables	 is	 GCS_sum	 which	 is	calculated	 from	 the	 sum	 of	 GCS_eye,	 GCS_verbal	 and	 GCS_motor	 scores.	
GCS_sum	is	initially	removed	as	a	variable,	howevere	it	will	be	calculated	from	imputed	 values	 for	 GCS_eye,	 GCS_verbal	 and	 GCS_motor	 scores,	 and	reinserted	following	completion	of	the	multiple	imputation.	
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6.4.2.5	Determine	the	imputation	method	for	each	imputed	variable	
Mice	 can	analyse	the	variables	present	 in	a	data	 frame	and	generate	a	matrix	indicating	 which	 variables	 should	 be	 used	 to	 model	 missing	 data	 for	 each	variable	 (see	 table	 6.6).	 This	matrix	 is	modifiable	 by	 the	 user	 if	 they	 feel	 an	important	 relationship	 has	 been	 omitted.	 For	 example,	 Resps	 is	 imputed	utilising	a	model	that	includes	Imp,	SpO2, Pulse, SBP, Temp, BM and CBRT.		
Table	6.6	Predictor	matrix	
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Imp 0	 1	 1	 1	 0	 0	 1	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	
Resps 1	 0	 1	 1	 1	 0	 1	 1	 0	 0	 0	 0	 1	 0	 0	 0	 0	 0	
SpO2 1	 1	 0	 1	 0	 0	 1	 1	 1	 1	 1	 1	 1	 1	 0	 0	 0	 0	
Pulse 1	 1	 1	 0	 0	 1	 1	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	
SBP 0	 1	 0	 1	 0	 1	 0	 0	 0	 0	 0	 1	 0	 0	 0	 0	 0	 0	
DBP 0	 0	 0	 1	 1	 0	 0	 0	 0	 0	 0	 1	 0	 0	 0	 0	 0	 0	
Temp 1	 1	 1	 1	 0	 0	 0	 0	 0	 0	 0	 1	 0	 0	 0	 0	 0	 0	
BM 0	 1	 1	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	
GCS_eye 0	 0	 1	 0	 0	 0	 0	 0	 0	 0	 0	 0	 1	 1	 1	 0	 1	 0	
GCS_verbal 0	 0	 1	 0	 0	 0	 0	 0	 0	 0	 0	 0	 1	 1	 1	 0	 1	 0	
GCS_motor 0	 0	 1	 0	 0	 0	 0	 0	 0	 0	 0	 0	 1	 1	 1	 0	 1	 0	
Skin 0	 0	 1	 0	 1	 1	 1	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	
CBRT 0	 1	 1	 0	 0	 0	 0	 0	 1	 1	 1	 0	 0	 1	 1	 0	 1	 0	
AVPU 0	 0	 1	 0	 0	 0	 0	 0	 1	 1	 1	 0	 1	 0	 1	 0	 1	 0	
RPupilReact 0	 0	 0	 0	 0	 0	 0	 0	 1	 1	 1	 0	 1	 1	 0	 0	 1	 0	
RPupilSize 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 1	
LPupilReact 0	 0	 0	 0	 0	 0	 0	 0	 1	 1	 1	 0	 1	 1	 1	 0	 0	 0	
LPupilSize 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 0	 1	 0	 0						
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The	default	methods	for	imputation	were	employed.	See	table	6.7.	
Table	6.7	Imputation	method	
Variable	 Imputation	method		
Imp polytomous	regession	
Resps predictive	mean	matching	
SpO2 predictive	mean	matching	
Pulse predictive	mean	matching	
SBP predictive	mean	matching	
DBP predictive	mean	matching	
Temp predictive	mean	matching	
BM predictive	mean	matching	
GCS_eye polytomous	regession	
GCS_verbal polytomous	regession	
GCS_motor polytomous	regession	
Skin polytomous	regession	
CBRT logistic	regession	
AVPU polytomous	regession	
RPupilReact logistic	regession	
RPupilSize predictive	mean	matching	
LPupilReact logistic	regession	
LPupilSize predictive	mean	matching	
	
6.4.2.6	Determine	the	visit	sequence		There	 were	 no	 dependencies	 within	 the	 variables.	 As	 such,	 the	 default	 visit	sequence	(left	to	right)	was	used.	
6.4.2.7	Determine	the	number	of	imputations		The	number	of	imputations	is	dependent	upon	proportion	of	cases	with	missing	data.	 There	 are	 22945	 cases	 of	 which	 12517	 are	 complete	 (54.6%),	 leaving	slightly	over	45%	of	cases	with	at	least	1	missing	data	point.	Consequently,	based	upon	 the	 rule	 of	 thumb	 requiring	 one	 imputation	 per	 1%	 missing	 data,	 the	number	of	imputations	required	was	set	at	50.	
6.4.2.8	Choose	the	number	of	iterations		There	are	no	reliable	methods	to	prospectively	determine	the	precise	number	of	iterations	 that	will	be	required	 to	achieve	healthy	convergence,	 it	 is	generally	confirmed	 in	 retrospect.	 The	 default	 number	 of	 iterations	 in	 mice	 is	 five	iterations.	 Plotting	 the	 five	 imputed	 data	 chains	 failed	 to	 demonstrate	 that		convergence	had	been	achieved,	consequently	the	chain	length	was	increased	to	
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ten	iterations,	and	the	imputation	plots	were	reassessed.	This	plot	again	failed	to	show	 convergence	 had	 been	 achieved.	 This	 process	 was	 repeated	 with	 20	iterations,	30	iterations,	40	iterations	and	finally	50	iterations. 
6.4.2.9	Assess	imputed	data		Convergence	plots	demonstrated	excellent	convergence,	seen	by	healthy	mixing	of	the	chains,	for	all	imputed	variables	except	for	LPupilSize	and	RPupilSize.	See	figure	6.9.	
Figure	6.9	Convergence	plots
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		Rhat	 statistics	 indicate	 successful	 convergence	of	 imputations	 for	 all	 imputed	variables	except	LPupilSize	and	RPupilSize.	See		table	6.8.	
Table	6.8	Rhat	scores	
Variable	 %	Missing	 Mean	 Variance	
Imp 0.9762475	 1.0016182	 1.0047219	
Resps 0.2571366	 0.9991814	 1.0523770	
SpO2 0.7103944	 1.0026238	 1.0008604	
Pulse 0.5665722	 1.0037685	 0.9977388	
SBP 1.7127915	 1.0248377	 1.0073032	
DBP 1.8609719	 1.0253729	 1.0076894	
Temp 15.4281979	 1.0011967	 0.9988709	
BM 22.8285029	 1.0017126	 1.0002574	
GCS_eye 1.3161909	 1.0092198	 1.0081991	
GCS_verbal 1.3161909	 1.0126162	 1.0070718	
GCS_motor 1.3161909	 1.0095771	 1.0100301	
Skin 11.4970582	 0.9984954	 0.9984608	
CBRT 13.3013728	 0.9993559	 0.9993735	
AVPU 0.2135542	 1.0334403	 1.0201990	
RPupilReact 9.4879059	 1.0446562	 1.0445606	
RPupilSize 6.8642406	 1.2355947	 1.2227659	
LPupilReact 9.1697538	 1.0489290	 1.0491825	
LPupilSize 6.4937895	 1.2547893	 1.2512539	
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	Density	plots	for	continuous	variables	indicate	appropriate	distributions	across	the	imputed	datasets	were	achieved.	See	figures	6.10		to	6.18.	
Figure	6.10	Density	plot	Resps	
	
Figure	6.11	Density	plot	SpO2 
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Figure	6.12	Density	plot	Pulse
 
 
Figure	6.13	Density	plot	SBP 
 
Figure	6.14	Density	plot	DBP 
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Figure	6.15	Density	plot	BM 
 
Figure	6.16	Density	plot	Temp 
 
Figure	6.17	Density	plot	LPupilSize	
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Figure	6.18	Density	plot	RPupilSize 
	Box	 and	 whisker	 plots	 for	 continuous	 variables	 also	 indicate	 appropriate	distributions	 across	 the	 imputed	datasets	were	 achieved.	 See	 figures	6.19	 to	
6.27.		
Figure	6.19	Box	and	Whisker	plot	Resps 
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Figure	6.20	Box	and	Whisker	plot	SpO2 
 
Figure	6.21	Box	and	Whisker	plot	Pulse 
 
Figure	6.22	Box	and	Whisker	plot	SBP 
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Figure	6.23	Box	and	Whisker	plot	DBP 
	
Figure	6.24	Box	and	Whisker	plot	BM 
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Figure	6.25	Box	and	Whisker	plot	Temp 
 
Figure	6.26	Box	and	Whisker	plot	LPupilSize	
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Figure	6.27	Box	and	Whisker	plot	RPupilSize 
		
6.5	Conclusion	Missing	data	is	a	universal	problem	in	healthcare	research.	This	chapter	outlined	varying	approaches	to	management	of	missing	data	and	detailed	how	missing	data	in	the	WMAS	dataset	were	addressed.	The	next	chapter	is	concerned	with	development	 of	 the	 SEPSIS	 screening	 tool	 and	will	 describe	 the	 analysis	 and	pooling	phases	of	multiple	imputation.	 		
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Chapter	7	
Derivation	of	the	SEPSIS	
screening	tool 
 
7.1	Introduction	This	chapter	describes	how	the	Screening	to	Enhance	PrehoSpital	Identification	of	Sepsis	(SEPSIS)	tool	was	developed.	Development	of	the	SEPSIS	screening	tool	adheres	 to	 the	methods	proposed	by	Labarère	et	al,58	previously	described	 in	
chapter	2.	Not	all	elements	of	the	Labarère	checklist	are	reported	in	this	chapter.	Validation	 of	 the	 SEPSIS	 screening	 tool	 is	 reported	 in	 chapter	 8,	 while	comparison	of	 the	 SEPSIS	 screening	 tool	with	different	models	 is	 reported	 in	
chapter	9.	
7.2	Method	
7.2.1	Rationale		It	is	estimated	that	70%	of	sepsis	cases	arise	in	the	community	with	two-thirds	of	severe	sepsis	cases	initially	seen	in	the	emergency	department	(ED).28	Half	of	all	ED	sepsis	patients	will	arrive	via	emergency	medical	services	(EMS).26-28	170	171	Sepsis	patients	transported	to	the	ED	by	EMS	are	likely	to	be	sicker	than	those	arriving	by	other	means.170-173	Sepsis	can	be	very	challenging	to	identify	in	the	prehospital	 environment.39	 It	 has	 been	 suggested	 that	 a	 prehospital	 sepsis	screening	 tool	 would	 help	 improve	 recognition	 of	 sepsis	 by	 ambulance	clinicians.40	Earlier	recognition	of	sepsis	may	facilitate	delivery	of	antibiotics,	and	other	 treatments,	 by	 ambulance	 clinicians,	 before	 arriving	 at	 hospital.	 Early	intervention,	before	arrival	at	hospital,	has	the	potential	to	improve	outcomes	for	patients	with	sepsis.174			
7.2.2	Objective	Develop	a	simple	screening	tool,	using	routinely	collected	patient	demographic	and	 clinical	 data,	 for	use	by	 ambulance	 clinicians,	 at	 the	patient’s	 bedside,	 to	identify	patients	at	high	risk	for	sepsis	(as	per	NICE	clinical	guideline	51).	The	NICE	 sepsis	 guideline	 stratifies	 patients	 into	 four	 risk	 categories:	 no	 risk	(patients	 who	 do	 not	 have	 infection),	 low	 risk,	 moderate	 risk	 and	 high	 risk.	
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Patients	 classified	as	high	 risk	 should	be	 treated	with	 intravenous	 antibiotics	without	delay.	Moderate	 risk	 and	 low	 risk	patients	do	not	 require	 immediate	antibiotic	 prophylaxis.	 If	 the	 objective	 of	 prehospital	 sepsis	 screening	 is	 to	facilitate	early	intervention,	it	follows	that	any	prehospital	sepsis	screening	tool	should	identify	those	patients	who	require	immediate	antibiotic	therapy	as	per	the	 NICE	 guideline.	 Consequently,	 the	 objective	 of	 the	 study	 is	 to	 improve	identification	of	patients	with	high	risk	of	sepsis.	
7.2.3	Study	design	This	 study	 is	 a	 retrospective,	 cross-sectional	 study.	 The	 study	 utilises	 a	retrospective	dataset	from	West	Midlands	Ambulance	Service	NHS	Foundation	Trust	(WMAS).	The	data	include	consecutive	patients	(cases)	transported	to	the	Emergency	 Department	 of	 University	 Hospital	 North	 Staffordshire	 NHS	Foundation	Trust	(UHNS)	between	01	July	2013	and	30	June	2014.		
7.2.4	Participants	and	setting	The	study	setting	is	a	UK	NHS	Ambulance	Service.	All	patients	attended	by	WMAS	and	transported	to	UHNS	between	01	July	2013	and	30	June	2014	were	eligible	for	inclusion.	Exclusion	criteria	were	age	under	18	years,	and	all	cases	of	cardiac	arrest,	trauma	or	mental	health	diagnosis.	Only	electronic	patient	report	 form	(ePRF)	 records	were	 available.	Records	 stored	on	 paper	patient	 report	 forms	(pPRF)	was	not	intended	to	be	an	exclusion	criteria,	but	WMAS	were	unable	to	obtain	pPRF	data	due	to	technical	challenges.	The	included	population	therefore	comprised	 of	 adult	 patients,	 with	 a	 medical	 complaint,	 whose	 care	 was	documented	using	the	ePRF.	
7.2.5	Outcome	The	screening	tool	is	intended	to	predict	high	risk	sepsis	as	defined	by	the	2016	NICE	guideline	(NG51)	“Sepsis:	recognition,	diagnosis	and	early	management”.	Diagnostic	criteria	for	sepsis	are	outlined	in	table	7.1.		
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Table	7.1	Classification	of	risk	of	sepsis	(NICE	2016)	
Category		 High	risk	criteria		 Moderate	to	high	risk	criteria		
Low	risk	
criteria		
History		 Objective	evidence	of	new	altered	mental	state		
History	from	patient,	friend	or	relative	of	new	onset	of	altered	behaviour	or	mental	state		History	of	acute	deterioration	of	functional	ability		Impaired	immune	system	(illness	or	drugs	including	oral	steroids)		Trauma,	surgery	or	invasive	procedures	in	the	last	6	weeks		
Normal	behaviour		
Respiratory		
Raised	respiratory	rate:	25	breaths	per	minute	or	more		New	need	for	oxygen	(more	than	40%	FiO2)	to	maintain	saturation	more	than	92%	(or	more	than	88%	in	known	chronic	obstructive	pulmonary	disease)		
Raised	respiratory	rate:	21–24	breaths	per	minute		
No	high	risk	or	moderate	to	high	risk	criteria	met		
Blood	
pressure		
Systolic	blood	pressure	90	mmHg	or	less	or	systolic	blood	pressure	more	than	40	mmHg	below	normal		 Systolic	blood	pressure	91–100	mmHg		
No	high	risk	or	moderate	to	high	risk	criteria	met		
Circulation	
and	hydration		
Raised	heart	rate:	more	than	130	beats	per	minute	Not	passed	urine	in	previous	18	hours.		For	catheterised	patients,	passed	less	than	0.5	ml/kg	of	urine	per	hour		
Raised	heart	rate:	91–130	beats	per	minute	(for	pregnant	women	100–130	beats	per	minute)	or	new	onset	arrhythmia		Not	passed	urine	in	the	past	12–18	hours		For	catheterised	patients,	passed	0.5–1	ml/kg	of	urine	per	hour		
No	high	risk	or	moderate	to	high	risk	criteria	met		
Temperature		 	 Tympanic	temperature	less	than	36°C		 	
Skin		
Mottled	or	ashen	appearance	Cyanosis	of	skin,	lips	or	tongue	Non-blanching	rash	of	skin		
Signs	of	potential	infection,	including	redness,	swelling	or	discharge	at	surgical	site	or	breakdown	of	wound		
No	non-blanching	rash			
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	High	risk	sepsis	status	was	determined	by	examination	of	UHNS	clinical	data,	and	not	simply	extracted	from	UHNS	diagnostic	fields.	All	records	were	assessed	to	determine	if	high	risk	sepsis	criteria	were	present	to	ensure	no	patients	were	misclassified.	 Presence	of	 any	one	high	 risk	 criteria	 results	 in	a	patient	being	classified	as	at	high	risk	of	sepsis.	
7.2.6	Missing	values	Missing	data,	and	the	management	thereof,	have	previously	been	described	in	
Chapter	6.	
7.2.7	Candidate	predictor	variables		All	patient	demographic	and	clinical	variables	were	eligible	for	inclusion	in	the	clinical	prediction	model.	
7.2.8	Sample	size	The	 original	 data	 sample	 of	 22945	 cases	 was	 divided	 into	 derivation	 and	validation	cohorts.	The	derivation	cohort	is	used	to	develop	the	SEPSIS	screening	tool,	while	the	validation	cohort	is	used	to	assess	the	performance	of	the	SEPSIS	screening	 tool	 (see	 chapter	 8).	 It	 has	 been	 argued	 that,	 when	 developing	 a	predictive	model,	at	 least	ten	instances	of	the	outcome	of	interest	(in	this	case	high	risk	of	sepsis)	are	required,	per	candidate	predictor	included	in	the	model,	to	ensure	statistically	valid	results.59	69	71	175-177	Twenty-eight	potential	variables	are	available	for	inclusion	in	the	model	(see	table	6.5).	Consequently,	at	least	280	cases	with	high	risk	of	sepsis	must	be	included	in	the	derivation	cohort.	Similarly,	Vergouwe	et	al178	argue	that	at	least	100	events	(high	risk	of	sepsis)	and	100	non-events	 (no	 sepsis)	 are	 required	 to	 assess	 model	 performance.	 However,	Steyerberg59	suggests	that,	to	detect	small	differences	in	model	performance,	the	validation	sample	should	contain	at	least	250	cases	of	the	outcome	of	interest	(high	risk	of	sepsis).			The	R	package	caret	(version	6.0-71)	was	used	to	divide	the	original	dataset	into	derivation	and	validation	cohorts,	ensuring	equal	distribution	of	population	characteristics.	The	dataset	was	divided	to	ensure	250	cases	of	high	risk	sepsis	were	available	in	the	validation	dataset.	Ultimately	the	dataset	was	divided	into	70%	derivation,	30%	validation	cohorts.	The	derivation	cohort	comprised	13083	cases,	while	the	validation	cohort	comprised	5607	cases.	The	number	of	cases	classified	as	high	risk	of	sepsis	within	each	of	the	datasets	is	given	in	table	7.2.		
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Table	7.2	Sepsis	cases	in	each	imputed	dataset	
Dataset	 No	sepsis	risk									n	(%)	 Low	Risk	Sepsis	n	(%)	 Moderate/High	Risk	Sepsis	n	(%)	 High	Risk	Sepsis	n	(%)	WMAS	(complete)	 18690	(81.4)	 1496	(6.5)	 1912	(8.3)	 847	(3.7)	WMAS	(derivation)	 13083	(81.4)	 1048	(6.5)	 1339	(8.3)	 593	(3.7)	WMAS	(validation)	 5607	(81.5)	 448	(6.5)	 573	(8.3)	 254	(3.7)			The	 derivation	 dataset	 contains	 593	 cases	 with	 high	 risk	 of	 sepsis,	 thus	 the	maximum	number	 of	 candidate	 predictor	 variables	 that	 could	 conceivably	 be	considered	during	development	of	 the	 screening	 tool	 is	 59	 (593/10,	 rounded	down).	 The	 number	 of	 events	 per	 candidate	 predictor	 is	 21	 (593/28).	 The	number	of	high	risk	of	sepsis	cases	present	in	the	derivation	dataset	is	therefore	sufficient	 to	 calculate	 reliable	 estimates.	 The	 validation	 dataset	 contains	 254	cases	 of	 high	 risk	 of	 sepsis,	 sufficient	 to	 detect	 small	 changes	 in	 model	performance.		
7.2.9	Model	specification	The	outcome	of	interest	is	a	binary	outcome	(presence	or	absence	of	high	risk	sepsis	as	per	NICE	Guideline	51),	consequently	logistic	regression	was	required	for	model	development.	The	outcome	of	interest	is	high	risk	of	sepsis	at	hospital.		Simple	logistic	regression	was	undertaken	to	quantify	the	relationship	between	individual	candidate	predictor	variables,	and	the	outcome	of	interest.	Regression	coefficients	are	often	used	as	a	first	stage	to	filter	out	variables	from	inclusion	in	the	multivariate	model.	The	threshold	at	which	candidate	predictor	variables	are	excluded	from	the	multivariable	model	clearly	impacts	the	number	of	predictors	selected.	 Only	 selecting	 highly	 correlated	 candidate	 predictor	 variables	generates	models	with	fewer	predictors,	with	the	trade-off	of	potentially	missing	useful	predictors.69	It	can	also	result	in	over-fitting	leading	to	optimistic	models	that	yield	biased	model	coefficient	estimations.59	69	71	To	reduce	the	likelihood	of	overfitting,	 no	 candidate	 predictor	 variables	 were	 excluded	 following	 simple	logistic	regression.		Next,	 candidate	 predictor	 variables	 were	 assessed	 for	 multicollinearity.	Multicollinearity	occurs	when	a	high	correlation	between	two	or	more	predictor	variables	 and	 the	outcome	of	 interest	 is	 identified.	Medical	 statisticians	warn	
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against	the	use	of	explanatory	variables	that	are	not	independent,179-181	as	use	of	highly	correlated	variables	within	regression	models	can	give	rise	 to	spurious	results.182-184	In	other	words,	if	two	predictor	variables	are	highly	correlated	with	each	 other,	 it	may	 be	 appropriate	 to	 include	 only	 one	 of	 the	 variables	 in	 the	prediction	 model.	 	 Within	 this	 study,	 highly	 correlated	 candidate	 predictor	variables	 were	 reduced	 to	 a	 single	 predictor	 variable	 for	 inclusion	 in	 the	multivariable	model	(see	section	3.2.2).			Selection	of	independent	predictor	variables	to	be	included	in	the	parsimonious	model	was	informed	by	stepwise	selection.	Stepwise	selection	of	variables	can	be	by	either	backward	elimination	or	forward	selection.	Backward	elimination	is	generally	 preferred	 to	 forward	 selection	 because	 the	 former	 assesses	 all	candidate	 predictors	 simultaneously	 and	 performs	 better	 should	 candidate	predictors	 be	 highly	 correlated	 with	 each	 other.68	 71	 In	 stepwise	 selection	candidate	predictors	are	removed	from,	or	added	to,	the	model	in	a	sequential	manner.	 The	 order	 in	 which	 variables	 are	 removed	 is	 dependent	 upon	 their	correlation	 with	 the	 outcome	 of	 interest,	 expressed	 as	 their	 correlation	coefficient.	During	backward	elimination,	the	candidate	predictor	variable	with	the	lowest	correlation	is	removed	from	the	full	multivariable	model	first,	then	the	second	lowest	correlated	variable	is	removed	and	so	on.	Each	time	a	variable	is	 removed	 from	 the	 model,	 performance	 of	 ‘the	 smaller	 model’	 is	 assessed	relative	to	that	of	‘the	larger	model’.			Relative	performance	is	assessed	by	calculating	the	Akaike	Information	Criteria	(AIC).	The	AIC	is	an	index	that	measures	statistical	goodness	of	fit	relative	to	the	number	of	variables	included	in	a	model.	It	imposes	a	penalty	for	increasing	the	number	of	variables.	Lower	values	of	the	AIC	indicate	the	preferred	model,	that	is,	 it	 helps	 to	 identify	 the	 model	 with	 the	 fewest	 variables	 that	 provides	 an	adequate	fit	to	the	data.185	In	other	words,	if	the	AIC	calculated	for	‘the	smaller	model’	(the	model	with	the	variable	removed)	is	lower	than	the	AIC	for	‘the	larger	model’	(the	model	without	the	variable	removed),	it	implies	‘the	smaller	model’	is	a	better	model	than	‘the	larger	model’.	The	variable	excluded	from	‘the	smaller	model’	should	not	therefore	be	included	in	the	parsimonious	model.	Conversely,	if	the	AIC	calculated	for	‘the	larger	model’	is	lower	than	the	AIC	of	‘the	smaller	model’,	 then	 ‘the	 larger	model’	 is	 the	 better	model,	 and	 the	 omitted	 variable	should	be	included	in	the	parsimonious	model.			
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Although	AIC	is	useful	to	select	the	best	model	from	a	group	of	models,	it	does	not	provide	a	reliable	estimate	of	model	quality,	that	is,	it	is	useful	to	select	the	best	 performing	 model,	 but	 the	 selected	 model	 will	 not	 necessarily	 be	 an	accurate	model.			In	 forward	 selection,	 the	method	 is	 reversed.	 The	 first	 model	 comprises	 the	candidate	 predictor	 variable	 with	 the	 greatest	 regression	 coefficient,	 and	variables	are	added	sequentially	in	order	of	decreasing	regression	coefficients.	Comparison	of	models	is	similarly	based	upon	estimation	of	the	AIC.			An	additional	complexity	arises	due	to	the	presence	of	missing	data,	and	use	of	multiple	imputation.	The	standard	statistical	approach	to	multiply	imputed	data	has	three	distinct	phases:		 • Impute	the	missing	data	m	times	via	Markov	chained	equations.	• Perform	 statistical	 analysis	 on	 each	 of	 the	m	 imputed	 datasets	independently.	• Pool	the	m	statistical	analyses	calculated	in	phase	2.	
Stepwise	 variable	 selection	occurs	during	phase	 two,	 however	because	 the	m	datasets	are	different,	it	can	result	in	different	selections	of	variables	across	the	
m	datasets.	In	other	words,	backwards	selection	of	variables	occurs	on	each	of	the	m	datasets.	However,	because	the	data	in	each	of	the	m	datasets	is	different,	it	can	result	in	different	variables	being	selected	across	the	m	datasets.	How	then	do	we	manage	these	disparate	selections?			It	is	not	immediately	obvious	how	parameters	should	be	pooled	in	phase	three,	should	 this	 occur.	 The	 approach	 adopted	 in	 this	 study	 adheres	 to	recommendations	by	van	Buuren,127	who	developed	the	mice	package	(used	to	impute	data	 in	 this	study).	 Put	 simply,	 the	 approach	 considers	 the	number	of	times	a	variable	is	selected	across	the	m	datasets	and	utilises	the	Wald	statistic	to	determine	if	the	variable	should	be	included	in	the	multivariable	model.			The	Wald	statistic	quantifies	the	contribution	of	a	variable	(or	group	of	variables)	to	 the	 performance	 of	 a	 statistical	 model,	 and	 is	 estimated	 by	 maximum	likelihood.185	A	significant	Wald	statistic	(p=<0.05)	indicates	that	the	variable	(or	group	of	variables)	impacts	model	performance,	whereas	a	non-significant	Wald	
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statistic	 (p>0.05)	 indicates	 that	 the	 variable	 (or	 group	 of	 variables)	does	 not	impact	model	performance.			For	clarity,	in	the	context	of	this	screening	tool	development,	the	AIC	is	used	to	determine	if	a	variable	should	be	included	in	a	model	developed	from	a	single	dataset,	whereas	 the	Wald	 statistic	 is	 used	 to	measure	 the	 contribution	 of	 a	variable	to	model	performance	across	multiple	datasets.		Consequently,	 in	 the	 context	 of	 backward	 elimination	 processed	 on	 multiple	imputed	 datasets,	 a	 significant	 Wald	 statistic	 indicates	 that	 the	 candidate	predictor	variable	should	be	included	in	the	parsimonious	model.	Conversely,	a	non-significant	Wald	 statistic	 (p>0.05)	 indicates	 that	 the	 candidate	 predictor	variable	should	be	excluded	from	the	parsimonious	model.	Wald	statistics	were	calculated	for	all	variables	identified	during	stepwise	selection	to	confirm	if	they	should	be	included	in	the	parsimonious	model	or	not.		The	 final	 selection	 of	 independent	 predictor	 variables	 included	 in	 the	parsimonious	model	was	informed	by	the	systematic	review	reported	in	chapter	
2,	stepwise	selection	as	reported	above,	and	practical	utility.	
7.2.10	Continuous	predictors	Regression	models	with	 continuous	predictor	 variables	 require	 computers	or	specialist	 software	 to	 generate	 answers.	 Consequently,	 regression	models	 are	unsuitable	 for	 use	 in	 the	 prehospital	 environment.	 It	 is	 usually	 necessary	 to	simplify	 a	model	 to	 enable	 bedside	 use,	 by	 the	 ambulance	 clinician,	 without	requiring	any	additional	equipment.	A	common	approach	to	simplification	is	to	reduce	 continuous	 variables	 into	 categorical	 variables,	 by	 subdividing	 the	variable	range	into	intervals.			Regression	 purists	 argue	 against	 transforming	 continuous	 variables	 into	categorical	 variables,	 as	 to	 do	 so	 may	 lead	 to	 a	 loss	 of	 precision	 within	 the	model.59	71	175	186	However,	loss	of	precision	needs	to	be	balanced	against	ease	of	use.	 Conversion	 of	 continuous	 predictor	 variables	 into	 categorical	 predictor	variables	using	clinically	meaningful	thresholds	 from	clinical	practice	 that	are	easily	 remembered	 by	 clinicians	 is	 a	 common	 approach,187	 188	 and	 has	 been	adopted	in	this	study.		
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Cut	 points	 for	 continuous	 predictors	 were	 determined	 pragmatically.	 Several	approaches	informed	cut	point	selection.	First,	the	normal	physiologic	range	of	clinical	variables	was	considered.	For	example,	a	normal	pulse	rate	would	be	in	the	 range	 60	 -100	 beats	 per	 minute.	 Second,	 cut	 points	 used	 in	 previously	published	 screening	 tools	 were	 assessed.	 For	 example,	 the	 PreSep	 score	identifies	a	cut	point	 for	respirations	at	22	breaths	per	minute.54	Third,	Loess	curves	were	plotted	for	each	continuous	predictor	variable,	with	respect	to	risk	of	sepsis,	to	visually	identify	important	thresholds.	Fourth,	theoretical	cut	points,	to	 identify	 thresholds	 at	 which	 risk	 of	 sepsis	 increases	 or	 decreases,	 were	calculated	 for	 each	predictor	 variable.	 Cut	points	were	 calculated	using	 the	R	package	OptimalCutpoints	(version	1.1-3).			
OptimalCupoints	allows	the	user	to	specify	the	method	used	to	calculate	upper	and	 lower	 cut	 points.	 The	 method	 adopted	 in	 this	 thesis	 was	 prevalence	
matching.	 The	 upper	 cut	 point	 represents	 the	 upper	 boundary	 where	 sepsis	becomes	more	 common	 than	 the	mean	of	 the	population.	 For	 example,	when	considering	 respiratory	 rate,	 the	 upper	 cut	 point	 is	 the	 boundary	 where	 the	proportion	of	patients	with	sepsis	is	greater	than	3.7%	(the	mean	incidence	of	high	risk	of	sepsis).	Similarly,	the	lower	cut	point	represents	the	boundary	below	which	the	incidence	of	sepsis	is	greater	than	the	mean	of	the	population.		When	 calculating	 cut	 points,	 several	 different	 diagnostic	 standards	 for	 sepsis	were	considered	(NICE	high,	moderate	and	low	of	risk	sepsis,	SIRS	sepsis,	SOFA	sepsis,	and	ED	Doctor	diagnosis	of	sepsis)	to	help	provide	greater	detail.		Each	 of	 the	 above	 informed	 the	 decision	 of	 how	 to	 subdivide	 the	 continuous	predictor	variables	 into	 intervals	 for	 further	assessment.	To	guard	against	the	potential	loss	of	precision,	continuous	predictor	variables	were	subdivided	into	several	small	intervals,	rather	than	a	single	threshold.	
7.2.10.1	Model	simplification	To	enable	bedside	calculation	of	the	SEPSIS	screening	tool,	without	the	need	for	additional	 equipment,	 regression	 coefficients	 were	 converted	 into	 rounded	scores	 to	 enable	 the	 creation	 of	 a	 simple	 arithmetic	 tool.	 Each	 regression	coefficient	was	 rounded	 to	 the	 nearest	 integer.	 	 The	 bedside	 clinician	 simply	summates	the	score	for	all	variables	included	in	the	model.	
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7.2.11	Model	performance	
7.2.11.1	Model	calibration	The	 Hosmer-Lemeshow	 statistic	 was	 used	 to	 assess	 goodness	 of	 fit.189	 The	Hosmer-Lemeshow	 test	 compares	 fitted	 values	 with	 observed	 values.190	 A	statistically	 significant	 (p<0.05)	 Hosmer-Lemeshow	 statistic	 suggests	 that	 a	model	may	be	overfitted.190	However,	a	significant	Hosmer-Lemeshow	statistic	is	often	observed	when	models	have	been	derived	from	large	samples.191	Where	the	 Hosmer-Lemeshow	 statistic	 is	 significant,	 assessment	 of	 the	 model	calibration	 slope	 provides	 an	 alternate	 means	 to	 determine	 if	 the	 model	 is	overfitted.192	The	concordance	statistic	 	(c-statistic)	is	an	alternate	measure	of	goodness	of	 fit	 and	quantifies	 the	predictive	 accuracy	of	 a	 logistic	 regression	model.193	 However,	 	 for	 a	 binary	 outcome,	 as	 in	 this	 case,	 the	 c-statistic	 is	identical	to	area	under	the	receiver	operating	characteristic	(ROC)	curve.	59	194	The	ROC	curve	is	calculated	to	assess	model	discrimination	(see	below),	so	there	is	no	need	to	calculate	the	c-statistic.	
7.2.11.2	Model	discrimination	Model	discrimination	was	assessed	by	calculating	 the	area	under	 the	receiver	operating	 characteristic	 curve	 (ROC)	 for	 the	 outcome	 of	 high	 sepsis	 risk	 at	hospital.	ROC	curve	analysis	allows	visual	evaluation	of	the	trade-offs	between	sensitivity	and	specificity	associated	with	different	values	of	 the	 test	result.195	The	 ideal	 medical	 diagnostic	 model	 would	 have	 an	 ROC≥0.95,	 with	 good	performance	indicated	by	ROC≥0.80.195	
7.2.11.3	Model	operating	characteristics	Model	performance	was	assessed	by	calculating	sensitivity,	specificity,	positive	likelihood	ratio,	negative	likelihood	ratio	and	diagnostic	odds	ratio.	
7.3	Results	
7.3.1	Candidate	predictor	variables		The	 variables	 in	 table	 7.3	 were	 excluded	 from	 consideration	 as	 candidate	predictor	variables.	The	majority	were	excluded	as	they	were	neither	related	to	the	 patient	 or	 their	 clinical	 condition.	 Four	 potential	 candidate	 predictor	variables	were	excluded	due	to	very	high	missingness.					
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Table	7.3	Excluded	candidate	predictor	variables	
Variable		 Reason	for	exclusion	
PatientID	 Unique	ID.	Not	patient/clinically	related	
UHNS_ID Unique	ID.	Not	patient/clinically	related	
Dispatch Complaint1 Not	patient/clinically	related	
Dispatch Complaint2 Not	patient/clinically	related	
Dispatch Category Not	patient/clinically	related	
Forename	 PID	removed	following	linkage	
Surname	 PID	removed	following	linkage	
Address 1	 PID	removed	following	linkage	
Address 2	 PID	removed	following	linkage	
City	 PID	removed	following	linkage	
County	 PID	removed	following	linkage	
Post Code	 PID	removed	following	linkage	
DOB	 Age	variable	calculated	in	preference	
Incident Address	 PID	removed	following	linkage	
Incident City	 PID	removed	following	linkage	
Incident Postcode	 PID	removed	following	linkage	
Incident Time	 Not	patient/clinically	related	
Response Priority	 Not	patient/clinically	related	
Mobile	 Not	patient/clinically	related	
Arrive Scene	 Not	patient/clinically	related	
Leaving Scene	 Not	patient/clinically	related	
Destination Arrival	 Not	patient/clinically	related	
Peak Flow (l/min)	 Very	high	missingness	
End Tidal CO2 (kPa)	 Very	high	missingness	
Airway Signs	 Very	high	missingness	
Airway Status	 Very	high	missingness	
Arrest Occurance	 Excluded	case	type	
Crew Level 1	 Not	patient/clinically	related	
Crew Level 2	 Not	patient/clinically	related	
Institution Name	 Not	patient/clinically	related	PID	–	personal	identifiable	data		
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All	 remaining	 variables	 were	 included	 as	 candidate	 predictor	 variables	 (see	
table	7.4).		
Table	7.4	Candidate	predictor	variables	
Variable		 Variable	name	 Type	Impression	 Imp	 Factor	Location	 Location	 Factor	Age	 Age	 Integer	Sex	 Gender	 Factor	Respiratory	Rate	(BPM)	 Resps	 Integer	Oxygen	Saturation	(%)	 SpO2	 Integer	Heart	Rate	(BPM)	 Pulse	 Integer	Systolic	BP	(mmHg)	 SBP	 Integer	Diastolic	BP	(mmHg)	 DBP	 Integer	Temperature	(Celcius)	 Temp	 number	Blood	Glucose	(mmol/L)	 BM	 number	Glasgow	Coma	Scale	 GCS_sum	 Integer	GCS	Eye	 GCS_eye	 Ordered	Factor	GCS	Verbal	 GCS_verbal	 Ordered	Factor	GCS	Motor	 GCS_motor	 Ordered	Factor	Skin	Colour	 Skin	 Factor	Cap	Refill	Time	 CBRT	 Ordered	Factor	AVPU	 AVPU	 Ordered	Factor	Pupil	Right	-	Reactivity	 RPupilReact	 Ordered	Factor	Pupil	Right	-	Size	 RPupilSize	 Integer	Pupil	Left	-	Reactivity	 LPupilReact	 Ordered	Factor	Pupil	Left	-	Size	 LPupilSize	 Integer	Oxygen		 Oxygen 	 Factor	Fluids	 Fluids	 Factor		
	
7.3.2	Model	specification	
7.3.2.1	Regression	of	candidate	predictor	variables	Regression	 coefficients,	 pooled	 following	 multiple	 imutation,	 for	 continuous	predictor	 variables	 are	 reported	 in	 table	 7.5,	 while	 those	 for	 categorical	candidate	predictors	are	reported	in	table	7.6.	
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Table	7.5	Regression	of	continuous	candidate	predictor	variables	
Variable	 intercept	 ß	 95%	CI	 p-value	Age	 -5.2	 0.028	 0.023	to	0.033	 <0.001	Resps	 -5.9	 0.11	 0.10	to	0.12	 <0.001	SpO2	 6.6	 -0.11	 -0.11	to	-0.96	 <0.001	Pulse	 -5.8	 0.026	 0.023	to	0.028	 <0.001	SBP	 -1.4	 -0.015	 -0.018	to	-0.011	 <0.001	DBP	 -1.9	 -0.018	 -0.023	to	-0.013	 <0.001	Temp	 -33.1	 0.8	 0.72	to	0.88	 <0.001	BM	 -3.6	 0.053	 0.032	to	0.074	 <0.001	GCS_sum	 -1.2	 -0.15	 -0.18	to	-0.12	 <0.001	RPupilSize	 -2.9	 -0.12	 -0.23	to	-0.0089	 0.034	LPupilSize	 -2.9	 -0.12	 -0.23	to	-0.0057	 0.039	ß	–	regression	coefficient,	CI	–	confidence	interval	
	
Table	7.6	Regression	of	categorical	candidate	predictor	variables	
Variable	 Category	 intercept	 ßi 95%	CI	 p-value	
Imp General	medical	 Reference	category	
 Other	 -3.5	 -0.45	 -0.26	to	1.20	 0.21	
 Cardiovascular	 -3.5	 -0.36	 -0.68	to	-0.044	 0.026	
 Neurological	 -3.5	 -1.80	 -2.50	to	-1.20	 <0.001	
 Obstetric/Gynae	 -3.5	 -13.00	 -340	to	310	 0.94	
 Respiratory	 -3.5	 1.50	 1.30	to	1.70	 <0.001	
Location Home	 Reference	category	
 Nursing	home	 -3.3	 1.20	 0.95	to	1.40	 <0.001	
 Other	 -3.3	 -0.94	 -1.20	to	-0.65	 <0.001	
Gender Male	 Reference	category	
 Female	 -3.2	 -0.026	 -0.19	to	0.14	 0.75	
GCS_eye Spontaneous	 Reference	category	
 Verbal	 -3.4	 1.00	 0.74	to	1.30	 <0.001	
 Pain	 -3.4	 1.10	 0.58	to	1.50	 <0.001	
 No	response	 -3.4	 1.10	 0.60	to	1.60	 <0.001	
GCS_verbal Oriented	 Reference	category	
 Confused	 -3.4	 0.44	 0.18	to	0.69	 <0.001	
 Inappropriate	words	 -3.4	 1.40	 0.86	to	1.90	 <0.001	
 Incomprehensible	sounds	 -3.4	 1.30	 0.87	to	1.70	 <0.001	
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 No	response	 -3.4	 1.30	 0.91	to	1.60	 <0.001	
GCS_motor Obeys	 Reference	category	
 Localises	 -3.4	 1.20	 0.87	to	1.50	 <0.001	
 Withdraws	 -3.4	 1.20	 0.80	to	1.60	 <0.001	
 Flexion	 -3.4	 0.83	 -0.61	to	2.30	 0.26	
 Extension	 -3.4	 2.30	 0.98	to	3.60	 <0.001	
 No	response	 -3.4	 1.20	 0.72	to	1.70	 <0.001	
Skin Normal	 Reference	category	
 Cyanosed	 -3.7	 1.80	 1.40	to	2.30	 <0.001	
 Flushed	 -3.7	 1.10	 0.82	to	1.40	 <0.001	
 Jaundice	 -3.7	 1.50	 0.82	to	2.20	 <0.001	
 Mottling	 -3.7	 2.20	 1.40	to	2.90	 <0.001	
 Pallor	 -3.7	 1.10	 0.95	to	1.30	 <0.001	
 Rash	 -3.7	 -11.0	 -390	to	370	 0.96	
CBRT Normal	 Reference	category	
 Delayed	 -3.4	 1.30	 1.00	to	1.50	 <0.001	
AVPU Alert	 Reference	category	
 Verbal	 -3.4	 0.96	 0.70	to	1.20	 0.63	
 Pain	 -3.4	 1.10	 0.75	to	1.50	 0.90	
 No	response	 -3.4	 0.99	 0.49	to	1.50	 0.001	
RPuPilReac
t Brisk	 Reference	category	
 Sluggish	 -3.3	 0.55	 0.26	to	0.84	 <0.001	
 Fixed	 -3.3	 -0.40	 -1.60	to	0.74	 0.49	
LPuPilReac
t Brisk	 Reference	category	
 Sluggish	 -3.3	 0.59	 0.31	to	0.88	 <0.001	
 Fixed	 -3.3	 0.28	 -0.62	to	1.20	 0.54	
Oxygen No	oxygen	given		 Reference	category	
 Oxygen	given	 -3.7	 1.9	 1.70	to	2.00	 <0.001	
Fluids No	fluids	given	 Reference	category	
 Fluids	given	 -3.3	 1.9	 1.40	to	2.40	 <0.001	ß	–	regression	coefficient,	CI	–	confidence	interval				
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7.3.2.2	 Test	 for	 multicollinearity	 between	 candidate	 predictor	
variables	Multicollinearity	 was	 assessed	 by	 identifying	 correlations	 among	 individual	candidate	predictor	variables.	Figure	7.1	graphically	displays	the	relationship	between	 variables.	 Correlation	 coefficients	 between	 candidate	 predictor	variables	are	reported	in	Table	7.7	
Figure	7.1.	Correlations	between	candidate	predictor	variables	
	
	Blue	circles	indicate	a	positive	relationship,	while	red	circles	indicate	an	inverse	relationship.	Darker	colour	shades	and	increasing	circle	size	indicate	increasing	strength	 of	 the	 relationship.	 	 The	 dark	 blue	 diagonal	 represents	 the	 perfect	relationship	of	each	variable	with	itself.		
A	near	perfect	positive	relationship	is	seen	between	left	and	right	pupils	with	respect	 to	reactions	and	pupil	size,	 that	 is	LPupilReact	=	RPupilReact	and	
LPupilSize	 ≈	 RPupilSize.	 It	 can	 also	 be	 seen	 that	 there	 is	 a	 very	 strong	correlation	between	GCS_sum	and	the	components	of	the	Glasgow	Coma	Score	(GCS_eye,	GCS_verbal	and	GCS_motor).	This	is	to	be	expected	as	GCS_sum	is	a	composite	score	of	 the	Glasgow	Coma	Score	components.	Similarly,	 there	 is	a	positive	 relationship	 between	 AVPU	 and	 the	 Glasgow	 Coma	 score	 (sum	 and	
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components).	This	too	is	to	be	expected	as	both	Glasgow	Coma	Score	and	AVPU	are	 both	 measures	 of	 consciousness.	 An	 additional	 positive	 relationship	 is	apparent	between	systolic	and	diastolic	blood	pressures.		
Fewer	 inverse	 relationships	 are	 visible,	 and	all	are	 considerably	weaker.	The	most	 notable	 inverse	 relationships	 occur	 between	 oxygen	 use	 (oxygen)	 and	peripheral	 oxygen	 saturations	 (SpO2).	 This	 is	 because	 patients	 with	 reduced	oxygen	saturations	will	be	treated	with	oxygen.	Similarly,	there	appears	to	be	a	relationship	 between	 measures	 of	 consciousness	 (AVPU,	 GCS_sum,	 GCS_eye,	
GCS_verbal	 and	 GCS_motor)	 and	 pupil	 reactions	 (LPupilReact	 and	
RPupilReact)	which	is	consistent	with	pupil	reactions	becoming	increasingly	sluggish	or	slow	when	consciousness	is	considerably	reduced.
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Table	7.7	Correlations	between	variables	
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Imp 1.00 -0.02 0.03 -0.02 0.40 -0.30 0.10 0.03 0.03 0.10 0.01 -0.01 -0.03 -0.02 -0.02 -0.07 0.04 -0.01 <0.01 <0.01 <0.01 <0.01 0.30 -0.03 
Location -0.02 1.00 -0.20 0.05 -0.08 0.08 -0.01 -0.05 0.01 -0.06 -0.05 -0.07 -0.06 -0.04 -0.06 0.01 -0.02 -0.07 0.05 0.06 0.05 0.06 -0.03 -0.01 
Age 0.03 -0.20 1.00 -0.03 0.10 -0.30 -0.10 0.09 -0.20 0.01 0.10 -0.04 -0.08 -0.03 -0.05 0.03 0.10 -0.03 0.04 -0.20 0.03 -0.20 0.10 0.03 
Gender -0.02 0.05 -0.03 1.00 <0.01 -0.03 -0.05 -0.03 0.03 -0.07 0.02 <0.01 <0.01 <0.01 <0.01 -0.03 0.02 <0.01 0.02 0.01 0.02 0.01 0.02 <0.01 
Resps 0.40 -0.08 0.10 <0.01 1.00 -0.40 0.30 0.04 0.06 0.20 0.07 <0.01 -0.01 -0.01 -0.01 -0.07 0.10 0.01 -0.01 <0.01 -0.01 <0.01 0.30 0.01 
SpO2 -0.30 0.08 -0.30 -0.03 -0.40 1.00 -0.20 0.02 0.05 -0.10 -0.09 0.10 0.10 0.10 0.20 0.10 -0.20 0.10 -0.08 0.07 -0.08 0.07 -0.40 -0.02 
Pulse 0.10 -0.01 -0.10 -0.05 0.30 -0.20 1.00 0.03 0.20 0.30 0.08 -0.01 -0.02 -0.03 -0.02 -0.08 0.05 -0.02 0.01 0.08 0.01 0.08 0.20 <0.01 
SBP 0.03 -0.05 0.09 -0.03 0.04 0.02 0.03 1.00 0.70 0.01 0.01 0.10 0.08 0.07 0.09 -0.06 -0.09 0.09 -0.05 -0.01 -0.05 -0.01 -0.04 -0.10 
DBP 0.03 0.01 -0.20 0.03 0.06 0.05 0.20 0.70 1.00 -0.01 -0.04 0.09 0.08 0.06 0.08 -0.07 -0.08 0.09 -0.04 0.05 -0.03 0.05 -0.03 -0.10 
Temp 0.10 -0.06 0.01 -0.07 0.20 -0.10 0.30 0.01 -0.01 1.00 0.05 0.02 0.01 0.02 0.01 -0.10 -0.03 0.02 -0.04 -0.01 -0.04 -0.01 0.09 0.02 
BM 0.01 -0.05 0.10 0.02 0.07 -0.09 0.08 0.01 -0.04 0.05 1.00 0.01 <0.01 <0.01 <0.01 <0.01 0.03 <0.01 0.01 -0.03 0.01 -0.03 0.06 0.04 
GCS_eye -0.01 -0.07 -0.04 <0.01 <0.01 0.10 -0.01 0.10 0.09 0.02 0.01 1.00 0.70 0.80 0.90 0.03 -0.10 0.80 -0.30 -0.01 -0.30 -0.01 -0.20 -0.05 
GCS_verbal -0.03 -0.06 -0.08 <0.01 -0.01 0.10 -0.02 0.08 0.08 0.01 <0.01 0.70 1.00 0.70 0.90 0.03 -0.10 0.70 -0.40 -0.01 -0.40 -0.01 -0.20 -0.04 
GCS_motor -0.02 -0.04 -0.03 <0.01 -0.01 0.10 -0.03 0.07 0.06 0.02 <0.01 0.80 0.70 1.00 0.90 0.04 -0.10 0.80 -0.30 -0.01 -0.30 -0.01 -0.20 -0.05 
GCS_sum -0.02 -0.06 -0.05 <0.01 -0.01 0.20 -0.02 0.09 0.08 0.01 <0.01 0.90 0.90 0.90 1.00 0.04 -0.10 0.80 -0.40 -0.01 -0.40 -0.01 -0.20 -0.05 
Skin -0.07 0.01 0.03 -0.03 -0.07 0.10 -0.08 -0.06 -0.07 -0.10 <0.01 0.03 0.03 0.04 0.04 1.00 0.01 0.03 -0.02 -0.01 -0.02 -0.01 -0.05 0.02 
CBRT 0.04 -0.02 0.10 0.02 0.10 -0.20 0.05 -0.09 -0.08 -0.03 0.03 -0.10 -0.10 -0.10 -0.10 0.01 1.00 -0.10 0.10 -0.03 0.10 -0.03 0.20 0.06 
AVPU -0.01 -0.07 -0.03 <0.01 0.01 0.10 -0.02 0.09 0.09 0.02 <0.01 0.80 0.70 0.80 0.80 0.03 -0.10 1.00 -0.40 -0.01 -0.40 -0.02 -0.20 -0.06 
RPupilReact <0.01 0.05 0.04 0.02 -0.01 -0.08 0.01 -0.05 -0.04 -0.04 0.01 -0.30 -0.40 -0.30 -0.40 -0.02 0.10 -0.40 1.00 0.03 0.90 0.02 0.08 <0.01 
RPupilSize <0.01 0.06 -0.20 0.01 <0.01 0.07 0.08 -0.01 0.05 -0.01 -0.03 -0.01 -0.01 -0.01 -0.01 -0.01 -0.03 -0.01 0.03 1.00 0.02 1.00 -0.03 -0.03 
LPupilReact <0.01 0.05 0.03 0.02 -0.01 -0.08 0.01 -0.05 -0.03 -0.04 0.01 -0.30 -0.40 -0.30 -0.40 -0.02 0.10 -0.40 0.90 0.02 1.00 0.03 0.08 0.01 
LPupilSize <0.01 0.06 -0.20 0.01 <0.01 0.07 0.08 -0.01 0.05 -0.01 -0.03 -0.01 -0.01 -0.01 -0.01 -0.01 -0.03 -0.02 0.02 1.00 0.03 1.00 -0.03 -0.03 
Oxygen 0.30 -0.03 0.10 0.02 0.30 -0.40 0.20 -0.04 -0.03 0.09 0.06 -0.20 -0.20 -0.20 -0.20 -0.05 0.20 -0.20 0.08 -0.03 0.08 -0.03 1.00 0.03 
Fluids -0.03 -0.01 0.03 <0.01 0.01 -0.02 <0.01 -0.10 -0.10 0.02 0.04 -0.05 -0.04 -0.05 -0.05 0.02 0.06 -0.06 <0.01 -0.03 0.01 -0.03 0.03 1.00 
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Perfect	correlation	occurs	when	the	correlation	coefficient	is	1.	This	can	be	1	(a	positive	 correlation)	 or	 -1	 (a	 negative/inverse	 correlation).	 There	 is	 no	established	method	to	manage	predictor	variables	that	are	highly	correlated.	The	threshold	 at	 which	 a	 candidate	 predictor	 variable	 is	 deemed	 to	 be	 highly	correlated	is	subjective.	In	this	study,	a	correlation	coefficient	of	0.9	(positive	or	negative)	was	the	threshold	to	assess	the	potential	impact	of	highly	correlated	candidate	predictor	variables	on	the	model.	
A	perfect	correlation	exists	between	left	and	right	pupil	reactions	(correlation	coefficient	 =1).	 Pupil	 size	 between	 left	 and	 right	 eyes	 are	 also	 very	 highly	correlated	(correlation	coefficient	=0.9).	Differences	between	a	patient’s	pupil	reactions,	and	pupil	sizes,	are	known	to	be	associated	with	cerebral	pathologies,	however	 no	 such	 link	 has	 been	 established	 for	 sepsis.	 Furthermore,	 the	systematic	review	reported	earlier	in	this	thesis	failed	to	identify	any	known	link	between	 pupil	 size	 or	 reaction	 and	 sepsis.	 Therefore,	 analysing	data	 for	 both	pupils	will	not	be	of	benefit	over	analysing	data	from	one	pupil.	Consequently,	data	relating	to	the	left	pupil	were	excluded	from	further	modelling,	so	that	only	data	pertaining	to	the	right	pupil	were	employed	during	modelling.	
The	 strong	 relationships	 between	 elements	 of	 the	 Glasgow	 Coma	 Score,	 the	summated	 Glasgow	 Coma	 Score	 and	 AVPU	 score	 were	 more	 challenging	 to	manage.	 Existing	 scores	 or	 screening	 tools	 utilise	 different	 measures	 of	consciousness.	 For	 example,	 the	 Critical	 Illness	 Score	 utilises	 Glasgow	 Coma	Score	while	 the	NEWS	score	utilises	AVPU.	 It	was	not	clear	at	 this	early	stage	which	 measure	 of	 consciousness,	 if	 any,	 would	 be	 the	 optimal	 measure	 for	inclusion	in	the	prediction	model	being	developed.	Consequently,	each	measure	of	consciousness	(Glasgow	Coma	Score	elements,	the	summated	Glasgow	Coma	Score	 and	AVPU)	was	modelled	 separately.	That	 is,	 one	model	was	 generated	using	the	Glasgow	Coma	Score	elements	as	the	measure	of	consciousness	(Model	A),	another	was	generated	using	the	Glasgow	Coma	Score	sum	as	the	measure	of	consciousness	(Model	B)	and	a	third	was	generated	using	the	AVPU	score	as	the	measure	of	consciousness	(Model	C).	Performance	of	 the	 three	models	 (using	differing	measures	of	consciousness)	were	subsequently	compared	to	determine	the	best	performing	model.		 	
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7.3.2.3	Generation	of	multivariable	models	The	 following	 variables	 were	 previously	 identified	 as	 being	 used	 in	 existing	screening	tools	during	the	systematic	review	(see	Chapter	3,	table	3.6):		 • Respiratory	rate	• Heart	rate	• Temperature	• Level	of	consciousness	• Peripheral	oxygen	saturations	• Blood	pressure	• Shock	Index	• Lactate	• Blood	glucose	• Skin	• Capillary	bed	refill	time	• Dispatch	category	• Location	• Age	
	Dispatch	category	is	not	considered	as	a	potential	predictor	in	this	study	as	it	is	not	 directly	 patient	 related.	 Dispatch	 category	 is	 assigned	 during	 the	 initial	emergency	 call	 and	 is	 related	 to	 the	 call	 priority	 assigned	 by	 the	 call	 taker.	Furthermore,	 there	 are	 numerous	 dispatch	 categorisation	 models	 in	 use	internationally,	consequently	inclusion	of	dispatch	categorisation	would	limit	the	generalisability	of	this	screening	tool	if	it	was	included.	Lactate	is	not	considered	in	this	screening	tool	as	it	is	not	measured	by	ambulance	clinicians	in	the	UK.		Allgöwer	and	Buri	proposed	the	shock	index	in	1967	to	quantify	the	degree	of	hypovolaemia	in	haemorrhagic	and	infectious	shock	states.196 Shock	index	is	a	bedside	assessment	defined	as	heart	rate	divided	by	systolic	blood	pressure.	The	normal	range	is	0.5	to	0.7	in	healthy	adults.	Shock	index	is	not	considered	as	a	potential	 predictor	 in	 this	 study	 as	 it	 requires	 calculation,	 adding	 additional	complexity	for	the	attending	ambulance	clinician,	and	may	result	in	erroneous	conclusions	in	the	event	of	mis-calculation.			Stepwise	 selection	was	 applied	 to	 the	derivation	dataset	 to	 identify	predictor	variables.	A	backward	elimination	procedure	was	employed	to	identify	variables	
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for	consideration	of	inclusion	in	the	parsimonious	model.	Three	parallel	models	were	developed	using	different	measures	of	consciousness.	Model	A	utilised	the	Glasgow	Coma	Score	(GCS_sum),	Model	B	utilised	the	components	of	the	Glasgow	Coma	Score	(GCS_eye,	GCS_verbal	and	GCS_motor)	while	model	C	utilised	the	
AVPU	score.	Results	of	the	stepwise	selection	are	reported	in	table	7.8.		
Table	7.8	Selection	of	predictor	variables	
Model	A		 Number	of	selections	 Model	B		
Number	of	
selections	 Model	C		
Number	of	
selections	
Imp	 50	 Imp	 50	 Imp	 50	
Location 50	 Location 50	 Location 50	
Age	 50	 Age	 50	 Age	 50	
Gender 0	 Gender 0	 Gender 0	
Resps	 50	 Resps	 50	 Resps	 50	
SpO2	 50	 SpO2	 50	 SpO2	 50	
Pulse	 50	 Pulse	 50	 Pulse	 50	
SBP	 50	 SBP	 50	 SBP	 50	
DBP 0	 DBP 0	 DBP 0	
Temp	 50	 Temp	 50	 Temp	 50	
BM	 1	 BM	 1	 BM	 0	
Skin	 50	 Skin	 50	 Skin	 50	
CBRT 0	 CBRT 0	 CBRT 0	
RPupilReact	 11	 RPupilReact	 12	 RPupilReact	 8	
RPupilSize 0	 RPupilSize 0	 RPupilSize 0	
Oxygen 	 50	 Oxygen 	 50	 Oxygen 	 50	
Fluids	 50	 Fluids	 50	 Fluids	 50	
GCS_sum 50	 GCS_eye	 0	 AVPU	 50	
 	 GCS_verbal 50	 	 	
 	 GCS_motor 0	 	 			To	determine	which	of	the	variables,	identified	during	stepwise	selection,	should	be	included	in	the	parsimonious	model,	Wald	statistics	were	calculated	on	the	pooled	results,	and	are	reported	in	table	7.9.			 	
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Table	7.9	Wald	statistics	for	variables	identified	during	stepwise	selection	
Model	A		 Wald	statistic	 Model	B		 Wald	statistic	 Model	C		 Wald	statistic	
Imp	 <0.001	 Imp	 <0.001	 Imp	 <0.001	
Location 0.002	 Location 0.004	 Location 0.003	
Age	 <0.001	 Age	 <0.001	 Age	 <0.001	
Resps	 <0.001	 Resps	 <0.001	 Resps	 <0.001	
SpO2	 <0.001	 SpO2	 <0.001	 SpO2	 <0.001	
Pulse	 0	 Pulse	 0	 Pulse	 0	
SBP	 <0.001	 SBP	 <0.001	 SBP	 <0.001	
Temp	 0	 Temp	 0	 Temp	 0	
BM	 0.86	 BM	 0.85	 BM	 0.87	
Skin	 0.007	 Skin	 0.007	 Skin	 0.014	
RPupilReact	 0.42	 RPupilReact	 0.41	 RPupilReact	 0.46	
Oxygen 	 <0.001	 Oxygen 	 <0.001	 Oxygen 	 <0.001	
Fluids	 <0.001	 Fluids	 <0.001	 Fluids	 <0.001	
GCS_sum <0.001	 GCS_verbal	 <0.001	 AVPU	 <0.001			The	variables	identified	by	stepwise	selection	are	largely	consistent	with	those	utilised	in	existing	screening	tools.	Two	of	the	variables	identified	by	stepwise	selection	had	non-significant	Wald	statistics	(BM	and	RPupilReact)	and	are	thus	excluded	from	further	consideration.	Of	the	remainder,	clinical	impression	(Imp),	oxygen	administration	(Oxygen)	and	 intravascular	fluid	therapy	(Fluids)	are	not	used	in	existing	sepsis	screening	tools.			
Imp	 is	 a	 subjective	 assessment	 made	 by	 the	 attending	 ambulance	 crew	 that	categorises	the	patients	underlying	condition	as	being	either	“general	medical”,	“other”,	 “cardiovascular”,	 “neurologic”,	 “obstetric	 or	 gynaecologic”	 or	“respiratory”	 in	 nature.	 It	 is	 unclear	what	 the	 inter-rater	 reliability	 (between	ambulance	 clinicians)	 would	 be	 for	 this	 variable.	 For	 example,	 two	 different	clinicians	might	classify	a	case	of	suspected	pulmonary	embolus	as	“respiratory”	due	 to	 respiratory	 system	 involvement,	 “cardiovascular”	due	vascular	 system	involvement	or	“other”	due	to	the	occlusive	nature	of	the	underlying	condition.	Due	 to	 the	 subjective	nature	of	 this	 variable,	 and	a	 lack	of	 guidance	 from	 the	ambulance	service	in	how	to	categorise	patients,	a	pragmatic	decision	was	made	to	exclude	Imp	from	further	consideration.	
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	Although	 both	 oxygen	 administration	 (Oxygen)	 and	 Fluid	 administration	(Fluids)	were	identified	as	independent	predictors	of	high	risk	of	sepsis,	 it	 is	important	 to	 note	 that	 both	 are	 interventions	 performed	 by	 ambulance	clinicians,	 rather	 than	 observable	 clinical	 characteristics	 derived	 from	 the	patient.	 Furthermore,	 administration	 of	 oxygen	 (Oxygen)	 is	 triggered	 when	peripheral	 oxygen	 saturation	 (SpO2)	 falls	 below	 93%.	 Similarly,	 intravenous	fluids	should	only	be	administered	(Fluids)	when	the	systolic	blood	pressure	(SBP)	falls	below	90mmHg,	and	then	only	by	paramedic	level	staff.	Because	both	peripheral	 oxygen	 saturations	 (SpO2)	 and	 systolic	 blood	 pressure	 (SBP)	 are	measured,	 and	 identified	 as	 independent	 predictors	 for	 high	 risk	 of	 sepsis,	 a	pragmatic	decision	was	made	to	exclude	both	oxygen	administration	(Oxygen)	and	 fluid	 administration	 (Fluids)	 from	 further	 consideration.	 The	 variables	ultimately	 included	 as	 independent	 predictor	 variables	 are	 reported	 in	 table	
7.10.		
Table	7.10	Final	selection	of	independent	predictor	variables	
Model	A		 Wald	statistic	 Model	B		 Wald	statistic	 Model	C		 Wald	statistic	
Location	 0.002	 Location	 0.004	 Location	 0.003	
Age	 <0.001	 Age	 <0.001	 Age	 <0.001	
Resps	 <0.001	 Resps	 <0.001	 Resps	 <0.001	
SpO2	 <0.001	 SpO2	 <0.001	 SpO2	 <0.001	
Pulse	 <0.001	 Pulse	 <0.001	 Pulse	 <0.001	
SBP	 <0.001	 SBP	 <0.001	 SBP	 <0.001	
Temp	 <0.001	 Temp	 <0.001	 Temp	 <0.001	
Skin	 0.007	 Skin	 0.007	 Skin	 0.014	
GCS_sum <0.001	 GCS_verbal	 <0.001	 AVPU	 <0.001		
	
7.3.3	Continuous	predictors	The	ranges	of	continuous	independent	predictor	variables	are	subdivided	into	small	manageable	intervals	to	minimise	the	impact	of	conversion	into	categorical	variables	 and	 subsequently	 to	 enable	 generation	 of	 scores	 that	 facilitate	calculation	of	a	simple	summative	risk	score.		In	all	cases	a	reference	interval	is	established	and	all	other	intervals	are	subject	to	logistic	regression	against	the	reference	level.	
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Age	It	 is	 generally	 accepted	 that	 the	 risk	 of	 sepsis	 increases	with	advancing	 age,3	however	there	are	no	established	thresholds	for	age,	above	which,	one	can	state	with	 conviction	 that	 the	 risk	 of	 sepsis	 has	 increased.	 Table	 7.11	 identifies	thresholds	 previously	 established	 in	 the	 literature,	 while	 table	 7.12	 reports	calculated	cut	points	calculated	with	the	package	OptimalCutpoints	(version	1.1-3)	for	several	sepsis	diagnoses	with	respect	to	age.	It	can	be	seen	from	tables	
7.11	and	7.12	that	there	is	considerable	variation	in	thresholds.			
Table	7.11	Existing	thresholds	for	age	
	 	 range	Normal	physiologic	range	 	 -	NICE	Sepsis	(low	risk)	 	 -	NICE	Sepsis	(mod	risk)	 	 -	NICE	Sepsis	(high	risk)	 	 -	NEWS	(0)	 	 -	NEWS	(1)	 	 -	NEWS	(2)	 	 -	NEWS	(3)	 	 -	UK	Sepsis	Trust	(red	flag)	 	 -	UK	Sepsis	Trust	(amber	flag)	 	 -	Critical	Illness	Score	(0)	 	 <45	Critical	Illness	Score	(1)	 	 >44	Critical	Illness	Score	(2)	 	 -	PRESS	(0)	 	 18	–	39	PRESS	(1)	 	 -	PRESS	(2)	 	 >60	PRESS	(3)	 	 -	PRESS	(4)	 	 40	-	59	PRESS	(5)	 	 -	PreSep	 	 -		
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Table	7.12	Cut	points	for	Age	
Sepsis	diagnosis	 	 lower	cut	point	 upper	cut	point	ED	Doctor	diagnosis	 estimate	 20	 94	
AUC	(95%CI)	 0.352	(0.326-0.378)	 0.648	(0.622-0.674)	Infection	+	2SIRS	 estimate	 29	 88	
AUC	(95%CI)	 0.359	(0.346-0.372)	 0.641	(0.628-0.654)	SSC	SOFA	 estimate	 20	 94	
AUC	(95%CI)	 0.301	(0.279-0.324)	 0.699	(0.676-0.721)	NICE	(low,	mod,	high	risk)	 estimate	 39	 84	
AUC	(95%CI)	 0.357	(0.346-0.367)	 0.643	(0.633-0.654)	NICE	(mod	&	high	risk)	 estimate	 31	 87	
AUC	(95%CI)	 0.378	(0.365-0.391)	 0.622	(0.609-0.635)	NICE	(high	risk	only)	 estimate	 21	 92	
AUC	(95%CI)	 0.357	(0.337-0.378)	 0.643	(0.622-0.663)	ED	–	Emergency	Department,	SIRS	–	Systemic	Inflammatory	Response	Criteria,	SSC	–	Survive	Sepsis	Campaign,	SOFA	–	Sequential	Organ	Failure	Score,	AUC	–	area	under	the	curve	
	
Figure	7.2	graphically	indicates	that	below	40	to	50	years	of	age	there	is	minimal	change	in	risk	of	‘high	risk	sepsis’.	At	a	little	below	50	years	of	age	risk	of	sepsis	begins	 to	 increase	 at	 a	more-or-less	 steady	 rate.	 Consequently,	age	 below	40	years	was	adopted	as	a	reference	standard,	with	increments	established	every	ten	years.		
Figure	7.2	Loess	curve	for	Age	vs	NICE	high	sepsis	risk	
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Respiratory	rate	The	normal	physiological	range	for	respirations	is	10	to	20	breaths	per	minute.197		
Table	7.13	 identifies	thresholds	previously	established	in	the	literature,	while	
table	 7.14	 reports	 theoretical	 cut	 points	 for	 different	 sepsis	 diagnoses	 with	respect	 to	 respiratory	 rate.	 It	 appears	 that	 respiratory	 rates	 below	 10	 to	 12	breaths	per	minute	are	established	as	a	lower	threshold	in	the	literature,	while	calculated	lower	thresholds	range	between	10	and	15	breaths	per	minute.		The	upper	threshold	varies	considerably	between	20	and	40	breaths	per	minutes.		
Table	7.13	Existing	thresholds	for	respirations	
	 	 range	Normal	physiologic	range	 	 10	-	20	NICE	Sepsis	(low	risk)	 	 -	NICE	Sepsis	(mod	risk)	 	 21	-	24	NICE	Sepsis	(high	risk)	 	 >25	NEWS	(0)	 	 12-20	NEWS	(1)	 	 9	–	11	NEWS	(2)	 	 21-24	NEWS	(3)	 	 <9	or	>24	UK	Sepsis	Trust	(red	flag)	 	 >24	UK	Sepsis	Trust	(amber	flag)	 	 21-24	Critical	Illness	Score	(0)	 	 12	-	23	Critical	Illness	Score	(1)	 	 <12	or	24	-	35	Critical	Illness	Score	(2)	 	 >35	PRESS	(0)	 	 -	PRESS	(1)	 	 -	PRESS	(2)	 	 -	PRESS	(3)	 	 -	PRESS	(4)	 	 -	PRESS	(5)	 	 -	PreSep	 	 >22		
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Table	7.14	Cut	points	for	Respirations	
Sepsis	diagnosis	 	 lower	cut	point	 upper	cut	point	ED	Doctor	diagnosis	 estimate	 12	 40	
AUC	(95%CI)	 0.371	(0.34-0.402)	 0.629	(0.598-0.66)	Infection	+	2SIRS	 estimate	 15	 29	
AUC	(95%CI)	 0.319	(0.304-0.333)	 0.681	(0.667-0.696)	SSC	SOFA	 estimate	 12	 40	
AUC	(95%CI)	 0.36	(0.33-0.39)	 0.64	(0.61-0.67)	NICE	(low,	mod,	high	risk)	 estimate	 16	 24	
AUC	(95%CI)	 0.379	(0.368-0.391)	 0.621	(0.609-0.632)	NICE	(mod	&	high	risk)	 estimate	 15	 28	
AUC	(95%CI)	 0.325	(0.312-0.339)	 0.675	(0.661-0.688)	NICE	(high	risk	only)	 estimate	 14	 38	
AUC	(95%CI)	 0.218	(0.197-0.239)	 0.782	(0761-0.803)	ED	–	Emergency	Department,	SIRS	–	Systemic	Inflammatory	Response	Criteria,	SSC	–	Survive	Sepsis	Campaign,	SOFA	–	Sequential	Organ	Failure	Score,	AUC	–	area	under	the	curve	
	
Figure	 7.3	 graphically	 indicates	 that	 risk	 of	 ‘high	 risk	 sepsis’	 is	 unchanging	below	 18	 breaths	 per	 minute,	 but	 begins	 to	 increase	 at	 a	 rapid	 rate	 at	approximately	20	breaths	per	minute.		
 
Figure	7.3	Loess	curve	for	Respirations	vs	NICE	high	sepsis	risk 
	Because	the	normal	physiological	range	begins	at	10	breaths	per	minute	this	was	taken	 to	be	 the	 lower	 threshold.	 Similarly,	 the	upper	 threshold	was	 set	 at	 20	breaths	per	minute	as	this	is	approximately	the	point	when	risk	of	sepsis	begins	to	increase.	The	reference	range	is	thus	10	to	20	breaths	per	minute.	Increments	
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of	 5	 breaths	 per	 minute	 were	 established	 given	 the	 wide	 variation	 in	 the	published	literature.	
Peripheral	oxygen	saturations	The	normal	physiological	range	for	peripheral	oxygen	saturations	is	above	93%	in	patients	who	 do	not	 have	 chronic	 obstructive	 pulmonary	disease.198	Table	
7.15	 identifies	thresholds	previously	established	in	 the	 literature,	while	table	
7.16	reports	calculated	cut	points	for	different	sepsis	diagnoses	with	respect	to	peripheral	 oxygen	 saturations.	 It	 appears	 that	 peripheral	 oxygen	 saturations	below	93%	are	established	as	a	lower	threshold	in	the	literature,	while	calculated	cut	points	range	between	80%	and	95%.			
Table	7.15	Existing	thresholds	for	peripheral	oxygen	saturations	
	 	 range	Normal	physiological	range	 	 >94	NICE	Sepsis	(low	risk)	 	 -	NICE	Sepsis	(mod	risk)	 	 -	NICE	Sepsis	(high	risk)	 	 <93	NEWS	(0)	 	 >95	NEWS	(1)	 	 94	-	95	NEWS	(2)	 	 92	-	93	NEWS	(3)	 	 <92	UK	Sepsis	Trust	(red	flag)	 	 <93	UK	Sepsis	Trust	(amber	flag)	 	 -	Critical	Illness	Score	(0)	 	 >91	Critical	Illness	Score	(1)	 	 <92	Critical	Illness	Score	(2)	 	 -	PRESS	(0)	 	 >89	PRESS	(1)	 	 80	–	89	PRESS	(2)	 	 -	PRESS	(3)	 	 70	–	79	PRESS	(4)	 	 60	-	69	PRESS	(5)	 	 <60	PreSep	 	 <92	
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Table	7.16	Cut	points	for	Oxygen	saturations	(SpO2)	
Sepsis	diagnosis	 	 lower	cut	point	 upper	cut	point	ED	Doctor	diagnosis	 estimate	 79	 100	
AUC	(95%CI)	 0.663	(0.634-0.693)	 0.337	(0.307-0.366)	Infection	+	2SIRS	 estimate	 91	 100	
AUC	(95%CI)	 0.71	(0.696-0.724)	 0.29	(0.276-0.304)	SSC	SOFA	 estimate	 79	 100	
AUC	(95%CI)	 0.675	(0.646-0.703)	 0.325	(0.297-0.354)	NICE	(low,	mod,	high	risk)	 estimate	 94	 99	
AUC	(95%CI)	 0.657	(0.646-0.668)	 0.343	(0.332-0.354)	NICE	(mod	&	high	risk)	 estimate	 92	 100	
AUC	(95%CI)	 0.692	(0.679-0.706)	 0.308	(0.294-0.321)	NICE	(high	risk	only)	 estimate	 84	 100	
AUC	(95%CI)	 0.775	(0.754-0.797)	 0.225	(0.203-0.246)	ED	–	Emergency	Department,	SIRS	–	Systemic	Inflammatory	Response	Criteria,	SSC	–	Survive	Sepsis	Campaign,	SOFA	–	Sequential	Organ	Failure	Score,	AUC	–	area	under	the	curve		
	
Figure	 7.4	 graphically	 indicates	 that	 risk	 of	 sepsis	 increases	 below	 95%	(approximately),	 risk	 increases	 at	 a	 rapid	 rate	 until	 peripheral	 oxygen	saturations	 approach	 60%,	 after	 which	 risk	 appears	 to	 reduce	 once	 more.	Peripheral	 oxygen	 saturations	 are	 a	 non-invasive	 estimate	 of	 arterial	oxyhaemoglobin	 saturations,	 which	 in	 turn	 are	 dependent	 upon	 the	 partial	pressure	of	oxygen	in	the	arterial	blood	stream.	The	relationship	between	partial	pressure	 of	 oxygen	 and	 oxyhaemoglobin	 saturations	 is	 described	 by	 the	oxyhaemoglobin	 dissociation	 curve	 (see	 figure	 7.5).	 The	 oxyhaemoglobin	dissociation	curve	is	sigmoid	in	nature,	and	while	the	partial	pressure	of	oxygen	is	above	80	mmHg,	peripheral	oxygen	saturations	remain	above	95%.	However,	relatively	small	decreases	in	partial	pressure	of	oxygen,	below	about	75mmHg,	can	 produce	 significant	 reductions	 in	 peripheral	 oxygen	 saturations.	 For	 this	reason,	peripheral	oxygen	saturation	readings	below	75%	can	be	prone	to	error.	Furthermore,	 peripheral	 oxygen	 saturation	 readings	 are	 also	 prone	 to	 error	whenever	 perfusion	 of	 the	 finger	 nail	 bed,	 where	 the	 measuring	 sensor	 is	normally	applied,	is	poor.	Inadequate	perfusion	is	a	hallmark	feature	of	patients	
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with	 sepsis,	 thus	 inaccurate	 peripheral	 oxygen	 saturation	 readings	 are	 not	unexpected	 among	patients	with	 sepsis.	 Peripheral	 oxygen	 saturations	 below	75%	may	be	unreliable.	
 
Figure	7.4	Loess	curve	for	peripheral	oxygen	saturations	(SpO2)	vs	NICE	high	sepsis	risk 
		
Figure	7.5	Oxygen	dissociation	curve	
	image	from:	https://en.wikipedia.org/wiki/Hemoglobin#/media/File:Hemoglobin_saturation_curve.svg	
	Because	the	normal	physiological	range	for	peripheral	oxygen	saturations	is	 above	 93%,	 this	 was	 taken	 to	 be	 the	 reference	 threshold.	 Further	intervals	were	established	in	the	ranges	89%	to	93%,	85%	to	88%	and	below	85%.	
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Heart	rate	A	heart	rate	below	60	beats	per	minute	 is	established	 in	 the	 literature	as	 the	onset	 of	 bradycardia,	 while	 heart	 rates	 above	 100	 beats	 per	 minute	 are	categorised	as	tachycardia.197		The	widely	accepted	normal	physiological	range	for	heart	rate	is	therefore	60	to	100	beats	per	minute.197	Table	7.17	 identifies	thresholds	 previously	 established	 in	 the	 literature,	 while	 table	 7.18	 reports	calculated	cut	points	for	different	sepsis	diagnoses	with	respect	to	heart	rate.		
Table	7.17	Existing	thresholds	for	heart	rate	
	 	 range	Normal	physiological	range	 	 60	-	100	NICE	Sepsis	(low	risk)	 	 -	NICE	Sepsis	(mod	risk)	 	 91-130	NICE	Sepsis	(high	risk)	 	 >129	NEWS	(0)	 	 51	-	90	NEWS	(1)	 	 41-50	or	91-110	NEWS	(2)	 	 111	-	130	NEWS	(3)	 	 <41	or	>130	UK	Sepsis	Trust	(red	flag)	 	 >130	UK	Sepsis	Trust	(amber	flag)	 	 111	-	130	Critical	Illness	Score	(0)	 	 <121	Critical	Illness	Score	(1)	 	 >120	Critical	Illness	Score	(2)	 	 -	PRESS	(0)	 	 -	PRESS	(1)	 	 -	PRESS	(2)	 	 -	PRESS	(3)	 	 -	PRESS	(4)	 	 -	PRESS	(5)	 	 -	PreSep	 	 <90		 			
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Table	7.18	Cut	points	for	heart	rate	
Sepsis	diagnosis	 	 lower	cut	point	 upper	cut	point	ED	Doctor	diagnosis	 estimate	 52	 151	
AUC	(95%CI)	 0.325	(0.295-0.354)	 0.675	(0.646-0.705)	Infection	+	2SIRS	 estimate	 64	 122	
AUC	(95%CI)	 0.324	(0.31	-	0.338)	 0.676	(0.662-0.69)	SSC	SOFA	 estimate	 52	 150	
AUC	(95%CI)	 0.418	(0.387-0.45)	 0.582	(0.55-0.613)	NICE	(low,	mod,	high	risk)	 estimate	 70	 112	
AUC	(95%CI)	 0.413	(0.401-0.424)	 0.587	(0.576-0.599)	NICE	(mod	&	high	risk)	 estimate	 65	 120	
AUC	(95%CI)	 0.328	(0.315-0.341)	 0.672	(0.659-0.685)	NICE	(high	risk	only)	 estimate	 56	 140	
AUC	(95%CI)	 0.271	(0.25-0.239)	 0.729	(0.707-0.75)	ED	–	Emergency	Department,	SIRS	–	Systemic	Inflammatory	Response	Criteria,	SSC	–	Survive	Sepsis	Campaign,	SOFA	–	Sequential	Organ	Failure	Score,	AUC	–	area	under	the	curve			
Figure	7.6	demonstrates	that	risk	of	sepsis	is	minimal	when	heart	rate	is	below	100	 beats	 per	 minute,	 but	 begins	 to	 increase	 at	 a	 rapid	 rate	 as	 heart	 rate	increases	beyond	100	beats	per	minute.	Risk	of	sepsis	peaks	at	around	160	beats	per	minute,	and	thereafter	begins	to	decline.	This	decline	in	risk	of	sepsis	at	rates	above	160	beats	per	minute	may	reflect	that	rates	above	160	beats	per	minute	are	 more	 likely	 to	 be	 associated	 with	 an	 electrophysiological	 origin	 than	 a	compensatory	response	to	low	cardiac	output.	
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Figure	7.6	Loess	curve	for	heart	rate	(Pulse)	vs	NICE	high	sepsis	risk 
 	The	reference	range	for	heart	rate	is	60	to	100	beats	per	minute.	Rates	below	60	were	combined	into	a	single	interval,	while	rates	above	100	were	established	at	10	beat	intervals	up	to	180	beats	per	minute.	Rates	above	180	were	considered	a	single	interval.	
Systolic	blood	pressure	The	 normal	 physiological	 range	 for	 systolic	 blood	 pressure	 is	 100	 to	120mmHg.197	 Table	 7.19	 identifies	 thresholds	 previously	 established	 in	 the	literature,	 while	 table	 7.20	 reports	 calculated	 cut	 points	 for	 different	 sepsis	diagnoses	with	respect	to	systolic	blood	pressure.			 	
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Table	7.19	Existing	thresholds	for	systolic	blood	pressure	
	 	 range	Normal	physiological	range	 	 90	-	120	NICE	Sepsis	(low	risk)	 	 -	NICE	Sepsis	(mod	risk)	 	 91	-	100	NICE	Sepsis	(high	risk)	 	 <91	NEWS	(0)	 	 111-219	NEWS	(1)	 	 101	–	110	NEWS	(2)	 	 91-100	NEWS	(3)	 	 <91	or	>219	UK	Sepsis	Trust	(red	flag)	 	 <91	UK	Sepsis	Trust	(amber	flag)	 	 91	-	100	Critical	Illness	Score	(0)	 	 >89	Critical	Illness	Score	(1)	 	 <90	Critical	Illness	Score	(2)	 	 -	PRESS	(0)	 	 >99	PRESS	(1)	 	 90	–	99	PRESS	(2)	 	 80	–	89	PRESS	(3)	 	 70	–	79	PRESS	(4)	 	 60	–	69	PRESS	(5)	 	 <60	PreSep	 	 <90			 	
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Table	7.20	Cut	points	for	systolic	blood	pressure	(SBP)	
Sepsis	diagnosis	 	 lower	cut	point	 upper	cut	point	ED	Doctor	diagnosis	 estimate	 82	 194	
AUC	(95%CI)	 0.599	(0.566-0.633)	 0.401	(0.367-0.434)	Infection	+	2SIRS	 estimate	 100	 169	
AUC	(95%CI)	 0.537	(0.521-0.552)	 0.463	(0.448-0.479)	SSC	SOFA	 estimate	 83	 193	
AUC	(95%CI)	 0.65	(0.618-0.681)	 0.35	(0.319-0.382)	NICE	(low,	mod,	high	risk)	 estimate	 109	 157	
AUC	(95%CI)	 0.55	(0.538-0.561)	 0.45	(0.439-0.462)	NICE	(mod	&	high	risk)	 estimate	 102	 166	
AUC	(95%CI)	 0.560	(0.546-0.574)	 0.44	(0.426-0.454)		NICE	(high	risk	only)	 estimate	 88	 186	
AUC	(95%CI)	 0.601	(0.576-0.627)	 0.399	(0.373-0.424)	ED	–	Emergency	Department,	SIRS	–	Systemic	Inflammatory	Response	Criteria,	SSC	–	Survive	Sepsis	Campaign,	SOFA	–	Sequential	Organ	Failure	Score,	AUC	–	area	under	the	curve	
	
	
Figure	7.7	depicts	that	risk	of	sepsis	is	minimal	when	systolic	blood	pressure	is	above	 110mmHg	 (approximately),	 but	 begins	 to	 increase	 at	 a	 rapid	 rate	 as	systolic	pressure	decreases	below	100mmHg.			
Figure	7.7	Loess	curve	for	systolic	blood	pressure	(SBP)	vs	NICE	high	sepsis	risk	
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The	 reference	 range	 for	 systolic	 blood	 pressure	 is	 100mmHg	 to	 120mmHg.	Below	100mmHg	intervals	were	established	every	10mmHg	down	to	60mmHg,	and	 below	 60mmHg	 were	 combined	 into	 a	 single	 interval.	 Above	 120mmHg	intervals	were	 established	every	10mmHg	up	 to	180mmHg,	 above	180mmHg	were	combined	into	a	single	interval.	
Glasgow	Coma	Score	The	Glasgow	Coma	Score	is	a	thirteen-point	ordinal	score,	developed	by	Teasdale	and	Jennet,	to	assess	consciousness	in	head	injured	patients.199	A	patient	without	altered	consciousness	would	score	15	out	of	15,	consequently	this	is	the	normal	physiological	range.199	Table	7.21	identifies	thresholds	previously	established	in	the	literature,	while	table	7.22	reports	calculated	cut	points	for	different	sepsis	diagnoses	with	respect	to	Glasgow	Coma	Score.			 	
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Table	7.21	Existing	thresholds	for	Consciousness	(GCS)	
	 	 range	Normal	physiological	range	 	 15	NICE	Sepsis	(low	risk)	 	 -	NICE	Sepsis	(mod	risk)	 	 -	NICE	Sepsis	(high	risk)	 	 <15	NEWS	(0)	 	 -	NEWS	(1)	 	 -	NEWS	(2)	 	 -	NEWS	(3)	 	 -	UK	Sepsis	Trust	(red	flag)	 	 -	UK	Sepsis	Trust	(amber	flag)	 	 -	Critical	Illness	Score	(0)	 	 15	Critical	Illness	Score	(1)	 	 8	–	14	Critical	Illness	Score	(2)	 	 <8	PRESS	(0)	 	 -	PRESS	(1)	 	 -	PRESS	(2)	 	 -	PRESS	(3)	 	 -	PRESS	(4)	 	 -	PRESS	(5)	 	 -	PreSep	 	 <15	
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Table	7.22	Cut	points	for	GCS	(sum)	
Sepsis	diagnosis	 	 lower	cut	point	 upper	cut	point	ED	Doctor	diagnosis	 estimate	 8	 15	
AUC	(95%CI)	 0.601	(0.575-0.627)	 0.399	(0.373-0.425)	Infection	+	2SIRS	 estimate	 13	 15	
AUC	(95%CI)	 0.548	(0.537-0.559)	 0.452	(0.441-0.463)	SSC	SOFA	 estimate	 8	 15	
AUC	(95%CI)	 0.591	(0.566-0.616)	 0.409	(0.384-0.434)	NICE	(low,	mod,	high	risk)	 estimate	 14	 15	
AUC	(95%CI)	 0.543	(0.535-0.551)	 0.457	(0.449-0.465)	NICE	(mod	&	high	risk)	 estimate	 14	 15	
AUC	(95%CI)	 0.544	(0.535-0.554)	 0.456	(0.446-0.465)	NICE	(high	risk	only)	 estimate	 10	 15	
AUC	(95%CI)	 0.570	(0.551-0.589)	 0.430	(0.411-0.449)	ED	–	Emergency	Department,	SIRS	–	Systemic	Inflammatory	Response	Criteria,	SSC	–	Survive	Sepsis	Campaign,	SOFA	–	Sequential	Organ	Failure	Score,	AUC	–	area	under	the	curve	
	
	
Figure	7.8	illustrates	that	risk	of	sepsis	fluctuates	considerably,	with	peaks	easily	identified	at	approximately	GCS10	and	GCS6.			
Figure	7.8	Loess	curve	for	Glasgow	Coma	Score	vs	NICE	high	sepsis	risk	
		The	reference	score	for	GCS	is	15.	As	GCS	reduces,	 the	first	peak	on	the	Loess	curve	 appears	 in	 the	 range	 7-12.	 The	 second	 peak	 occurs	 at	 GCS	 below	 7.	
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Ambulance	 staff	 commonly	 associate	GCS	below	9	with	 “unconsciousness”.	 In	addition,	GCS	8	or	below	was	calculated	as	a	cut	point,	and	has	been	utilised	as	a	threshold	in	the	Critical	Illness	Score.	Consequently,	intervals	were	established	at	GCS	15,	13-14,	9-12	and	8	or	lower.	
Temperature	The	 normal	 physiological	 range	 for	 body	 temperature	 is	 36.6°C	 to	 37.4°C.197	
Table	7.22	 identifies	thresholds	previously	established	in	the	literature,	while	
table	 7.23	 reports	 calculated	 cut	 points	 for	 different	 sepsis	 diagnoses	 with	respect	to	temperature.			
Table	7.23	Existing	thresholds	for	temperature	
	 	 Range	(°C)	Normal	physiological	range	 	 36.5	–	38	NICE	Sepsis	(low	risk)	 	 -	NICE	Sepsis	(mod	risk)	 	 <36	NICE	Sepsis	(high	risk)	 	 -	NEWS	(0)	 	 36.1	-	38	NEWS	(1)	 	 35.1-36	or	38.1-39	NEWS	(2)	 	 >39	NEWS	(3)	 	 <35.1	UK	Sepsis	Trust	(red	flag)	 	 -	UK	Sepsis	Trust	(amber	flag)	 	 <36	Critical	Illness	Score	(0)	 	 -	Critical	Illness	Score	(1)	 	 -	Critical	Illness	Score	(2)	 	 -	PRESS	(0)	 	 Normal	PRESS	(1)	 	 -	PRESS	(2)	 	 -	PRESS	(3)	 	 hot	PRESS	(4)	 	 -	PRESS	(5)	 	 -	PreSep	 	 <36	or	>38	
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Table	7.24	Cut	points	for	temperature	
Sepsis	diagnosis	 	 lower	cut	point	(°C)	 upper	cut	point	(°C)	ED	Doctor	diagnosis	 estimate	 34.9	 39.2	
AUC	(95%CI)	 0.232	(0.198-0.267)	 0.768	(0.733-0.802)	Infection	+	2SIRS	 estimate	 35.8	 37.8	
AUC	(95%CI)	 0.302	(0.286-0.319)	 0.698	(0.681-0.714)	SSC	SOFA	 estimate	 35	 39.1	
AUC	(95%CI)	 0.349	(0.313-0.385)	 0.651	(0.615-0.687)	NICE	(low,	mod,	high	risk)	 estimate	 36	 37.4	
AUC	(95%CI)	 0.326	(0.313-0.339)	 0.674	(0.661-0.687)	NICE	(mod	&	high	risk)	 estimate	 35.8	 37.7	
AUC	(95%CI)	 0.318	(0.302-0.334)	 0.682	(0.666-0.698)	NICE	(high	risk	only)	 estimate	 35.2	 38.7	
AUC	(95%CI)	 0.288	(0.262-0.314)	 0.712	(0.686-0.738)	ED	–	Emergency	Department,	SIRS	–	Systemic	Inflammatory	Response	Criteria,	SSC	–	Survive	Sepsis	Campaign,	SOFA	–	Sequential	Organ	Failure	Score,	AUC	–	area	under	the	curve	
	
	
Figure	7.9	depicts	that	risk	of	sepsis	is	minimal	when	body	temperature	is	below	37.5°C	 (approximately),	 but	 begins	 to	 increase	 at	 a	 rapid	 rate	 as	 body	temperature	increases	above	37.5°C.		
	
Figure	7.9	Loess	curve	for	body	temperature	vs	NICE	high	sepsis	risk 
	The	 reference	 range	 for	 body	 temperature	 is	 36.6°C	 to	 37.4C.	 Below	 36.6°C	intervals	were	established	every	0.5°C	down	to	35.0°C,	and	below	35.0°C	were	
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combined	into	a	single	interval.	Above	37.4°C,	intervals	were	established	every	0.5°C	up	to	40.0°C,	and	above	40.0°C	were	combined	into	a	single	interval.	
7.3.3.1	Regression	of	multivariate	models	to	generate	scores	Three	multivariable	models,	utilising	different	measures	of	consciousness,	were	evaluated.	Tables	7.25,	7.26	and	7.27	report	the	regression	coefficients,	95%	confidence	 interval	 and	 p	 value	 for	 each	 variable	 used,	 for	 each	 of	 the	 three	models.	 Scores	 are	 assigned	 by	 rounding	 statistically	 significant	 regression	coefficients	 to	 the	 nearest	 integer.	 For	 example,	 in	 table	 7.25	 the	 regression	coefficient	for	Age	“60	to	69”	is	0.82.	This	is	rounded	up	to	1.	Similarly,	in	table	
7.26	the	regression	coefficient	for	“pallid”	skin	is	0.40.	This	is	rounded	down	to	a	score	of	0	despite	being	highly	significant	(p<0.001).	Non-significant	regression	coefficients	are	highlighted,	and	all	are	allocated	a	score	of	0.		
Table	7.25	Regression	of	Model	A	(utilising	GCS	sum)		 	 ßi	 lo	95	 hi	95	 p-value	 Score	
assigned	 intercept	 -5.46	 -5.98	 -4.93	 0.00	
Location home	 reference	 0	
 nursing	home	 0.21	 -0.14	 0.56	 0.23	 0	
 other	 -0.28	 -0.64	 0.08	 0.13	 0	
Age below	40	 reference	 0	
 40	to	49	 0.12	 -0.58	 0.81	 0.74	 0	
 50	to	59	 0.40	 -0.20	 1.00	 0.19	 0	
 60	to	69	 0.82	 0.30	 1.33	 <0.001	 1	
 70	to	79	 0.94	 0.45	 1.43	 <0.001	 1	
 80	to	89	 0.87	 0.37	 1.36	 <0.001	 1	
 90	to	99	 1.35	 0.79	 1.92	 <0.001	 1	
 100	plus	 1.59	 -0.17	 3.35	 0.08	 0	
Respirations below	10	 -13.20	 -948.66	 922.25	 0.98	 0	
 10	to	20	 reference	 0	
 21	to	25	 0.52	 0.19	 0.86	 <0.001	 1	
 26	to	30	 0.89	 0.56	 1.22	 <0.001	 1	
 31	to	35	 1.00	 0.57	 1.44	 <0.001	 1	
 36	to	40	 1.28	 0.91	 1.65	 <0.001	 1	
 41	to	45	 2.14	 1.46	 2.81	 <0.001	 2	
 46	to	50	 0.87	 -0.03	 1.76	 0.06	 0	
 51	to	55	 1.27	 -0.17	 2.70	 0.08	 0	
 56	to	60	 1.96	 1.02	 2.91	 <0.001	 2	
 60	plus	 -12.60	 -3227.5	 3202.2	 0.99	 0	
SpO2 above	93	 reference	 0	
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 89	to	93	 0.92	 0.64	 1.20	 <0.001	 1	
 85	to	88	 0.79	 0.39	 1.19	 <0.001	 1	
 below	85	 1.19	 0.84	 1.55	 <0.001	 1	
Pulse below	60	 -0.58	 -1.43	 0.27	 0.18	 0	
 60	to	100	 reference	 0	
 101	to	110	 0.62	 0.29	 0.94	 <0.001	 1	
 111	to	120	 0.63	 0.29	 0.97	 <0.001	 1	
 121	to	130	 0.96	 0.58	 1.34	 <0.001	 1	
 131	to	140	 0.88	 0.42	 1.33	 <0.001	 1	
 141	to	150	 1.84	 1.34	 2.35	 <0.001	 2	
 151	to	160	 1.11	 0.39	 1.83	 <0.001	 1	
 161	to	170	 0.38	 -0.86	 1.63	 0.55	 0	
 171	to	180	 0.04	 -2.11	 2.18	 0.97	 0	
 180	plus	 1.07	 -0.13	 2.28	 0.08	 0	
SBP below	60	 0.74	 -1.35	 2.82	 0.49	 0	
 60	to	69	 1.39	 0.43	 2.36	 <0.001	 1	
 70	to	79	 1.04	 0.26	 1.82	 0.01	 1	
 80	to	89	 0.72	 0.19	 1.25	 0.01	 1	
 90	to	99	 0.65	 0.24	 1.05	 <0.001	 1	
 100	to	120	 reference	 0	
 121	to	129	 -0.06	 -0.44	 0.32	 0.74	 0	
 130	to	139	 -0.09	 -0.46	 0.28	 0.64	 0	
 140	to	149	 -0.21	 -0.60	 0.18	 0.30	 0	
 150	to	159	 -0.05	 -0.46	 0.36	 0.80	 0	
 160	plus	 -0.72	 -1.13	 -0.32	 <0.001	 -1	
GCS (sum) 15	 reference	 0	
 13	to	14	 -0.25	 -0.62	 0.12	 0.19	 0	
 9	to	12	 0.67	 0.27	 1.08	 <0.001	 1	
 3	to	8	 0.48	 -0.08	 1.05	 0.09	 0	
Temperature below	35.0	 -0.49	 -1.49	 0.50	 0.33	 0	
 35.0	to	35.5	 0.18	 -0.41	 0.76	 0.55	 0	
 35.6	to	36.0	 -0.24	 -0.70	 0.22	 0.31	 0	
 36.1	to	36.5	 -0.21	 -0.56	 0.15	 0.25	 0	
 36.6	to	37.4	 reference	 0	
 37.5	to	38.0	 0.55	 0.20	 0.91	 <0.001	 1	
 38.1	to	38.5	 1.16	 0.78	 1.54	 <0.001	 1	
 38.6	to	39.0	 1.23	 0.79	 1.66	 <0.001	 1	
 39.1	to	39.5	 1.09	 0.53	 1.64	 <0.001	 1	
 39.6	to	40.0	 1.65	 1.07	 2.23	 <0.001	 2	
 above	40.0	 1.91	 1.09	 2.74	 <0.001	 2	
Skin normal	 reference	 0	
 cyanosed	 -0.05	 -0.68	 0.58	 0.88	 0	
 flushed	 0.13	 -0.25	 0.50	 0.50	 0	
 jaundice	 0.90	 0.01	 1.79	 0.05	 1	
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 mottling	 0.82	 -0.33	 1.96	 0.16	 0	
 pallor	 0.40	 0.14	 0.66	 <0.001	 0	
 rash	 -12.76	 -1121.5	 1095.9	 0.98	 0	
CBRT normal	 reference	 0		 delayed	 -0.06	 -0.42	 0.31	 0.75	 0	Highlighted	estimates	indicate	non-significant	estimates	
	
Table	7.26	Regression	of	Model	B	(utilising	GCS	components)	 		 	 ßi	 lo	95	 hi	95	 p-value	
Score	
assigned		 Intercept	 -5.46	 -5.98	 -4.93	 0.00	
Location home	 reference	 0	
 nursing	home	 0.20	 -0.14	 0.55	 0.25	 0	
 other	 -0.28	 -0.64	 0.07	 0.12	 0	
Age under	40	 reference	 0	
 40	to	49	 0.10	 -0.60	 0.79	 0.79	 0	
 50	to	59	 0.39	 -0.21	 0.99	 0.20	 0	
 60	to	69	 0.79	 0.28	 1.31	 <0.001	 1	
 70	to	79	 0.93	 0.44	 1.42	 <0.001	 1	
 80	to	89	 0.84	 0.34	 1.33	 <0.001	 1	
 90	to	99	 1.33	 0.77	 1.90	 <0.001	 1	
 100	plus	 1.63	 -0.07	 3.34	 0.06	 0	
Respiration
s below	10	 -13.47	 -940.42	 913.48	 0.98	 0	
 10	to	20	 reference	 0	
 21	to	25	 0.53	 0.20	 0.87	 <0.001	 1	
 26	to	30	 0.89	 0.56	 1.22	 <0.001	 1	
 31	to	35	 1.01	 0.57	 1.45	 <0.001	 1	
 36	to	40	 1.30	 0.92	 1.67	 <0.001	 1	
 41	to	45	 2.12	 1.45	 2.80	 <0.001	 2	
 46	to	50	 0.85	 -0.06	 1.75	 0.07	 0	
 51	to	55	 1.21	 -0.22	 2.64	 0.10	 0	
 56	to	60	 1.94	 1.00	 2.88	 <0.001	 2	
 60	plus	 -12.59	 -3230.28	 3205.09	 0.99	 0	
SpO2 above	93	 reference	 0	
 89	to	93	 0.91	 0.63	 1.19	 <0.001	 1	
 85	to	88	 0.79	 0.38	 1.19	 <0.001	 1	
 below	85	 1.18	 0.83	 1.53	 <0.001	 1	
Pulse below	60	 -0.58	 -1.43	 0.27	 0.18	 0	
 60	to	100	 reference	 0	
 101	to	110	 0.64	 0.31	 0.96	 <0.001	 1	
 111	to	120	 0.63	 0.29	 0.97	 <0.001	 1	
 21	to	130	 0.96	 0.59	 1.34	 <0.001	 1	
 131	to	140	 0.87	 0.42	 1.32	 <0.001	 1	
 141	to	150	 1.84	 1.33	 2.34	 <0.001	 2	
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 151	to	160	 1.09	 0.37	 1.81	 <0.001	 1	
 161	to	170	 0.45	 -0.78	 1.67	 0.47	 0	
 171	to	180	 0.01	 -2.13	 2.16	 0.99	 0	
 180	plus	 1.05	 -0.16	 2.27	 0.09	 0	
SBP below	60	 0.87	 -1.11	 2.85	 0.39	 0	
 60	to	69	 1.44	 0.48	 2.40	 <0.001	 1	
 70	to	79	 1.06	 0.29	 1.83	 0.01	 1	
 80	to	89	 0.71	 0.18	 1.25	 0.01	 1	
 90	to	99	 0.64	 0.24	 1.05	 <0.001	 1	
 100	to	120	 reference	 0	
 121	to	129	 -0.07	 -0.45	 0.31	 0.71	 0	
 130	to	139	 -0.08	 -0.46	 0.29	 0.66	 0	
 140	to	149	 -0.19	 -0.59	 0.20	 0.33	 0	
 150	to	159	 -0.07	 -0.48	 0.34	 0.75	 0	
 160	plus	 -0.72	 -1.13	 -0.32	 <0.001	 -1	
GCS 
(verbal) oriented	 reference	 0	
 confused	 0.02	 -0.33	 0.36	 0.92	 0	
 Inapp.	words	 0.50	 -0.25	 1.25	 0.19	 0	
 Incomp.	sounds	 0.46	 -0.21	 1.13	 0.18	 0	
 no	response	 0.83	 0.31	 1.34	 <0.001	 1	
Temperature below	35	 -0.50	 -1.49	 0.48	 0.32	 0	
 35.0	to	35.5	 0.17	 -0.42	 0.75	 0.58	 0	
 35.6	to	36.0	 -0.25	 -0.71	 0.21	 0.28	 0	
 36.1	to	36.5	 -0.21	 -0.56	 0.15	 0.25	 0	
 36.6	to	37.4	 reference	 0	
 37.5	to	38.0	 0.55	 0.19	 0.90	 <0.001	 1	
 38.1	to	38.5	 1.15	 0.78	 1.53	 <0.001	 1	
 38.6	to	39.0	 1.22	 0.78	 1.66	 <0.001	 1	
 39.1	to	39.5	 1.09	 0.53	 1.64	 <0.001	 1	
 39.6	to	40.0	 1.62	 1.04	 2.20	 <0.001	 2	
 above	40	 1.89	 1.06	 2.72	 <0.001	 2	
Skin normal	 reference	 0	
 cyanosed	 0.00	 -0.63	 0.62	 1.00	 0	
 flushed	 0.13	 -0.24	 0.51	 0.48	 0	
 jaundice	 0.89	 0.00	 1.78	 0.05	 1	
 mottling	 0.79	 -0.36	 1.93	 0.18	 0	
 pallor	 0.40	 0.14	 0.66	 <0.001	 0	
 rash	 -12.76	 -1121.39	 1095.86	 0.98	 0	
CBRT normal	 reference	 0		 delayed	 -0.06	 -0.42	 0.31	 0.76	 0	Highlighted	estimates	indicate	non-significant	estimates			
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Table	7.27	Regression	of	Model	C	(utilising	AVPU)		 	 ßi	 lo	95	 hi	95	 p-value	 Score	
assigned		 intercept	 -5.50	 -6.02	 -4.97	 0.00	
Location home	 reference	 0	
 nursing	home	 0.24	 -0.09	 0.58	 0.15	 0	
 other	 -0.28	 -0.64	 0.07	 0.12	 0	
Age below	40	 reference	 0	
 40	to	49	 0.14	 -0.55	 0.84	 0.69	 0	
 50	to	59	 0.45	 -0.16	 1.05	 0.15	 0	
 60	to	69	 0.83	 0.32	 1.34	 <0.001	 1	
 70	to	79	 0.98	 0.49	 1.47	 <0.001	 1	
 80	to	89	 0.88	 0.38	 1.37	 <0.001	 1	
 90	to	99	 1.37	 0.81	 1.93	 <0.001	 1	
 100	plus	 1.34	 -0.40	 3.08	 0.13	 0	
Respirations below	10	 -13.25	 -945.34	 918.84	 0.98	 0	
 10	to	20	 reference	 0	
 21	to	25	 0.54	 0.21	 0.87	 <0.001	 1	
 26	to	30	 0.91	 0.58	 1.24	 <0.001	 1	
 31	to	35	 1.01	 0.57	 1.45	 <0.001	 1	
 36	to	40	 1.32	 0.95	 1.69	 <0.001	 1	
 41	to	45	 2.15	 1.49	 2.80	 <0.001	 2	
 46	to	50	 0.80	 -0.10	 1.69	 0.08	 0	
 51	to	55	 1.23	 -0.18	 2.64	 0.09	 0	
 56	to	60	 1.99	 1.05	 2.93	 <0.001	 2	
 60	plus	 -12.55	 -3229.45	 3204.36	 0.99	 0	
SpO2 above	93	 reference	 0	
 89	to	93	 0.90	 0.62	 1.18	 <0.001	 1	
 85	to	88	 0.76	 0.35	 1.16	 <0.001	 1	
 below	85	 1.16	 0.81	 1.50	 <0.001	 1	
Pulse below	60	 -0.58	 -1.42	 0.27	 0.18	 0	
 60	to	100	 reference	 0	
 101	to	110	 0.62	 0.30	 0.95	 <0.001	 1	
 111	to	120	 0.64	 0.30	 0.98	 <0.001	 1	
 121	to	130	 0.99	 0.61	 1.36	 <0.001	 1	
 131	to	140	 0.89	 0.45	 1.33	 <0.001	 1	
 141	to	150	 1.88	 1.38	 2.37	 <0.001	 2	
 151	to	160	 1.14	 0.43	 1.85	 <0.001	 1	
 161	to	170	 0.74	 -0.39	 1.87	 0.20	 0	
 171	to	180	 0.07	 -2.07	 2.21	 0.95	 0	
 180	plus	 1.12	 -0.08	 2.33	 0.07	 0	
SBP below	60	 0.72	 -1.33	 2.78	 0.49	 0	
 60	to	69	 1.40	 0.45	 2.36	 <0.001	 1	
 70	to	79	 1.01	 0.23	 1.79	 0.01	 1	
 80	to	89	 0.73	 0.20	 1.26	 0.01	 1	
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 90	to	99	 0.64	 0.24	 1.04	 <0.001	 1	
 100	to	120	 reference	 0	
 121	to	129	 -0.10	 -0.47	 0.28	 0.62	 0	
 130	to	139	 -0.11	 -0.48	 0.27	 0.58	 0	
 140	to	149	 -0.20	 -0.59	 0.19	 0.30	 0	
 150	to	159	 -0.08	 -0.49	 0.32	 0.69	 0	
 160	plus	 -0.71	 -1.11	 -0.31	 <0.001	 -1	
AVPU alert	 reference	 0	
 verbal	 0.44	 0.08	 0.80	 0.02	 0	
 pain	 0.48	 -0.12	 1.07	 0.12	 0	
 no	response	 0.61	 -0.13	 1.36	 0.11	 0	
Temperature below	35.0	 -0.50	 -1.49	 0.49	 0.32	 0	
 35.0	to	35.5	 0.13	 -0.45	 0.71	 0.66	 0	
 35.6	to	36.0	 -0.28	 -0.74	 0.18	 0.23	 0	
 36.1	to	36.5	 -0.19	 -0.54	 0.16	 0.28	 0	
 36.6	to	37.4	 reference	 0	
 37.5	to	38.0	 0.53	 0.17	 0.88	 <0.001	 1	
 38.1	to	38.5	 1.17	 0.79	 1.54	 <0.001	 1	
 38.6	to	39.0	 1.17	 0.74	 1.60	 <0.001	 1	
 39.1	to	39.5	 1.13	 0.59	 1.67	 <0.001	 1	
 39.6	to	40.0	 1.60	 1.02	 2.18	 <0.001	 2	
 above	40.0	 1.90	 1.07	 2.73	 <0.001	 2	
Skin normal	 reference	 0	
 cyanosed	 -0.10	 -0.73	 0.53	 0.76	 0	
 flushed	 0.12	 -0.26	 0.49	 0.54	 0	
 jaundice	 0.82	 -0.08	 1.71	 0.07	 0	
 mottling	 0.99	 -0.06	 2.05	 0.07	 0	
 pallor	 0.39	 0.13	 0.65	 <0.001	 0	
 rash	 -12.73	 -1122.95	 1097.49	 0.98	 0	
CBRT normal	 reference	 0		 delayed	 -0.04	 -0.40	 0.32	 0.82	 0	Highlighted	estimates	indicate	non-significant	estimates	
7.3.3.2	Pragmatic	adjustments	of	models		The	intervals	chosen	when	subdividing	each	continuous	variable	will	ultimately	dictate	 the	 calculated	 regression	 coefficients	 (ßi).	 The	 calculated	 regression	coefficients	(ßi)	are	utilised	to	generate	scores.	It	stands	to	reason	therefore,	that	the	 intervals	 chosen	 will	 significantly	 impact	 the	 scores	 generated,	 and	ultimately	ease	of	use	of	the	final	screening	tool.	To	minimise	loss	of	precision,	small	intervals	have	been	employed	in	the	preceding	multivariable	regressions.	This	has	resulted	in	the	generation	of	scores,	that	although	more	precise,	would	also	be	more	complex	for	the	end-user.	For	example,	if	we	were	to	consider	the	
PRoSAiC	Thesis	
180	
regression	 coefficients	 (ßi)	 generated	 in	 table	 7.25,	 we	 assign	 scores	 for	respiratory	rate	as	reported	in	table	7.28.		
 
Table	7.28	Scores	for	respirations	in	Model	A	
Variable	 Respiratory	rate		 Score	
Resps 20	or	lower	 0		 21	to	40	 1		 41	to	45	 2		 46	to	55	 0		 56	to	60	 2		 61	or	over	 0	
 Examination	of	figure	7.3	suggests	that	risk	of	sepsis	increases	at	a	steady	rate	when	Respirations	are	in	the	range	20	to	60,	consequently	we	would	not	expect	respiratory	rates	in	the	interval	“46	to	50”	to	generate	a	score	of	“0”.	Inspection	of	table	7.25	reveals	that,	in	Model	A,	for	the	variable	Resps,	the	interval	“46	to	50”	has	a	regression	coefficient	(ßi)	of	0.87	and	p	value	of	0.06,	while	the	interval	“51	 to	 55”	 has	 a	 regression	 coefficient	 (ßi)	 of	 1.27	 and	 p	 value	 of	 0.08.	 Both	intervals	approach,	but	 fail	to	achieve	significance,	and	are	 thus	automatically	assigned	 a	 score	 of	 “0”.	 	 However,	 if	 the	 intervals	 for	 Resps	 for	 ModelA	 are	redefined	to	merge	the	“41	to	45”	and	“46	to	50”	into	a	single	“41	to	50”	interval,	the	resulting	regression	coefficient	 (ßi)	 is	1.66	and	p	value	 is	 less	 than	0.001.	Similarly,	if	the	intervals	for	Resps	are	redefined	to	merge	the	“51	to	55”	and	“56	to	60”	into	a	single	“51	to	60”	interval,	the	regression	coefficient	(ßi)	is	1.78	and	p	 value	 is	 less	 than	 0.001.	 The	 resulting	 adjusted	 scores	 for	 respirations	 are	reported	in	table	7.29.									This	simplification	of	 the	model	was	undertaken	to	reduce	complexity,	and	to	facilitate	 ease	 of	 use	 by	 ambulance	 clinicians.	 The	 simplification	 is	 justified	through	the	sustained	statistical	significance;	however,	it	is	acknowledged	that	the	simplification	may	lead	to	a	small	loss	of	precision	in	the	model.		
Table	7.29	Adjusted	scores	for	respirations	
Variable	 Respiratory	rate	 Score	
Resps 20	or	lower	 0		 21	to	40	 1		 41	to	60	 2		 61	or	0ver	 0	
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Four	variables,	utilised	across	all	three	models,	have	been	subject	to	pragmatic	adjustment	to	facilitate	ease	of	use.	These	variables	include	Age,	Resps,	Pulse	and	Skin.	Adjustments	 for	Age	and	Pulse	are	outlined	below	in	tables	7.30,	
7.31,	 7.32	 and	 7.33.	 Regression	 tables,	 upon	 which	 these	 adjustments	 are	predicated,	are	reported	in	Appendix	3.		
Table	7.30	Scores	for	Age	before	adjustment	
Variable	 Age		 Score	
Age Under	60	 0		 60	to	99	 1		 100	or	older	 0			
Table	7.31	Scores	for	Age	following	adjustment	
Variable	 Age		 Score	
Age Under	60	 0		 60	or	older	 1	
 	
Table	7.32	Scores	for	Pulse	before	adjustment	
Variable	 Pulse	rate		 Score	
Pulse 100	or	lower	 0		 101	to	140	 1		 141	to	150	 2		 151	to	160	 1		 161	or	0ver	 0		
Table	7.33	Scores	for	Pulse	following	adjustment	
Variable	 Pulse	rate		 Score	
Pulse 100	or	lower	 0		 101	to	140	 1		 141	to	160	 2		 161	or	0ver	 0			Regression	models	suggest	that	the	only	category	of	Skin	that	correlated	with	high	risk	of	sepsis,	and	produced	a	regression	coefficient	(ßi)	sufficiently	high	to	generate	a	score	is	“jaundice”.	These	same	regression	models	indicate	that	the	category	 “pallor”	 correlated	 with	 sepsis	 in	 some	 models,	 but	 the	 regression	coefficient	 (ßi)	 was	 small	 and	 generated	 a	 score	 of	 zero.	 Furthermore,	 the	category	“mottling”	approached,	but	failed	to	achieve	statistical	significance.	As	with	the	Age	variable,	failure	to	achieve	statistical	significance	may	be	related	to	the	relatively	small	numbers	of	cases	in	each	category	(see	table	7.34).	 
 
 
PRoSAiC	Thesis	
182	
	
 
Table	7.34	Cases	of	high	risk	sepsis	according	to	Skin	category		 cyanosed	 flushed	 jaundice	 mottling	 normal	 pallor	 rash	no	sepsis	 158	 798	 83	 44	 10126	 2484	 21	sepsis	 23	 58	 9	 9	 240	 185	 0	
 Previously	 published	 sepsis	 assessment	 tools	 have	 suggested	 that	 pale	 or	mottled	skin	should	be	considered	an	indicator	for	risk	of	sepsis.5	A	pragmatic	adjustment,	 predicted	 on	 a	 combination	 of	 clinical	 reasoning,	 and	 the	 low	number	of	cases	reported	in	potentially	important	skin	findings,	resulted	in	the	
Skin	 categories	 “jaundice”,	 “pallor”	and	“mottling”	being	merged	 into	a	single	category.	The	results	of	this	adjustment	are	reported	in	tables	7.35	and	7.36.		
Table	7.35	Categories	for	Skin	before	adjustment	
Category	 ßi	 p-value	 score	normal	 [reference]	cyanosed	 -0.05	 0.88	 0	flushed	 0.13	 0.50	 0	jaundice	 0.90	 0.05	 1	mottling	 0.82	 0.16	 0	pallor	 0.40	 <0.001	 0	rash	 -12.76	 0.98	 0				
Table	7.36	Categories	for	Skin	after	adjustment	
Category	 ßi	 p-value	 score	normal	 [reference]	jaundice,	pallor,	mottling	 0.51	 <0.001	 1	any	other		 0.23	 0.14	 0			GCS	(sum)	is	only	utilised	in	one	of	the	three	models	(Model	A).	The	intervals	chosen	 for	 the	 original	 regression	 were	 informed	 by	 previous	 studies	 and	accepted	clinical	norms.	The	interval	“9	to	12”	achieved	statistical	significance,	and	generated	a	score	of	1,	while	the	interval	“3	to	8”	approached,	but	failed	to	achieve	statistical	significance.	Had	the	result	been	statistically	significant,	the	regression	coefficient	(ßi)	of	0.48	comes	close	to	being	assigned	a	score	of	“1”.		As	with	 Age,	 and	 Skin,	 the	 number	 of	 cases	 of	 high	 risk	 sepsis	 in	 important	
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categories	is	relatively	low.	Failure	to	achieve	statistical	significance	may	reflect	too	few	cases	(see	table	7.37).			
Table	7.37	Cases	of	high	risk	sepsis	according	to	GCS_sum	category		 3	to	8	 9	to	12	 13	to	14	 15	no	sepsis	 330	 561	 1373	 12992	sepsis	 34	 67	 61	 421	
 Previously	published	sepsis	assessment	tools	have	suggested	that	reduced	GCS,	including	scores	in	the	interval	“3	to	8”	should	be	considered	an	indicator	for	risk	of	sepsis.107		If	the	categories	for	GCS_sum	are	redefined	to	merge	the	“3	to	8”	and	“9	to	12”	into	a	single	“3	to	12”	category,	the	resulting	regression	coefficient	(ßi)	is	0.78	and	p	value	is	less	than	0.001.	This	suggests	that	it	may	be	appropriate	to	merge	these	two	categories.	However,	unlike	the	previously	listed	adjustments,	the	GCS_sum	is	the	sum	of	three	ordered	categorical	variables,	and	so	is	not	a	typical	continuous	variable,	despite	being	reported	as	a	numeric	value.	In	other	words,	 the	 “difference”	 between	 GCS	 scores	 of	 4	 and	 5	 is	 not	 necessarily	equivalent	to	the	difference	between	scores	of	14	and	15.	As	a	consequence,	it	is	less	 clear	 whether	 it	 is	 clinically	 or	 statistically	 appropriate	 to	 merge	 the	categories	further	(“3	to	12”,	“13	to	15”)	or	to	remain	as	above	(“3	to	8”,	“9	to	12”,	“13	 to	 15”).	 Consequently,	 an	 additional	 model	 (Model	 A2)	with	 the	merged	categories	has	been	specified.	
7.3.3.3	Model	simplification	Each	 of	 the	 adjusted	 models	 can	 be	 simplified	 by	 merging	 together	 those	intervals,	 within	 each	 variable,	 that	 have	 a	 consistent	 score.	 The	 scores	associated	with	each	model	are	reported	below	in	tables	7.38.	7.39,	7.40	and	
7.41.		 	
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Table	7.38	Final	scoring	Model	A	(GCS	9-12	only)	
Variable	 Interval		 Score	
Age Under	60	 0	
 60	or	older	 1	
Respirations 20	or	lower	 0	
 21	to	40	 1	
 41	o	60	 2	
 61	or	over	 0	
SpO2 94	or	higher	 0	
 93	or	lower	 1	
Pulse 100	or	lower	 0	
 101	to	140	 1	
 141	to	160	 2	
 161	or	over	 0	
SBP Under	60	 0	
 60	to	99	 1	
 100	to	159	 0	
 160	or	higher	 -1	
Temperature 37.4	or	lower	 0	
 37.5	to	39.5	 1	
 39.6	or	higher	 2	
Skin Jaundice,	pallor,	mottling	 1	
 Any	other	 0	
GCS (sum) 13	to	15	 0	
 9	to	12	 1		 8	or	lower	 0				 	
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Table	7.39	Final	scoring	Model	A2	(GCS<=12)	
Variable	 Interval		 Score	
Age Under	60	 0	
 60	or	older	 1	
Respirations 20	or	lower	 0	
 21	to	40	 1	
 41	to	60	 2	
 61	or	over	 0	
SpO2 94	or	higher	 0	
 93	or	lower	 1	
Pulse 100	or	lower	 0	
 101	to	140	 1	
 141	to	160	 2	
 161	or	over	 0	
SBP Under	60	 0	
 60	to	99	 1	
 100	to	159	 0	
 160	or	higher	 -1	
Temperature 37.4	or	lower	 0	
 37.5	to	39.5	 1	
 39.6	or	higher	 2	
Skin Jaundice,	pallor,	mottling	 1	
 Any	other	 0	
GCS (sum) 13	to	15	 0		 3	to	12	 1			 	
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Table	7.40	Final	scoring	Model	B	(GCS	verbal)	
Variable	 Interval		 Score	
Age Under	60	 0	
 60	or	older	 1	
Respirations 20	or	lower	 0	
 21	to	40	 1	
 41	to	60	 2	
 61	or	over	 0	
SpO2 94	or	higher	 0	
 93	or	lower	 1	
Pulse 100	or	lower	 0	
 101	to	140	 1	
 141	to	160	 2	
 161	or	over	 0	
SBP Under	60	 0	
 60	to	99	 1	
 100	to	159	 0	
 160	or	higher	 -1	
Temperature 37.4	or	lower	 0	
 37.5	to	39.5	 1	
 39.6	or	higher	 2	
Skin Jaundice,	pallor,	mottling	 1	
 Any	other	 0	
GCS (verbal) Any	response	 0		 No	response	 1					 	
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Table	7.41	Final	scoring	Model	C	(AVPU)	
Variable	 Interval		 Score	
Age Under	60	 0	
 60	or	older	 1	
Respirations 20	or	lower	 0	
 21	to	40	 1	
 41	to	60	 2	
 61	or	over	 0	
SpO2 94	or	higher	 0	
 93	or	lower	 1	
Pulse 100	or	lower	 0	
 101	to	140	 1	
 141	to	160	 2	
 161	or	over	 0	
SBP Under	60	 0	
 60	to	99	 1	
 100	to	159	 0	
 160	or	higher	 -1	
Temperature 37.4	or	lower	 0	
 37.5	to	39.5	 1		 39.6	or	higher	 2		
7.3.3.4	Model	comparison	Four	 different	 models,	 to	 identify	 high	 risk	 sepsis,	 have	 been	 proposed.	 To	determine	which	model	to	carry	forward,	each	model	is	compared	utilising	the	AIC	statistic,	to	determine	which	model	provides	the	best	 fit	to	 the	derivation	dataset.	The	AIC	statistic	for	each	model	is	reported	in	table	7.42.	
 
Table	7.42	Comparison	of	models	
Model	 AIC	statistic	Model	A	 2856.1	Model	A2	 2854.1	Model	B	 2864.4	Model	C	 3315.0	
 
 AIC	statistics	for	Model	A,	Model	A2	and	Model	B	are	similar,	while	that	of	Model	C	is	a	little	higher.	Technically,	Model	A2	has	the	lowest	AIC	statistic	suggesting	it	is	 the	 best	 fitting	 model.	 However,	 in	 clinical	 practice	 there	 may	 not	 be	 a	
PRoSAiC	Thesis	
188	
noticeable	difference	in	performance	between	Model	A,	Model	A2	and	Model	B.	To	determine	which	of	the	four	different	models	best	predicts	the	likelihood	of	high	sepsis	risk	we	can	consider	the	Brier	Score	for	each	model.			Brier	 Scores	 were	 originally	 developed	 to	 assess	 the	 accuracy	 of	 weather	forecasts.	However,	 they	are	commonly	used	 in	 the	assessment	of	accuracy	of	probabilistic	forecasts.	The	Brier	score	is	calculated	utilising	the	squared	error	of	a	probabilistic	forecast. Put	simply,	the	Brier	Score	is	a	measure	of	how	well	your	 prediction	 model	 compares	 to	 the	 true	 outcome.	 A	 Brier	 Score	 of	 “0”	indicates	perfect	prediction,	while	a	score	of	 “1”	 indicates	a	wholly	 inaccurate	prediction.	The	Brier	score	was	used	to	quantify	how	well	each	model	predicted	the	outcome	of	high	risk	of	sepsis.		
Table	7.43	Comparison	of	models	
Model	 Brier	Score	Model	A	 0.03212072	Model	A2	 0.03207829	Model	B	 0.03209519	Model	C	 0.03248747	
 Brier	Scores	reported	 in	table	7.43	 indicate	 there	 is	 little	difference	between	model	performance	with	respect	to	accuracy.	Model	A2,	utilising	GCS_sum	as	the	measure	of	consciousness,	with	intervals	established	between	“3	to	12”,	“13	to	14”	and	“15”,	is	technically	the	most	appropriate	model	to	take	forward.	Of	the	four	models	 proposed,	 Models	 B	 and	 C	 were	 excluded	 due	 to	 their	 high	 AIC	scores.	Model	A2	was	a	simplification	of	Model	A,	without	any	observed	loss	of	performance.	Model	A2	also	has	both	the	 lowest	AIC	statistic	and	Brier	Score,	indicating	 that	 it	 is	 the	model	 with	 the	 best	 fit	 for	 the	 data	 and	 is	 the	most	accurate.		
7.3.4	Model	estimation	The	 final	 regression	 model	 (Model	 A2)	 used	 to	 generate	 the	 SEPSIS	 score,	including	 regression	 coefficients	 for	 the	merged	 intervals	 is	 fully	 reported	 in	
table	7.44.	
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Table	7.44	Regression	model	following	pragmatic	adjustments		 	 ßi	 lo	95	 hi	95	 p-value	 Score	
assigned		 intercept	 -5.46	 -5.98	 -4.93	 0.00	
Age below	40	 reference	 0	
 40	to	60	 0.35	 -0.15	 0.86	 0.17	 0	
 over	60	 0.94	 0.51	 1.36	 <0.001	 1	
Respirations Below	10	 -12.44	 -559.61	 534.73	 0.96	 0	
 10	to	20	 reference	 0	
 21	to	40	 0.90	 0.66	 1.14	 <0.001	 1	
 40	to	60	 1.72	 1.26	 2.18	 <0.001	 2	
 60	plus	 -11.77	 -1970.04	 1946.51	 0.99	 0	
SpO2 above	93	 reference	 0	
 below	94	 1.03	 0.80	 1.26	 <0.001	 1	
Pulse below	60	 -0.56	 -1.40	 0.28	 0.19	 0	
 60	to	100	 reference	 0	
 101	to	140	 0.75	 0.51	 0.99	 <0.001	 1	
 141	to	160	 1.67	 1.27	 2.08	 <0.001	 2	
 over	160	 0.60	 -0.16	 1.35	 0.12	 0	
SBP below	60	 0.50	 -1.53	 2.52	 0.63	 0	
 60	to	99	 0.65	 0.33	 0.97	 <0.001	 1	
 100	to	120	 reference	 0	
 121	to	160	 -0.21	 -0.47	 0.05	 0.11	 0	
 over	160	 -0.72	 -1.10	 -0.34	 <0.001	 -1	
GCS (sum) 15	 reference	 0	
 13	to	15	 -0.13	 -0.48	 0.21	 0.45	 0	
 3	to	12	 0.78	 0.47	 1.09	 <0.001	 1	
Temperature below	36.6	 -0.20	 -0.48	 0.09	 0.18	 0	
 36.6	to	37.4	 reference	 0	
 37.5	to	39.5	 0.97	 0.71	 1.23	 <0.001	 1	
 above	39.5	 1.71	 1.23	 2.18	 <0.001	 2	
Skin normal	 reference	 0	
 jaundice,	pallor,	mottling	 0.51	 0.27	 0.75	 <0.001	 1	
 any	other	 0.23	 -0.08	 0.55	 0.14	 0		 	 	 	 Maximum	score	 11	
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7.3.5	Model	performance	
7.3.5.1	Model	calibration	When	calculated	on	the	derivation	sample,	the	Hosmer-Lemeshow	goodness-of-fit	test	demonstrated	statistical	evidence	of	inadequate	fit	(l2=	1443.1;	p<0.001).	However,	 as	previously	 identified,	 a	 significant	Hosmer-Lemeshow	 statistic	 is	common	when	using	large	datasets.	The	alternate	means	of	assessing	overfitting,	the	calibration	slope	(1.0),	suggested	little	overfitting	(see	figure	7.10).		
Figure	7.10	Calibration	plot	for	Model	A2	
	Further	 evidence	 of	 adequate	 model	 specification	 is	 seen	 by	 examining	 the	observed	versus	predicted	outcomes	(based	on	predicted	risk)	generated	when	calculating	the	Hosmer-Lemeshow	statistic	(see	table	7.45).		
Table	7.45	Hosmer-Lemeshow	observed	vs	predicted	risk	Estimated	risk	 Observed	 Predicted	Interval	 no	sepsis	 sepsis	 no	sepsis	 sepsis	1.55e-08	-	0.00394	 1436	 2	 1434	 4	0.00394	-	0.00531	 1466	 1	 1460	 7	0.00531	-	0.00692	 1497	 8	 1495	 10	0.00692	-	0.00874	 1162	 5	 1157	 10	0.00874	-	0.0112	 1171	 7	 1166	 12	0.0112	-	0.017	 1227	 11	 1221	 17	0.017	-	0.0238	 1238	 31	 1243	 26	0.0238	-	0.0423	 1275	 48	 1281	 42	0.0423	-	0.0987	 1204	 112	 1232	 84	0.0987	-	0.879	 1000	 289	 987	 302			
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7.3.5.2	Model	discrimination	Area	under	the	receiver	operating	characteristic	curve	was	0.87	(95%	CI	0.85	to	0.88)	for	the	outcome	of	high	sepsis	risk	at	hospital	(see	figure	7.11).	
	
Figure	7.11	Area	under	the	Curve	
	
7.3.5.3	Model	operating	characteristics	Several	measures	of	model	performance	were	 calculated	 including	 sensitivity,	specificity,	positive	predictive	value,	negative	predictive	value,	positive	likelihood	ratio,	 negative	 likelihood	 ratio	 and	diagnostic	 odds	 ratio	 for	 each	point	score.	Performance	characteristics	of	the	SEPSIS	score	among	adult	medical	patients	is	reported	in	table	7.46,	while	performance	in	patients	with	infection	is	reported	in	table	7.47.	Figure	7.12	graphically	depicts	probability	of	sepsis	for	each	point	on	the	SEPSIS	score.			
Figure	7.12	Observed	vs	expected	probability	of	sepsis	
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Table	7.46	Operating	characteristics	for	the	SEPSIS	score	among	patients	with	undifferentiated	medical	complaints	
score	 ≥1	 ≥2	 ≥3	 ≥4	 ≥5	 ≥6	 ≥7	 ≥8	 ≥9	
Outcome	 	 	 	 	 	 	 	TP	 588 559 489 376 230 128 54 16 4 FP	 111776 6898 3570 1647 633 196 51 12 1 TN	 3694 8572 11900 13823 14837 15274 15419 15458 15469 FN	 5 34 104 217 363 465 539 577 593 
Operating	characteristics      Sens	 0.99 (0.98-1.00) 0.94 (0.92-0.96) 0.82 (0.79-0.85) 0.63 (0.59-0.67) 0.39 (0.35-0.43) 0.22 (0.18-0.25) 0.09 (0.11-0.17) 0.03(0.02-0.04) 0.01 (0.0-0.02) Spec	 0.24 (0.23-0.25) 0.55 (0.55-0.56) 0.77 (0.76-0.78) 0.89 (0.89-0.90) 0.96 (0.96-0.96) 0.99 (0.99-0.99) 1.0 (1.0-1.0) 1.0 (1.0-1.0) 1.0 (1.0-1.0) PPV	 0.05 (0.04-0.05) 0.07 (0.07-0.08) 0.12 (0.11-0.13) 0.19 (0.17-0.20) 0.27 (0.24-0.30) 0.40 (0.34-0.45) 0.51 (0.41-0.61) 0.57 (0.37-0.76) 0.80 (0.28-0.99) NPV	 1.00(1.00-1.00) 1.00(0.99-1.00) 0.99 (0.99-1.00) 0.98 (0.98-0.99) 0.98 (0.97-0.98) 0.97 (0.97-0.97) 0.97 (0.96-0.97) 0.96 (0.96-0.97) 0.96 (0.96-0.97) PLR	 1.30 (1.29-1.32) 2.11 (2.06-2.17) 3.57 (3.41-3.75) 5.96 (5.52-6.43) 9.48 (8.35-10.76) 17.0 (13.9-21.0) 27.6 (19.01-40.1) 34.8 (16.5-73.2) 104 (11.7-932.2) NLR	 0.04 (0.01-0.08) 0.10 (0.07-0.14) 0.23 (0.19-0.27) 0.41 (0.37-0.46) 0.64 (0.60-0.68) 0.79 (0.76-0.83) 0.91 (0.89-0.94) 0.97 (0.96-0.99) 0.99 (0.98-1.0) DOR	 36.9 (15.3-89.0) 20.4 (14.4-28.9) 15.7 (12.6-19.4) 14.5 (12.2-17.3) 14.9 (12.4-17.8) 21.5 (16.9-27.3) 30.3 (20.5-44.8) 35.7 (16.9-75.6) 105 (11.7-941.3) 
Sens-sensitivity, Spec-specificity, PPV-positive predictive value, NPV-negative predictive value, PLR-positive likelihood ratio, NLR-negative likelihood ratio, DOR-diagnostic odds ratio 
Items in brackets () 95% confidence interval 
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Table	7.47	Operating	characteristics	for	the	SEPSIS	score	among	patients	with	undifferentiated	medical	complaints	
score	 ≥1	 ≥2	 ≥3	 ≥4	 ≥5	 ≥6	 ≥7	 ≥8	 ≥9	
Outcome	 	 	 	 	 	 	 	TP	 588 559 489 376 230 128 54 16 4 FP	 2148 1563 984 514 230 80 22 5 1 TN	 13322 13907 14486 14929 15240 15390 15448 15465 15469 FN	 5 34 104 217 363 465 539 577 593 
Operating	characteristics      Sens	 0.99 (0.98-1.00) 0.94 (0.92-0.96) 0.82 (0.79-0.85) 0.63 (0.59-0.67) 0.39 (0.35-0.43) 0.22 (0.26-0.34) 0.09 (0.11-0.17) 0.03 (0.02-0.04) 0.01 (0.0-0.02) Spec	 0.86 (0.86-0.87) 0.90 (0.92-0.96) 0.94 (0.93-0.94) 0.97 (0.96-0.97) 0.99 (0.98-0.99) 0.99 (0.99-1.0) 1.0 (1.0-1.0) 1.0 (1.0-1.0) 1.0 (1.0-1.0) PPV	 0.21 (0.20-0.23) 0.26 (0.24-0.28) 0.33 (0.31-0.36) 0.41 (0.38-0.44) 0.5 (0.45-0.55) 0.62 (0.55-0.68) 0.71 (0.60-0.81) 0.76 (0.53-0.92) 0.80 (0.28-0.99) NPV	 1.0 (1.0-1.0) 1.0 (1.0-1.0) 0.99 (0.99-0.99) 0.99 (0.98-0.99) 0.98 (0.97-0.98) 0.97 (0.97-0.97) 0.97 (0.96-0.97) 0.96 (0.96-0.97) 0.96 (0.96-0.97) PLR	 7.14 (6.86-7.43) 9.33 (8.87-9.82) 13.0 (12.1-13.9) 18.1 (16.4-20.1) 26.1 (22.2-30.1) 41.7 (32.0-54.5) 64.0 (39.3-104.4) 83.5 (30.7-227.1) 104.3 (11.7-932.2) NLR	 0.01 (0.00-0.02) 0.06 (0.05-0.09) 0.19 (0.16-0.22) 0.38 (0.34-0.42) 0.62 (0.58-0.66) 0.79 (0.76-0.82) 0.91 (0.89-0.93) 0.97 (0.96-0.99) 0.99 (0.98-1.0) DOR	 704 (291-1700) 179 (117-276) 86 (67-113) 54 (44-65) 39 (32-47) 42 (33-52) 62 (42-91) 118. (48-288) 211 (26-1694) 
Sens-sensitivity, Spec-specificity, PPV-positive predictive value, NPV-negative predictive value, PLR-positive likelihood ratio, NLR-negative likelihood ratio, DOR-diagnostic odds ratio 
Items in brackets () 95% confidence interval 
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7.4	Conclusion	This	 chapter	 has	 described	 the	 development	 of	 the	 SEPSIS	 screening	 tool.	Development	adhered	to	the	methods	proposed	by	Labarère	et	al,58	however	not	all	elements	of	the	checklist	were	reported	in	this	chapter.	 	First	predictors	of	sepsis	were	 identified,	 followed	 by	 the	 development	 of	 several	multivariable	models.	Appropriate	 intervals	were	established	 for	each	variable,	 referring	 to	existing	standards,	and	by	calculation	of	optimal	cut	points.	Each	of	the	models	was	compared,	and	the	best	performing	model	selected.	Model	calibration	and	discrimination	 have	 been	 reported.	 Operating	 characteristics	 for	 successive	SEPSIS	point	scores	have	been	calculated.	
In	 an	 undifferentiated	 medical	 population,	 applying	 a	 cut-off	 of	 3	 or	 higher,	sensitivity	for	the	SEPSIS	screening	tool	was	0.80	(95%CI	0.74-0.84),	specificity	was	0.78	 (95%CI	0.77-0.79),	 positive	predictive	 value	was	0.12	 (95%CI	0.10-0.14),	negative	predictive	value	was	0.99	(95%CI	0.99-0.99),	positive	likelihood	value	was	3.56	(95%CI	3.30-3.85),	negative	 likelihood	valve	was	0.26	(95%CI	0.21-0.34)	and	the	diagnostic	odds	ratio	was	13.5	(95%CI	9.9-18.4).			If	use	of	the	SEPSIS	screening	tool	was	limited	to	patients	with	infection,	applying	a	cut-off	of	3	or	higher,	sensitivity	for	the	SEPSIS	screening	tool	was	0.82	(95%CI	0.79-0.85),	specificity	was	0.94	(95%CI	0.93-0.94),	positive	predictive	value	was	0.33	(95%CI	0.31-0.36),	negative	predictive	value	was	0.99	(95%CI	0.99-0.99),	positive	likelihood	value	was	13.0	(95%CI	12.1-13.9),	negative	likelihood	valve	was	0.19	(95%CI	0.16-0.22)	and	 the	diagnostic	odds	ratio	was	86	(95%CI	67-113).			Internal	validation	utilising	a	clean	dataset	is	reported	will	be	chapter	8,	while	comparison	of	the	SEPSIS	screening	tool	with	different	models	will	be	reported	
chapter	9.	
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Chapter	8	
Validation	of	the	SEPSIS	screening	
tool 
	
“Any	classification	system,	be	it	nominal,	ordinal,	or	scalar,	should	
be	proved	to	be	a	workable	tool	before	it	is	used	in	a	
discriminatory	or	predictive	manner.”	(A.H.	Burnstein,	1993)	200 
8.1	Introduction	There	are	several	potential	approaches	to	validation	of	a	clinical	prediction	tool.	This	chapter	describes	the	internal	validation	of	the	SEPSIS	screening	tool	based	upon	a	split-sampling	method.	An	overview	of	approaches	to	validation	will	be	provided	 along	 with	 a	 justification	 for	 the	 method	 ultimately	 adopted.	 The	chapter	includes	a	description	of	the	data	used	to	validate	the	SEPSIS	screening	tool	and	will	 report	 the	operating	characteristics	of	 the	SEPSIS	screening	 tool	when	 applied	 to	 a	 new	 dataset.	 In	 addition,	 model	 calibration,	 model	discrimination	and	goodness	of	fit	will	be	assessed.	
8.2	Background	It	 is	essential	to	determine	 if	a	model	derived	 from	one	population	 is	reliable	when	applied	 to	a	different	population.201	 	 Conceptually,	 this	 is	 referred	 to	 as	generalisability	or	validity.	A	model	that	generates	reliable	predictions	in	a	new	population	 is	 said	 to	 have	 been	 validated.59	 	 Statistical	 estimates	 in	 turn,	 are	dependent	upon	adequate	sample	size	from	which	the	estimates	are	calculated.		There	are	no	hard	and	fast	rules	dictating	the	sample	size	required	to	validate	a	clinical	prediction	model.202		It	has	been	suggested	that	at	least	ten	instances	of	the	outcome	of	interest	are	required	per	candidate	predictor	in	order	to	ensure	statistically	valid	results.59	69	71	175-177	On	the	other	hand,	Vergouwe	et	al178	advise	at	 least	 100	 events	 and	 100	 non-events	 are	 required	 for	 assessing	 model	performance.	They	conducted	a	series	of	simulation	studies	and	reported	that,	for	 a	 logistic	 regression	model	 comprising	 six	predictors,	 a	 validation	 sample	comprising	100	events	had	approximately	80%	power	to	detect	mis-calibration,	with	predicted	probabilities	1.5	times	too	high	(or	too	low)	on	an	odds	scale,	and	a	0.1	decrease	in	the	c-statistic.178	 	The	c-statistic,	also	called	the	concordance	statistic,	can	be	used	to	assess	goodness	of	fit	in	a	logistic	regression	model.	It	is	equal	to	the	area	under	the	receiver	operating	characteristics	curve.203	For	the	
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detection	 of	 smaller	 differences	 in	 model	 performance,	 larger	 sample	 sizes	comprising	 more	 than	 250	 events	 and	 250	 non-events	 are	 believed	 to	 be	required.59		Several	approaches	to	selecting	the	validation	population	exist,	however	they	can	be	broadly	categorised	as	either	external	or	internal.	External	validation	implies	use	of	a	sample	from	a	population	different	to	that	from	which	it	was	derived,	for	example	 from	another	geographic	region,	or	 from	a	different	dataset.	 Internal	validation	implies	use	of	a	sample	drawn	for	the	same	population,	for	example	by	dividing	the	primary	data	sample	into	derivation	and	validation	cohorts.58	67	176	177	In	 general,	 external	 validation	methods	 are	 preferred	 to	 internal	 validation.58	External	validation	methods	maximise	use	of	the	primary	dataset	as	no	data	are	set	aside	for	validation.	Maximising	the	available	data	improves	model	accuracy.	However,	if	the	primary	dataset	is	sufficiently	large	to	generate	reliable	statistical	estimates,	 there	 is	 no	 disadvantage	 to	 undertaking	 an	 internal	 validation	 by	dividing	the	dataset	into	derivation	and	validation	cohorts	(split-sampling).	An	additional	potential	benefit	of	external	validation	is	the	opportunity	to	test	the	model	on	a	population	that	may	have	a	different	makeup,	for	example	ethnicity	or	age	distribution,	rather	than	the	population	on	which	the	model	was	derived.	This	helps	to	confirm	generalisability	beyond	the	derivation	population.		Internal	validation	methods	broadly	comprise	split-sampling,	cross-validation	or	bootstrapping	methods.58	In	split-sampling	the	primary	dataset	is	divided	into	derivation	and	validation	subsets.	Typically,	the	primary	dataset	is	divided	into	equal	halves	or	 in	a	2:1	ratio	with	 the	 two	thirds	of	 the	sample	being	used	to	derive	the	model	and	one	third	to	validate	the	model.	Split-sampling	should	only	be	undertaken	if	the	sample	size	is	large,	as	to	do	so	with	small	samples	reduces	model	 accuracy	 as	 estimates	 have	 more	 variability,	 and	 potentially	 leads	 to	imprecise	performance	estimates.59	201			Cross-validation	attempts	to	address	the	potential	weaknesses	of	spilt-sampling	in	 small	 population	 samples.71	 The	 primary	 sample	 is	 divided	 into	 multiple	subsets,	for	example	ten	equal	size	subsets.	The	model	is	derived	on	a	population	composed	of	nine	of	the	ten	samples,	and	validated	on	the	remaining	sample.	The	approach	differs	 from	split-sampling	 in	 that	 this	process	 is	 repeated	multiple	times.	Each	time	the	validation	sample	is	different,	while	the	derivation	sample	
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contains	slightly	different	data	each	time.	Performance	is	estimated	across	the	repeated	measures.	The	advantage	of	cross-validation	over	split-sampling	is	that	cross-validation	utilises	a	much	larger	proportion	of	the	data	to	derive	the	model.	In	the	example	previously	stated	each	repetition	utilises	90%	of	available	data	for	 derivation	 while	 10%	 is	 used	 for	 validation.	 Because	 of	 the	 repeated	iterations	utilising	the	different	subsets,	all	data	will	eventually	be	used	in	both	derivation	and	validation	datasets.	Cross-validation	can	yield	differing	statistical	estimates	with	each	 iteration,	consequently	it	may	be	necessary	 to	have	more	than	200	replications	to	derive	an	accurate	estimate.		Bootstrapping,	 an	 alternative	 to	 cross-validation,	 is	 a	 popular	 choice	 for	validating	prognostic	models,	particularly	in	samples	of	limited	size.58	It	is	a	non-parametric	 technique,	 whereby	 alternate	 versions	 of	 the	 original	 dataset	 are	created	by	randomly	re-sampling	from	the	original	dataset.58	59	71		For	example,	if	the	original	dataset	comprises	the	letters	A,	B,	C	and	D,	bootstrap	samples	could	include:	• A,	B,	D,	D	• A,	C,	D,	D	• B,	C,	C,	C	• D,	D,	D,	D	
Because	 the	 bootstrap	 samples	 are	 drawn	 from	 the	 original	 sample	 they	 are	comparable,	 but	not	 identical,	 to	 the	original	dataset.68	Model	performance	 is	assessed	 in	 the	 original	 dataset	 and	 each	 bootstrap	 dataset.204	 The	 bootstrap	datasets	 are	 plausible	 alternate	 populations	 with	 assumptions	 being	 made	regarding	 performance	 of	 the	 model	 in	 plausible	 bootstrap	 populations.	 A	statistical	 estimate	 is	 generated	 by	 approximating	 the	 ideal	 bootstrap	distribution.	 Bootstrapping	 is	 a	 computationally	 intensive	 approach	 as	many	thousands	of	bootstrap	samples	are	required	to	generate	reliable	results.	
8.3	Methods	No	 external	data	was	 available,	 hence	 external	 validation	was	not	possible.	A	single	data	sample	was	utilised	to	develop	and	validate	the	SEPSIS	screening	tool.	The	data	sample	was	sufficiently	large,	in	that	it	contained	sufficient	numbers	of	events	and	non-events	in	relation	to	the	numbers	of	predictors.	Thus	there	was	no	need	to	utilise	cross-validation	or	bootstrap	approaches.	This	study	utilises	an	internal	validation	approach,	using	a	split-sample	methodology.	
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8.3.1	Overview	of	the	validation	dataset	Characteristics	of	the	derivation	and	validation	populations	are	reported	in	table	
8.1.	Prevalence	of	sepsis	(all	risk	categories)	is	reported	in	figures	8.1	and	8.2.		
Table	8.1	Population	characteristics	 	 	
Variable	(n=6882)	 Derivation	 Validation	Location		 Home,	n	(%)	 11408	(71)	 4964	(72)		 Nursing	home,	n	(%)	 1028	(6)	 414	(6)		 Other,	n	(%)	 3627	(23)	 1504	(22)	Age	(years),	mean	(SD)	 63	(21)	 62	(21)	
	Gender		 Male,	n	(%)	 3346	(49)	 3346	(49)	Respirations	(breaths/min),	mean	(SD)	 20	(6)	 20	(6)	Oxygen	saturation	(%),	mean	(SD)	 96	(5)	 96	(5)	Heart	rate	(beats/min),	mean	(SD)	 92	(24)	 92	(24)	Systolic	blood	pressure	(mmHg),	mean	(SD)	 133	(27)	 133	(27)	Diastolic	blood	pressure	(mmHg),	mean	(SD)	 78	(17)	 78	(17)	Temperature	(°C),	mean	(SD)	 36.8	(0.9)	 36.8	(0.9)	Blood	sugar	(mmol/L),	mean	(SD)	 7.0	(3.4)	 7.0	(3.3)	Glasgow	Coma	Score,	median	(IQR)	 15	(15-15)	 15	(15-15)	Capillary	bed	refill	time	 Normal	(<2	sec),	n	(%)	 13194	(82)	 6567	(95)		 Delayed	(>2	sec),	n	(%)	 744	(5)	 315	(5)	Skin	 Normal,	n	(%)	 10366	(73)	 5320	(77)		 Pallor,	n	(%)	 2669	(19)	 1037	(15)		 Flushed,	n	(%)	 856	(6)	 359	(5)		 Cyanosed,	n	(%)	 181	(1)	 83	(1)		 Jaundice,	n	(%)	 92	(0.6)	 51	(0.7)		 Mottled,	n	(%)	 53	(0.4)	 20	(0.2)		 Rash,	n	(%)	 21	(0.1)	 12	(0.1)	Pupil	size	(mm),	median	(IQR)	 3	(3-4)	 3	(3-4)	Pupil	reaction	 Brisk,	n	(%)	 13447	(93)	 6462	(94)		 Sluggish,	n	(%)	 923	(6)	 381	(6)		 Fixed,	n	(%)	 128	(0.5)	 39	(0.5)				 	
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Figure	8.1	Prevalence	of	sepsis	
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Figure	8.2	Prevalence	of	sepsis	(continued)		
		
8.3.2	Model	calibration	Goodness	of	 fit	 for	 the	 SEPSIS	 screening	 tool	was	assessed	by	 calculating	 the	Hosmer-Lemeshow	 statistic.	 A	 statistically	 significant	 (p<0.05)	 Hosmer-Lemeshow	statistic	commonly	suggests	that	the	model	is	overfitted,	however	a	significant	 Hosmer-Lemeshow	 statistic	 is	 often	 observed	 when	 models	 have	been	derived	 from	 large	samples.191	Where	 the	Hosmer-Lemeshow	statistic	 is	significant,	 suggesting	 the	 model	 is	 overfitted,	 assessment	 of	 the	 model	calibration	slope	provides	an	alternate	means	to	determine	if	indeed	the	model	is	overfitted.192		
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8.3.3	Model	discrimination	Discrimination	of	the	SEPSIS	screening	tool	was	assessed	by	calculating	the	area	under	the	receiver	operating	characteristic	curve	(AUC)	for	the	outcome	of	high	sepsis	risk	at	hospital.	A	perfect	model	will	score	“1”,	while	a	model	that	performs	no	better	than	chance	alone	will	score	“0.5”.	In	the	context	of	medical	diagnosis	an	AUC	of	0.95	or	higher	is	preferred.	
8.3.4	Brier	score	Accuracy	 of	 the	 SEPSIS	 screening	 tool	 was	 assessed	 by	 calculating	 the	 Brier	score.	 The	 Brier	 score	 represents	 the	 mean	squared	 difference	 between	 the	predicted	 outcome	 and	 actual	 outcome.	 The	 lower	 the	 Brier	 score	 the	more	accurate	the	model	is.	A	model	with	perfect	prediction	will	score	“0”.		
8.3.5	Model	operating	characteristics	Performance	of	the	SEPSIS	screening	tool	was	assessed	by	calculating	sensitivity,	specificity,	 positive	 likelihood	 ratio,	 negative	 likelihood	 ratio,	 diagnostic	 odds	ratio	as	well	as	the	area	under	the	curve	for	each	point	score.	
8.4	Results 
8.4.1	Overview	of	the	validation	dataset	To	 ensure	 adequate	 model	 performance	 and	 to	 maximise	 the	 size	 of	 the	derivation	data	sample,	the	combined	multiple	imputed	dataset	was	randomly	partitioned	(using	the	R	package	‘Caret’)	into	derivation	and	validation	cohorts,	such	 that	 each	 imputation	 of	 the	 validation	 cohort	 included	 250	 instances	 of	high-risk	sepsis.	This	resulted	in	the	combined	dataset	being	divided	in	a	70:30	split	as	reported	in	table	8.2.	The	number	of	events	per	predictor	variable	was	31	(254/8).	The	number	of	high	risk	cases	present	in	the	validation	dataset	is	therefore	sufficient	to	calculate	reliable	estimates.		
Table	8.2	Sepsis	cases	in	validation	dataset	
Dataset	 No	sepsis	risk									n	(%)	 Low	Risk	Sepsis	n	(%)	 Moderate/High	Risk	Sepsis	n	(%)	 High	Risk	Sepsis	n	(%)	WMAS	(complete)	 18690	(81.4)	 1496	(6.5)	 1912	(8.3)	 847	(3.7)	WMAS	(validation	dataset)	 5607	(81.5)	 448	(6.5)	 573	(8.3)	 254	(3.7)		
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8.4.2	Calibration	of	the	SEPSIS	screening	tool	The	 Hosmer-Lemeshow	 goodness-of-fit	 test	 was	 statistically	 significant	suggesting	inadequate	fit	(l2=	16.8;	p<0.03).	However,	a	statistically	significant	Hosmer-Lemeshow	 goodness-of-fit	 statistic	 is	 common	 where	 large	 data	samples	have	been	used,	consequently	this	finding	should	be	interpreted	with	caution.			Plotting	observed	risk	versus	predicted	risk	suggests	the	data	are	not	overfitted,	and	indeed	the	calibration	slope	of	0.97	confirms	this	to	be	the	case	(see	figure	
8.3).		
Figure	8.3	Calibration	plot	for	the	SEPSIS	screening	tool	
	Further	 evidence	 of	 adequate	 model	 specification	 is	 seen	 by	 examining	 the	observed	versus	predicted	outcomes	(based	on	predicted	risk)	generated	when	calculating	the	Hosmer-Lemeshow	statistic	(see	table	8.3).		
Table	8.3	Hosmer-Lemeshow	observed	vs	expected	risk	Estimated	risk	 Observed	 Predicted	Interval	 no	sepsis	 sepsis	 no	sepsis	 sepsis	0.00057,0.00285	 570	 0	 569	 1	0.00285,0.00424	 567	 1	 566	 2	0.00424,0.00651	 569	 0	 566	 3	0.00651,0.00716	 613	 0	 609	 4	0.00716,0.0104	 538	 4	 537	 5	0.0104,0.0138	 540	 5	 539	 7	0.0138,0.021	 593	 17	 599	 11	0.021,0.0378	 516	 18	 518	 16	0.0378,0.0956	 508	 45	 518	 35	0.0956,0.892	 441	 127	 435	 133		
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8.4.3	Model	discrimination	of	the	SEPSIS	screening	tool	Area	under	the	receiver	operating	characteristic	curve	was	0.86	(95%	CI	0.84-0.88)	for	the	outcome	of	high	sepsis	risk	at	hospital	(see	figure	8.4).	This	is	below	the	desired	0.95	that	would	indicate	excellent	diagnostic	capability,	but	an	AUC	above	0.8	suggests	the	SEPSIS	screening	tool	performs	adequately.	
	
Figure	8.4	Area	under	the	Receiver	Operating	Characteristics	(ROC)	Curve	
	
8.4.4	Brier	score	Brier	score	for	the	SEPSIS	screening	tool	was	0.0528.	This	value	is	close	to	“0”	indicating	the	SEPSIS	screening	tool	demonstrated	very	high	levels	of	accuracy	when	evaluated	with	the	validation	dataset.	
8.4.5	Operating	characteristics	of	the	SEPSIS	screening	tool	Several	measures	of	model	performance	were	 calculated	 including	 sensitivity,	specificity,	positive	predictive	value,	negative	predictive	value,	positive	likelihood	ratio,	 negative	 likelihood	 ratio	 and	diagnostic	 odds	 ratio	 for	 each	point	score.	Performance	characteristics	of	the	SEPSIS	score	among	adult	medical	patients	is	reported	in	table	8.4,	while	performance	in	patients	with	infection	is	reported	in	table	8.5.	Figure	8.5	graphically	depicts	probability	of	sepsis	for	each	point	on	the	SEPSIS	score.	
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Table	8.4	Operating	characteristics	for	the	SEPSIS	score	among	patients	with	undifferentiated	medical	complaints	(validation	data)	
score	 ≥1	 ≥2	 ≥3	 ≥4	 ≥5	 ≥6	 ≥7	 ≥8	 ≥9	
Outcome	 	 	 	 	 	 	 	TP	 251 241 202 145 95 47 19 5 3 FP	 5028 3750 1479 671 255 91 20 6 1 TN	 1600 2878 5149 5957 6373 6537 6608 6622 6627 FN	 3 13 52 109 159 207 235 249 251 
Operating	characteristics	 	 	 	 	 	 	Sens	 0.99 (0.97-1.00) 0.95 (0.91-0.97) 0.80 (0.74-0.84) 0.57 (0.51-0.63) 0.37 (0.31-0.44) 0.19 (0.14-0.24) 0.07 (0.05-0.11) 0.02 (0.01-0.05) 0.01 (0.00-0.03) Spec	 0.24 (0.23-0.25) 0.57 (0.55-0.58) 0.78 (0.77-0.79) 0.90 (0.89-0.91) 0.96 (0.96-0.97) 0.99 (0.98-0.99) 1.0 (1.0-1.0) 1.0 (1.0-1.0) 1.0 (1.0-1.0) PPV	 0.05 (0.04-0.05) 0.08 (0.07-0.09) 0.12 (0.10-0.14) 0.18 (0.15-0.21) 0.27 (0.23-0.32) 0.34 (0.26-0.43) 0.49 (0.32-0.65) 0.45 (0.17-0.77) 0.75 (0.19-0.99) NPV	 1.00 (0.99-1.00) 1.00 (0.99-1.00) 0.99 (0.99-0.99) 0.98 (0.98-0.99) 0.98 (0.97-0.98) 0.97 (0.96-0.97) 0.97 (0.96-0.97) 0.96 (0.96-0.97) 0.96 (0.96-0.97) PLR	 1.30 (1.28-1.33) 2.19 (2.10-2.27) 3.56 (3.30-3.85) 5.6 (4.96-56.41) 9.7 (7.96-11.87) 13.5 (9.7-18.73) 24.8 (13.4-45.9) 21.75 (6.68-70.8) 78.3 (8.17-750) NLR	 0.05 (0.02-0.15) 0.09 (0.05-0.15) 0.26 (0.21-0.34) 0.48 (0.41-0.55) 0.65 (0.59-0.72) 0.83 (0.78-0.88) 0.93 (0.90-0.96) 0.98 (0.96-1.0) 0.99 (0.98-1.0) DOR	 26.6 (8.5-83.2) 24.2 (13.8-42.3) 13.5 (9.9-18.4) 11.8 (9.1-15.3) 14.9 (11.2-19.8) 16.3 (11.2-23.8) 26.7 (14.1-50.7) 22.2 (6.7-73.1) 79.2 (8.2-764.1) 
Sens-sensitivity,	Spec-specificity,	PPV-positive	predictive	value,	NPV-negative	predictive	value,	PLR-positive	likelihood	ratio,	NLR-negative	likelihood	ratio,	DOR-diagnostic	odds	ratio.	Items	in	brackets	()	95%	confidence	interval	 		
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Table	8.5	Operating	characteristics	for	the	SEPSIS	score	among	patients	with	infection	(validation	data)	
score	 ≥1	 ≥2	 ≥3	 ≥4	 ≥5	 ≥6	 ≥7	 ≥8	 ≥9	
Outcome	 	 	 	 	 	 	 	TP	 251 241 202 145 95 47 19 5 3 FP	 933 691 1479 671 100 42 12 3 1 TN	 5695 5937 5149 5957 6528 6586 6616 6625 6627 FN	 3 13 52 109 159 207 235 249 251 
Operating	characteristics	 	 	 	 	 	Sens	 0.99 (0.97-1.00) 0.95 (0.91-0.97) 0.80 (0.74-0.84) 0.57 (0.51-0.63) 0.37 (0.31-0.44) 0.19 (0.14-0.24) 0.07 (0.05-0.11) 0.02(0.01-0.05) 0.01 (0.00-0.03) Spec	 0.86 (0.85-0.87) 0.90 (0.89-0.90) 0.93 (0.93-0.94) 0.96 (0.96-0.97) 0.98 (0.98-0.99) 0.99 (0.99-1.0) 1.0 (1.0-1.0) 1.0 (1.0-1.0) 1.0 (1.0-1.0) PPV	 0.21 (0.19-0.24) 0.26 (0.23-0.29) 0.32 (0.28-0.36) 0.38 (0.33-0.43) 0.49 (0.42-0.56) 0.53 (0.42-0.63) 0.61 (0.42-0.78) 0.62 (0.24-0.91) 0.75 (0.19-0.99) NPV	 1.0 (1.0-1.0) 1.0 (1.0-1.0) 0.99 (0.99-0.99) 0.98 (0.98-0.99) 0.98 (0.97-0.98) 0.97 (0.97-0.97) 0.97 (0.96-0.97) 0.96 (0.96-0.97) 0.96 (0.96-0.97) PLR	 7.02 (6.60-7.46) 9.1 (8.43-9.82) 12.2 (10.9-13.6) 16.2 (113.7-19.1) 24.8 (19.3-31.9) 29.2 (19.6-43.4) 41.3 (20.3-84.2) 43.5 (10.5-181) 78.3 (8.2-750) NLR	 0.01 (0.00-0.04) 0.06 (0.03-0.10) 0.22 (0.17-0.28) 0.44 (0.39-0.51) 0.64 (0.58-0.70) 0.82 (0.77-0.87) 0.93 (0.90-0.96) 0.98 (0.96-1.0) 0.99 (0.98-1.0) DOR	 511 (163-1598) 159 (90.7-280) 55.6 (40.4-76.5) 36.3 (27.5-48.1) 39.0 (28.3-53.8) 35.6 (23.0-55.2) 44.6 (21.4-92.9) 44.3 (10.5-187) 79.2 (8.2-764) 
Sens-sensitivity,	Spec-specificity,	PPV-positive	predictive	value,	NPV-negative	predictive	value,	PLR-positive	likelihood	ratio,	NLR-negative	likelihood	ratio,	DOR-diagnostic	odds	ratio	Items	in	brackets	()	95%	confidence	interval	
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Figure	8.5	Probability	of	sepsis	for	each	point	score	
		
8.4.6	Choosing	the	appropriate	cut-off	for	the	SEPSIS	score	A	 perfect	 sepsis	 screening	 tool	 would	 accurately	 discriminate	 between	 those	patients	who	have	sepsis,	and	those	who	do	not.	Sensitivity	and	specificity	are	the	 most	 commonly	 reported	 metrics	 to	 describe	 how	 a	 test	 performs.		Sensitivity	can	be	defined	as	the	proportion	of	subjects	who	have	the	disease	and	are	 classified	 as	disease	positive	by	 the	 test.	 Specificity	 can	be	defined	as	 the	proportion	of	subjects	who	do	not	have	the	disease	and	are	classified	as	disease	negative	by	the	test.	There	is	almost	always	a	trade-off	between	sensitivity	and	specificity.	That	 is,	highly	sensitive	 tests	ensure	 few	patients	are	missed	(false	negative	cases),	but	commonly	result	in	many	false	positive	cases.	On	the	other	hand,	highly	specific	tests	minimise	false	positive	cases,	but	commonly	result	in	many	missed	cases	(false	negatives).			The	 context	 in	 which	 the	 screening	 tool	 is	 being	 used	 will	 often	 inform	 the	balance	 between	 sensitivity	 and	 specificity.	 For	 example,	 in	 a	 disease	 that	 is	rapidly	 fatal,	 a	 highly	 sensitive	 test	 is	 desirable	 to	 ensure	 patients	 with	 the	disease	 are	not	missed.	 	 The	 clinician	will	 tolerate	 a	high	proportion	of	 “false	negative”	results,	to	ensure	no	patient	with	the	disease	“slips	through	the	net”.	On	the	other	hand,	if	the	decision	relates	to	a	very	expensive	intervention,	or	an	intervention	with	significant	unpleasant	side	effects,	a	highly	specific	test	may	be	preferred	 to	 ensure	 only	 patients	 with	 the	 disease	 are	 treated.	 As	 a	 result,	
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patients	lacking	overt	features	of	a	disease	may	be	missed	by	a	highly	specific	test,	resulting	in	many	patients	“slipping	through	the	net”.		With	respect	to	the	SEPSIS	score,	the	context	of	use	will	impact	the	choice	of	cut-off	used.	If	the	SEPSIS	score	is	being	used	to	identify	patients	at	risk	of	sepsis,	then	a	low	cut-off	score,	for	example	SEPSIS	score	>=3,	may	be	appropriate.		Very	few	patients,	who	have	sepsis,	will	be	classified	as	not	having	sepsis,	using	a	score	of	3.	 	However,	using	a	score	of	3,	a	significant	number	of	patients	who	do	not	have	sepsis,	will	be	incorrectly	classified	as	having	sepsis.	 	If	the	SEPSIS	score	was	being	used	to	decide	which	patients	required	antibiotic	treatment	for	sepsis,	then	a	cut-off	of	3	would	not	be	advised	as	this	would	result	in	many	patients	receiving	antibiotics	inappropriately.	In	this	instance,	using	a	higher	score	of	5	would	significantly	reduce	the	inappropriate	administration	of	antibiotics,	but	at	the	expense	of	missing	several	patients	who	have	 less	pronounced	 features	of	sepsis.		The	objective	of	this	thesis	is	to	develop	a	screening	tool	to	assist	paramedics	in	identifying	 sepsis.	 It	 is	 not,	 in	 the	 first	 instance,	 intended	 to	 be	 a	 trigger	 for	treatment.	In	addition,	 later	chapters	will	compare	performance	of	the	SEPSIS	score	with	alternate	screening	tools,	concerning	their	ability	to	identify	sepsis.	As	such,	a	pragmatic	approach	to	balance	sensitivity	with	specificity	has	been	adopted	in	this	thesis,	rather	than	one	that	favours	sensitivity	over	specificity	or	vice	 versa.	 In	other	words,	 rather	 than	 choose	 an	 approach	 that	 identifies	 all	patients	with	sepsis	(maximises	sensitivity),	or	one	that	only	identifies	patients	with	sepsis	(maximises	specificity),	I	have	sought	to	identify	most	patients	with	sepsis,	while	 accepting	 that	 there	 will	 be	 false	 positive	 cases.	 Over-triage,	 as	occurs	 in	 this	 example,	 is	 a	 common	 and	 accepted	 approach	 in	 prehospital	medicine.		The	ROC	curve	is	a	graphical	representation	of	the	trade-off	between	sensitivity	and	 specificity	 and	 can	 inform	 the	 choice	 of	 cut-off	 adopted.	 Figure	 8.4	demonstrates	how	sensitivity	and	specificity	are	related.	A	SEPSIS	score	>=3	has	been	 adopted	 as	 this	 represents	 a	 good	 balance	 between	 sensitivity	 and	specificity	in	the	undifferentiated	medical	population.	That	is,	sensitivity	is	0.80	indicating	80%	of	patients	with	sepsis	are	identified	by	this	cut	point	(20%	of	sepsis	 cases	 are	 missed).	 Specificity	 is	 0.78	 indicating	 that	 78%	 of	 patients	without	sepsis	are	identified	as	being	disease	free	(22%	are	incorrectly	identified	
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as	having	sepsis).	This	represents	an	acceptable	over	triage	to	minimise	missing	sepsis	 cases	without	 overwhelming	 the	 hospital	with	 too	many	 false	 positive	cases.	Such	over	triage	would	not	be	appropriate	if	the	SEPSIS	score	were	to	be	used	to	guide	antibiotic	treatment.		
8.5	Comparison	of	SEPSIS	screening	tool	performance	on	
derivation	and	validation	datasets	Performance	of	a	clinical	prediction	model	may	be	substantially	different	when	compared	across	the	derivation	and	validation	datasets.	The	derived	model	 may	 be	 overly	 optimistic,	 leading	 to	 poor	 performance	 in	 the	validation	assessment.	There	are	several	potential	reasons	for	differences	in	 performance	 including	 overfitting	 during	 derivation,	 omission	 of	important	predictors	and	differences	in	the	population.		When	performance	of	the	SEPSIS	screening	tool	is	compared	across	the	derivation	 and	 validation	 datasets,	 performance	 estimates	 are	comparable	(see	table	8.6).	
	
Table	8.6	Comparison	of	performance	across	datasets	(SEPSIS	score≥3)	
Estimate		 Derivation	cohort	 Validation	cohort	Sensitivity	 0.82	(95%CI	0.79-0.85)	 0.80	(95%CI	0.74-0.84)	Specificity	 0.77	(95%CI	0.76-0.78)	 0.78	(95%CI	0.77-0.79)	Positive	predictive	value	 0.12	(95%CI	0.11-0.13)	 0.12	(95%CI	0.10-0.14)	Negative	predictive	value	 0.99	(95%CI	0.99-1.00)	 0.99	(95%CI	0.99-0.99)	Positive	likelihood	ratio	 3.57	(95%CI	3.41-3.75)	 3.56	(95%CI	3.30-3.85)	Negative	likelihood	ratio	 0.23	(95%CI	0.19-0.27)	 0.26	(95%CI	0.21-0.34)	Diagnostic	odds	ratio	 15.7	(95%CI	12.6-19.4)	 13.5	(95%CI	9.9-18.4)	Area	under	ROC	curve	 0.87	(95%	CI	0.85-0.88)	 0.86	(95%	CI	0.84-0.88)	ROC	-	Receiver	operating	characteristic	
8.6	Conclusion	This	 chapter	 described	 the	 internal	 validation	 of	 the	 SEPSIS	 screening	 tool.	Validation	 employed	 a	 split-sample	 methodology.	 A	 description	 of	 the	 data	utilised	was	provided	and	performance	of	the	SEPSIS	screening	tool	with	respect	to	 goodness	 of	 fit,	 model	 calibration,	 model	 discrimination,	 Brier	 score	 and	operating	characteristics	was	provided.		Using	a	threshold	of	3	points,	the	SEPSIS	screening	tool	was	identified	to	have	a	sensitivity	of	0.80	(95%CI	0.74-0.84),	a	specificity	of	0.78	(95%CI	0.77-0.79),	a	
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positive	predictive	value	of	0.12	(95%CI	0.10-0.14),	a	negative	predictive	value	of	0.99	(95%CI	0.99-0.99),	positive	likelihood	ratio	was	3.56	(95%CI	3.30-3.85),	a	negative	likelihood	ratio	of	0.26	(95%CI	0.21-0.34)	and	a	diagnostic	odds	ratio	of	 13.5	 (95%CI	 9.9-18.4),	 for	 high	 risk	 of	 sepsis,	 among	 patients	 with	 an	undifferentiated	medical	complaint.		Similarly,	a	threshold	of	3	points	had	a	sensitivity	a	sensitivity	of	0.80	(95%CI	0.74-0.84),	a	specificity	of	0.93	(95%CI	0.93-0.94),	a	positive	predictive	value	of	0.32	(95%CI	0.28-0.36),	a	negative	predictive	value	of	0.99	(95%CI	0.99-0.99),	positive	likelihood	value	was	12.2	(95%CI	10.9-13.6),	a	negative	likelihood	valve	of	0.22	(95%CI	0.17-0.28)	and	a	diagnostic	odds	ratio	of	55.6	(95%CI	40.4-76.5),	for	high	risk	of	sepsis,	when	applied	to	patients	with	infection.		
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Chapter	9	
Comparison	of	prehospital	sepsis	
screening	tools 
 
9.1	Introduction	Previous	 chapters	have	 identified	 the	need	 for	 a	prehospital	 sepsis	 screening	tool,	and	subsequently	described	how	such	a	tool	(the	SEPSIS	screening	tool)	was	developed	and	validated.	In	this	chapter,	performance	of	the	SEPSIS	screening	tool	is	assessed	relative	to	existing	screening	tools.	It	should	be	noted	that	no	prehospital	 sepsis	 screening	 tool	 has	 been	 validated	 in	 routine	 prehospital	clinical	practice.		
9.2	Background	In-hospital	 data	 indicate	 that	 early	 administration	 of	 antibiotics	 in	 cases	 of	severe	sepsis	is	associated	with	reduced	mortality.205	206	However,	the	diagnosis	of	sepsis	is	often	only	confirmed	many	hours	after	hospital	admission,	when	all	the	required	clinical	evidence,	such	as	biomarkers	for	organ	 failure	and	blood	culture	results,	become	available.4	15	22	Consequently,	pragmatic	approaches	that	advocate	 early	 administration	 of	 antibiotics,	 before	 a	 definitive	 diagnosis	 of	sepsis	has	been	made,	have	been	developed.4	5	15	22	The	2016	National	Institute	for	 Health	 Care	 Excellence	 (NICE)	 guideline	 (NG51)	 “Sepsis:	 recognition,	diagnosis	and	early	management”	is	one	such	example	of	a	pragmatic	guideline	that	advocates	administration	of	antibiotics	to	patients	with	a	high	risk	of	sepsis,	before	 a	 definitive	 diagnosis	 has	 been	 confirmed	 by	 laboratory	 tests.21	 This	guideline	includes	an	algorithm	for	use	in	acute	health	care	settings	such	as	the	Emergency	Department	(ED).	It	has	been	reported	that	more	than	two-thirds	of	severe	sepsis	cases	are	initially	seen	in	the	ED173	and	around	half	of	ED	sepsis	patients	arrive	by	ambulance.26-28	170-172	Sepsis	patients	arriving	at	the	ED	via	Emergency	Medical	Services	(EMS)	are	likely	to	be	sicker	than	those	arriving	by	other	means;28	29	170-172	and	up	to	80%	of	severe	sepsis	patients	admitted	to	intensive	care	from	the	ED	will	have	been	transported	by	EMS.26	30		
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It	 has	 been	 argued	 that	 there	 is	 an	 opportunity	 for	 ambulance	 clinicians	 to	improve	outcomes	for	this	population	in	the	same	manner	as	they	do	with	other	time	 critical,	 life-threatening	 conditions	 such	 as	acute	myocardial	 infarction,89	stroke82	and	major	trauma.85	Early	recognition	of	sepsis	by	ambulance	clinicians	could	 reduce	 time	 to	 delivery	 of	 key	 interventions	 such	 as	 antibiotic	 therapy.	However,	 evidence	 suggests	 that	 recognition	of	 sepsis	by	paramedics	 is	 often	poor.31	 32	 36	 108	 170	 Use	 of	 a	 prehospital	 sepsis	 screening	 tool	 to	 optimise	prehospital	recognition	of	sepsis	has	been	advocated.40	173	207	A	prehospital	sepsis	screening	tool,	able	to	reliably	identify	those	patients	who	are	categorised	as	at	high	risk	of	sepsis	as	per	NICE	guideline	(NG51)	“Sepsis:	recognition,	diagnosis	and	 early	 management”,	 could	 reduce	 the	 interval	 to	 administration	 of	antibiotics,	and	potentially	improve	outcomes	among	patients	with	sepsis.21	
9.3	Method	To	enable	a	 true	comparison	of	screening	 tool	performance,	 the	same	dataset	utilised	to	validate	the	SEPSIS	screening	tool,	 is	used	to	assess	performance	of	the	alternate	screening	tools.	This	dataset	is	comprised	of	6882	adult	patients,	attended	by	West	Midlands	Ambulance	Service	NHS	Foundation	Trust	(WMAS),	and	 transported	 to	 University	 Hospital	 North	 Staffordshire	 NHS	 Foundation	Trust	(UHNS)	between	01	July	2013	and	30	June	2014.	Patients	under	18	years	of	age,	and	all	cases	of	cardiac	arrest,	trauma	or	mental	health	diagnosis	were	excluded.	 	 The	 included	population	 therefore	comprised	adult	patients	with	a	medical	 complaint	 only.	 The	 gold	 standard	 hospital	 diagnosis	 is	 “high	 risk	 of	
sepsis”	 as	 defined	 by	 the	 2016	 National	 Institute	 for	 Health	 Care	 Excellence	(NICE)	guideline	(NG51)	“Sepsis:	recognition,	diagnosis	and	early	management”.	Diagnostic	criteria	for	sepsis	are	outlined	in	table	9.1.	High	risk	sepsis	status	was	determined	by	examination	of	hospital	(UHNS)	clinical	data,	and	not	extracted	from	diagnostic	fields	in	the	hospital	record.							
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Table	9.1	Classification	of	risk	of	sepsis	(NICE	2016)	
Category		 High	risk	criteria		 Moderate	to	high	risk	criteria		
Low	risk	
criteria		
History		 Objective	evidence	of	new	altered	mental	state		
History	from	patient,	friend	or	relative	of	new	onset	of	altered	behaviour	or	mental	state		History	of	acute	deterioration	of	functional	ability		Impaired	immune	system	(illness	or	drugs	including	oral	steroids)		Trauma,	surgery	or	invasive	procedures	in	the	last	6	weeks		
Normal	behaviour		
Respiratory		
Raised	respiratory	rate:	25	breaths	per	minute	or	more		New	need	for	oxygen	(more	than	40%	FiO2)	to	maintain	saturation	more	than	92%	(or	more	than	88%	in	known	chronic	obstructive	pulmonary	disease)		
Raised	respiratory	rate:	21–24	breaths	per	minute		
No	high	risk	or	moderate	to	high	risk	criteria	met		
Blood	
pressure		
Systolic	blood	pressure	90	mmHg	or	less	or	systolic	blood	pressure	more	than	40	mmHg	below	normal		 Systolic	blood	pressure	91–100	mmHg		
No	high	risk	or	moderate	to	high	risk	criteria	met		
Circulation	
and	hydration		
Raised	heart	rate:	more	than	130	beats	per	minute	Not	passed	urine	in	previous	18	hours.		For	catheterised	patients,	passed	less	than	0.5	ml/kg	of	urine	per	hour		
Raised	heart	rate:	91–130	beats	per	minute	(for	pregnant	women	100–130	beats	per	minute)	or	new	onset	arrhythmia		Not	passed	urine	in	the	past	12–18	hours		For	catheterised	patients,	passed	0.5–1	ml/kg	of	urine	per	hour		
No	high	risk	or	moderate	to	high	risk	criteria	met		
Temperature		 	 Tympanic	temperature	less	than	36°C		 	
Skin		
Mottled	or	ashen	appearance	Cyanosis	of	skin,	lips	or	tongue	Non-blanching	rash	of	skin		
Signs	of	potential	infection,	including	redness,	swelling	or	discharge	at	surgical	site	or	breakdown	of	wound		
No	non-blanching	rash		
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Performance	 of	 the	 new	 “screening	 to	 enhance	 prehospital	 identification	 of	sepsis	 (SEPSIS)	 tool”,	 and	 existing	 tools	 “out	 of	 hospital	 NICE	 sepsis	 risk”,	“National	 Early	 Warning	 Score	 (NEWS)”,	 “Modified	 Early	 Warning	 Score	(MEWS)”,	 “prehospital	 early	 sepsis	 detection	 score	 (PRESS)”,	 “prehospital	identification	of	severe	sepsis	(PreSep)”,	“critical	illness	score	(CIS)”,	“UK	Sepsis	Trust	screening	tool	(Red	Flag	Sepsis)”,	“Swedish	‘Andningsfrekvens’	(BAS	90-30-90)”,	Survive	Sepsis	Campaign	“quick	Sepsis	Organ	Failure	Assessment	(qSOFA)”	and	the	2012	Survive	Sepsis	Campaign	definition	utilising	two	or	more	systemic	inflammatory	response	syndrome	criteria	(SIRS)	were	compared.	
The	SEPSIS	screening	tool	has	been	described	in	detail	in	previous	chapters.	The	2016	 NICE	 guideline	 (NG51)	 “Sepsis:	 recognition,	 diagnosis	 and	 early	management”	 includes	 an	 algorithm	 specifically	 for	 use	 outside	 the	 acute	hospital	 environment,	 that	 ambulance	 clinicians	 would	 use.	 The	 algorithm	requires	the	user	to	identify	those	patients	at	risk	of	sepsis	by	considering	a	likely	source	 of	 infection	 as	well	as	additional	 risk	 factors	 and	 indicators	of	 clinical	concern.	Patients	who	are	at	risk	of	sepsis	are	then	stratified	into	high,	moderate	and	low	risk	categories.	Indicators	of	high	risk	include	objective	evidence	of	new	altered	mental	state,	respiratory	rate	greater	than	25	breaths/min	(or	the	need	for	supplemental	oxygen	to	maintain	normal	oxygen	saturations),	heart	rate	of	130	 beats/min	 or	 higher,	 systolic	 blood	 pressure	 of	 90	 mmHg	 or	 lower,	 not	passed	urine	for	18	hours	(or	passed	less	than	0.5mlkg	if	catheterised),	mottled	or	 ashen	 appearance,	 cyanosis	 of	 skin,	 lips	 or	 tongue	 or	 presence	 of	 a	 non-blanching	 rash.	A	patient	 at	 risk	of	 sepsis	with	 any	one	high	 risk	 indicator	 is	classified	as	being	at	high	risk	of	sepsis.21	
NEWS	is	an	early	warning	score,	developed	by	the	Royal	College	of	Physicians.208	It	 is	 intended	 to	be	used	as	 a	 surveillance	 system	 for	 all	 patients	 in	hospital,	tracking	 their	 clinical	 condition,	 alerting	 the	 clinical	 team	 to	 any	 medical	deterioration	 and	 triggering	 a	 timely	 clinical	 response.	 	 The	 NEWS	 score	comprises	 six	 routine	 physiological	 measurements	 -	 respiratory	 rate,	 oxygen	saturations,	 temperature,	 systolic	 blood	 pressure,	 pulse	 rate	 and	 level	 of	consciousness.	A	score	is	allocated	for	each	as	they	are	measured,	the	magnitude	of	 the	 score	 reflecting	 how	 extreme	 the	 parameter	 varies	 from	 the	 norm.	This	score	is	then	aggregated,	and	uplifted	for	people	requiring	oxygen.208	The	
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maximum	 NEWS	 score	 is	 20	 points.	 Although	 not	 developed	 specifically	 for	sepsis	screening,	it	has	been	studied	in	this	context.209	210	
MEWS	is	another	early	warning	score,	intended	to	detect	early	deterioration	of	surgical	patients,	comprising	four	physiological	findings	and	one	observation.110	A	MEWS	score	is	calculated	from	systolic	blood	pressure,	heart	rate,	respiratory	rate,	temperature	and	an	assessment	of	consciousness	using	the	AVPU	score.	Like	NEWS,	MEWS	allocates	a	score	for	each	variable	that	reflects	deviation	from	the	norm.	 The	 maximum	 MEWS	 score	 is	 14	 points.	 Although	 MEWS	 was	 not	developed	 specifically	 for	 sepsis	 screening,	 its	 use	 in	 this	 context	 has	 been	reported.36	54	211	
The	PRESS	score	was	developed	by	Polito	et	al108	to	identify	severe	sepsis	in	adult	patients.	Screening	follows	several	stages.	First	patients	must	meet	the	following	criteria:	over	18	years	of	age,	systolic	blood	pressure	below	110	mmHg,	heart	rate	 above	 90	 beats/min	 and	 respiratory	 rate	 above	 20	 breaths	 per	 minute.	Patients	not	meeting	these	criteria	are	not	eligible.	Next,	specific	case	types	are	excluded.	Traumatic	injury,	cardiac	arrest,	pregnancy,	psychiatric	emergency	or	confirmed	 toxic	 ingestion	 excludes	 patients	 from	 further	 screening.	 All	remaining	patients	are	classified	as	at-risk	and	a	score	is	calculated.	Scores	are	allocated	 to	 six	 components:	 a	 dispatch	 code	 of	 “sick	 person”,	 nursing	 home	residence,	 age,	 hot	 tactile	 temperature,	 systolic	 blood	 pressure	 and	 oxygen	saturations.	The	maximum	score	is	24	points.	Any	at-risk	patient	scoring	above	1	is	classified	as	having	severe	sepsis,	however	a	higher	points	score	does	not	indicate	increasing	sepsis	severity.	
The	PreSep	score	was	developed	by	Bayer	et	al54	to	identify	severe	sepsis	in	adult	patients.	 Scores	 are	 allocated	 to	 five	 components:	 temperature	 above	38°C	or	below	 36°C,	 oxygen	 saturations	 below	 92%,	 respiratory	 rate	 above	 22	breaths/min,	heart	rate	above	90	beats/min	and	systolic	blood	pressure	below	90mmHg.	The	maximum	score	is	11	points,	and	any	patient	scoring	above	3	is	classified	as	having	severe	sepsis.	
The	CIS	 score	was	developed	by	 Seymour	at	al107	 to	 identify	patients	 in	need	critical	 care	 services.	 Critical	 illness	 was	 defined	 as	 in-hospital	 diagnosis	 of	severe	sepsis,	delivery	of	mechanical	ventilation,	or	death	at	any	point	during	hospitalisation.	 Scores	 are	allocated	 to	 five	 components:	 age,	 respiratory	 rate,	systolic	blood	pressure,	heart	rate,	oxygen	saturations	and	Glasgow	Coma	Score.	
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The	maximum	score	is	8	points,	and	any	patient	scoring	above	3	is	classified	as	requiring	critical	care	services.	The	authors	describe	using	this	score	as	a	proxy	for	a	diagnosis	of	severe	sepsis	requiring	admission	to	intensive	care	(ICU)	
“Red	Flag	Sepsis”	is	a	screening	algorithm	developed	and	promoted	by	the	UK	Sepsis	Trust	to	stratify	patients	according	to	need	for	senior	review	and	initial	treatment.5	It	comprises	several	stages,	the	first	of	which	is	to	identify	patients	at	risk	with	reference	to	their	NEWS	score	and	appearance.	The	next	stage	is	to	consider	 if	 the	 cause	 could	 be	 due	 to	 infection,	 and	 if	 so	 the	 final	 stage	 is	 to	categorise	the	patient	as	either	“Red	Flag”	(high	risk	of	sepsis)	or	“Amber	Flag”	(moderate	 risk	 of	 sepsis).	 There	 are	 nine	 potential	 “Red	 Flag”	 indicators:	responds	only	to	voice	or	pain/unresponsive,	systolic	blood	pressure	90	mmHg	or	lower,	heart	rate	above	130	beats/min,	respiratory	rate	above	24	breaths/min,	supplemental	oxygen	required	to	maintain	peripheral	oxygen	saturations	of	92%	or	higher,	presence	of	a	non-blanching	rash,	mottled,	ashen	or	cyanotic	skin,	not	passed	 urine	 in	 the	 preceding	 18	 hours,	 lactate	 of	 2mmol/L	 or	 higher	 and	 a	recent	history	of	chemotherapy.	The	presence	of	any	one	“Red	Flag”	implies	the	patient	is	at	high	risk	of	sepsis,	that	a	treatment	package	should	be	implemented	without	delay	and	that	the	patient	should	be	reviewed	by	a	senior	clinician	as	soon	as	possible.5	
The	 BAS	 90-30-90	 score	 is	 a	 Swedish	 screening	 tool	 (‘Andningsfrekvens’)	comprising	systolic	blood	pressure	below	90mmHg,	respiratory	rate	above	30	breaths/min	and	oxygen	saturation	below	90%.	The	maximum	score	is	3	points,	and	any	patient	scoring	above	0	is	classified	as	having	severe	sepsis.36		The	qSOFA	score	(also	known	as	quickSOFA)	is	a	bedside	assessment	to	identify	patients	with	suspected	infection	who	are	at	greater	risk	for	a	poor	outcome.	It	was	developed	by	the	Survive	Sepsis	Campaign	and	is	intended	for	use	outside	the	 intensive	 care	 unit	 (ICU)	 environment.4	 Scores	 are	 allocated	 to	 three	components:	systolic	blood	pressure	of	100mmHg	or	lower,	respiratory	rate	of	22	 breaths/min	 or	 higher	 and	 Glasgow	Coma	 Scale	 below	 15.	 The	maximum	score	 is	 3	 points,	 and	 any	 patient	 scoring	 2	 or	 3	 requires	 that	 clinicians	investigate	for	organ	dysfunction,	initiate	or	escalate	therapy	as	appropriate,	and	consider	referral	to	critical	care	or	increase	the	frequency	of	monitoring,	if	such	actions	have	not	already	been	undertaken.4		
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A	perfect	sepsis	screening	tool	would	correctly	identify	those	patients	who	are	septic	 (have	 sepsis),	 and	 those	 who	 are	 not	 (no	 sepsis).	 To	 date,	 no	 such	screening	tool	has	been	identified	for	sepsis.	Several	metrics	are	used	to	describe	the	accuracy	of	screening	tools,	and	the	context	in	which	the	screening	tool	is	being	 used	 may	 inform	 which	 metric	 is	 most	 important	 in	 the	 given	circumstance.	For	example,	for	a	disease	that	is	rapidly	fatal,	a	highly	sensitive	test	may	be	required	to	ensure	patients	with	the	disease	are	not	missed.	On	the	other	 hand,	 if	 the	 decision	 relates	 to	 a	 very	 expensive	 intervention,	 or	 an	intervention	with	significant	unpleasant	side	effects,	a	highly	specific	test	may	be	preferred	to	ensure	only	patients	with	the	disease	are	treated.	However,	for	the	bedside	clinician	it	is	also	vital	to	be	able	to	interpret	a	test	result	and	apply	it	to	their	clinical	practice.	In	other	words,	if	the	screening	tool	suggests	the	patient	has	 the	 disease,	 how	 likely	 is	 it	 that	 the	 patient	 has	 disease	 and	 should	 the	clinician	be	more	 confident	 to	provide	 treatment	appropriate	 for	 the	disease,	based	upon	the	test	result?	For	this,	positive	predictive	values	(PPV)	and	positive	likelihood	 ratios	 (PLR)	which	 are	defined	below,	 are	 important.	 Conversely,	 if	screening	suggests	the	patient	does	not	have	the	disease,	should	the	clinician	be	confident	that	patient	does	not	have	the	disease	and	not	provide	treatment	for	the	 disease?	 Negative	 predictive	 values	 (NPV)	 and	 negative	 likelihood	 ratios	(NLR)	which	are	defined	below,	will	inform	the	clinician	in	this	instance.	In	this	chapter,	 screening	 tool	 performance	 is	 assessed	 by	 reporting	 the	 following	measures:			 • Sensitivity	-	the	ability	of	a	test	to	identify	those	with	the	disease.	A	test	with	sensitivity	=	1	identifies	all	cases	with	the	disease.	• Specificity	 -	 the	ability	of	a	 test	 to	 identify	 those	who	do	not	have	 the	disease.	A	test	with	specificity	=	1	identifies	all	cases	without	the	disease.	• Positive	predictive	 value	 (PPV)	 -	 probability	 that	an	 individual	with	a	positive	 test	 has	 the	 disease.	 A	 test	 with	 PPV	 =	 1	 implies	 all	 cases	classified	as	having	disease	will	have	the	disease.	• Negative	predictive	value	(NPV)	-		probability	that	an	individual	with	a	negative	test	does	not	have	the	disease.	A	test	with	NPV	=	1	implies	all	cases	classified	as	being	disease	free	will	not	have	the	disease.	• Positive	likelihood	ratio	(PLR)	-	the	probability	that	an	individual	with	the	 disease	 will	 test	 positive,	 divided	 by,	 the	 probability	 that	 an	individual	 without	 the	 disease	 will	 test	 positive.	 A	 PLR	 provides	 an	estimate	 of	 how	much	 a	 positive	 test	 result	will	 increase	 the	 odds	 of	
PRoSAiC	Thesis	
217	
having	the	disease	(See	table	9.2	for	interpretation	of	likelihood	ratios).	To	interpret	a	PLR	it	is	essential	to	know	the	pre-test	odds	of	having	a	disease.	 The	 pre-test	 odds	 of	 having	 the	 disease	 are	 related	 to	 the	prevalence	of	disease	in	the	population	being	studied.	In	the	population	examined	the	pre-test	odds	for	high	risk	sepsis	is	0.037	(see	table	9.3).	• Negative	likelihood	ratio	(NLR)	-	the	probability	that	an	individual	with	the	 disease	 will	 test	 negative,	 divided	 by,	 the	 probability	 that	 an	individual	 without	 the	 disease	 will	 test	 negative.	 A	 NLR	 provides	 an	estimate	of	how	much	a	negative	 test	result	will	decrease	 the	odds	of	having	the	disease	(See	table	9.2	for	interpretation	of	likelihood	ratios).	As	with	PLR,	interpretation	of	a	NLR	requires	knowledge	of	the	pre-test	odds	of	having	a	disease	(see	table	9.3).	
Table	9.2	Interpretation	of	Likelihood	Ratios	(LR)	
LR	 Interpretation	>	10	 Large	and	often	conclusive	increase	in	the	likelihood	of	disease	5	-	10	 Moderate	increase	in	the	likelihood	of	disease	2	-	5	 Small	increase	in	the	likelihood	of	disease	1	-	2	 Minimal	increase	in	the	likelihood	of	disease	1	 No	change	in	the	likelihood	of	disease	0.5	-	1.0	 Minimal	decrease	in	the	likelihood	of	disease	0.2	-	0.5	 Small	decrease	in	the	likelihood	of	disease	0.1	-	0.2	 Moderate	decrease	in	the	likelihood	of	disease	<	0.1	 Large	and	often	conclusive	decrease	in	the	likelihood	of	disease			
9.4	Results	Characteristics	of	the	population	are	reported	in	table	9.3.												
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Table	9.3	Validation	cohort	characteristics	
Variable	(n=6882)	 Estimate	Location		 Home,	n	(%)	 4964	(72)		 Nursing	home,	n	(%)	 414	(6)		 Other,	n	(%)	 1504	(22)	Age	(years),	mean	(SD)	 62	(21)	
	Gender		 Male,	n	(%)	 3346	(49)	Respirations	(breaths/min),	mean	(SD)	 20	(6)	Oxygen	saturation	(%),	mean	(SD)	 96	(5)	Heart	rate	(beats/min),	mean	(SD)	 92	(24)	Systolic	blood	pressure	(mmHg),	mean	(SD)	 133	(27)	Diastolic	blood	pressure	(mmHg),	mean	(SD)	 78	(17)	Temperature	(°C),	mean	(SD)	 36.8	(0.9)	Blood	sugar	(mmol/L),	mean	(SD)	 7.0	(3.3)	Glasgow	Coma	Score,	median	(IQR)	 15	(15-15)	Capillary	bed	refill	time	 Normal	(<2	sec),	n	(%)	 6567	(95)		 Delayed	(>2	sec),	n	(%)	 315	(5)	Skin	 Normal,	n	(%)	 5320	(77)		 Pallor,	n	(%)	 1037	(15)		 Flushed,	n	(%)	 359	(5)		 Cyanosed,	n	(%)	 83	(1)		 Jaundice,	n	(%)	 51	(0.7)		 Mottled,	n	(%)	 20	(0.2)		 Rash,	n	(%)	 12	(0.1)	Pupil	size	(mm),	median	(IQR)	 3	(3-4)	Pupil	reaction	 Brisk,	n	(%)	 6462	(94)		 Sluggish,	n	(%)	 381	(6)		 Fixed,	n	(%)	 39	(0.5)	NICE	risk	of	sepsis	 No	risk	(no	infection),	n	(%)	 5607	(81.5)		 Low	risk,	n	(%)	 448	(6.5)		 Moderate	risk,	n	(%)	 573	(8.3)		 High	risk,	n	(%)	 254	(3.7)	
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Two	sets	of	performance	metrics	for	each	screening	tool	are	presented.	In	table	
9.4	metrics	are	reported	when	applying	the	screening	tools	to	an	undifferentiated	adult	medical	patient	population,	that	is	patients	with	all	medical	conditions	are	included.	 In	 table	 9.5	 performance	 metrics	 are	 reported	 when	 applying	 the	screening	tools	to	a	population	of	patients	with	infection.	In	other	words,	table	
9.5	provides	and	approximation	of	performance	of	the	screening	tools	applied	to	patients	with	suspected	infection.			The	most	sensitive	screening	tool,	applied	to	an	undifferentiated	adult	medical	population,	is	NEWS>=2.	This	screening	tool	maximises	the	number	of	patients	correctly	 identified	 as	 having	 sepsis.	 However,	 it	 also	 generates	 the	 highest	number	 of	 false	 positive	 cases.	 Positive	 predictive	 value	 is	 lowest	 for	 this	screening	tool	suggesting	that	a	clinician	using	this	screening	tool	will	have	the	least	confidence	that	a	patient	with	positive	test	result	does	in	fact	have	sepsis	(one	 patient	 in	 every	 20	 with	 a	 positive	 result	 will	 have	 high	 risk	 sepsis).	Conversely,	if	the	screening	tool	indicates	that	a	patient	does	not	have	sepsis	the	treating	clinician	can	be	very	confident	that	the	patient	does	not	have	sepsis.		The	 most	 specific	 screening	 tool	 is	 the	 PRESS	 score.	 This	 screening	 tool	maximises	 the	 number	 of	 patients	 correctly	 identified	 as	 not	 having	 sepsis.	However,	it	also	generates	the	highest	number	of	false	negative	cases	-	in	other	words,	 of	 all	 the	 screening	 tools	assessed	 this	 screening	 tool	misses	 the	most	sepsis	cases.	PRESS	fails	to	identify	80%	of	cases	with	high	risk	sepsis.			The	tool	with	the	greatest	PPV	is	the	CIS	score.	In	an	undifferentiated	population,	approximately	one	patient	out	of	every	five	who	test	positive	will	have	high	risk	sepsis,	whereas	in	a	population	of	patients	with	infection	this	will	improve	to	one	patient	in	every	two	with	a	positive	result.	Whilst	this	is	very	promising,	the	CIS	score	fails	to	identify	almost	60%	of	high	sepsis	risk	cases.		
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Table	9.4	Comparison	of	screening	tools	(All	medical	patients)	
Screening	Tool	
TP	 FP	 Apparent	
prevalence	 Sensitivity	 Specificity	 PPV	 NPV	 PLR	 NLR	FN	 TN	SEPSIS>=2	 241	 2878	 0.45	(0.44	–	0.47)	 0.95	(0.74	–	0.84)	 0.57	(0.77	–	0.79)	 0.08	(0.07	–	0.09)	 0.99	(0.99	–	1.00)	 2.19	(2.10	–	2.27)	 0.09	(0.05	–	0.15)	13	 3750	SEPSIS>=3	 202	 1479	 0.24	(0.23	–	0.25)	 0.80	(0.74	–	0.84)	 0.78	(0.77	–	0.79)	 0.12	(0.10	–	0.14)	 0.99	(0.99	–	0.99)	 3.56	(3.30	–	3.85)	 0.26	(0.21	–	0.34)	52	 5149	SEPSIS>=5	 95	 255	 0.05	(0.05	–	0.06)	 0.37		(0.31	–	0.44)	 0.96	(0.96	–	0.97)	 0.27	(0.23	–	0.32)	 0.97	(0.96	–	0.97)	 24.8	(13.4	–	45.9)	 0.93		(0.90	–	0.96)	159	 6373	CIS	 114	 398	 0.07	(0.07	–	0.08)	 0.45	(0.39	–	0.51)	 0.94	(0.93	–	0.95)	 0.22	(0.19	–	0.26)	 0.98	(0.97	–	0.98)	 7.47	(6.33	–	8.83)	 0.59	(0.52	–	0.66)	140	 6230	PreSep	 155	 836	 0.14	(0.15	–	0.15)	 0.61	(0.55	–	0.67)	 0.87	(0.87	–	0.88)	 0.16	(0.13	–	0.18)	 0.98	(0.98	–	0.99)	 4.84	(4.30	–	5.44)	 0.45	(0.38	–	0.52)	99	 5792	PRESS	 45	 170	 0.03	(0.03	–	0.04)	 0.18	(0.14	–	0.24)	 0.97	(0.97	–	0.98)	 0.21	(0.16	–	0.27)	 0.97	(0.96	–	0.97)	 7.04	(5.20	–	9.53)	 0.84	(0.79	–	0.89)	203	 6422	qSOFA	 74	 464	 0.08	(0.07	–	0.08)	 0.29	(0.24	–	0.35)	 0.93	(0.92	–	0.94)	 0.14	(0.11	–	0.17)	 0.97	(0.97	–	0.98)	 4.16	(3.37	–	5.14)	 0.76	(0.70	–	0.82)	180	 6164	SIRS>=2	 204	 2242	 0.36	(0.34	–	0.37)	 0.80	(0.75	–	0.85)	 0.66	(0.65	–	0.67)	 0.08	(0.07	–	0.10)	 0.99	(0.99	–	0.99)	 2.37	(2.21	–	2.55)	 0.30	(0.23	–	0.38)	50	 4385	BAS	90-30-90	 159	 847	 0.15	(0.14	–	0.15)	 0.63	(0.56	–	0.69)	 0.87	(0.86	–	0.88)	 0.16	(0.14	–	0.18)	 0.98	(0.98	–	0.99)	 4.90	(4.37	–	5.49)	 0.43	(0.37	–	0.50)	95	 5781	MEWS>=4	 161	 988	 0.17	(0.16	–	0.18)	 0.63	(0.57	–	0.69)	 0.85	(0.84	–	0.86)	 0.14	(0.12	–	0.16)	 0.98	(0.98	–	0.99)	 4.25	(3.81	–	4.75)	 0.43	(0.37	–	0.51)	93	 5640	NEWS>=2	 251	 5146	 0.78	(0.77	–	0.79)	 0.99	(0.97	–	1.00)	 0.22	(0.21	–	0.23)	 0.05	(0.04	–	0.05)	 1.00	(0.99	–	1.00)	 1.27	(1.25	–	1.30)	 0.05	(0.02	–	0.16)	3	 1482	NEWS>=3	 247	 3656	 0.57	(0.56	–	0.58)	 0.97	(0.94	–	0.99)	 0.45	(0.44	–	0.45)	 0.06	(0.06	–	0.07)	 1.00	(1.00	–	1.00)	 1.76	(1.71	–	1.82)	 0.06	(0.03	–	0.13)	7	 2972	NEWS>=5	 217	 1920	 0.31	(0.30	–	0.32)	 0.85	(0.80	–	0.90)	 0.71	(0.70	–	0.72)	 0.10	(0.09	–	0.12)	 0.99	(0.99	–	0.99)	 2.95	(2.77	–	3.14)	 0.21	(0.15	–	0.28)	37	 4708		
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Table	9.5	Comparison	of	screening	tools	(Infection	patients	only)	
Screening	Tool	 TP	 FP	 Apparent	prevalence	 Sensitivity	 Specificity	 PPV	 NPV	 PLR	 NLR	FN	 TN	SEPSIS>=2	 241	 691	 0.14	(0.13	–	0.14)	 0.95	(0.91	–	0.97)	 0.90	(0.89	–	0.90)	 0.26	(0.23	–	0.29)	 1.00	(1.00	–	1.00)	 9.10	(8.43	–	9.82)	 0.06	(0.03	–	0.10)	13	 5937	SEPSIS>=3	 202	 433	 0.09	(0.09	–	0.10)	 0.80	(0.74	–	0.84)	 0.93	(0.93	–	0.94)	 0.32	(0.28	–	0.36)	 0.99	(0.99	–	0.99)	 12.17	(10.90	–	13.59)	 0.22	(0.17	–	0.28)	52	 6195	SEPSIS>=5	 95	 100	 0.04	(0.03	–	0.04)	 0.37	(0.31	–	0.44)	 0.98	(0.98	–	0.99)	 0.49	(0.42	–	0.56)	 0.98	(0.97	–	0.98)	 24.8	(19.3	-31.9)	 0.64	(0.58	–	0.70)	159	 6528	NICE	(high	risk	only)	 214	 510	 0.11	(0.10	–	0.11)	 0.84	(0.79	–	0.89)	 0.92	(0.92	–	0.93)	 0.30	(0.26	–	0.33)	 0.99	(0.99	–	1.00)	 10.95	(9.92	–	12.09)	 0.17	(0.163	–	0.23)	40	 6118	Red	Flag	Sepsis	(UK	sepsis	Trust)	 212	 449	 0.10	(0.09	–	0.10)	 0.83	(0.78	–	0.88)	 0.93	(0.93	–	0.94)	 0.32	(0.29	–	0.36)	 0.99	(0.99	–	1.00)	 12.32	(11.10	–	13.68)	 0.18	(0.13	–	0.23)	42	 6179	CIS	 114	 115	 0.03	(0.03	–	0.04)	 0.45	(0.39	–	0.51)	 0.98	(0.98	–	0.99)	 0.50	(0.43	–	0.56)	 0.98	(0.98	–	0.98)	 25.87	(20.62	–	32.45)	 0.56	(0.50	–	0.63)	140	 6513	PreSep	 155	 317	 0.07	(0.06	–	0.07)	 0.61	(0.55	–	0.67)	 0.95	(0.95	–	0.96)	 0.33	(0.29	–	0.37)	 0.98	(0.98	–	0.99)	 12.76	(11.03	–	14.76)	 0.41	(0.35	–	0.48)	99	 6311	PRESS	 45	 53	 0.01	(0.01	–	0.02)	 0.19	(0.14	–	0.24)	 0.99	(0.99	–	0.99)	 0.46	(0.36	–	0.56)	 0.97	(0.97	–	0.97)	 22.75	(15.68	–	33.00)	 0.82	(0.77	–	0.87)	203	 6569	qSOFA	 74	 125	 0.03	(0.03	–	0.03)	 0.29	(0.24	–	0.35)	 0.98	(0.98	–	0.98)	 0.37	(0.30	–	0.44)	 0.97	(0.97	–	0.98)	 15.45	(11.93	–	20.01)	 0.72	(0.67	–	0.78)	180	 6503	SIRS>=2	 204	 472	 0.10	(0.09	–	0.11)	 0.80	(0.75	–	0.85)	 0.93	(0.92	–	0.93)	 0.30	(0.27	–	0.34)	 0.99	(0.99	–	0.99)	 11.28	(10.14	–	12.54)	 0.21	(0.17	–	0.27)	50	 6156	BAS	90-30-90	 159	 216	 0.05	(0.05	–	0.06)	 0.63	(0.56	–	0.69)	 0.97	(0.96	–	0.97)	 0.42	(0.37	–	0.48)	 0.99	(0.98	–	0.99)	 19.21	(16.34	–	22.59)	 0.39	(0.33	–	0.45)	95	 6412	MEWS>=4	 161	 246	 0.06		(0.05	–	0.06)	 0.63	(0.57	–	0.69)	 0.96	(0.96	–	0.97)	 0.40	(0.35	–	0.44)	 0.99	(0.98	–	0.99)	 17.08	(14.64	–	19.93)	 0.38	(0.32	–	0.45)	93	 6382	NEWS>=2	 251	 890	 0.17	(0.16	–	0.17)	 0.99	(0.97	–	1.00)	 0.87	(0.86	–	0.87)	 0.22	(0.20	–	0.25)	 1.00	(1.00	–	1.00)	 7.36	(6.91	–	7.83)	 0.01	(0.00	–	0.04)	3	 5738	NEWS>=3	 247	 714	 0.14	(0.13	–	0.15)	 0.97	(0.94	–	0.99)	 0.89	(0.88	–	0.90)	 0.26	(0.23	–	0.29)	 1.00	(1.00	–	1.00)	 9.03	(8.40	–	9.70)	 0.03	(0.01	–	0.06)	7	 5914	NEWS>=5	 217	 472	 0.10	(0.09	–	0.11)	 0.85	(0.80	–	0.90)	 0.93	(0.92	–	0.93)	 0.31	(0.28	–	0.35)	 0.99	(0.99	–	1.00)	 12.00	(10.85	–	13.27)	 0.16	(0.12	–	0.21)	37	 6156	
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9.5	Discussion		From	the	metrics	reported,	no	single	tool	can	be	deemed	to	be	‘the	best’	for	use	by	ambulance	clinicians.	Sensitivity	needs	to	be	balanced	against	specificity	as	well	as	predictive	values	and	likelihood	ratios.			In	this	regard,	three	screening	tools,	SEPSIS>=3,	SIRS>=2	and	NEWS>=5,	appear	to	 offer	 a	 respectable	 balance	 between	 sensitivity,	 specificity	 and	 PPV	 in	 an	undifferentiated	 adult	medical	 population.	Respectively,	 these	 three	 screening	tools,	missed	52,	50	and	37	patients	with	a	high	risk	of	sepsis.	On	the	other	hand,	the	number	of	false	positive	cases,	that	is	patients	identified	as	high	risk	sepsis	when	they	are	not,	are	1479,	2242	and	1920	respectively.			There	is	a	trade-off	between	missing	high	risk	of	sepsis	cases	and	increasing	false	positive	cases.	In	this	comparison,	minimising	missed	cases	(NEWS>=5	misses	37	 cases)	 will	 results	 in	 an	 addition	 441	 false	 positive	 cases	 (1920-1479),	whereas	 minimising	 false	 positive	 cases	 (SEPSIS>=3	 results	 in	 1479	 false	positive	cases)	results	in	an	additional	15	missed	high	risk	sepsis	cases	(52-37).	The	decision	as	to	which	is	better,	15	missed	cases	or	an	increase	of	441	false	positive	cases,	is	a	decision	needing	input	from	multiple	stakeholders	within	the	emergency	care	network.			From	the	ambulance	clinicians’	perspective,	practitioners	will	want	to	minimise	the	number	of	high	risk	sepsis	patients	who	are	missed.	However,	they	also	need	to	 be	 confident	 in	 the	 result	 of	 the	 screening.	 PPV	 is	 marginally	 better	 for	SEPSIS>=3	than	for	SIRS>=2	and	NEWS>=5	at	0.12	(95%CI	0.10-0.14)	compared	with	0.08	(95%CI	0.07-0.10)	and	0.10	(95%	0.09-0.12)	respectively.	However,	all	three	 screening	 tools	 have	 low	 PPV.	 This	 result	 indicates	 that	 a	 patient	 with	positive	test	result	using	SEPSIS>=3	is	marginally	more	likely	to	have	high	risk	sepsis	than	if	the	test	was	positive	using	SIRS>=2	or	NEWS>=5.		There	is	a	similar	increase	in	PLR	for	SEPSIS>=3	than	for	SIRS>=2	and	NEWS>=5	at	3.56	(95%CI	3.30-3.85)	 compared	with	 2.37	 (95%CI	 2.21-2.55)	 and	 2.95	 (95%	2.77-3.14)	respectively.	This	indicates	that	an	ambulance	clinician	with	a	positive	test	result	using	 SEPSIS>=3	 should	 be	 more	 confident	 that	 the	 high-risk	 sepsis	categorisation	is	due	 to	sepsis,	 rather	 than	another	cause,	 than	 if	 the	test	was	positive	 using	 SIRS>=2	 or	 NEWS>=5.	 	 However,	 in	 practice	 this	 improved	
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performance	 equates	 to	between	2	 and	4	more	 cases	of	 sepsis	per	100	 cases	screened.	
9.6	Conclusion	In	this	chapter	performance	of	the	SEPSIS	screening	tool	was	assessed	relative	to	 existing	 screening	 tools.	 In	 an	 undifferentiated	 adult	 medical	 population,	NEWS>=2	was	the	most	sensitive,	whereas	PRESS	was	the	most	specific.	When	considering	both	 sensitivity	 and	 specificity,	 three	 screening	 tools,	 SEPSIS>=3,	SIRS>=2	and	NEWS>=5,	appeared	to	offer	similar	performance.	PPV	and	PLR	was	greatest	for	SEPSIS>=3.	Choosing	the	most	appropriate	screening	tool	to	use	to	identify	high	risk	sepsis	patients	is	complex,	and	requires	input	from	multiple	stakeholders	in	the	emergency	care	network.
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Chapter	10	
Conclusion 
	
10.1	Introduction	Chapters	1	to	3	of	this	thesis	identified	a	need	for	a	reliable	prehospital	sepsis	screening	 tool.	 Chapter	 4	 described	 the	 acquisition	 of	 data	 from	 a	 NHS	ambulance	service	and	a	NHS	Emergency	Department	(ED).	This	was	followed	by	 reporting	 the	 methods	 for	 linking	 the	 two	 datasets	 (chapter	 5)	 and	 the	management	of	missing	data	(chapter	6).	Chapters	7	and	8	provided	a	detailed	exposition	of	the	derivation	and	validation	of	a	new	prehospital	sepsis	screening	tool.	 Chapter	 9	 compared	 the	 performance	 of	 this	 new	 prehospital	 sepsis	screening	 tool	 with	 existing	 screening	 tools.	 This	 concluding	 chapter	 will	consider	 the	 implications	 of	 this	 work	 in	 the	 context	 of	 current	 prehospital	clinical	practice	in	the	United	Kingdom	(UK).	
10.2	Summary	of	findings	The	 overall	 incidence	 of	 high	 risk	 of	 sepsis,	 as	 per	 the	 National	 Institute	 for	Health	and	Care	Excellence	(NICE)	sepsis	guideline	[NG51],	among	adult	patients	in	a	UK	ambulance	service,	was	determined	to	be	2.8%,	calculated	as:	
!847	&'()(	*+	ℎ-.ℎ	()/(-(	0-(1 33289	56-75)	&'()( − 2536	&ℎ-;<	&'()(= > ∗ 100	
In	 this	 study,	 predictors	 of	 sepsis	 in	 the	 prehospital	 environment	 comprise	demographic	(age),	Systemic	Inflammatory	Response	Syndrome	(SIRS)	criteria	(respiratory	 rate,	 heart	 rate	 and	 temperature)	 as	well	 potential	 indicators	 of	organ	failure	(peripheral	oxygen	saturations,	systolic	blood	pressure	and	level	of	consciousness).		
Recognition	 of	 sepsis	 can	 be	 challenging.	 Historically,	 a	 sepsis	 diagnosis	 was	made	 combining	 both	 Systemic	 Inflammatory	 Response	 Syndrome	 (SIRS)	criteria	and	indicators	of	organ	failure	in	patients	with	infection.15	However,	SIRS	criteria	have	recently	fallen	out	of	favour,	as	they	are	overly	sensitive,	without	adequate	 specificity.16	 18	 212	 International	 diagnostic	 standards	 have	migrated	toward	more	quantifiable,	and	more	specific,	indicators	of	organ	failure.4		
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Sadly,	the	technology	to	measure	these	specific	indicators	of	organ	failure	has	not	yet	migrated	 into	 routine,	 frontline	 ambulance	 use.	 Ambulance	 clinicians	 still	have	the	challenging	task	of	recognising	a	difficult	to	diagnose	condition,	with	sub-optimal	 indicators	of	the	condition.	Despite	 these	 limitations,	a	pragmatic	prehospital	sepsis	 screening	 tool	 has	been	developed	using	 clinical	data	 from	both	the	ambulance	service	and	the	ED.		
Ambulance	 staff	 routinely	 attend	 patients	 with	 undifferentiated	 medical	complaints.	The	 SEPSIS	 screening	 tool	 has	a	 sensitivity	of	0.80	 (95%	CI	0.74-0.84),	specificity	of	0.78	(95%	CI	0.77-0.79),	positive	predictive	value	(PPV)	of	0.12	(95%	CI	0.10-0.14),	negative	predictive	value	(NPV)	of	0.99	(95%	CI	0.99-0.99),	a	positive	likelihood	ratio	(PLR)	of	3.56	(95%	CI	3.30-3.85)	and	a	negative	likelihood	 ratio	 of	 0.26	 (95%	 CI	 0.21-0.34)	 in	 an	 adult	 population	 with	undifferentiated	 medical	 complaints.	 Area	 under	 the	 receiver	 operating	characteristic	curve	(AUC	ROC)	is	0.86	for	the	SEPSIS	screening	tool.	
10.3	Strengths	of	this	study	This	study	is	the	first	of	its	nature	to	be	conducted	in	the	UK.	Several	aspects	set	this	work	apart	from	existing	international	findings.	First,	the	diagnostic	 ‘gold	standard’	was	not	simply	extracted	from	hospital	records.	The	classification	of	high	 risk	 of	 sepsis,	 as	 per	 the	 2016	 National	 Institute	 for	 Health	 and	 Care	Excellence	(NICE)	sepsis	guideline,21	was	confirmed	utilising	clinical	data	from	the	ED	clinical	record.	This	is	significant	as	it	is	well	documented	that	sepsis	is	under	reported.10	11	213	Indeed,	diagnoses	of	sepsis	appear	under	reported	in	the	data	employed	in	this	study	-		2.0%	of	patients	received	an	ED	diagnosis	of	sepsis,	whereas	10.0%	met	the	2013	diagnostic	criteria	for	sepsis15	while	18.5%	were	classified	 as	 “at	 risk”	 per	 the	 NICE	 sepsis	 guideline	 (6.5%	 low	 risk,	 8.3%	moderate	risk	and	3.7%	high	risk).21	
Second,	the	classification	of	high	risk	of	sepsis,	as	per	the	NICE	sepsis	guideline,21	is	a	pragmatic,	rather	than	concrete,	clinical	diagnosis.	Patients	classified	as	high	risk	 for	 sepsis	 should	 receive	 antibiotic	 therapy	 and	 be	 reviewed	 by	 a	 senior	clinician	without	delay.	Treatment	for	sepsis	is	initiated	before	the	diagnosis	is	confirmed.	The	screening	 tool	developed	in	 this	study	 is	similarly	 intended	to	identify	those	patients	who	should	receive	early	antibiotic	therapy	due	to	their	high	risk	of	sepsis,	rather	than	attempting	to	confirm	a	sepsis	diagnosis.	
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Third,	 multiple	 imputation	 is	 the	 defacto	 standard	 for	 the	 management	 of	missing	data.	Previous	studies	to	develop	prehospital	sepsis	screening	tools	have	failed	to	manage	missing	data	by	multiple	imputation.	Missing	data	have	been	substituted	with	‘normal’	values,54	108	or	a	single	value	was	imputed.107		In	this	study	missing	data	were	imputed	prior	to	development	of	the	SEPSIS	screening	tool.	
Finally,	this	study	employed	a	large	dataset	which	guards	against	overfitting,	and	has	established	a	baseline	rate	for	high	risk	sepsis	in	UK	ambulance	services.	
10.4	Limitations	of	this	study	It	was	not	possible	to	obtain	all	the	clinical	variables	requested.	Because	some	clinical	 variables	 were	 missing,	 it	 was	 not	 possible	 to	 calculate	 an	 accurate	Sequential	Organ	Failure	Assessment	(SOFA)	score.	The	SOFA	score	 forms	the	basis	of	the	most	recent	international	consensus	definitions	for	sepsis.4	It	was	hoped	that	performance	of	the	SEPSIS	screening	tool	could	be	evaluated	against	the	SOFA	score	in	addition	to	the	NICE	high	risk	of	sepsis	category	to	determine	how	well	it	performs	as	a	diagnostic	aide.	
Sadly,	 there	were	 several	 prolonged	delays	 obtaining	 the	 data	 to	 develop	 the	SEPSIS	 screening	 tool.	 Consequently,	 there	was	 insufficient	 time	 to	 conduct	 a	clinical	validation	study	to	assess	performance	of	the	SEPSIS	screening	tool	in	clinical	 practice	 by	 ambulance	 clinicians.	 It	 remains	 to	 be	 seen	 how	well	 the	SEPSIS	screening	tool	performs	in	clinical	practice.	
Finally,	 the	 data	 used	 in	 this	 study	 derives	 from	 one	 geographic	 area,	consequently	performance	of	the	SEPSIS	screening	tool	may	be	different	in	other	areas	of	the	UK.	That	is,	the	SEPSIS	screening	tool	may	lack	generalisability.	
10.5	Implications	for	practice/policy	If	ambulance	services	are	to	make	a	positive	contribution	to	the	management	of	sepsis	patients	it	 is	vital	that	ambulance	service	clinicians	receive	appropriate	education	 and	 training	 to	 enable	 them	 to	 identify	 septic	 patients,	 and	 that	Emergency	Departments	act	upon	pre-alert	 information	passed	by	ambulance	clinicians.	Optimal	use	of	National	Health	Service	(NHS)	resources	is	dependent	upon	 accurate	 diagnosis	 by	 ambulance	 clinicians;	 over-triage	 by	 ambulance	clinicians	 will	 place	 unnecessary	 burden	 on	 limited	 high	 acuity	 Emergency	
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Department	resources,	whereas	under-triage	risks	acutely	ill	patients	 ‘slipping	through	the	net’,	delaying	time	to	diagnosis	and	potentially	worsening	outcomes	for	these	patients.			It	would	be	beneficial	to	establish	a	mechanism	to	enable	clinical	feedback	from	hospital	 services	 to	 ambulance	 services.	 At	 present	 NHS	 Ambulance	 Trusts	design	 the	 provision	 of	 services	 in	 co-operation	 with	 partner	 agencies,	 but	seldom	receive	feedback	from	hospitals	regarding	how	well	ambulance	clinicians	are	performing	within	these	pathways.	That	is,	data	are	often	available	regarding	the	numbers	of	patients	managed	within	a	pathway	(as	the	ambulance	trust	can	track	these	data	themselves	from	within	their	own	clinical	records).	However,	there	is	little	data	concerning	the	appropriate	use	of	the	pathway.	For	example,	in	the	care	of	stroke	patients,	ambulance	crews	identify	FAST-positive	patients	and	 transport	 them	 to	 hyper	 acute	 stroke	 centres.	 Ambulance	 services	 can	measure	 their	performance	with	respect	 to	 the	numbers	of	patients	managed	using	 these	 pathways,	 documentation	 standards	 for	 patients	 who	 are	 fast	positive	 and	 time	 intervals	 for	 patients	 transported	 under	 these	 pathways.	However,	 ambulance	 crews	 are	 not	 informed	 of	 the	 hospital	 diagnosis.	Ambulance	clinicians	receive	minimal	feedback	concerning	diagnostic	accuracy.	Establishing	 formal	 data	 sharing	 mechanisms	 between	 acute	 Trusts	 and	 the	Ambulance	Services	has	the	potential	to	improve	care	provided	by	ambulance	services	over	a	range	of	conditions,	not	just	for	sepsis	patients.		Ongoing	 monitoring,	 reported	 at	 a	 national	 level,	 designed	 to	 capture	 the	management	 of	 sepsis	 patients	 by	 NHS	 Ambulance	 Services.	 For	 example,	development	of	an	Ambulance	Service	Clinical	Performance	Indicator	for	Sepsis	will	 be	 essential	 to	 ensure	 Ambulance	 Services	 focus	 sufficient	 resources	 to	proactively	manage	this	population.	
	
10.6	Implications	for	further	research	Further	research	will	be	required	to	validate	the	SEPSIS	screening	tool	for	use	by	ambulance	 clinicians.	 It	 is	 essential	 to	 ensure	 that	 ambulance	 clinicians	 can	reliably	 identify	 sepsis	 patients,	 before	 considering	 the	 introduction	 of	 new	treatments	such	as	intravenous	antimicrobial	therapy.			
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There	is	a	paucity	of	evidence	addressing	sepsis	in	UK	Ambulance	Services.	It	is	essential	to	establish	baseline	data	to	determine	the	incidence	and	severity	of	sepsis	patients	managed	by	NHS	Ambulance	Services.	This	knowledge	will	help	inform	the	design	of	education	packages,	the	potential	need	 for	 investment	 in	equipment	 such	 as	 point	 of	 care	 monitoring,	 the	 need	 to	 introduce	 new	treatments	such	as	intravenous	antibiotic	therapy	and	the	design	of	pathways	for	sepsis	patients.		Other	potential	 research	 topics	 include	 the	 impact	 of	 pre-alert	 strategies	 and	sepsis	 pathways	 on	 outcomes.	 The	 evaluation	 of	 point	 of	 care	 monitoring	equipment,	 for	 example;	 would	 the	 introduction	 of	 point	 of	 care	 lactate	monitoring	improve	risk	stratification	and	lead	to	improved	patient	outcomes?	Alternately,	is	there	any	benefit	from	interventions	to	optimise	perfusion,	such	a	fluid	 resuscitation	 and	 inotropic	 support?	 Finally,	 in	 relation	 to	 prehospital	antibiotic	therapy,	are	ambulance	staff	able	to	obtain	sterile	blood	samples	in	the	prehospital	environment?	Does	prehospital	antibiotic	therapy	lead	to	improved	patient	outcomes?		
10.7	Conclusion		This	 thesis	 represents	 a	 four-year	 journey	 of	 learning	 and	 discovery.	 At	 the	outset,	I	hoped	to	develop	a	screening	tool	that	reliably	identified	sepsis	in	the	prehospital	environment.	At	the	conclusion,	I	realise	that	identification	of	sepsis	is	far	more	challenging	than	I	first	anticipated.	In	between,	I	have	learnt	a	great	deal	of	statistics,	developed	as	an	academic	writer	and	have	learnt	to	deal	with	uncertainty.	I	have	evolved.	Considerably.		This	 thesis	extends	 the	body	of	evidence	concerning	sepsis	 in	 the	prehospital	environment.		The	systematic	review	chapter	describes	the	burden	of	sepsis	on	ambulance	services.	It	highlights	that	diagnosis	of	sepsis,	without	reference	to	diagnostic	tests	available	to	in-hospital	practitioners,	 is	extremely	challenging.		Several	prehospital	sepsis	screening	tools	are	available,	none	of	which	is	ideal.		The	main	body	of	the	thesis	describes	the	derivation	and	validation	of	the	SEPSIS	score,	 derived	 from	 UK	 ambulance	 service	 data.	 The	 methods	 employed	 are	robust	 and	 methodologically	 sound.	 	 	 The	 resulting	 SEPSIS	 score	 is	 a	 useful	
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addition	to	the	armament	of	NHS	ambulance	clinicians.	As	the	SEPSIS	score	rises,	so	 too	 does	 the	 probability	 of	 sepsis.	 Utilising	 a	 low	 SEPSIS	 score	 threshold	ensures	high	sensitivity,	and	minimises	the	possibility	of	‘missing’	a	patient	with	sepsis.	 Utilising	 a	 high	 SEPSIS	 score	 threshold	 ensures	 high	 specificity,	 and	minimises	 the	 possibility	 of	 initiating	 inappropriate	 treatments,	 such	 as	antibiotic	therapy.		In	 addition	 to	 describing	 the	 development	 of	 sepsis	 screening,	 this	 thesis	identifies	 the	burden	of	 sepsis	 on	a	UK	ambulance	 service,	 and	 compares	 the	performance	of	 several	 potential	screening	 tools.	This	 information	 is	 likely	 to	prove	 useful	 to	 commissioners	 and	 those	 with	 responsibility	 to	 ensure	 that	appropriate	services	are	provided	to	meet	patient’s	needs.				
PRoSAiC	Thesis	
230	
Appendix	1	Published	papers	
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1.2	Impact	of	prehospital	care	on	outcomes	in	sepsis:	a	
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Appendix	3	Pragmatic	variable	adjustments		
3.1	Adjustments	to	Age	variable		Model	A	(GCS	sum)	
Age Interval	 ßi	 95	low	 95	high	 p-value	
 below	40	 reference		 40-49	 0.13	 -0.56	 0.82	 0.71		 50-59	 0.41	 -0.19	 1.01	 0.18		 60-69	 0.82	 0.31	 1.33	 <0.001		 70-79	 0.94	 0.45	 1.42	 <0.001		 80-89	 0.86	 0.37	 1.36	 <0.001		 90	plus	 1.34	 0.78	 1.89	 <0.001			Model	B	(GCS	verbal)	
Age Interval	 ßi	 95	low	 95	high	 p-value	
 
 below	40	 reference		 40-49	 0.11	 -0.58	 0.81	 0.75		 50-59	 0.40	 -0.20	 1.00	 0.19		 60-69	 0.80	 0.29	 1.31	 <0.001		 70-79	 0.92	 0.43	 1.41	 <0.001		 80-89	 0.84	 0.34	 1.33	 <0.001		 90	plus	 1.31	 0.76	 1.87	 <0.001			Model	C	(AVPU)		
Age Interval	 ßi	 95	low	 95	high	 p-value	
 below	40	 reference		 40-49	 0.15	 -0.54	 0.84	 0.68		 50-59	 0.45	 -0.15	 1.05	 0.14		 60-69	 0.83	 0.31	 1.34	 <0.001		 70-79	 0.96	 0.47	 1.45	 <0.001		 80-89	 0.86	 0.37	 1.36	 <0.001		 90	plus	 1.32	 0.77	 1.88	 <0.001		 	
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3.2	Adjustments	to	Resps	variable		Model	A	(GCS	sum)	
Resps Interval	 ßi	 95	low	 95	high	 p-value	
 below	10	 -12.33	 -579.16	 554.49	 0.97		 10-20	 reference		 21-25	 0.53	 0.20	 0.87	 <0.001		 26-30	 0.89	 0.57	 1.22	 <0.001		 31-35	 1.01	 0.57	 1.44	 <0.001		 36-40	 1.27	 0.90	 1.65	 <0.001		 41-50	 1.66	 1.10	 2.21	 <0.001		 51-60	 1.78	 1.00	 2.56	 <0.001		 60	plus	 -11.57	 -1964.57	 1941.43	 0.99			Model	B	(GCS	verbal)	
Resps Interval	 ßi	 95	low	 95	high	 p-value		 below	10	 -12.47	 -575.63	 550.69	 0.97		 10-20	 reference		 21-25	 0.54	 0.21	 0.87	 <0.001		 26-30	 0.89	 0.56	 1.22	 <0.001		 31-35	 1.01	 0.57	 1.45	 <0.001		 36-40	 1.29	 0.92	 1.66	 <0.001		 41-50	 1.65	 1.10	 2.20	 <0.001		 51-60	 1.75	 0.97	 2.53	 <0.001		 60	plus	 -11.56	 -1966.06	 1942.94	 0.99			Model	C	(AVPU)	
Resps Interval	 ßi	 95	low	 95	high	 p-value		 below	10	 -12.26	 -579.25	 554.74	 0.97		 10-20	 reference		 21-25	 0.55	 0.22	 0.88	 <0.001		 26-30	 0.91	 0.59	 1.24	 <0.001		 31-35	 1.02	 0.58	 1.45	 <0.001		 36-40	 1.31	 0.94	 1.68	 <0.001		 41-50	 1.66	 1.12	 2.20	 <0.001		 51-60	 1.77	 0.99	 2.55	 <0.001		 60	plus	 -11.51	 -1966.16	 1943.13	 0.99				 	
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3.3	Adjustments	to	Pulse	variable		Model	A	(GCS	sum)	
Pulse Interval	 ßi	 95	low	 95	high	 p-value	
 below	60	 -0.57	 -1.42	 0.28	 0.19		 60-100	 reference		 101-110	 0.62	 0.29	 0.94	 <0.001		 111-120	 0.64	 0.30	 0.98	 <0.001		 121-130	 0.96	 0.59	 1.34	 <0.001		 131-140	 0.89	 0.44	 1.33	 <0.001		 141-160	 1.59	 1.16	 2.03	 <0.001		 161-170	 0.46	 -0.75	 1.67	 0.46		 171-180	 0.10	 -2.04	 2.24	 0.93		 180	plus	 1.02	 -0.20	 2.25	 0.10			Model	B		(GCS	verbal)	
Pulse Interval	 ßi	 95	low	 95	high	 p-value	
 below	60	 -0.58	 -1.43	 0.27	 0.18		 60-100	 reference		 101-110	 0.64	 0.31	 0.96	 <0.001		 111-120	 0.65	 0.31	 0.99	 <0.001		 121-130	 0.97	 0.59	 1.34	 <0.001		 131-140	 0.88	 0.44	 1.33	 <0.001		 141-160	 1.59	 1.15	 2.02	 <0.001		 161-170	 0.52	 -0.67	 1.71	 0.39		 171-180	 0.10	 -2.04	 2.24	 0.93		 180	plus	 1.01	 -0.22	 2.24	 0.11			Model	C	(AVPU)	
Pulse Interval	 ßi	 95	low	 95	high	 p-value	
 below	60	 -0.57	 -1.42	 0.27	 0.19		 60-100	 reference		 101-110	 0.62	 0.30	 0.95	 <0.001		 111-120	 0.65	 0.32	 0.99	 <0.001		 121-130	 0.98	 0.61	 1.35	 <0.001		 131-140	 0.91	 0.47	 1.35	 <0.001		 141-160	 1.64	 1.21	 2.07	 <0.001		 161-170	 0.79	 -0.32	 1.90	 0.16		 171-180	 0.15	 -1.99	 2.28	 0.89		 180	plus	 1.07	 -0.14	 2.29	 0.08			
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